Articles of Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences | Volume , Issue suppl.1 / 2015

Search by Journal

HOME
> Search by Journal
> Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences

Volume , Issue suppl.1 / 2015

English Article

Japanese Article

Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.

	For the quarter of century of progress of the clinical pharmacy and future - next - 安原眞人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 2-2, 2015.

	The progress of 1 drug administration technique and future medical care 橋田充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 3-3, 2015.

	For display of the true value of 2 pharmacists 森和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 4-4, 2015.

	The thing which is bought by medical care and us from 3 of this 福井次矢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 5-5, 2015.

	We press a mystery of 4 automatic fuzzy 水島昇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 6-6, 2015.

	5 Standards for Clinical Pharmacy Practice Wafa Y.Dahdal Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 7-7, 2015.

	We think about the way of 6 medical care in economics 井伊雅子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 8-8, 2015.

	Study aiming at a scientific base of the TDM and clinical application expansion 谷川原祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 9-9, 2015.

	Optimization support and the side effect management of the medical treatment that assumed clinical Pharmacometrics a base 猪川和朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 10-10, 2015.

	Study on disease and side effect that paid their attention to a role of MCT 小林正紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 11-11, 2015.

	Qualitative improvement of the cancer medical therapy by discovery, an evaluation, the prophylaxis of the side effect having low recognition of the medical person 菅幸生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 12-12, 2015.

	Drug interactions analysis of the antiepileptic drug for patients with refractory epilepsy 山本吉章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 13-13, 2015.

	Study on intervention effect of the pharmacist to the medical therapy in the intensive care unit 今浦将治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 14-14, 2015.

	Study of the clinical pharmacy for the chemotherapy support to patients with blood-forming organ tumor 宇佐美英績 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 15-15, 2015.

	The coinhibition of EGFR/Met/VEGFR2 overcomes EGFR-TKI tolerance by the HGF of the EGFR mutation lung cancer 中出順也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 16-16, 2015.

	Study on contribution of multidrug resistance-associated protein (MRP) in the extracellular release process of Eicosanoid 古堅彩子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 17-17, 2015.

	About suggestion of the aggressive medical therapy from a pharmacist in pressure sore treatment and the usefulness 溝神文博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 18-18, 2015.

	About the future of the pharmacy education which saw from innovative drug development person upbringing education face chirognomy - of - medicine 大高章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 19-19, 2015.

	Pharmacy education plan supporting producing of "name pharmacist" 賀川義之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2015.

	As need - pharmacy education leader of the integrated education in the pharmacy education from the situation of the patients - 北河修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 20-20, 2015.

	The past, the present, the future of the pharmacy education in Kitasato University 伊藤智夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 21-21, 2015.

	23-1-SP-1 The future that the pharmacist working in the medical field draws : What pharmacists should do in cancer treatment 川上和宜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2015.

	How should there be the development of the field of pharmacy from 23-1-SP-2 this; through the activity in ... area? 手嶋無限1),2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 25-25, 2015.

	Construction of the new evidence by 23-1-SP-3 Pharmacist scientist 松元一明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2015.

	Systems construction and personnel training ... for support - pharmaceutical products proper use, Ikuyaku promotion by the academia to 23-1-SP-4 community medical care, care, health care 堀里子1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 26-26, 2015.

	Contribution and expectation to the low invasive medical treatment, preparation development of the 23-1-SP-5 drug, nucleic acid service technology 高島由季 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2015.

	The recent topic about the pharmacist of 23-1-SP-6 drugstore and the medical institution and future expectation 安川孝志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 27-27, 2015.

	21-10-IS-1 Advancing Direct Patient Care (DPC) Through Postgraduate Pharmacy Residency/Fellowship Program Suphat Subongkot Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2015.

	21-10-IS-2 Characteristic Factors and Prescription Patterns that Affect Regimen Complexity in Parkinson Patients, Using Medication Regimen Complexity Index (MRCI) Score Tool Jae Eun Han, Hyo Sim Back, Yung Hee Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 29-29, 2015.

	21-10-IS-3 The development of evidence-based medicine research capabilities Suodi Zhai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2015.

	21-10-IS-4 Current status and future progress of pharmaceutical care and sciences in Japan Hisakazu Ohtani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 30-30, 2015.

	The general remarks of 21-2-S1-1 diabetic nephropathy 田中元子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2015.

	Pharmaceutical management of patients with 21-2-S1-2 early diabetic nephropathy 西村博之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 32-32, 2015.

	We think about the usage of the oral diabetes therapeutic drug which is effective for patients with 21-2-S1-3 diabetic nephropathy, and is safe 柴田啓智1),2), 田上治美1), 丸山徹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2015.

	How to use insulin to patients with 21-2-S1-4 diabetic nephropathy 堀井剛史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 33-33, 2015.

	How to use diabetes therapeutic drug to 21-2-S1-5 patients on dialysis 平田純生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 34-34, 2015.

	The present conditions and the latest information of the 21-2-S2-1 anti doping 浅川伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2015.

	It is ... from the situation of role ... university teacher of the pharmacist in the 21-2-S2-2 anti doped region 鳴海克哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 36-36, 2015.

	21-2-S2-3 pharmacy student and sports pharmacy 佐塚泰之, 杉山育美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2015.

	About information dispatch for 21-2-S2-4 pharmaceutical products proper use 鳥井真由美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 37-37, 2015.

	It is ... from the situation of the pharmacist belonging to appropriate medical treatment in the 21-2-S2-5 sports domain and role - competition group of pharmacists (Japan Table Tennis Association, International Ping-Pong Federation) 岡田拓朗1), 松尾史朗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2015.

	An anti doping activity and future pharmacist image to send from the 21-2-S2-6 Iwate pharmacist society 本田昭二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 38-38, 2015.

	About the precaution of the study for people from 21-2-S3-1 有吉範高 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2015.

	About benefit reciprocity (COI) at the 21-2-S3-2 article contribution 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 40-40, 2015.

	Let's post it on 21-2-S3-3 official journal of a scientific society "clinical pharmacy" 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2015.

	Do you not post it on 21-2-S3-4 English sentence magazine JPHCS? 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 41-41, 2015.

	Efforts for the 21-2-S3-5 first article contribution 肥田裕丈1), 毛利彰宏2), 野田幸裕1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2015.

	It is a contribution to becoming it and JPHCS English of 21-2-S3-6 results of research 鍛治園誠, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 42-42, 2015.

	The need of the risk and safety measures of the 21-3-S4-1 anticancer medicine exposure 中山季昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2015.

	Because the 21-3-S4-2 anticancer medicine exposure measures think about the whole - environment carried out by a team, and an effect is higher 櫻井美由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 44-44, 2015.

	"The present conditions of exposure measures" judging from the questionnaire for the 21-3-S4-3 anticancer agent exposure measures council pharmacist 小林由佳1),2),3), 中西弘和1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2015.

	A fact and problem of exposure measures of the nurse in the 21-3-S4-4 cancer medical therapy 飯野京子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 45-45, 2015.

	With the exposure measures to recommend in 21-3-S4-5 guidelines? (from the situation of the pharmacist) 野村久祥1), 森田智子1), 日浦寿美子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2015.

	With the exposure measures to recommend in 21-3-S4-6 guidelines? (from the situation of the nurse) 平井和恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 46-46, 2015.

	Because 21-3-S4-7 anticancer medicine exposure measures "utilize joint guidelines" 杉浦伸一1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 47-47, 2015.

	We think about the medical future from the public hospital for a chronic phase for 21-3-S5-1 acute phase 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2015.

	The nourishment management of 21-3-S5-2 elderly people and adequacy of the medical treatment 大井一弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 49-49, 2015.

	Polypharmacy measures in the 21-3-S5-3 chronic phase medical care 小田慎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2015.

	Outcome of the ward drug duties in the 21-3-S5-4 medical treatment ward 棗則明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 50-50, 2015.

	Relation of 21-3-S5-5 end of life care and the pharmacist 久保川直美1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 51-51, 2015.

	The present of the pharmacist system specialized in 21-3-S6-1 medical therapy 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2015.

	Training guidelines for the pharmacist training specialized in 21-3-S6-2 medical therapy and intensive lecture 百瀬泰行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 53-53, 2015.

	Three viewpoints (infection domain) not to overlook 21-3-S6-3 problems 吉田優子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2015.

	For qualitative improvement of the 21-3-S6-4 medical therapy (surgical domain) 山崎美保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 54-54, 2015.

	Point (blood domain) of the mention improvement of the 21-3-S6-5 case summary 鈴木貴明, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2015.

	Expect it of a pharmacist specialized in 21-3-S6-6 medical therapy 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 55-55, 2015.

	The present conditions of the physical assessment education in the 21-9-S7-1 University 大鳥徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2015.

	Development of the virtual physical assessment learning teaching materials for 21-9-S7-2 pharmacy student, pharmacists 徳永仁, 高村徳人, 緒方賢次, 瀬戸口奈央, 佐藤圭創 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 57-57, 2015.

	Skill physical assessment to raise a 21-9-S7-3 hospital pharmacist power 大林恭子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2015.

	Prescription suggestion utilized the physical assessment to practice in cottage-hospital out of 21-9-S7-4 川崎美紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 58-58, 2015.

	Revolution chain ... which a series of 21-9-S7-5 miracles was necessity or chance or ... physical assessment, and occurred 坂井美千子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2015.

	What is the purpose of the physical assessment of the 21-9-S7-6 pharmacist? 狭間研至1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 59-59, 2015.

	With the next step on the basis of the physical assessment that you should work on in the whole 21-9-S7-7 pharmacy 高村徳人, 徳永仁, 緒方賢次, 瀬戸口奈央 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 60-60, 2015.

	Significance to describe test value in ... prescription by team approach in medical care to 21-9-S8-1 outpatient 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2015.

	The efforts which utilizes the clinical test value that we attached to outside Parliament prescription in 21-9-S8-2 Fukui 矢野七恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 62-62, 2015.

	Inflection of "clinical test value" that we thought about pharmaceutical products proper use in the 21-9-S8-3 health insurance pharmacy 松尾陽介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2015.

	The medicine medicine cooperation that utilized FAX for proper use of the 21-9-S8-4 oral anticancer medicine 黒岩勇人, 眞継賢一, 上田綾佳, 倉橋基尚, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 63-63, 2015.

	Inflection of "outside Parliament prescription" improving precision of the 21-9-S8-5 pharmaceutical products proper use 松田雅史, 炭昌樹, 田淵陽平, 佐々木恭子, 星野伸夫, 森田真也, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2015.

	We think about validity of the prescription by utilizing 21-9-S8-6 clinical test value 三宅健文, 日置透子, 國枝亜矢香, 塩見紗和子, 東野公亮, 辻芙美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 64-64, 2015.

	Sedation, sedative management in the 21-9-S9-1 intensive care 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2015.

	Efforts to 21-9-S9-2 postoperative pain management 宮坂善之1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 66-66, 2015.

	Sedative sedation in 21-9-S9-3 cancer treatment, the mild medical domain 岸田悦子1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2015.

	Sedative management judging from 21-9-S9-4 psychiatry medical therapy 中村友喜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 67-67, 2015.

	It is ... from the situation of efforts - nurse of the sedative sedative management in the 21-9-S9-5 childhood cancer domain 木須彩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 68-68, 2015.

	The business training in the pharmacy education model core curriculum that 21-10-S10-1 is new: Purpose explanation 野田幸裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2015.

	Aim of guidelines about the 21-10-S10-2 pharmacy business training 前島一実 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 70-70, 2015.

	For promotion of the business training along guidelines about the 21-10-S10-3 pharmacy business training 鈴木匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2015.

	Efforts of the adjustment mechanism for the business training based on the 21-10-S10-4 new model core curriculum 伊東明彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 71-71, 2015.

	About realization of the cooperation to be able to put of guidelines about the pharmacy business training at the 21-10-S10-5 drugstore 山田純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 72-72, 2015.

	For realization of the new pharmacy business training in the 21-10-S10-6 Hospital 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 72-72, 2015.

	21-10-S11-1 HIV infection to the times of the comprehensive medical care 青木眞 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2015.

	Thing to buy to HIV infection practice and the pharmacist whom the 21-10-S11-2 primary physician thinks about 赤石雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 74-74, 2015.

	From the situation of pharmaceutical care - hospital pharmacist as the generalist for patients with 21-10-S11-3 HIV infection 國本雄介, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2015.

	It is ... from the situation of pharmaceutical care - drugstore pharmacist as the generalist for patients with 21-10-S11-4 HIV infection 田橋美佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 75-75, 2015.

	A viewpoint and skill necessary for intervention to 21-11-S12-1 infection practice 高倉俊二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2015.

	We evaluate the condition of a patient and the renal function of the 21-11-S12-2 CKD patients and think about validity of the antimicrobial proper use 田中麻衣子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 77-77, 2015.

The individual administration plan based on the 21-11-S12-3 antimicrobial standard administration method and the evaluation
小川暁生1),2), 淵上尚彦1),2), 遠藤正憲1),2), 谷田仁司2), 近澤秀己2), 林沼聖子2), 白井直美2), 津田智樹2), 近江弘一郎2), 吉田忍2), 辻本雅之3), 西口工司3), 塚本有子1),2), 高橋良一2), 宮下浩明2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2015.

	Approach to the candidemia that there is simply because it is 21-11-S12-4 pharmacist 眞継賢一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 78-78, 2015.

	Approach to the bacteremia case that resulted in acute renal failure during 21-11-S12-5 cancer chemotherapy 上田覚 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2015.

	Case ... of sepsis in patients with precaution - CKD which is "feeling" in the 21-11-S12-6 antibacterial chemotherapy "kidney" 門村将太 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 79-79, 2015.

	Infection measures in 21-11-S13-1 medical treatment bed and the elderly people institution 足岡秀樹1),2), 石倉優子1),2), 柳原美夏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2015.

	21-11-S13-2 I will not give up at the psychiatric hospital! Infection control: What a pharmacist can do to advance one step ahead 別所千枝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 81-81, 2015.

	Efforts of infection measures in the 21-11-S13-3 health insurance pharmacy 大久保耕嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2015.

	Relation of infection measures and the pharmacist by the 21-11-S13-4 treatment at home 本田泰斗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 82-82, 2015.

	Infection management in the 21-11-S13-5 old age assistance institution 辻明良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 83-83, 2015.

	From the viewpoint of the specialty physician of the antibiotic exposure for the 21-11-S14-1 infection of childhood 宮入烈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2015.

	21-11-S14-2 Infantile infection Be careful with hospitalization care From a pharmacist's point of view 諏訪淳一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 85-85, 2015.

	Human pharmacology of the 21-11-S14-3 cold medicine 田中敏博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2015.

	21-11-S14-4 Infantile infection Be careful with outpatient treatment From a pharmacist's point of view 木村誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 86-86, 2015.

	The latest information of the 21-12-S15-1 health medical care welfare information system industry society 池田和之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 88-88, 2015.

	Point to keep in mind when we use 21-12-S15-2 good use master 岡橋孝待 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 88-88, 2015.

	Efforts based on figure "which should have" prescription mention for the purpose of the 21-12-S15-3 big data utilization 柴崎淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2015.

	Optimization of the injection prescription mention contents in the changes from a 21-12-S15-4 clinical record to an electronic chart 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 89-89, 2015.

	Problem of the quantity of one time of 21-12-S15-5 electronic chart prescription 木下元一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2015.

	Shifts from 21-12-S15-6 electronic chart daily dose prescription input to once quantity prescription input 野村浩子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 90-90, 2015.

	Trend of computerization and the standardization of the 21-12-S15-7 prescription 土屋文人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 91-91, 2015.

	Significance of the present conditions of the psychiatric practice of 21-12-S16-1 Japan and the out reach 伊藤弘人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2015.

	The present conditions and problem of the 21-12-S16-2 Chiba Univ. psychiatry temporary nursing at home 森内加奈恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 93-93, 2015.

	Way - of the cooperation with setup - hospital of the out reach of the 21-12-S16-3 mental hospital pharmacist and other organizations 加藤剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2015.

	Practice report of the out reach by the 21-12-S16-4 psychiatry pharmacist 佐合絵里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 94-94, 2015.

	The present conditions and problem of the medical treatment for 21-12-S17-1 dementia 朝田隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2015.

	The family wants information patients with 21-12-S17-2 dementia; is result ... of ... pharmacist outpatient department 渡邉ゆきの Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 96-96, 2015.

	How do you see through 21-12-S17-3 drug-related delirium? 橋本保彦1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2015.

	Efforts to medical treatment for 21-12-S17-4 BPSD 鈴木弘道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 97-97, 2015.

	About the duties of the pharmacist in the 22-2-S18-1 perioperative care team 落合亮一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2015.

	We think about a strategic theme from the national fact-finding results about patients and pharmacist duties in the operating room for the 22-2-S18-2 perioperative period 舟越亮寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 99-99, 2015.

	Drug duties to join change, a discharge together before 22-2-S18-3 hospitalization for the perioperative period 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2015.

	22-2-S18-4 The needs of the perioperative management team and what to do as a pharmacist : The progress and future of our hospital surgeons 阿部猛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 100-100, 2015.

Significance - of the making of system and the pharmacist intervention of post-operative pain management - Acute Pain Service carried out by 22-2-S18-5 team
長谷川哲也1), 寺田享志2), 大岩彩乃2), 結束さやか2), 落合亮一2), 池田貴之1), 馬渕匠1), 花井雄貴1), 疋田真理1), 小杉隆祥1), 西澤健司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 101-101, 2015.

	How do you obtain up to date - information of the 22-2-S19-1 first aid intensive care? 織田順 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2015.

	22-2-S19-2 Let's learn from case Infusion control of shock 添田博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 103-103, 2015.

	22-2-S19-3 Learn from case : Management of sepsis 今浦将治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 104-104, 2015.

	Expectation to importance and a pharmacist of the many types of job cooperation in the 22-2-S20-1 intensive care domain 氏家良人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2015.

	We think about many types of job cooperation for palliative care promotion in the 22-2-S20-2 circulatory organ intensive care 立野淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 106-106, 2015.

	Role of the pharmacist in the intensive care unit of the 22-2-S20-3 area core hospital 中薗健一, 横山美恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2015.

	Than a viewpoint of 22-2-S20-4 medical care security and the management of the quality the intervention of the pharmacist in the intensive care unit 堀川幸子, 田上治美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 107-107, 2015.

	Crosstalk of many types of job cooperation and the specialty in the 22-2-S20-5 intensive care domain 中馬真幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 108-108, 2015.

	Knowledge of the genome pharmacology necessary for 22-3-S21-1 pharmacist 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2015.

	Individual difference and genetic information in main effect and the side effect of the 22-3-S21-2 medicine 石川和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 110-110, 2015.

	Examination for SNP of the drug reply gene using the 22-3-S21-3 nucleic acid black mark 山下裕樹, 小郷和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2015.

	The dose adjustment of CPT-11 by the 22-3-S21-4 UGT1A1 genetic polymorphism is useful; or attempt - by the pancreatic cancer FOLFIRINOX therapy of - our hospital 小林美沙樹1), 篠原旭1), 入澤愛1), 梅本久美子2), 高橋秀明2), 池田公史2), 齊藤真一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 111-111, 2015.

	Practice example - in search study - urology department of the side effect genome marker aiming at application and the cooperation to 22-3-S21-5 ward drug duties 山本和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2015.

	Example - of genome marker search - serious case drug eruption for the onset evasion of the serious side effect in the 22-3-S21-6 Japanese and the rhabdomyolysis 佐井君江, 中村亮介, 斎藤嘉朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 112-112, 2015.

	From the results of the student questionnaire about the 22-3-S22-1 business training 高橋秀依 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2015.

	Mediation education (from the situation of the organic chemistry) of a 22-3-S22-2 basics pharmacy and the clinical pharmacy 宮田興子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 114-114, 2015.

	Is it a chemical structural formula in the settings of 22-3-S22-3 formulations? ? 柴田奈央1), 浅井考介2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2015.

	The pharmacy basic knowledge that is made use of in treatment with 22-3-S22-4 molecules target anticancer medicine 石川和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 115-115, 2015.

	The present conditions and problem of the 22-3-S22-5 Hospital training 石井伊都子, 大久保正人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 116-116, 2015.

	Efforts ... of the pharmacist specialized in prophylaxis - Shizuoka of the dermatopathy with the 22-3-S23-1 anticancer medicine Prefectural Shizuoka cancer center cancer 石川寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2015.

	Participation in planning of the medical treatment from 22-3-S23-2 pressure sore treatment to the skin domain that developed 森川拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 118-118, 2015.

	Basic information and clinical application to help 22-3-S23-3 drug for external use proper use 松元一明, 木津純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2015.

	Dermatopathy and the prevention with the patch which 22-3-S23-4 dry skin expression brings 大井一弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 119-119, 2015.

	You read, and how do you solve 22-9-S24-1 "case?" Thought process ... which leads to the patients care that fixed its eyes on ... treatment GOAL 蔵田靖子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2015.

	How to get along understanding and Systematic review ... of ... GRADE system knowing 22-9-S24-2 Systematic review 五十嵐俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 121-121, 2015.

	With the practice guidelines that 22-9-S24-3 is reliable? ... thing that we want to know to use it 南郷栄秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2015.

In 22-9-S24-4 settings, how do you make use in patients care? Does problem - pharmacist of the patients with ... practice care whom we saw from circulation utilize the practice that how about practice guidelines and a systematic review? ... ... which finds it, and examines it closely, and acts
伊藤武志, 山添譲
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 122-122, 2015.

	The present conditions and the problem that a pharmacist of the cottage-hospital out of 22-9-S25-1 saw in foreign cancer chemotherapy patients's house in the medical care in remote area 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2015.

	It is a problem of the cottage-hospital in the need of the at-home team approach in medical care in the 22-9-S25-2 cranial nerve disease domain 荒川隆之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 124-124, 2015.

	... which thinks about a breakthrough of the intervention from pharmaceutical management ... case to reduce rehospitalization of the 22-9-S25-3 elderly people heart failure 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2015.

	Because it is at home a required pharmacist 22-9-S25-4; is ... based on an activity as of ... 中村薫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 125-125, 2015.

	Pharmacist ... which we saw from 22-9-S25-5 user-oriented pharmacist - user 黒沢愼五 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2015.

	Let's jump out of the drugstore which an area buys in 22-9-S25-6 now! 加賀田茂子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 126-126, 2015.

	Wish as mother of the 22-10-S26-1 children patient 横幕真紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2015.

	Dosage form of the 22-10-S26-2 pediatrics domain and present conditions - of medication support - clinical practice and the development 石川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 128-128, 2015.

	Research of the 22-10-S26-3 orally disintegrating tablet 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2015.

	Dosage form design for patients with 22-10-S26-4 difficulty in swallowing and dementia with the adherence 原田努 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 129-129, 2015.

	Proper use of the hospital preparation to the 22-10-S26-5 condition of a patient 大谷道輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2015.

	Globalization of the 22-10-S26-6 dosage form and the medication support that is asked for 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 130-130, 2015.

	How are you concerned with an NOAC administration case as 22-10-S27-1 pharmacist? 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2015.

	Role of 22-10-S27-2 warfarin introduction nomogram and the pharmacist 五十嵐正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 132-132, 2015.

	Safe securing of 22-10-S27-3 antiarrhythmic drug by the therapeutic drug monitoring (TDM) in consideration of an internal change 松尾和廣1), 小杉隆祥2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2015.

	Pharmaceutical approach to an atrial fibrillation case in the 22-10-S27-4 first aid intensive care domain 今井徹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 133-133, 2015.

	How is a pharmacist concerned with an atrial fibrillation case in 22-10-S27-5 regular hospital? 細田宏美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2015.

	Pharmaceutical approach for the proarrhythmic effect with the 22-10-S27-6 antiarrhythmic drug 高井靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 134-134, 2015.

	Hospital preparation duties in the hospital attached to the 22-10-S28-1 Nagoya University faculty of medicine 宮崎雅之, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2015.

	The hospital preparation which supports the medical therapy of the 22-10-S28-2 pediatrics domain 石川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 136-136, 2015.

	It is ... based on preparation management of hospital preparation - our hospital supporting the 22-10-S28-3 patients 篠原章能 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2015.

	Evidence-Based Hospital Formulation (EBHF) to send it to from the 22-10-S28-4 University 河野弥生, 花輪剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 137-137, 2015.

	Clinical basic pharmacy-like study approach - by explanation - pharmacist of the 22-11-S29-1 symposium purpose 松尾宏一1), 林稔展2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2015.

	Study on anaphylactic prediction approach with the 22-11-S29-2 anticancer medicine 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 139-139, 2015.

	Approach - from cognitive function with the 22-11-S29-3 anticancer agent administration and mentation change - fundamental researches 北村佳久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2015.

	Practice - of clinical studies by the cooperation with risk factor analysis - pharmacy of the adverse effect expression that utilized 22-11-S29-4 genetic polymorphism information 辻大樹1), 塩川満2), 鈴木賢一3), 伊藤邦彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 140-140, 2015.

	Search of the therapeutic drug for stomatitis induced by 22-11-S29-5 cancer chemotherapy, radiotherapy 渡邉真一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 141-141, 2015.

	Summary - of the authorized examination such as pharmacists specialized in policy and trend - 2014 cancer of the pharmacist authorized examination specialized in 22-11-S30-1 cancer 濱敏弘1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2015.

	A fact and case summary (colon cancer) of the 22-11-S30-2 pharmaceutical intervention 三島江津子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 143-143, 2015.

	A fact and case summary (pancreatic cancer) of the 22-11-S30-3 pharmaceutical intervention 丹田雅明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2015.

	A fact and case summary (lung cancer) of the 22-11-S30-4 pharmaceutical intervention 藤原季美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 144-144, 2015.

	A fact and case summary (leukemia) of the 22-11-S30-5 pharmaceutical intervention 宇佐美英績 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2015.

	A tendency and questions intention of the pharmacist authorized study specialized in 22-11-S30-6 cancer 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 145-145, 2015.

	Background and process of the 22-12-S31-1 immunosuppressive drug TDM standardization guidelines development 谷川原祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2015.

	22-12-S31-2 calcineurin inhibitor: Kidney transplantation domain 竹内裕紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 147-147, 2015.

	22-12-S31-3 calcineurin inhibitor: Liver transplant domain 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2015.

	The present conditions of the TDM of 22-12-S31-4 mycophenolic acid and directionality in the future 内藤隆文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 148-148, 2015.

	22-12-S31-5 Everolimus 本間真人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2015.

	Characteristic of a blood level assay and the each apparatus of the 22-12-S31-6 immunosuppressive drug 三浦昌朋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 149-149, 2015.

	Ethic examination of clinical epidemiologic studies in the 22-12-S32-1 clinical pharmacy 飯嶋久志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2015.

	The present conditions of clinical studies in the 22-12-S32-2 hospital pharmacy 土岐浩介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2015.

	Conduct a pharmacist-led clinical study using 22-12-S32-3 OpenClinica 小茂田昌代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2015.

	The present conditions and problem of the 22-12-S32-4 medicine system ethic examination 東丸貴信 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2015.

	Importance of the 22-12-S32-5 informed consent 山下洋一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2015.

	Expect it of a pharmacist from a summary of the 22-12-S33-1 hematopoietic stem cell transplantation and the situation of the blood physician 齋藤文護 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2015.

	Expect it of a role and the pharmacist of the nurse in the 22-12-S33-2 hematopoietic stem cell transplantation 守屋佳美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2015.

	Role of the pharmacist in the 22-12-S33-3 hematopoietic stem cell transplantation team 内田ゆみ子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2015.

	Construction and development ... of ward drug duties in medical treatment support - University of Tokyo Hospital by the pharmacist in the 22-12-S33-4 hematopoietic stem cell transplantation treatment 折山豊仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2015.

	It is ... from practice by pharmacist duties - clinical practice of the hematopoietic stem cell transplantation in the 22-12-S33-5 Kunitachi cancer research center center Hospital to education, a study 小井土啓一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2015.

	We regard dose correlation as teratogenicity of 23-2-S34-1 fluconazole 山根律子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2015.

	We regard dose correlation as teratogenicity of the 23-2-S34-2 methotrexate 中島研 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 159-159, 2015.

	We regard dose correlation as the teratogenicity of the 23-2-S34-3 antiepileptic drug 刈込博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2015.

	We regard dose correlation as effect on nerve development of the 23-2-S34-4 sodium valproate 小西久美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 160-160, 2015.

	From the situation of the 23-2-S35-1 university hospital: Practice of the team approach in medical care in the outpatient 矢野育子1),2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2015.

	From the situation of the 23-2-S35-2 medical office mainly on - outpatient department chemotherapy - 宮本康敬 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2015.

	Way of thinking that the medical treatment in the treatment at home is necessary from the situation of the 23-2-S35-3 opening of an office pharmacist 大木一正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2015.

	Essential function of the pharmacist by the 23-2-S35-4 patients information sharing 今井博久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2015.

	The present conditions and problems of the Chinese medicine education in the 23-3-S36-1 medical education 間宮敬子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2015.

	The present conditions and problems of the Chinese medicine education in the 23-3-S36-2 pharmacy education 伊藤美千穂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2015.

	A fact and problems of the Chinese medicine utilization in the 23-3-S36-3 ward 川添和義 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2015.

	Expect it of a problem and a pharmacist of the 23-3-S37-1 inhalation therapy 福井基成 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2015.

	It is ... from the situation of attempt - hospital pharmacist of the 23-3-S37-2 inhalation instruction network 三井克巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2015.

	Role of the drugstore pharmacist in regional alliances of the 23-3-S37-3 inhalational instruction 金子雅好1),2), 古川晴浩2), 稲葉眞也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2015.

	Attempt of the 23-3-S37-4 multicenter interval inhalational instruction unification 山下悠希 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 169-169, 2015.

	Efforts as the 23-3-S37-5 area pharmacist society 上田憲司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2015.

	From 23-3-S37-6 inside the hospital to inhalation therapy to support by illness medicine cooperation 嶋津史恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 170-170, 2015.

	Through step of practice - Oita hospital pharmacist society infusion of nutrient workshop Committee of the collaboration medical care to snuggle up to the 23-9-S38-1 patients - 北英士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2015.

	It is ... with the optimal nourishment management after clinical nutrition - operation on the heart taught by the 23-9-S38-2 patients 井上真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2015.

	For an offer and cooperation of the nourishment management that is better than 23-9-S38-3 role - of the pharmacist in - clinical nutrition 藤谷竜磨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2015.

	- that Hospitality - I whom 23-9-S38-4 pharmacist should have entrust a pharmacist to here 鶴知光1),4), 長嶋フクヱ2),4), 小野沙織2),4), 黨久瑠美2),4), 岩屋祐子3),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2015.

	23-9-S38-5 clinical nutrition and team approach in medical care, role of the pharmacist 丸山道生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2015.

	With the physical assessment to be able to make use of in 23-9-S39-1 nutrition therapy? (prologue) 増田修三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2015.

	The need of the physical assessment in the 23-9-S39-2 at-home nutrition therapy 杉浦伸一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2015.

	Physical assessment about the elderly people dehydration in the 23-9-S39-3 treatment at home 齊藤直裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2015.

	Physical assessment in the nourishment management of the 23-9-S39-4 chronic phase patients 井上俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2015.

	Physical assessment in the nourishment management that we saw from the pharmacist of the hospital for 23-9-S39-5 acute phase 小園幸輝1),2), 西澤健司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2015.

	The physical assessment that we saw from the nurse of the hospital for 23-9-S39-6 acute phase 朝倉之基 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2015.

	Physical assessment in the nourishment management that we saw from the physician of the hospital for 23-9-S39-7 acute phase 鷲澤尚宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2015.

	Physical assessment epilog (unification) in the 23-9-S39-8 nutrition therapy 林宏行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2015.

	Problem of the community medical care network where 23-10-S40-1 pharmacist participates in 小枝伸行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2015.

	Relation of the present conditions and the pharmacist of the 23-10-S40-2 Miyagi medical care welfare information network council 中村浩規1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2015.

	Relation of the pharmacist in the 23-10-S40-3 hydrangea net 七種均1), 天本耕一郎2), 神近竜二3), 山口健太郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2015.

	The electronic proof business of the prescription in the medical care net which we go to 23-10-S40-4, and it is impossible to do and the future prospects 田能村祐一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2015.

	23-10-S40-5 Expectation for pharmacists in Fujinokuni virtual mega hospital (Fujinokuni net) 森典子1), 角入壽彦2), 鈴木貴也2), 木村緑2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2015.

	Thing - present conditions and problem ... which 23-10-S41-1 area inclusion care system aims at 片岡佳和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2015.

	The present conditions and problem of the pharmaceutical management by a drugstore, the pharmacist in the 23-10-S41-2 area inclusion care system and the at-home medication support 坂巻弘之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2015.

	23-10-S41-3 What you expect from your family pharmacy, pharmacist : Report from the field 井益雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2015.

	It is the participation in planning of a drugstore, the pharmacist to making it the town where old age is reached in peace in 23-10-S41-4 area 山浦知之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2015.

	Efforts - of the exploring - Yamato Ayase pharmacist society of 23-10-S41-5 settings 加藤久幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2015.

	Approach to the decreased renal function patients in the scale hospital out of 23-11-S42-1 佐古守人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2015.

	"Continuous" pharmaceutical management - young intervention ... in patients with 23-11-S42-2 renal failure 吉田拓弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2015.

	23-11-S42-3 nothing? What would you do? Treatment with anticancer agent at impaired renal function 小井土啓一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2015.

	Strategy ... to patients with antimicrobial doses setting - serious case in the 23-11-S42-4 acute renal failure 前田幹広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2015.

	Extension of the 23-12-S43-1 antibody pharmaceutical products development: Expectation and problem in cancer treatment 石井明子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2015.

	23-12-S43-2 Antibody engineering for cancer immunotherapy 井川智之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2015.

	Process made by 23-12-S43-3 new immune checkpoint inhibitor antiPD-1 antibody nivolumab - wound and future development ... 吉田隆雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2015.

	The present conditions and problem of the antibody pharmaceutical products in the 23-12-S43-4 healthcare setting 花輪剛久1), 河野弥生1), 河田圭司2), 手塚春樹2), 鈴木正彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2015.

	An allergic reaction with 23-12-S43-5 antibody medicine: Individualization prophylactic possibility 岩本卓也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2015.

	Usefulness of the Teiko plastic Nin high dose loading dose in the 21-4-O1-01 decreased renal function patients 植田貴史1), 竹末芳生1), 中嶋一彦1), 一木薫1), 土井田明弘1), 和田恭直1), 高橋佳子2), 石原美佳2), 木村健2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2015.

	Association with clinical response - MIC of Teiko plastic Nin in the 21-4-O1-02 MRSA bacteremia 鏡圭介1), 山田武宏1),2), 今井俊吾1),2), 福元達也2), 石黒信久2), 井関健1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2015.

	Analysis of the convalescence-related factor by the clinical and molecular epidemiologic approach in the 21-4-O1-03 MRSA bacteremia 前田真之1), 小司久志2), 白倉哲郎3), 詫間隆博2), 宇賀神和久4), 福地邦彦5), 石野敬子1), 二木芳人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2015.

Improvement of the clinical response of the blood culture-positive case with the surveillance system of all 21-4-O1-04 injectable antimicrobial
丹羽隆1),2), 渡邉珠代2), 後藤貴之1), 太田浩敏2), 中山麻美2), 鈴木景子1), 土屋麻由美2), 安田浩二1), 村上啓雄2), 伊藤善規1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2015.

	Examination of blood level in the 21-4-O1-05 fosphenytoin chronic administration and the optimal dose 大野雄太1), 平井啓太2), 丹羽隆1), 鈴木景子1), 大畑紘一1), 大竹真梨花1), 廣瀬智恵美1), 鈴木昭夫1), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2015.

In the transplacental antiarrhythmic drug (digoxin, sotalol) administration for the 21-4-O2-06 fetuses tachyarrhythmia is pharmacodynamic; about pharmacokinetic approach
小竹武1), 玄番瑛子1), 井上知美1), 石渡俊二1), 桑原健2), 和田恭一2), 橋詰宏美2), 三好剛一3), 桂木真司4), 左合治彦5), 前野泰樹6), 池田智明7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2015.

	The development of the dexmedetomidine concentrations assay in out of the 21-4-O2-07 human plasma and mother's milk and the clinical application 中西里佳1), 須野学1),2), 伊藤雄大1), 国沢卓之3), 吉村学4), 青木和葉1), 黒澤温3), 菅原亜美3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2015.

	Blood transitional quantitative evaluation of the chloramphenicol vaginal tablet in the pregnant woman of the 21-4-O2-08 bacterial vaginosis 原内智慧1), 大澤隆志1), 久保野尚子1), 内藤隆文1), 伊東宏晃2), 金山尚裕2), 川上純一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2015.

	1 case that blood level monitoring of the nilotinib was useful in 21-4-O2-09 chronic myelogenous leukemia treatment 炭本隆宏1), 中原良介1), 藤岡孝志1), 田中遼大1), 佐藤雄己1), 緒方正男2), 伊東弘樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2015.

	Effect of blood tacrolimus levels on antiHLA antigens expression of 21-4-O2-10 kidney transplantation one year 藤山信弘1),2),3), 奥山慎1), 斎藤満2), 井上高光2), 新岡丈典3), 加賀谷英彰3), 三浦昌朋3), 羽渕友則2), 佐藤滋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2015.

	Obese effect to have an influence on the internal change of 21-4-O3-11 5-FU 児玉亮二1), 春名真理子1), 河渕真治1), 伊藤由佳子1), 田村孝雄2), 栄田敏之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2015.

	Development of the new cultured cell system for expression, a function of alien substance discharge pump P-gp in the 21-4-O3-12 alveolar epithelium and the analysis 西本沙央里1), 佐々木佳寛2), 仲亮輔1), 青木彩子2), 湯元良子2), 高野幹久2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2015.

	Transitional comparison between 21-4-O3-13 antiMRSA medicine vancomycin and linezolid to cells intercellular fluid 宇野智哉1), 稲垣勇斗1), 佐々木健二1), 河渕真治1), 伊藤由佳子1), 高田寛治2), 栄田敏之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2015.

Inspection of the effect that the protein-binding rate of the drug using the 21-4-O3-14 haemodialysis model rat gives to dialysability
福永雅樹1), 門脇大介1), 成田勇樹1), 田中遼大2), 渡邊博志1), 山崎啓之3), 田口和明3), 伊東弘樹2), 丸山徹1), 小田切優樹3), 平田純生1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2015.

Establishment of simple and easy plasma piperacillin concentrations assay using the 21-4-O3-15 HPLC
三谷健人1), 曽田翠1), 宮原有里1), 片桐七海1), 鈴木昭夫2), 小林亮2), 丹羽隆2), 鈴木景子2), 吉田省造3), 小倉真治3), 伊藤善規2), 北市清幸1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2015.

	Population kinetic analysis of mizoribine in consideration of individual difference of the 21-4-O4-16 bioavailability 坂井友里絵, 深尾美紀, 橋本征也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2015.

The effect that accumulation of 21-4-O4-17 CYP3A5 genetic polymorphism and the indoxyl sulfate gives for recovery of the CYP3A activity after the living renal transplantation
村谷菜々子1), 鈴木陽介1), 藤岡孝志1), 佐藤文憲2), 松本邦洋3), 田中遼大1), 佐藤雄己1), 大野恵子3), 三股浩光2), 岸野吏志3), 伊東弘樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2015.

One patient who measured valproic acid levels out of the 21-4-O4-18 mother's milk, and examined safety in the colostrum
乾有希子1),2),3),4),5),6), 池田久雄1), 平田貴宏1), 宮麻紀子1), 大西秀美1), 六車裕一1), 松元麻美1), 江川功3), 尾上昌世2), 佐伯典厚2), 中西康詞4), 赤木幹弘4), 中野博明5), 安田穣6), 野村浩英1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2015.

	Theoretical consideration about the advisability of the administration to a nursing mother of the 21-4-O4-19 Laninamivir 大久保正1), 田中真理子2), 大久保七枝3), 大久保節子4), 阿部慧5), 大久保美穂5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2015.

One case of the children who used bosentan together with tacrolimus while conducting the blood level measurement for pulmonary hypertension due to the interstitial pneumonia after the 21-4-O4-20 peripheral blood stem cell transplantation
神山直也1),2), 杉本昌也3), 畠山直樹3), 谷香苗1), 福土将秀1), 東寛3), 田崎嘉一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2015.

Examination about the incompatibility of meropenem parenteral injection and the amino acid preparation under the administration condition of the 21-5-O5-01 NICU
若杉陽子, 村岡香代子, 石田茂, 富松裕美, 山田孝明, 池末裕明, 渡邊裕之, 江頭伸昭, 増田智先
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2015.

Usefulness of the pharmacist intervention for the treatment using the 21-5-O5-02 antiMRSA medicine: A clinical response by medical treatment management and the many types of job intervention based on the protocol and medical economic effect
岡田直人1), 伏谷秀治1),2), 東桃代2), 中村敏己1), 寺岡和彦1), 川添和義1),3), 石澤啓介1),3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2015.

	Intervention to polypharmacy using STOPP criteria version 2 by the 21-5-O5-03 pharmacist 木村丈司, 小倉史愛, 澤田有記美, 宇田篤史, 赤澤由子, 野間千尋, 野崎晃, 山本和宏, 五百蔵武士, 西岡達也, 久米学, 槇本博雄, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2015.

	Improvement of the stress ulcer protective efficacy by the practice of the medical treatment management based on 21-5-O5-04 protocol 池村舞1),2), 中浴伸二2), 藤原秀敏2), 土肥麻貴子2), 瀬尾龍太郎3), 渥美生弘3), 有吉孝一3), 橋田亨2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2015.

	Examination of the effect that the change of prescription by the 21-5-O5-05 ward pharmacist gives 加藤隆寛, 岩澤瞳, 甚目陽子, 築山郁人, 松浦克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2015.

	Examination of the liver damage onset risk in the antiphthisic drug multidrug therapy using the 21-5-O6-06 adverse event spontaneous report database 河合加奈, 小川喜寛, 頭金正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2015.

Analysis of the taste disturbance with the multiple myeloma therapeutic drug administration using the 21-5-O6-07 FDA size scale adverse event spontaneous report database
井野場郁乃1), 角山香織1), 南景子1),2), 多門啓子3), 津田真弘1), 栄田敏之1),4), 奥野恭史5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2015.

	The examination of the risk factor about the dermatopathy of the 21-5-O6-08 lamotrigine and investigation of the expression time 傍示幸1), 祖川倫太郎1), 持永早季子1), 島ノ江千里2), 田崎正信1), 原英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2015.

Effect of the fluid intake recommendation to give to the adverse event of the allergy-like symptom with 21-5-O6-09 nonionic agent characteristics iodine contrast media
鋒山香苗1), 元井玲子1), 矢野育子1), 尾崎淳子1), 山本崇2), 深津祥央1), 石塚良子1), 松村由美2), 谷口正洋3), 東村享治3), 松原和夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2015.

	The actual situation and evaluation of the drug-related fall in the pay nursing home with the 21-5-O6-10 care 朴恵林1), 三木晶子1), 佐藤宏樹1), 漆原尚巳2), 澤田康文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2015.

	Investigation about the malnourished situation by the combination of 21-5-O7-11 cancer cachexia staging and GPS evaluation 辻本貴江1), 渡邊亜紀穂1), 入江慶2), 岡田裕2), 片上信之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2015.

It is usefulness of the fat-containing nutrient preparation in the early stage after 21-5-O7-12 cancer of the esophagus technique
佐藤佑一朗1), 早坂州生1), 平田力1), 竹内公美1), 小川聖子2), 北原裕子3), 川島有美子3), 吉川智宏4), 高橋宏明5), 細川正夫4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2015.

	About examination and the actions to be taken of the cause of the low Na blood symptom in the 21-5-O7-13 nutrient for intestinal administration 中川義浩1),2), 横田千明1), 水町純一1), 桑原貴美子1), 藤野祥1), 山形真一1), 幸邦憲1), 小園亜希2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2015.

Evaluation ... of the rehospitalization of patients with 21-5-O7-14 heart failure and effect on nourishment of investigation - drug about medication, the nourishment and the pharmaceutical intervention
高井靖1), 前田雄太郎1), 木本珠美1), 伊藤涼子1), 梶間勇樹1), 鈴木啓之2), 宮原眞敏2), 西川英郎2), 大井一弥3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2015.

	Role of the pharmacist in the 21-5-O7-15 childhood cancer nourishment project team 甲斐維子1), 熊坂治1), 和田碧2), 後藤裕明3), 高増哲也4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2015.

	21-5-O8-16 Examination of moisturizing effect by white petrolatum sodium bicarbonate of Hirudoid(R) Soft Ointment 眞部遥香, 野澤茜, 松元美香, 大谷道輝, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2015.

Attempt of the interactive type drug instruction for the construction of the understanding degree visualization in the epoprostenol continuous intravenous infusion therapy for patients with 21-5-O8-17 pulmonary hypertension
高橋智子1),3), 杉本浩一2),3), 義久精臣2),3), 中里和彦2),3), 竹石恭知2),3), 赤羽沙織3), 渡部ますい3), 尾形浩2),3), 鳥羽衛3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2015.

Effect to give to an extension of the EPA preparation on patients with 21-5-O8-18 heart failure
上田浩貴1), 山本真里江2), 辰見明俊2), 上田綾佳1), 丹生亜希子1), 小正晃裕3), 芝本恵3), 永井崇博3), 浅田聡3), 多田英司3), 巣山環3), 濱口常男2), 石井克尚3), 濱口良彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2015.

	Role of a summary and the pharmacist of the rheumatoid arthritis medical treatment with the 21-5-O8-19 biological drug 大原雄希, 遠藤千夏, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2015.

	Stability of the principal ingredient in the application to the simple suspension method of the 21-5-O8-20 tram set (R) combination lock 高岡昌司1), 津郷佑規2), 中村承平2), 坂本宜俊2), 田頭尚士1), 二五田基文1), 湯淺宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2015.

	Efforts (the first report) to off-label use management in the 21-6-O9-01 Tokyo Women's Medical University Hospital 高橋麻利子, 高橋結花, 大石智春, 渋谷陽子, 高橋賢成, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2015.

Problem - pharmacist to 21-6-O9-02 securing of pharmaceutical products safety in the medical environment to change dynamically is ... from incident analysis to be concerned with
松川周平1),2),3), 藤本勝博1), 古角幸太1), 山上聡子1), 安田宗一郎1),2), 田中宏明3), 門脇裕子1), 中島和江3), 三輪芳弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2015.

	Effect of the part of doubt inquiry unnecessary protocol in the 21-6-O9-03 outside Parliament prescription 安達昂一郎, 櫻井香織, 尾崎淳子, 木村嘉彦, 松村勝之, 西脇布貴, 萱野勇一郎, 深津祥央, 矢野育子, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2015.

Simulation education - Simulation training for Clinical Pharmacist - in the 21-6-O9-04 clinical pharmacist
大澤晋1), 小川敦2), 白石奈緒子2),4), 山地民恵2), 日野隼人2), 武本あかね2), 西宮祐輔2), 川島理恵子2), 蔵田靖子2), 勝部理早2), 大川恭昌2), 川崎元弘5), 福永桂子5), 名和秀起2), 錦織淳美2), 万代康弘3), 北村佳久2), 佐野俊二1), 千堂年昭2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2015.

	Construction and evaluation ... of the business training program for upbringing (the fifth report) - EBM practice method acquisition of the pharmacist carrying the 21-6-O9-05 next generation 江角悟, 河崎陽一, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2015.

Multicenter questionary survey about the job satisfaction of the 21-6-O10-06 hospital pharmacist
植木哲也1),11), 橋口靖1), 村本眞由美2), 竹本伸輔3), 金澤康範3), 山澤理恵子4), 浅原稔生5), 溝口玄一郎6), 川崎美紀7), 小田桂子8), 中嶋弥穂子9), 城戸宏史10), 中嶋幹郎11)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2015.

The effect that 21-6-O10-07 thickness adjustment food gives to the collapse of the fast disintegration tablet of the nonprescription drug
後藤英和1), 富田隆1), 住谷賢治2), 中西利恵1), 小島千賀子1), 米島美穂子1), 吉田正3), 田中勝也4), 幸田幸直1),5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2015.

Effect of CYP3A5 giving it to drug interactions with tacrolimus and itraconazole in patients with 21-6-O10-08 collagenosis and the ABCB1 genetic polymorphism
新岡丈典1), 富樫賢2), 小松田敦2), 奈良瑞穂2), 奥山慎3), 面川歩4), 鐙屋舞子1), 涌井秀樹5), 高橋直人2), 三浦昌朋1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2015.

	Construction and evaluation of the examination for 21-6-O10-09 pharmacogenomics system 赤羽理也1), 野田哲史1), 磯野哲一郎1), 池田義人1), 平大樹1), 森田真也1), 堀江稔2), 寺田智祐1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2015.

	Elucidation of the factor having an influence on the internal change of mycophenolic acid before and after the 21-6-O10-10 kidney transplantation 加賀谷英彰1), 新岡丈典1), 齋藤満2), 沼倉一幸2), 羽渕友則2), 佐藤滋3), 三浦昌朋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2015.

Examination by the difference of the evaluation method of associated ... meta-analysis of treatment response and the genetic polymorphism of the methotrexate in patients with 21-6-O11-11 rheumatoid arthritis
袴田潤1), 橋口正行1), 清水美貴子2), 丸山順也1), 望月眞弓1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2015.

Association with the stomatitis onset and the MDR1 genetic polymorphism by the 21-6-O11-12 Everolimus
渡邉愛未1),2), 山本和宏2), 四宮一昭3), 平田佐智2), 石村武志4), 横山直己4), 三宅秀明4), 藤澤正人4), 中川勉1),2), 平野剛5), 平井みどり1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2015.

Establishment of CYP3A5 genetic polymorphism diagnostic method aiming at 21-6-O11-13 clinical application and the screening of the drug that CYP3A5 is associated with metabolism
松本准1), 岸隆斗1), 鬼頭佑太朗1), 佐藤輝1), 竹沢麻奈未1), 杉山奈津子1), 廣澤伊織1), 加藤芳徳1), 福田八寿絵1), 前澤佳代子1), 百瀬泰行1), 中村裕義1),2), 山田治美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2015.

Analysis of the individual difference factor of the onset of postoperative pain in fentanyl treated patients in the 21-6-O11-14 technique and nausea
八木達也1), 加藤弘美2),3), 田中紀章1), 石田卓矢1), 平野公美1), 加藤孝澄2),3), 佐藤重仁2),3), 内藤隆文1), 川上純一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2015.

	Examination about the Daclatasvir / Asunaprevir combination therapy in the 21-6-O11-15 true clinical practice 中村淳二, 永島貴裕, 市原航, 福井宗憲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2015.

Significance of the PNPLA3 mutation in the gene in the non-pycnic type for the 21-6-O12-16 non-alcoholic fat-related liver disease prevention
鬼木健太郎1), 武藤奈瑠美1), 守田和憲1), 居塚智子1), 梶原彩文1), 坂田美咲1), 北愛矢菜1), 熊谷直樹1), 大竹宏治2), 緒方康博2), 中川和子1),3), 猿渡淳二1),3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2015.

See the rear in patients with side effect expression investigation - UGT1A1 genetic polymorphism analysis of the FOLFIRINOX therapy for the 21-6-O12-17 pancreatic cancer impossible of excision; mark examination ...
南晴奈1), 田島壮一郎1), 川尻雄大1), 石田茂1), 中島貴史1), 秦晃二郎1), 池末裕明1), 渡邊裕之1), 江頭伸昭1), 増田智先1), 李倫學2), 伊藤鉄英2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2015.

	Effect of ABC to give it to 21-6-O12-18 cisplatin-induced impaired renal function and the SLC transporter genetic polymorphism 藤田一馬1), 本山悟2), 新岡丈典1), 三浦昌朋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2015.

	Effect of a drug transporter and the drug metabolizing enzyme genetic polymorphism on 21-6-O12-19 Clozapine body change 赤嶺由美子1), 菊池結花2), 新岡丈典1), 古郡規雄3), 宇野司4), 清水徹男2), 三浦昌朋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2015.

Effect to give a serum lipid level of genetic polymorphism and the ezetimibe of small intestine cholesterol transporter NPC1L1 in patients with dyslipidemia of the 21-6-O12-20 Japanese
柏原由佳1), 小林靖奈2), 木庭新治3), 神山紀子2), 大林真幸2), 小林洋一3), 山元俊憲2), 佐々木忠徳1),4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2015.

A multicenter retrospective study about the proteinuria protective efficacy of the inhibitor of Renin-Angiotensin for patients with 21-7-O13-01 Bevacizumab administration non-small cell lung cancer origin: NJLCG1303
岡田浩司1), 二瓶哲2), 久山彰一3), 鈴木俊郎4), 斎藤佳敬5), 木皿重樹6), 原田敏之7), 横田敦子8), 土屋雅美9), 照井一史10), 田所佑実子11), 佐藤淳也2), 守義明1), 森川直人2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2015.

	We look at the rear about eye disorders with 21-7-O13-02 oxaliplatin and examine a mark 野口裕介, 川島悠吾, 瓦比呂子, 徳山洋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2015.

	The zoledronic acid-induced nephropathic risk factor analysis that paid its attention to the physicochemical characteristic of the HMG-CoA reductase inhibitor in patients with 21-7-O13-03 cancer 大畠俊一, 池末裕明, 秦晃二郎, 渡邊裕之, 江頭伸昭, 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2015.

	Examination of the immune-mediated adverse effect in the nivolumab treatment for the 21-7-O13-04 malignant melanoma 山本将太1), 長谷川真理1), 吉良俊彦1), 池見泰明1), 大村友博1), 矢野育子1), 藤澤章弘2), 椛島健治2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2015.

	Effect of the CYP3A4 inhibitor combination to give to an onset of febrile neutropenia risk by the 21-7-O13-05 docetaxel 槙原克也1),2), 東さやか2), 上野裕之2), 中多泉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2015.

Prophylaxis of butylscopolamine for the dysarthria with the 21-7-O14-06 FOLFIRINOX therapy
小林大祐1), 大坪達弥1), 荻野仁未1), 福田喬士1), 加藤良隆1), 白川敦史2), 河端秀明2), 柿原直樹3), 山口明浩3), 野田能成1), 友金幹視1), 藤田敦夫1), 三上正1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2015.

Multicenter observational, prospective study of retching vomiting in the 21-7-O14-07 slightness emetic risk cancer chemotherapy
鳥山陽子1), 三原由記2), 石橋由佳3), 塩田喜美子4), 上田和明5), 下澤那津6), 丸田基史7), 渡辺健二8), 川俣洋生9), 後藤隆10), 鶴崎泰史8), 小薮真紀子11), 下川元継12), 林稔展3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2015.

	Examination of the risk factor of retching, vomiting in the 21-7-O14-08 elderly people lung cancer Carboplatin combination therapy 市川和哉1), 森瀬昌宏2), 宮崎雅之1), 亀島理沙1), 長谷哲成2), 近藤征史2), 長谷川好規2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2015.

Palonosetron, aprepitant for the prevention of retching, vomiting with the 21-7-O14-09 cisplatin day after day administration, open-label non-control phase II study of the dexamethasone
五百蔵武士1), 久米学1), 平田佐智1), 打保裕子1), 古川順也2), 三宅秀明2), 西岡達也1), 槇本博雄1), 藤澤正人2), 平井みどり1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2015.

	The effectiveness of the aprepitant administration extension in 21-7-O14-10 FP therapy and the BEP therapy and the cost effectiveness analysis 加藤優1), 大野雄太2), 小林亮2), 飯原大稔2), 鈴木昭夫2), 林秀樹1), 杉山正1), 伊藤善規2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2015.

Investigation about the antiemesis therapy of the Doxorubicin, Ifosfamide combination therapy for 21-7-O15-11 malignancy soft part tumor
佐野智望1), 小林英介2), 遠藤誠2), 丹澤義一2), 中谷文彦2), 川井章2), 橋本浩伸1), 大塚知信1), 中馬広一2), 林憲一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2015.

Phase II clinical trial of the olanzapine + palonosetron + dexamethasone combination antiemesis therapy for retching, vomiting by the 21-7-O15-12 cisplatin
前田章光1), 宇良敬2), 堀尾芳嗣3), 尾瀬功4), 梶田正樹1), 長谷川郁恵1), 平島佳代1), 高橋新次1), 長谷川彩子1), 栗原幸司1), 伊藤裕子1), 下村一景1), 伊藤基博1), 岩田修一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2015.

Examination of the 5HT3 blocker for the malignant lymphoma regimen including the 21-7-O15-13 high dose steroid
中川隼一1), 岡田悠美1), 桝茂典1), 上村苑子1), 伊藤あゆみ1), 生井加奈1), 伊沢景子1), 高橋真一1), 土橋史明2), 塩田祐子2), 大場理恵2), 蔭山博之1), 村上敏明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2015.

	It is ... for further progress of the anorectic expression situation investigation - antiemesis therapy with the 21-7-O15-14 cancer chemotherapy 杉山弘樹1),2), 嘉屋道裕1), 望月亜希子1), 原田晴司2), 木村緑1), 角入壽彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2015.

Usefulness - multicenter study - of aprepitant in the 21-7-O15-15 CHOP therapy
江尻将之1), 宮崎雅之2), 佐藤由美子2), 町支優和2), 大島有美子2), 小山佐知子2), 荒川裕貴2), 近藤有2), 佐々木英雄2), 壁谷めぐみ2), 間瀬広樹2), 横山聡2), 築山郁人1),2), 久田達也2), 板倉由縁2), 勝見章男3), 松浦克彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2015.

Comparison about the expression of chemotherapy-induced retching vomiting (CINV) time in the NK1 receptor blocker using the 21-7-O16-16 tendency score
古野龍也1), 傍示幸1), 持永早希子1), 與田幸恵2), 鈴木久美子3), 上田純二2),3), 柏田知美3), 荒金尚子1),3), 田崎正信1), 木村晋也3), 原英夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2015.

	Comparison between palonosetron and effectiveness of the ramosetron at aprepitant combination for the five days cisplatin regimen of patients with 21-7-O16-17 testicular tumors 高田慎也, 玉木慎也, 遠藤雅之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2015.

	An investigation of the stomatitis onset to be caused by according to the 21-7-O16-18 cytarabine administration method and measures of the risk factor 藤田真一1), 太田一郎2), 小池博文2), 西川能治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2015.

	Effect on effectiveness and neutrophils of the Hangeshashinto for oral mucositis with the 21-7-O16-19 hematopoietic stem cell transplantation 佐野尚平1), 嶋本めぐみ1), 西村知恭1), 園部比呂志1), 岩城久弥1), 花岡伸佳2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2015.

	The present conditions and problem of HBV reactivation measures for patients receiving 21-7-O16-20 rituximab 土手賢史1), 古田祐美子1), 土井章一2), 野崎歩1), 小林由佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2015.

	Optimal preparation environment of the dacarbazine parenteral injection which assumed 21-8-O17-01 photodegradation article levels an index and conditional examination 田代将貴, 内藤隆文, 山本千琴, 加藤真也, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2015.

	Examination for the proper use of 21-8-O17-02 BD PhaSeal TM protector P55 内田任仁弘1), 矢ヶ部良太1), 竹内耕治1), 細矢和久1), 持永早希子1), 田崎正信1), 原英夫1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2015.

Preparation precision criteria of the 21-8-O17-03 full automation type anticancer medicine preparation support equipment
三嶋一登1), 入佐俊弘1), 秦晃二郎1), 渡邊裕之1), 首藤洋幸2), 海藤壽彦2), 関口重夫2), 田坂茂二3), 村上宏彰3), 野村正行3), 大野誠樹3), 増田智先1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2015.

	21-8-O17-04 Survey on the actual situation of spill kit usage at anticancer drug contamination 飯村洋平1), 杉田一男1), 岩本寿美代2), 蓑輪雄一1), 長崎礼子2), 黒田直子2), 横井麻珠美2), 濱敏弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2015.

	Search of the risk factor about the onset of neutropenia in the 21-8-O17-05 pemetrexed Carboplatin combination therapy 荒木良介, 計良貴之, 加藤加奈恵, 菱沼隆一, 山田英紀, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2015.

Possibility ... which attenuates antitumor effect of oral 21-8-O18-06 melphalan and drug interaction - melphalan of the gastric-acid secretion antagonist
北澤文章1), 角陽子1), 上田久美1), 国府孝敏1), 淵田真一2), 岡野晃2), 初瀬真弓2), 村頭智2), 高良恒史3), 島崎千尋2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2015.

Study on payment intention for the 21-8-O18-07 medication counseling
東加奈子1), 川口崇2), 山口拓洋3), 佐野陽子1), 下平智秀1), 鳥居綾子1), 鮎原秀明1), 山田裕理1), 岩瀬哲4), 山田公人5), 松永忠東6), 竹内裕紀2), 畝崎榮2), 明石貴雄1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2015.

	Usefulness as the prostate cancer treatment target of 21-8-O18-08 Ca2+ activation K+ channel KCa2.2 丹羽里実1), 内木拓2), 佐々木昌一2), 高橋智3), 大矢進1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2015.

Usefulness of the TS-1-induced side effect discovery rate and side effect monitoring sheet in the 21-8-O18-09 outpatient department chemotherapy
中村知弘1), 河添仁2), 高取真吾1), 矢野安樹子2), 済川聡美2), 田中守2), 田中亮裕2), 難波弘行1), 湯淺宏1), 荒木博陽2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2015.

Clinical studies (the clinical second aspect study) of safety and the effectiveness of the L-leucine therapy for 21-8-O18-10 myelodysplastic syndrome (MDS)
伊藤佳織1),2), 安藤舞子2), 安藤洋介2), 柘植雅大2), 加藤貴大2), 増田雅也2), 鈴木慎二2), 加藤さや香2), 牧原俊康2), 林高弘2), 稲熊容子1), 柳田正光1), 水田秀一1), 岡本昌隆1), 山田成樹2), 恵美宣彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2015.

	Examination about the problem solving judging from the consultation example between medical persons in the 21-8-O19-11 cancer chemotherapy 坪井久美, 遠藤拓未, 平野公美, 小菅和仁, 渡邉進士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2015.

	One case of thyroid cancer which hyposensitization by the steroid combination succeeded in for erythema multiforme that 21-8-O19-12 sorafenib caused 倉田玲奈1), 林孝子2), 加藤彩2), 清水真3), 佐藤康幸2), 松本修一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2015.

	Construction of the cancer instruction to patient administrative work in the cottage-hospital out of 21-8-O19-13 大上寛子1), 仲由美子1), 細木慈子1), 植田実樹2), 末次知子2), 濱田拓男3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2015.

21-8-O19-14 physician and a pharmacist are the changes of the understanding degree of the patients by the treatment with hormone classroom after breast cancer technique to collaborate
猪熊容子1), 山本浩貴1), 池見泰明1), 石塚良子1), 深津祥央1), 大村友博1), 中川俊作1), 今井哲司1), 鈴木栄治2), 竹内恵2), 戸井雅和2), 松原和夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2015.

Relations from the hospitalization of patients with 21-8-O19-15 blood tumor to the outpatient department
小川智孝, 川村めぐみ, 矢敷祐子, 川畑大輔, 八十嶋しづか, 高松祐子, 井上味波, 矢野沙幸, 酒井千尋, 西居祐美, 和下田真美, 手島慶子, 岩城晶文
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2015.

	It is ... mainly on the role of the HBV infection screening study implementation present situation - pharmacist at the 21-8-O20-16 our hospital chemotherapy 稲益里映1), 藤田さやか2), 埋金朋子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2015.

Add many types of job cooperation - clinical phycologist, dietitian in the 21-8-O20-17 outpatient department chemotherapy center; and ...
木村緑1),2), 芹澤陽子3), 高木綾4), 藤巻奈緒美1),5), 須山由佳子2), 萩倉翔2), 内田亮2), 永峰槇子2), 中村和代1),2), 中條倫成1),2), 嘉屋道裕2), 中垣繁2), 遠藤一美1),5), 江藤尚1),6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2015.

	Intervention as the ward pharmacist in the 21-8-O20-18 thyroid cancer newcomer treatment medicine "Ren drumstick nib" use case 石川雄大, 龍伸和, 三村泰彦, 加藤敦, 足立伊佐雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2015.

	Relation of the pharmacist for IV (CV port) puncture nurse upbringing in the 21-8-O20-19 cancer chemotherapy 入江貞治1), 原田周平1), 井上知哉1), 福原香奈子2), 北崎健3), 福田正明3), 谷口英樹4), 藤田靖之1), 町田毅1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2015.

	Exploring of the joint medical treatment management (CDTM) introduction in the 21-8-O20-20 Prefectural Hiroshima Hospital tumor center 西川千晶1), 今津邦智1), 奈須ゆき2), 木下真由美2), 大山紀美江2), 前田昌徳1), 篠崎勝則3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2015.

Result ... of the non-expert skill training that we transduced in all consideration fourth report ... official posts and ranks about the satisfaction of the patients after consciousness and the instruction of the 22-4-O21-01 pharmacist
渡邉百合子1), 新井亘2), 岡添進3), 矢吹直寛4), 長谷川和正5), 矢嶋美樹6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2015.

Efforts of the consciousness change of the 22-4-O21-02 pharmacist and setting and the organization and methods of the clinical index in change - third report - AMG pharmacy of duties contents
新井亘1), 岡添進2), 矢吹直寛3), 長谷川和正4), 渡邉百合子5), 矢嶋美樹6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2015.

	Effect on consciousness and duties contents - second report ... of the pharmacist of the 22-4-O21-03 chronic phase hospital 岡添進1), 渡邉百合子2), 新井亘3), 矢吹直寛4), 長谷川和正5), 矢嶋美樹6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2015.

	About efforts and new duties development of the ward drug duties improvement in the 22-4-O21-04 Kokura memory hospital 町田聖治, 清水誉志, 萩原里実, 富田敏章, 福島将友, 樽善久, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2015.

	The database construction for the intervention example of the ward pharmacist in the 22-4-O21-05 medical therapy and data analysis 大谷寧次郎, 齊藤宏明, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2015.

	Than efforts of 22-4-O22-06 ward drug duties and evaluation ... is ... for enhancement 才津恵, 岡田淳芳, 石井一也, 原景子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2015.

Intervention ... of the pharmacist in hepatitis B reactivation measures in examination - cancer chemotherapy about the usefulness of the 22-4-O22-07 ward drug duties enforcement addition
宮崎美佳1), 末松那実子1), 古川順章1), 永井聡子1), 安宅信二2), 小林勝昭1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2015.

Prescription support by the pharmacist as 22-4-O22-08 Yokohama City ward drug duties in a stroke, the nerve backbone center
臼田誠1), 永井徹1), 青野壮1), 荒居典子1), 石橋直子1), 一澤里枝1), 加藤鮎子1), 小林留奈1), 櫻塲秀一1), 白井克子1), 須藤葉子1), 原弘士1), 間瀬尚子1), 高橋浩二1), 五十嵐俊1), 市田千佳2), 平野秀隆1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2015.

Clinical practice - of effect - polypharmacy improvement and the drugstore pharmacist of the bedside prescription suggestion by the pharmacist company to rounds in 22-4-O22-09 medical treatment bed, the Care health center for the elderly
新井克明, 清水範子, 菊地麻希, 須藤寛, 佐々木真澄, 郡司幸代
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2015.

Understanding degree investigation ... for the sleeping drug of suggestion and the nurse of the sleeping drug proper use from efforts - ward pharmacist to the reduction of 22-4-O22-10 fall, the delirium risk to a physician
古川大樹1), 清水智也1), 村瀬貴子1), 川口美香2), 長谷川雅哉1), 柴田浩範3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2015.

	The continuous intervention for patients who received 22-4-O23-11 outpatient department cancer chemotherapy and the evaluation 陶山登之, 松井頌明, 渋江理恵, 土井教雄, 井上昌樹, 上村智哉, 玉木宏樹, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2015.

	Fact-finding in the 22-4-O23-12 outpatient department chemotherapy hot line for pharmacist 出町健1), 龍島靖明1), 板垣麻衣1), 野村久祥1), 市田泰彦1), 池田公史2), 齊藤真一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2015.

	The present conditions of the efforts to the pharmacist outpatient department in the 22-4-O23-13 lung cancer EGFR-TKI treatment 早坂州生1), 芦崎雅之1), 平田力1), 竹内公美1), 平岡圭2), 山崎成夫2), 鈴木康弘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2015.

	Dermatopathy - during side effect management - Afatinib medication in the 22-4-O23-14 pharmacist outpatient department 古川順章1), 浅川由希子1), 宮崎美佳1), 小林勝昭1), 安宅信二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2015.

	By 22-4-O23-15 pharmacist medical examination front can contribute to XELOX therapy successful execution! 組橋由記1), 福島ゆかり1), 石倉久嗣2), 鈴江朋子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2015.

	Usefulness of the pharmacist outpatient department in the 22-4-O24-16 molecules target medicine internal use treatment and future problem 高瀬美咲枝, 小川浩平, 柴田和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2015.

	Research of the medication compliance of the 22-4-O24-17 regorafenib 副島梓1), 川上和宜1), 杉田一男1), 横川貴志1), 杉崎崇人1), 瀧口友美1), 鈴木賢一1), 井上彩花2), 町田昌明2), 末永光邦3), 水沼信之3), 山口俊晴3), 濱敏弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2015.

It is ... through the pilot case which a pharmacist attended in report - encounter of the process that led to new establishment and the pharmacist outpatient department start of the consulting room for exclusive use of the pharmacist in the 22-4-O24-18 our hospital
高柳信子1), 久保嘉靖1), 奥野昌宏1), 中田学1), 新里偉咲2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2015.

	Medication management of TAS102 in the 22-4-O24-19 pharmacist outpatient department 奥田泰考1), 須藤俊明1), 藤井博文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2015.

	Role of the 22-4-O24-20 pain clinic pharmacist outpatient department 中川左理1), 岡本禎晃2), 柴田政彦3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2015.

	About fact-finding and an effect of the perioperative pharmacist intervention in the 22-4-O25-21 anesthesiology outpatient department 大森崇行1), 阿部猛1), 川名賢一郎1), 片山正夫2), 宮坂勝之3), 後藤一美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2015.

	Efforts of the pharmacist in the 22-4-O25-22 hospitalization support center 古荘恵里, 佐藤大惣, 山内豊和, 山澤理恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2015.

Have hospital pharmacist for certain outpatient department medical therapy by security from 22-4-O25-23
久岡清子, 合田さやか, 佐々木健志, 澤口友紀, 亀岡喬, 間千晴, 鹿沼奈央, 足立雅, 盆子原唯, 川村大輔, 大荒政志, 浜野憲子, 平野真衣, 清居孝正, 吉川真央
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2015.

Establishment of the pharmacist outpatient department for the patients during interferon freelance treatment with 22-4-O25-24 hepatitis C and the evaluation
山本晴菜1), 山本香織1), 左近絢子1), 池村舞2), 鄭浩柄3), 杉之下与志樹3), 猪熊哲朗3), 橋田亨1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2015.

	Efforts - check sheet introduction of the SGLT2 inhibitor proper use in the 22-4-O25-25 pharmacist outpatient department and progress report ... 佐久間智子, 今井晴恵, 宇佐美勝, 池田弘毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2015.

	Intervention effect of the pharmacist in the medical treatment management of the lithium carbonate to 22-4-O26-26 outpatient 山田尚広1), 見野靖晃1), 佐野慎亮1), 内藤隆文1), 森則夫2), 川上純一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2015.

Representation answer - of the pharmacist by the doubt efficiency - doubt comprehensive instructions that are inquiry-free in the 22-4-O26-27 outside Parliament prescription for inquiry
小松めぐみ, 前田奈保, 宇都宮可奈, 青木佐菜, 市川麻美, 田所美和, 吉岡りえ, 市吉真貴子, 八木亜紀子, 田中照夫
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2015.

	Effect of the medicine classroom on person with 22-4-O26-28 congenital hearing disorder 俵口奈穂美2), 小林大介1), 窪田敏夫1), 島添隆雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2015.

	The efforts of the pharmacist for the 22-4-O26-29 preoperation patients and the result 矢川結香1), 居塚しのぶ1), 桑村恒夫1), 末松文博1), 有村博江2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2015.

	Intervention and evaluation for PONV by the 22-4-O26-30 operating room permanent residence pharmacist 大田泉, 阪上倫行, 明珍かおり, 辻美知瑠, 田中健太, 西岡達也, 久米学, 槇本博雄, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2015.

Prescription contents to diabetes are various by the 22-5-O27-01 prescription database analysis, but the correlation with the hemoglobin A1c level is low
嶋村弘史1), 田中広紀2),3), 向後麻里2),3), 竹ノ内敏孝4), 中野泰子5), 富田基郎5), 村山純一郎5), 谷山松雄6), 平野勉7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2015.

Introduction and effect of the sustained Exenatide for the purpose of the weight control in the 22-5-O27-02 obesity case
板東達也1), 奥村中2), 浅野昇悟2), 佐久間晶基1), 辻若子1), 多和田敏郎1), 小木曽梓1), 荻野由里惠1), 水野善晴1), 佐藤嘉孝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2015.

	The drug use situation of patients with diabetes with the 22-5-O27-03 ischemic heart disease 石橋真実1), 大森麻江1), 向井めぐみ1), 金井美緒1), 宮下雄博2), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2015.

	Inflection of the bringing medicine differentiation report aiming at the proper use of 22-5-O27-04 oral hypoglycemics 中村栄子1), 竹之下博正2), 茨木一夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2015.

	Importance of the equalization in the 22-5-O27-05 suspension insulin analog preparation 富岡節子1), 信田重成2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2015.

	The effect that the change of the insulin regimen gives to the quality of life of patients with type 1 and type 2 diabetes on 22-5-O28-06 Degludec 岡田守弘1),2), 岡田昌江1), 西上潤1), 山秋直人3), 大山公典3), 古川健治3), 嶋田努2),4), 崔吉道2),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2015.

	It is the questionary survey to hemocatharsis therapy center ambulatory patient three years after the change to 22-5-O28-07 one-touch ultra view TM and one-touch writing 鎌田敬志, 佐藤拓也, 石川大介, 田中大輔, 阿部和人, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2015.

	Effect of a liver function change and the insulin measures of the NAFLD (nonalcholic fatty liver disease) model mouse in the 22-5-O28-08 hyperglycemia state 小畑友紀雄1), 原田慎一1), 中本賀寿夫1), 森本泰子2), 金啓二3), 金守良4), 徳山尚吾1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2015.

Construction and usefulness evaluation of the new educational program of the diabetes-related field for 22-5-O28-09 young person pharmacists
斉藤麻美, 峯昌敏, 佐々木恵一, 福田未音, 中嶋一惠, 村岡香代子, 月野木祥子, グリム理恵子, 國分千代, 渡邊裕之, 江頭伸昭, 増田智先
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2015.

	22-5-O28-10 Investigation report on the effectiveness of selective SGLT2 inhibitor Tofogliflozin 久嶋真紀子, 野口景子, 葛葉守, 中野玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2015.

	Comparison about hemorrhagic complications of 22-5-O29-11 dabigatran and the apixaban 向井優太朗1),2), 竹中裕美1), 内堀聡子1), 藤本麻依3), 細見光一3), 和田恭一1),2), 粉川俊則1), 早川直樹1), 桑原健1),2), 高田充隆2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2015.

	Search of the risk factor giving it to the hemoglobin drop in the patients using the edoxaban after 22-5-O29-12 artificial joint replacement 森川祥彦1), 榎屋友幸1), 長谷川正裕2), 宮本明希1), 村木優一1), 岩本卓也1), 須藤啓広2), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2015.

Usefulness in oral administration and the simple suspension method transluminal administration of 22-5-O29-13 rivaroxaban and apixaban NOAC2 agent and safe examination
鳥谷部翔1),2), 花田和大1), 船水梨沙1), 阿部早苗1), 高瀬公子1), 久米田一喜1), 倉内寿孝1), 藤田尚子2), 萩井譲士3), 佐々木都子3), 清野聡3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2015.

	A pharmacist being able to be involved in proper use of NOAC and Warfarin to look back toward from the experience of five 22-5-O29-14 hemorrhagic complications 宮崎文子1), 金子伸吾2), 浅川隆重1), 今井智重子1), 織田佳人1), 伊藤誠3), 山内康照4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2015.

	It is examined the use of NSAIDs situation in the patients and the factor associated with the acute renal failure after 22-5-O29-15 artificial joint replacement 矢ヶ部良太1),2), 傍示幸1), 江口弘晃1), 園畑素樹2), 田崎正信1), 馬渡正明2), 原英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2015.

	Safe examination of edoxaban in the 22-5-O30-16 our hospital 宮村大佑1), 芦川直也2), 岩田晃佳1), 高橋麻美1), 石黒英行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2015.

	Safe examination of triple therapy by 22-5-O30-17 DAPT+NOAC 岩田晃佳1), 芦川直也2), 宮村大佑1), 高橋麻美1), 石黒英行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2015.

	Search of the phlebitis onset factor in the 22-5-O30-18 nicardipine undiluted solution periphery administration 澤田真嗣, 大塚充, 中西裕明, 堀内あす香, 藤田敦夫, 友金幹視, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2015.

Examination about 22-5-O30-19 amiodarone-induced thyroid function abnormality and amiodarone and the amiodarone metabolite blood level
大和幹枝1),2), 和田恭一1),2), 粉川俊則1), 早川直樹1), 安斉俊久3), 藤本麻依2), 細見光一2), 高田充隆2), 桑原健1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2015.

	Search of the factor associated with the onset of rhabdomyolysis period attributable to the 22-5-O30-20 HMG-CoA reductase inhibitor 高木彰子1), 小林統2), 橋本知貴1), 清野敏一1), 中村均1), 濃沼政美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2015.

	Comparison of adverse event frequencies in Monthly TC therapy and the dose22-dense TC therapy for 22-5-O31-21 ovarian cancer, the cancer of endometrium 前田知穂, 橋本未雷, 大園ゆかり, 林淳一郎, 平山俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2015.

	Taste in the 22-5-O31-22 bortezomib administration mouse-sensitive change 大石晃弘, 宮本花凜, 今井瑞香, 中西椋子, 小林恭子, 林亜希子, 西田健太朗, 長澤一樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2015.

An example of the patients on dialysis who 22-5-O31-23 Aki Shichi nib was given, and presented with an acute hepatitis severe form and cardiopulmonary arrest
岩崎瑛子, 岩本明日香, 藤江直輝, 綛谷哲也, 竹田健志, 小森桂子, 石樋康浩, 的場美香, 山東真寿美, 高木麻里, 藤田敬子, 坂上嘉浩, 室井政子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2015.

	About the onset of adverse event situation with azacitidine in the 22-5-O31-24 myelodysplastic syndrome 西村栄一, 近藤智幸, 紙谷章基久, 吉田さゆり, 増渕幸二, 簑島弓未子, 下道一史, 橋本光生, 後藤吉延 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2015.

	Examination of the associated factor of the excessive change of the serum Na level by the 22-5-O31-25 tolvaptan 廣瀬正幸1), 田中伸享2), 矢野裕子1), 吉田夕貴1), 寺本智彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2015.

	22-5-O32-26 physician, the pharmacist arrest you, and how do they report information on adverse drug reactions? 佐藤宏樹, 澤田康文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2015.

	Construction (the second report) of information on adverse drug reactions collection, analysis, the evaluation system in the 22-5-O32-27 community pharmacy 中嶋瞳1), 佐藤宏樹1), 笹嶋勝2), 澤田康文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2015.

	Role of the actual situation of the 22-5-O32-28 drug induced hepatic injury and the pharmacist 橋本陽1), 長谷川真左子1), 大森茂2), 小出哲朗1), 石川久高1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2015.

About the questionnaire results about the uterine cervix cancer vaccine second response in the specialist in citizen of 22-5-O32-29 Shizuoka consecutive drug committee and future correspondence
聞間明子1),2), 濱口祥子1), 竹端尚美2), 吉岡優子3), 中村ほなみ3), 米澤由希子4), 唐木良子5), 林昭文6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2015.

	The 2 symptom that produced hyponatremia by administration of the 22-5-O32-30 linezolid 穂積廣, 位田裕美, 竹本雄一, 水谷愛音 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2015.

	Measures and improvement effect in the drug control that raised an extraction rate of the 22-6-O33-01 generic medicine 室宮智彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2015.

	Examination and evaluation about the change of the 22-6-O33-02 generic medicine 関屋裕史, 奥村学, 岩切智美, 有森和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2015.

	The clinical effect on drug duties that a drug name printing design of the 22-6-O33-03 tablet gives and attitude survey of the patients 松本芳, 岡村央, 小山智代, 小池博文, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2015.

	What is 22-6-O33-04 "added value?" "Wish" that we put to ... naftopidil OD lock "Sawai" ... 河井嶺男1), 梅村香織2), 野沢健児2), 柳敏宏2), 徳永雄二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2015.

	Dosage form design of 22-6-O33-05 candesartan OD lock "Sawai" 福原康史, 中川知哉, 菊岡広晃, 徳永雄二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2015.

	Generic drug lectotype using the 22-6-O34-06 cluster analysis 早川正信, 柳川堯 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2015.

	Correlative evaluation with the usability of physicochemical data and humans of the 22-6-O34-07 heparinoid from animal organ-containing semisolid preparation 杉山育美1), 松本智典2), 伊藤勝彦2), 佐塚泰之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2015.

	The "safe rating system video of the generic drug" appreciation in the 22-6-O34-08 pharmacy education and the effect 中嶋幹郎1), 大山要1), 榎本初音1),2), 西村奈緒恵2), 立木秀尚2), 中嶋弥穂子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2015.

	A change and fact-finding of the number of the generic name prescription of the foreign outside Parliament prescription in the hospital attached to 22-6-O34-09 Nippon Medical School 萩原研, 大坂奈央子, 齊藤まみ, 伊勢雄也, 片山志郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2015.

	Efforts of the skill up multicenter through a choice evaluation of the 22-6-O34-10 generic medicine 廣井順子1), 舩津久美2), 樅山淳子3), 山田啓美3), 大工原ゆかり1), 森田理恵子1), 塩地園代4), 安藤恵5), 小竹慶子6), 石井紀子6), 大山修7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2015.

	It is suggested intelligence and the utilization system after marketing by the MS of the 22-6-O35-11 wholesaler of drug 澤田康文1), 佐藤宏樹1), 浅野貴代2), 増田眞由美2), 渡辺涼香2), 内藤温子2), 三浦康正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2015.

	Needs investigation to 22-6-O35-12 remote island, the use of OTC pharmaceutical products actual situation in the urban area and a pharmacist 三木晶子, 佐藤宏樹, 澤田康文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2015.

	Ethnography in the 22-6-O35-13 home Residual medicine 木村菜月1), 三木晶子2), 花輪りつ3), 矢吹久美子4), 平山匡彦5), 山口裕次6), 佐藤宏樹2), 澤田康文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2015.

	An attitude survey and the present conditions of the pharmacist for the 22-6-O35-14 Residual medicine adjustment 図師清二1), 北村通康1), 井上真理1), 松岡亜由美1), 宮本章平1), 東野純一1), 濱田篤秀1),2), 平松久嗣1), 京谷庄二郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2015.

22-6-O35-15 Awareness survey on proper use of drugs for elementary school students and efforts of medicine class
大林真幸1),2), 中山真織子1), 安井紗緒里1), 飯田謙司1), 早坂幹生2), 宮本千鶴子2), 平岡千英1), 神山紀子1), 石田伸一2), 金子敦美2), 山元俊憲1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2015.

	We investigate the problem of the pharmacist from the prescription trend of the osteoporosis treatment injection drug of the 22-6-O36-16 our hospital 中島恵子, 角井碧, 得能千晶, 瀧口幸子, 永田佳子, 清上和也, 大田博子, 橋本佳浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2015.

	The use actual situation and safety assessment of the edoxaban in 22-6-O36-17 venous thromboembolism treatment 佐藤信恵, 大橋養賢, 勝海学, 千田昌之, 谷地豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2015.

	The prescription situation of 22-6-O36-18 prescribed medicine and the driving prohibition medicine in the driving 1 general hospital outpatient department 春日章宏1), 大森一郎2), 打田佑人3), 石井千加2), 斉藤晴彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2015.

	International comparison between 22-6-O36-19 prescribed medicine and attention contents about the driving in the driving 2 package insert 大森一郎1), 春日章宏2), 石井千加1), 打田佑人3), 斉藤晴彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2015.

	Correspondence second report to the prescription of pharmaceutical products having an influence on the 22-6-O36-20 driving 木津純子1), 高橋佑介1), 黒田裕子1), 松元一明1), 山田純一2), 永田泰造2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2015.

	Fact-finding about the oral medicine management of patients with 22-6-O37-21 dementia 本樫寿裕, 小山遥, 横地由仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2015.

	Role of many types of job cooperation approach - pharmacist for patients with proximal 22-6-O37-22 thighbone bone fracture and pharmaceutical management ... 萩行正博1), 宮田志生1), 重本顕史2), 澤口毅2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2015.

Significance, the actual situation, problems and countermeasure of the cooperation between a pharmacist, the care people in the 22-6-O37-23 nursing facility
白石朗1), 古泉良1), 小田玲子1), 新海成美1), 加藤洋一1), 舟橋健一1), 馬来秀行2), 佐藤宏樹3), 三木晶子3), 小西ゆかり2), 臼井順信1), 澤田康文3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2015.

	Problems at inhalational instruction from the questionary survey on the 22-6-O37-24 whole country scale to understood elderly people 平大樹1), 小熊哲也2), 腰山節子3), 堀江健夫4), 吉村千恵5), 百瀬泰行6), 白木晶7), 寺田智祐1), 駒瀬裕子8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2015.

	Examination of the possibility that 22-6-O37-25 thickness adjustment food disturbs drug collapse 山島糸, 瀧本紫乃芙, 森野真由, 鳥羽英理子, 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2015.

	Discharge prescription investigation of patients with depression in the 22-6-O38-26 fine weather sum hospital 遠藤洋1), 稲垣中2),3), 稲田俊也1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2015.

	For the medical treatment that is effective by efforts - security of the consultation before medical examination by the pharmacist for patients receiving 22-6-O38-27 sustained-release antipsychotics parenteral injection - 菅野ゆみか, 平野弘美, 山下由季惠, 大谷美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2015.

	Usefulness of the SCAP method in the class of patients of the 22-6-O38-28 our hospital 加藤昭一, 福士陽子, 上川原麻弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2015.

	Ward drug duties - for patients with relation - chronic phase schizophrenia of the pharmacist in the 22-6-O38-29 mind medical treatment ward 細木加寿子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2015.

Efforts of the proper use of a 22-6-O38-30 benzodiazepine system antianxiety drug (antianxiety drug of BZ origin), the hypnotic drug
亀山聡美1),6), 竹内松美5),6), 松岡恵理香5),6), 岡部まどか5),6), 小林正則1),6), 横山道江2),6), 渡邉貴博3),6), 岩井雄司4),6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2015.

It is sleep hygiene instruction ... in ... health insurance pharmacy for the 22-6-O38-31 benzodiazepine system hypnotic drug reduction
岡部まどか1), 竹内松美1), 松岡恵理香1), 片田知花2), 山田菜央実1), 亀山聡美2), 土屋辰司1), 青山栄司1), 渡邉貴博3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2015.

	Examination about the change of the needs to the pharmacist of other types of job by the 22-7-O39-01 drug control instruction duties start 龍田涼佑, 内匠幸恵, 村谷菜々子, 佐藤雄己, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2015.

	Improvement of the pharmacist duties using the 22-7-O39-02 incompatibility list 山口泰弘, 川俣洋生, 林淳一郎, 平山俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2015.

	Examination about the usability of the 22-7-O39-03 percutaneous absorption antiphlogistic balm and document making 菅大地, 三上大貴, 佐藤裕資, 越田晋太郎, 手塚悠希, 鈴木千波, 田畑裕和, 柴波明男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2015.

	The category grant to drug information contents for 22-7-O39-04 patients, citizens and the evaluation 香川由美1), 堀里子1),2), 三木晶子1), 佐藤宏樹1), 澤田康文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2015.

	Fact-finding of the warning information of the ethical drug package insert in 22-7-O39-05 Japan 大城隼也, 見野靖晃, 上田香織, 山田尚広, 内藤隆文, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2015.

	It is ... through the role of the drug information room newspaper which became the periodical binding nine times and the questionary survey of the physician of evaluation - 99 for 22-7-O40-06 17 years 奥野昌宏, 久保嘉靖, 中田学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2015.

Present conditions investigation of the patients outcome with the operational start of the 22-7-O40-07 tracing report
畑中知笑美1), 村木優一2), 内田佳久1), 梅本彩加1), 草川美乃1), 津幡理恵1), 末澤千恵1), 須藤早百合1), 奥田真弘2), 野田明雄1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2015.

	Construction of the drug control instruction system superior in 22-7-O40-08 cost performance 飯田優太郎1), 佐々木貴寛1), 伊藤香織1), 相馬真志1), 中村悦子1), 小川義敬1), 中嶋俊之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2015.

	Does the 22-7-O40-09 patients basics information accord between drugstores? It is ... from the competitive review between ... plural drugstores 佐々木智美, 田中秀樹, 福岡勝志, 三津原庸介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2015.

	Construction of the 22-7-O40-10 ward drug duties support server 安福修平1), 森田紗代1), 田畑佳祐1), 池尾崇志1), 齋藤翔太1), 數田素子1), 雀部貴美代1), 石田達彦1), 吉田直恵1), 斉藤善久2), 丸尾原義3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2015.

	Rebuilding of the anticancer agent preparation support system with the 22-7-O41-11 preaudit screen 和田良浩, 池田和之, 吉村忠道, 吉川一吾, 辻力夫, 森田幸子, 梶井節子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2015.

	Decontamination effect of the anticancer medicine pollution environment using 22-7-O41-12 ozone water and the sodium hypochlorite 濱宏仁1),2), 橋田亨2), 田中詳二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2015.

The use situation after 22-7-O41-13 closed system anesthesia mixed preparation appliance [chemosafe] introduction of 5 years
中村美樹, 今井美恵子, 岡本安紀, 寺崎実希, 戸川尚美, 中森光子, 小倉朋子, 岸敬子, 仲西未佳, 平田貴大, 松山芽衣, 谷車彩夏, 常村弥生, 廣本真里, 多胡和樹, 黄前尚樹
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2015.

	Properties of matter change of the preparation with the 22-7-O41-14 polypharmacy and proper use of the drug 飯村菜穂子, 桐山和可子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2015.

	Study on insoluble particulate matter derived from 22-7-O41-15 injection syringe (the second report) 菅原拓也1), 荒井浩一1), 倉本敬二2), 東海林徹3), 白石正4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2015.

Examination of the simultaneous assay using the solid-phase sampling of immunosuppressive drug Cyclosporine, Tacrolimus, Sirolimus, Everolimus four drugs by the 22-7-O42-16 LC-MS method
島崎花梨, 田内淳子, 亀和田有紗, 阿部昌代, 藤井千香子, 飯塚瑞穂, 西村友希, 歌田優佳, 松本邦洋, 大野恵子, 岸野吏志
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2015.

Examination of the LC/MS/MS analysis system of the 22-7-O42-17 poison in medicine thing poisoning causative agent
前川正充1), 小梶哲雄2), 菊地正史1), 田中雅樹1), 中曽根正皓1), 野田あおい1), 矢内一成1), 鈴木博也1), 赤坂和俊1), 久道周彦1), 山口浩明1), 眞野成康1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2015.

Examination about the effect of blood tacrolimus levels in the acute GVHD prevention after the 22-7-O42-18 hematopoietic stem cell transplantation
今井奈津美1), 小井土啓一1), 渡部大介1), 西渕由貴子1), 橋本浩伸1), 大塚知信1), 金成元2), 山下卓也2), 福田隆浩2), 林憲一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2015.

	The comparison of the blood level assay of the 22-7-O42-19 methotrexate and clinical evaluation 畠山史朗, 佐藤一真, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2015.

	One case that 22-7-O42-20 pharmacist contributed to phenytoin doses adequacy of patients on dialysis with the hypoalbuminemia 岡田孝之1),2), 法橋純子1), 小山由美子1), 世良有雅1), 加茂美智子1), 高木好夫1), 阿瀬井宏一1), 徳山尚吾2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2015.

It is a case with suspected onset of neuromuscular blocking action by amikacin of the blood level in the 22-7-O43-21 therapeutic range
山形真一1), 久米正純2), 大石博史3), 井口ミサヲ4), 重松絹子4), 加藤愛子5), 幸邦憲1), 中川義浩1), 大神隆行3), 武藤庸一2), 冨澤達3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2015.

	Examination of the Teiko plastic Nin medication method in patients with 22-7-O43-22 febrile neutropenia 堀哲史1), 須田恭弘1), 澤井健太1), 多賀野正嗣1), 竹田和也1), 藤村保夫1), 熊野麻衣子2), 高木和貴3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2015.

	Examination about the initial administration plan of 22-7-O43-23 vancomycin 中田一孝, 冨田有香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2015.

	Change of our hospital Vancomycin TDM with the introduction of 22-7-O43-24 antimicrobial TDM guidelines 平野龍一1), 坂本勇一2), 山本章二1), 工藤久美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2015.

	Inspection of the use of vancomycin hydrochloride injection drug change of a situation by the 22-7-O43-25 antimicrobial round enforcement 大石泰也1), 西村紀子1), 東めぐみ1), 鷲見理恵1), 川野昭1), 田嶋信子2), 石丸敏之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2015.

	Evaluation of the use of antiMRSA medicine patients round in the 22-7-O44-26 Nagaoka Red Cross hospital 小林謙一1), 西堀武明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2015.

	Examination of the efforts contents by the ICT round in the 22-7-O44-27 our hospital 田中順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2015.

	The effect that a person coming to the hospital gives to 22-7-O44-28 inside the hospital MRSA distribution 柴田高洋1), 岡田直人1), 伏谷秀治1), 柴田洋文3), 川添和義1),2), 石澤啓介1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2015.

	Search of the risk factor of UTIs to assume 22-7-O44-29 ESBL-producing E.coli origin bacteria 橋本麻衣子1), 瀬角りほ2), 三村享3), 春日恵理子4), 松本剛4), 本田孝行4), 濱本知之2), 山折大1), 大森栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2015.

Examination about construction and the effect of the antimicrobial stewardship promotion system in the scale hospital out of 22-7-O44-30
佐村優, 倉田武徳, 廣瀬直樹, 石井淳一, 南雲史雄, 鯉淵寛之, 腰岡桜, 青木均文, 内田仁樹, 山本隼也, 川名絢子, 井上純樹, 関根寿一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2015.

Evaluation - of the use of antimicrobial fact-finding - oral switch therapy of the perioperative patients in the 22-7-O44-31 dentistry domain
吉田謙介1), 磯辺浩和1), 新木貴大1), 中川裕介1), 石田みなみ1), 田村隆1),4), 船山昭典2), 児玉泰光3),4), 小林正治2), 高木律男3), 田邊嘉也4), 外山聡1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2015.

Usefulness of the workshop for the drugstore pharmacist to support 22-8-O45-01 outside Parliament prescription test value indication
田中瑠美1), 渡邊裕之1), 秦晃二郎1), 末次王卓1), 田島壮一郎1), 大畠俊一1), 福田未音1), 了戒百合子1), グリム理恵子1), 金谷朗子1), 高木淳一2), 瀬尾隆2), 増田智先1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2015.

	Usefulness evaluation of the outside Parliament prescription which printed 22-8-O45-02 clinical test value 萱野勇一郎, 深津祥央, 木村嘉彦, 尾崎淳子, 石塚良子, 矢野育子, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2015.

	About efforts to the clinical test value and cancer chemotherapy protocol name indication to 22-8-O45-03 outside Parliament prescription 神原康佑1), 池田由香子1), 佐原理沙1), 大石知枝美1), 原景子1), 村上信行2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2015.

It is efforts ... of ... Iwakuni pharmacist society and the NHO Iwakuni medical center about the test value notation of the outside Parliament prescription which determined 22-8-O45-04 enforcement duties and the effect
尾崎誠一1), 中村嘉孝1), 河田尚己2), 村中扶美子2), 廣子真大2), 渡邉宗男2), 小澤秀弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2015.

	Efforts of the medicine medicine cooperation in the 22-8-O45-05 anticancer agent prescription 秋葉由華1), 小林篤史1), 武田智子2), 長谷川晃司2), 和田淳2), 乙黒万喜子3), 古曽部毅4), 箕輪圭一郎5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2015.

	We support 22-8-O46-06 depopulated old local drugstore activity using a prescription database 富田基郎1), 大林秀樹2), 瀬川正昭2), 藤原真治3), 田中正巳4), 中野泰子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2015.

	Case of Alzheimer's dementia that led to medication compliance, neurologic manifestation, the improvement of clinical manifestations by the intervention of the pharmacist in 22-8-O46-07 treatment at home care 成井繁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2015.

About introduction and the usefulness of the efforts - anticoagulant information cooperation sheet of the hospital pharmacy Monma information cooperation in the 22-8-O46-08 Sasebo district -
濱邊秋芳1), 嶋田聖子1), 納富貴子1), 武田典子1), 岩村直矢2), 溝口裕子3), 井福隆史4), 谷口一成5), 日置浩一郎6), 小島敏行3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2015.

	Efforts to Residual medicine adjustment by the 22-8-O46-10 medicine medicine cooperation 市野貴信1),2),3),4),5), 松田明里紗1), 勝弘毅1), 尾上涼馬1), 小林竜也2), 野間誠司3), 伊豆川愛4), 犬飼直也5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2015.

	Proper use situation ... of 1 pharmaceutical products risk minimization plan - cinacalcet in the 22-8-O47-11 Kurashiki center Hospital 赤木晋介, 木村洸, 加納沙代子, 長尾由佳, 亀井健人, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2015.

	22-8-O47-12 Minimization plan for drug risk at Kurashiki Chuo Hospital Part 2 : Proper usage of Seroquel(R) tablets, Zyprexa(R) tablets 加納沙代子, 木村洸, 赤木晋介, 長尾由佳, 亀井健人, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2015.

Indication ... of the test value to the prescription which stood on the use situation of 3 pharmaceutical products risk minimization plan - our hospital in the 22-8-O47-13 Kurashiki center Hospital
木村洸1), 加納沙代子1), 奥田亜希子1), 杉島佑美1), 財満奈央子1), 森美佳子1), 吉開晶一1), 村山慶2), 亀井健人1), 赤木晋介1), 高柳和伸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2015.

Effect on cancellation, weight loss ... at examination - serum potassium level drop of the effect factor to give to the proper use of the 22-8-O47-14 serum potassium remover
岡本伸也, 村上史承, 岡田昌浩, 杉原弘記, 後藤裕香, 星野祥儀, 神垣江里奈, 山田理恵, 岡崎和子, 向井弘恵, 竹井英介
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2015.

	22-8-O47-15 Prescription status of RELVAR(R) ELLIPTA(R) and guidance situation survey at insurance pharmacy 林万紀子, 眞継賢一, 塚本泰彦, 濱口良彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2015.

The future prospects including construction and the medicine medicine cooperation of the drug management system which was useful in palliative care team rounds in the 22-8-O48-16 our hospital
平野光枝, 鈴木博晃, 佐藤仁宣, 朝日仁美, 手渡和子, 米持奈津美, 石田琢人, 豊田康義, 加藤一郎
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2015.

	Approach ... for making - delirium of in-hospital delirium guidelines based on 22-8-O48-17 evidence 小川大介1), 中島美穂1), 武本千惠1), 今村牧夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2015.

	Proper use promotion of the fentanyl sublingual tablet by the 22-8-O48-18 fentanyl tight military ration protocol 杉山惠亮, 中村和行, 粟田浩文, 井原将太, 上條史帆里, 石川歩未, 鈴木穂奈美, 米山英二, 勝見章男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2015.

	Activity of the pressure sore medical treatment workshop in 22-8-O48-19 Chiba 柏倉康治1),2), 飯塚雄次2), 小池彩子2), 森本数子2), 本澤葉留美2), 飯嶋久志3), 棗則明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2015.

	Role of the pharmacist in the 22-8-O48-20 heart failure team 林慎二, 大西順子, 李美淑 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2015.

Attempt of medical treatment management (PBPM) based on the protocol of the oxybutynin hydrochloride patch by the 22-8-O49-21 area medicine cooperation
三橋悠希1),2),4), 永江浩史3), 前堀直美1),3), 清水義充1),5), 鈴木愛1),6), 森英祐1),7), 譲原康夫1),8), 鈴木常義1),9), 大森類1),10), 曽布川洋平1),2), 増井俊充1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2015.

	Work of the pharmacist changing in 22-8-O49-22 report, a prescription 杉田康1), 松岡由美子1), 大津裕美1), 南達也1), 畑谷侑希1), 狭間研至1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2015.

	Two cases that reached the change of prescription by the active intervention of the 22-8-O49-23 pharmacist 松岡由美子1), 狭間研至2), 南達也1), 畑谷侑希1), 大津裕美1), 杉田康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2015.

	To support community medical care cooperation aiming at patients with 22-8-O49-24 staying alone adherence improvement 上村忍1), 桑野淳1), 力丸龍二2), 立山勝規3), 鬼塚一郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2015.

	Fact-finding of the pharmacist participating in the oral anticancer medicine in the 22-8-O49-25 cancer practice cooperation base Hospital neighborhood drugstore 川澄賢司1), 鈴木真也1), 櫻井洋臣2), 山口雅也2), 齊藤真一郎1), 遠藤一司3),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2015.

22-8-O50-26 Approach to cooperation of disease medicine in Daklinza, Sunvepra combination therapy using drug information management shared sheet
井上裕貴1),2),3), 上床遙1), 石井ゆに香1), 平嶋昇2), 吉田知由3), 山口布沙1), 竹内正紀1), 島田昌明2), 松本修一1), 岩瀬弘明2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2015.

	Efforts of the medicine medicine cooperation aiming at adherence improvement of the 22-8-O50-27 teriparatide self injection preparation 三谷和恵1), 波多晶子1), 中澤美樹子1), 窪田真弓1), 高崎可奈2), 中田郁子2), 五十嵐健太郎3), 鶴居勝也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2015.

DPI preparation proper use investigation of the outpatient who assumed the inspiratory flow rate of the 22-8-O50-28 in check an index
本田愛実1), 尾崎誠一1), 河田尚己2), 村中扶美子2), 廣子真大2), 中村嘉孝1), 寺山恵子1), 田阪武志1), 渡邉宗男2), 小澤秀弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2015.

Examination ... from a questionnaire targeted for efforts of the pharmaceutical cooperation in the 22-8-O50-29 respiratory system inhalant and inhalational instruction study session - neighborhood health insurance pharmacy pharmacist
米田勝晃1),2), 高谷友里1), 生川賀代1), 徳永奈都子1), 西野真代1), 田辺涼1), 西尾佳奈1), 藤井久美子1), 増田晶子1), 中谷早希1), 小林厚2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2015.

The evaluation of the discharge teachers' textbook for the purpose of the promotion of the medicine medicine cooperation with the 22-8-O50-30 Nakagyo pharmacist society and questionary survey for the treatment at home
黄前尚樹1), 内藤舞2), 今井美恵子1), 岡本安紀1), 寺崎実希1), 戸川尚美1), 中森光子1), 岸敬子1), 仲西未佳1), 平田貴大1), 松山芽衣1), 常村弥生1), 谷車彩夏1), 廣本真里1), 小倉朋子1), 多胡和樹1), 中村美樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2015.

	The inflection of the 22-8-O50-31 Hitachinaka health IT network and the usefulness 名越ソッヴィリヤックヴァッティ1),2), 玉井典子1),2), 関利一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2015.

Association with the expression situation and the effect of treatment of hypomagnesemia by the antiEGFR monoclonal antibody in patients with 23-4-O51-01 metastasis colon cancer and the acneform rash
藤井宏典1), 飯原大稔1), 石原正志1), 松橋延壽2), 高橋孝夫2), 吉田和弘2), 伊藤善規1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2015.

	Measures to an allergic reaction at the 23-4-O51-02 Docetaxel administration 西村知恭1), 嶋本めぐみ1), 佐野尚平1), 園部比呂志1), 岩城久弥1), 下野千草2), 上田弘樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2015.

	About association with thrombocytopenia and APRI (AST to Platelet Ratio Index) in patients receiving oxaliplatin for patients with 23-4-O51-03 colon cancer 谷口賢二1), 和田祐一1), 上田愛1), 小林一彦2), 岩田真3), 福永浩也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2015.

It is an administration dose intensity of oxaliplatin of mFOLFOX6 treated patients in the adjuvant chemotherapy and association with the progression-free survival period after 23-4-O51-04 colon cancer technique
地主隆文, 鈴木直哉, 前川英輝, 菊地義明, 藤林遼, 福井美規子, 吉嶋抄苗, 徳村麻衣子, 高橋誠, 青田忠博
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2015.

	Examination of the dose of D-mannitol in the short hydration method of the 23-4-O51-05 cisplatin 今井千晶1), 佐伯宏美1), 栗本遼太2), 江畑貴大2), 岩澤俊一郎2), 堺田惠美子3), 鈴木貴明1), 有吉範高1), 滝口裕一2), 石井伊都子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2015.

	Investigation about the risk factor of the 23-4-O52-06 ifosfamide encephalopathy 川田将義1), 中川俊作1), 西村綾1), 矢野育子1), 中川貴之1), 岡本健2), 松田秀一2), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2015.

Self-control controlled trial - VANQUISH trial - about the protective efficacy of the vitamin K1-containing cream for the 23-4-O52-07 cetuximab-related cutaneous symptom
加藤敏明1), 山崎健太郎2), 多久佳成3), 對馬隆浩2), 吉田幸生2), 濱内諭2), 吉川周佐4), 八木宏明5), 木村仁1), 石川寛1), 木村緑6), 中條倫成6), 坂田茂代1), 増島広幸1), 宮澤綾1), 斎藤加織6), 伊澤真木子7), 石見香8), 山中竹春9), 清原祥夫4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2015.

	The establishment of the side effect prevention system for the 23-4-O52-08 Afatinib remedy patients and the evaluation 小森由理子1),2), 清水克次1), 中多陽子1), 高橋一栄2), 福島宣久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2015.

The expression situation of the hypothyroidism with the 23-4-O52-09 molecules target medicine and the enforcement situation of thyroid function tests
頼光翔1), 島林逸人1), 山田弓美1), 園山智宏1), 平野榮作1), 横手克樹1), 竹下和男1), 村瀬哲也2), 泉谷悟2), 櫻下弘志2), 西垣内亮2), 佐伯康之2), 松尾裕彰2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2015.

	Onset of neutropenia investigation in the 23-4-O52-10 modified FOLFIRINOX therapy 中村匡志, 鈴木賢一, 渡邉大至, 柴田直樹, 濱敏弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 250-250, 2015.

	The expression situation of the cholinergic syndrome with 23-4-O53-11 irinotecan and the measures 久保杏奈, 米澤美和, 山田千代子, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2015.

Evaluation of the expression situation and the risk factor of edema induced by 23-4-O53-12 pemetrexed
遠藤拓未1), 伊藤大輔2), 浅野裕紀2), 岩井美奈2), 安達志乃2), 岡田和智2), 宇佐美英績2), 吉村知哲2), 石原祥史3), 坪井久美3), 平野公美1), 小菅和仁1), 渡邉進士1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2015.

	Relations with a hand-and-foot syndrome and the temperature in 23-4-O53-13 docetaxel treated patients and the steam pressure 内田敬, 土屋雅美, 猪岡京子, 高村千津子, 鈴木幹子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2015.

	The effect that steroid to use for 23-4-O53-14 cancer chemotherapy gives in start of therapy time for febrile neutropenia 宇夛裕基, 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2015.

	About the adaptability to elderly patients of the 23-4-O53-15 gemcitabine / dexamethasone / cisplatin (GDP) relief therapy 片山実佳1), 北澤文章1), 角陽子1), 上田久美1), 初瀬真弓2), 島崎千尋2), 高良恒史3), 国府孝敏1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 251-251, 2015.

	The production of the video for patients introducing 23-4-O54-16 pharmacist duties and the evaluation 玉木啓文1),2), 佐藤宏樹1),2),3), 三木晶子1),2),3), 三浦康正2), 藤原眞理子2), 澤田康文1),2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2015.

The change of the number of trial trust and duties contents in the hospital attached to the 23-4-O54-17 Kyoto University faculty of medicine in these 10 years
吉田詩織1),2), 老本名津子1),2), 松山倫子1),2), 神山ゆかり1),2), 緒方奈津紀1),2), 因藤伊織1),2), 佐藤栄里子1),2), 松尾和美2), 石橋茜2), 猪熊容子1), 石塚良子1), 米澤淳1),2), 中川貴之1),2), 松原和夫1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2015.

	About a risk factor of the 23-4-O54-18 hypermagnesemia and eligibility criteria of the magnesium preparation 幸邦憲, 山形真一, 中川義浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2015.

	Examination in the prospective study of the serum creatinine level revision method to use for a 23-4-O54-19 renal function estimation type 森住誠1), 松野純男2), 松宮美沙1), 今岡寛美1), 池田理沙1), 金丸絵理1), 石原美加1), 松田光弘3), 北小路学2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 252-252, 2015.

The understanding situation and problem of the pharmacist of hepatitis B reactivation measures guidelines with 23-5-O55-01 immunodepression, the chemotherapy
伊東真由子1),2), 岡智之1),3), 尾崎正和1),4), 木下英樹1),5), 藏田康秀1),6), 塚原邦浩1),7), 平岡ひろ子1),8), 光末尚代1),9), 山本武史1),10), 佐藤真也1),11), 古川裕之1),4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2015.

	Hepatitis B measures to occur by 23-5-O55-02 immunodepression, chemotherapy 大沢幸嗣1),2),3), 高家心人5), 光井洋4), 橋本直明4), 秦宏樹3), 大谷道輝1), 佐藤孝雄6), 寺島裕夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2015.

	Efforts to the hepatitis B virus reactivation measures that functionalized 23-5-O55-03 PDCA cycle 木全司1), 吉田弘樹1), 鈴木雅人1), 天野杏南1), 高原悠子1), 山室理2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2015.

	Evolution to drugstore pre-Abo id of the 23-5-O55-04 doubt inquiry example 長谷川佳孝1), 藤枝正輝1), 野中琢哉2), 林愛子1), 藤井洋介1), 月岡良太1), 森澤あずさ1), 大石美也1), 佐藤宏樹3), 澤田康文3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2015.

	About construction and the introduction effect of the traceability system which utilized 23-5-O55-05 pharmaceutical products GS1 bar code 木戸圭晋1), 上田宏1), 五十嵐努1), 矢野啓子2), 中田精三3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2015.

	Inflection in medicine manufacture settings of appearance similarity ratio evaluation system (PTPases) of the 23-5-O56-06 press through pack 高橋斉1),2), 玉木啓文3), 佐藤宏樹2), 今堀悦郎1), 井黒ひとみ1), 澤田康文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2015.

	A fall, the fall in the 23-5-O56-07 inpatient and relative investigation of the prescribed medicine 諌見圭佑1), 小園亜希1), 塩田喜美子1), 津曲恭一1), 木山聡子2), 永野真久2), 井上大奨2), 平木洋一3), 中川義浩2), 神村英利4), 山道研1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2015.

	Development of the next-generation tablet packing (ESOP) for 23-5-O56-08 PTP mis-deglutition accident prevention 盛本修司, 野崎雅男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2015.

Efforts ... to maintenance - HBV reactivation measures of the cancer practice system using the PDCA cycle in the 23-5-O56-09 Aichi cancer practice cooperation base Hospital
黒田純子1),6), 木全司2),6), 楠本茂3), 小松弘和3),6), 河田健司4),6), 室圭5),6), 木村和哲1),7),8)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2015.

	A start and efforts of the 23-5-O56-10 healthcare setting and the next-generation pharmaceutical products packing technology development team "Atami project" connected directly with 宮川雅樹1), 鈴木高弘1),2), 相本恒陽1), 豊浦基雄3),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2015.

	About efforts of the Relief System for Sufferers from Adverse Drug Reactions education in the 23-6-O57-01 pharmacy business training 橋本義宏, 金住麻子, 久保淳一, 津田雅大, 土井佳子, 三本松泰孝, 船木映二, 佐藤弘康, 和泉秀明, 小森均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2015.

	Preliminary investigation about the correspondence to a representative disease of the pharmacy business training in the 23-6-O57-02 group training 小野浩重1), 雛元悦子2), 監物英男3), 滝波昇悟3), 安藤公江4), 貝原徹5), 加地弘明1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2015.

	Education effect of the emergency intensive care domain learning in the 23-6-O57-03 pharmacy education business training 原直己1), 座間味義人2), 内田佳菜子1), 松田俊之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2015.

	Change of the impression for the psychiatry of the trainee by having introduced experience-based training in 23-6-O57-04 psychopathic ward 佐々木典子1),2), 池村健治1), 三輪高市2), 河原佑樹1), 村木優一1), 岩本卓也1), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2015.

	Make it, and use a text for ... business training for better mild medical education in the 23-6-O57-05 business training; and ... 形部文寛1), 八本久仁子2), 八本聖秀3), 武智宣佳4), 山崎富士子5), 中村孝佑6), 林俊吾7), 増田都子8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2015.

	Usefulness of the backer-up introduction by the learning before business true taking lessons for the student with 23-6-O58-06 hearing disorder 真島崇1), 大原宏司2), 倉本敬二3), 伊藤鍛2), 早坂正孝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2015.

Role of the pharmacist of a pharmacy education curriculum and the community medical care of the 23-6-O58-07 at-home team approach in medical care promotion studies lecture
小林篤史1),2), 杉山正1), 林秀樹1), 神林純二2), 宇野進2), 北川靖3), 渡辺康介3), 上原春男3), 神野君夫3), 土井正樹3), 山脇正永4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2015.

	Obesity, alcohol metabolism-related genetic screening seminar for pharmacy school students aiming at the genetic information contribution as the 23-6-O58-08 pharmacist 池田佳代1), 細井徹1), 吉井美智子1), 杉山政則2), 小澤光一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2015.

	23-6-O58-09 Epinephrine autoinjector training program development 万代康弘1), 石原慎2), 近藤康人3), 松井俊和2), 岡本陽4), 筒井和美4), 白井正康5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2015.

	Introduction (to see power to think about) of the problem contents that a correct answer person was one person in a study of the 23-6-O58-10 first grader basic biology 佐藤亜希子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2015.

	The effectiveness of the injectable acetaminophen preparation in the 23-7-O59-01 thoracic surgery postoperative pain management and safe evaluation 新海大智1), 澤田和久1), 粟田浩文1), 奥平正美2), 勝見章男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2015.

	Attitude survey of the pharmacist before and after the class of the use of 23-7-O59-02 basic life support, automated external defibrillator 田村亮1), 高山慎司1), 川名賢一郎1), 石松伸一2),3), 後藤一美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2015.

	Safe examination of the vancomycin 24 hours continuous intravenous infusion therapy in 23-7-O59-03 neonates 辻村行啓1), 犬飼康子1), 大木茂2), 塩川満1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2015.

	Research of the effect of herbal medicinal products on delirium in the 23-7-O59-04 first aid domain 野田治代1), 名倉弘哲1),2), 平山敬浩2), 氏家良人2), 千堂年昭3), 波多野力1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2015.

	Analysis of the drug information offer by the pharmacist in the 23-7-O59-05 ICU 橋本直明, 飯塚史織, 齊藤麻加, 木村あおい, 柿崎詩野, 中島正人, 堀内学, 土岐浩介, 神林泰行, 本間真人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 257-257, 2015.

	Taste bitter prediction of the compound agent using the 23-7-O60-06 taste sensor 原口珠実, 中村早貴, 白石早祐子, 竹下華子, 小島穂菜美, 吉田都, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2015.

	Quality evaluation of the 23-7-O60-07 clarithromycin dry syrup 小島穂菜美, 福留夢姫, 松本早織, 原口珠実, 吉田都, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2015.

	23-7-O60-08 Promotion of appropriate use of hepatitis C drug Daklinza Tablets, Sunvepra Capsules by utilizing check sheet 加藤誠一1), 田中直哉2), 近藤澄子1), 矢島毅彦3), 田中秀和1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2015.

	Contribution to medical treatment by the prescription checking before compounding of medicines based on the 23-7-O60-09 drug history management 川崎好人, 橋本陽, 小出哲朗, 石川久高 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2015.

	Investigation of the PTP sheet pollution status with the 23-7-O60-10 5 α - inverting ferment inhibitor oral medicine 松岡哲史1), 高見陽一郎1), 岡崎大祐1), 小川壮寛1),2), 佐藤展子1), 森翔馬1), 酒井将弘1), 中川碧1), 江川孝1), 島田憲一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 258-258, 2015.

	It is> mainly on the activity of the relation <Japan Team for Disaster Relief medical care team second corps of the pharmacist in the medical service for the 23-7-O61-11 Nepal earthquake damage 江川孝1),5), 萬年琢也2),5), 加藤あゆみ3),5), 涌嶋伴之助4),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2015.

	Relation ... to the nation's first outdoor operating room function in the ... Nepal earthquake disaster reconsidering the medical support of the pharmacist at the 23-7-O61-12 disaster 加藤あゆみ1), 涌嶋伴之助2), 江川孝3), 萬年琢也4), 片山志郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2015.

	Usefulness at development and disaster of the 23-7-O61-13 drug identification support system (medicine fast for iOS) 木村敦, 木村真也, 逢坂智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2015.

Hold 23-7-O61-14 Japanese Red Cross Society disaster medical care relief squad - disaster relief pharmacist workshop; and ...
滝澤康志1),9), 小林映子2),9), 原田真理3),9), 近藤智之4),9), 追木正人5),9), 安藤和佳子6),9), 大塚万記子7),9), 下石和樹8),9)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2015.

	Effect of factor DDS preparation and the patients side factor CYP3A5 genetic polymorphism of the preparation giving it to costs in the 23-7-O62-15 tacrolimus year 加藤正太郎1), 新岡丈典1), 加賀谷英彰1), 佐々木克也1), 佐藤滋2), 三浦昌朋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2015.

	Does sequential treatment in the 23-7-O62-16 Helicobacter pylori sanitization become the Japanese standard therapy? 岡崎彰仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2015.

	Inspection of the medical expenses reduction effect that the standard adequacy of oral 23-7-O62-17 pharmaceutical products results in 白石奈緒子1),2), 小山敏広1), 座間味義人1), 建部泰尚2), 大島礼子1), 千堂年昭2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2015.

Inspection of the equivalency of a 5-FU innovator drug, the generic drug in the 23-8-O63-01 infusor pump continuation dosage law
小島一晃1), 美和孝之1), 仲忠士1), 松本弘誠1), 濱武清範1), 奥村優介1), 小西史子1), 飯田有香1), 足立那々緒1), 酒井ちひろ1), 福井美礼1), 千葉渉1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2015.

	Prescription suggestion of the pharmacist in patients with 23-8-O63-02 blood-forming organ tumor 南貴之, 風間静香, 花輪和己, 小林義文, 山本誠一, 磯部克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2015.

Comparison of the portable constant infusion pump varying in a flow quantity control system in the 23-8-O63-03 outpatient department chemotherapy
丸山卓哉1),2), 門脇督1), 蝦名勇樹1), 藤井達也1), 森田眞樹子1), 手塚悠希1), 鈴木千波1), 田畑裕和1), 佐藤明子2), 高橋理絵2), 柴波明男1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2015.

	Comparison of the antitumor effect by the combination of antihypertensive medications in 23-8-O63-04 basalioma treatment 中村希1), 門脇大介1), 高森紀衣1), 成田勇樹1), 小田切優樹2), 丸山徹1), 平田純生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2015.

	23-8-O63-05 Experience in using trifluridine, tipiracil hydrochloride (Lonsurf(R)) after tertiary therapy for advanced, recurrent colorectal cancer 辻井聡容1),2), 大垣孝文2), 中永かおり2), 今井清隆2), 木瀬大輔2), 多田章二2), 天野学1), 森山雅弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2015.

	Case study of TAS- 102 (Ron surf (R)) for inability to 23-8-O64-06 curative resection progress, recurrent colon cancer 菊地寛子1), 内山由貴1), 西脇瑞紀1), 養田裕行1),2),3), 関根佳代1), 浅子恵利4), 傳田忠道5), 松本美奈子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2015.

	The neutropenic expression of TAS-102 (Ron surf (R)) in the renal failure that assumed 23-8-O64-07 creatinine clearance an index situation 内山由貴1), 菊地寛子1), 西脇瑞紀1), 養田裕行1),2),3), 関根佳代1), 浅子恵利4), 傳田忠道5), 松本美奈子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2015.

Inspection of the effectiveness of the cancer-specific antigenic peptides opsonic therapy for patients with 23-8-O64-08 progress-related head and neck squamous cell carcinoma
城野博史1), 吉武義泰2),3), 福間大喜2), 湯野晃2),4), 平山真敏2),4), 中山秀樹2), 小島拓2), 中根未季2), 尾木秀直2), 平木昭光2), 濱田哲暢5), 齋藤秀之1), 西村泰治4), 中村祐輔6), 篠原正徳2),3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2015.

About the dose examination in the elderly people in the 23-8-O64-09 lung cancer CBDCA (AUC 4) + weekly nab-PTX (80 mg/m2 of day 1, 8, 15) therapy
長谷川英利1), 上中敏弘1), 松井駿亮1), 川端一功1), 田中巧1), 上田桂子2), 大内政嗣2), 尾崎良智2), 井上修平2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2015.

	Examination of the effectiveness of the pharmacist regimen observance intervention in the 23-8-O64-10 cancer chemotherapy 林誠1),2), 井上裕貴1), 松本修一1), 崔吉道2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2015.

	One case with suspected rise in lithium concentration by the interaction of 23-8-O65-11 lithium carbonate and the Terumi sultan 生島繁樹, 早見めぐみ, 前川聡美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2015.

	One case of progress colon cancer in acknowledgment of PT-INR rise with suspected interaction with 23-8-O65-12 Regorafenib and warfarin 北出紘規1), 北国憲剛1), 森光恵1), 矢野聖二2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2015.

	Example that an antiblood clotting effect of the warfarin reinforced at 23-8-O65-13 regorafenib combination 熊澤里美, 伊藤佳織, 安藤洋介, 安藤舞子, 太田秀基, 山田成樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2015.

	The case that caused significant extension of PT-INR by combination of 23-8-O65-14 high dose acetaminophen and warfarin 尾崎正和1), 幸田恭治1), 福田裕次郎2), 堀健志2), 植松俊成1), 古川裕之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2015.

	Effect of 23-8-O65-15 triazolam and menthol giving it to an internal change of the phenytoin 五十嵐信智, 星野心広, 廣部隆太, 楠欣己, 今理紗子, 落合和, 杉山清 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2015.

	Effect of the diet on drug interactions of amlodipine and the active carbon in the 23-8-O65-16 gastrointestinal tract 関耕平, 秋好健志, 今岡鮎子, 大谷壽一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2015.

	It is ... mainly on drug interactions with ... amiodarone through prescription support of the 23-8-O65-17 warfarin 塚井麻実1), 小松敏彰1), 小林昌宏1), 国分秀也1), 近藤留美子1), 厚田幸一郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 264-264, 2015.

	Examination of the method to alert on the in-hospital prescription for the quality improvement of the P0001-21-PM formulations inspection 前田力丸, 山野邉裕子, 田村賢士, 金子智一, 鈴木秀昭, 松井孝之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

	Efforts for the simple suspension method spread in the P0002-22-AM our hospital 志田里志1), 齋藤尚子1), 佐藤貴大1), 松田千佳1), 池本真紀2), 高橋美香子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

Study on preservation stability of the mixture consisting of P0003-21-PM W/O type moisture retention cream preparation and the adrenal cortical steroid ad usum externum preparation
山本佳久1), 久米谷萌水1), 大貫義則2), 深水啓朗3), 小出達夫4), 鈴木豊史5), 伴野和夫5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

	Construction ... of the formulations shelf label making system using efforts - Microsoft Access to P0004-22-AM formulations environmental management 奥村俊一, 高沢真央, 岡部由幸, 剱田侑希, 前波麻里子, 塩地園代, 白石範子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

	About the efficiency of compounding of medicines duties by the P0005-21-PM tablet inspection support system introduction 久保祐太, 阿部孝行, 倉林誠, 池井良貴, 山田英俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

	It is examination about the stability in formulations the package of P0006-22-AM ursodeoxycholanic acid tablets 毎田千恵子1),2), 秋山滋男3), 礒野淳一3), 玉井郁巳2), 松下良2),5), 宮本悦子4),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 266-266, 2015.

	Result and problem by the practice of the pharmaceutical instruction to P0007-21-PM outpatient 冨岡謙二, 淀川進也, 小田若那 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

	A decision of the P0008-22-AM outpatient department prescription inquiry simplification operation and the effect 内田雅士, 新井さやか, 山崎香織, 竹田真理子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

Analysis of the inquiry contents from the pharmacy service under health insurance drugstore for the P0009-21-PM outside Parliament prescription
正原東良1), 渋谷文則2), 江藤壮志2), 新倉卓2), 黄暁華2), 巣山郁子2), 村上瑛莉香2), 田嶋梓2), 滋田伊世2), 藤本菜奈2), 山崎智世2), 田中義幸2), 木村絢果2), 土屋純一2), 市川卓哉2), 櫻井恵理2), 内藤梨奈2), 小久保智裕2), 八巻俊哉2), 高橋信2), 廣井順子3), 中島由紀1), 杉浦宗敏1), 内川清次2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

About the effect that the representation input by the pharmacist at the P0010-22-AM doubt inquiry gives in change of prescription
岸敬子, 黄前尚樹, 今井美恵子, 岡本安紀, 戸川尚美, 寺崎実希, 中森光子, 仲西未佳, 平田貴大, 松山芽衣, 谷車彩夏, 常村弥生, 廣本真里, 小倉朋子, 多胡和樹, 中村美樹
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

	The effectiveness of the doubt inquiry using a section system at the P0011-21-PM initial administration 山本恭平, 岩瀬由枝, 野澤孝子, 大野愛, 吉田浩, 山下雅代, 勝見章男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

The operation of the test value printing system for the P0012-22-AM efficiency-like checking prescription and future examination
井上理香子, 廣澤真優, 稲垣孝行, 平岩真理子, 福澤翔太, 井上由佳梨, 野村英宏, 倉地茜, 太田小織, 鳥本真由美, 山田清文
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2015.

About the formulations of the P0013-21-PM public corporate judicial person Fukui pharmacist society narcissus drugstore and a prescription checking support system
平賀貴志1), 福岡美紀1), 杉本訓子1), 有田奈美1), 山口洋枝1), 服部はるか1), 塗茂佳世1), 安野さとみ1), 木村嘉明2), 高畠栄一3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

	Recognition investigation of the patients for the risk of P0014-22-AM drug remedy and the driving 今泉瑛那, 土橋安純, 平野裕美, 浦崎圭太, 菱田栄子, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

	Fact-finding of the doubt inquiry in the P0015-21-PM health insurance pharmacy 高道二千香1), 十万佐知子1), 植田愛1),2), 奥田浩人1), 三木知博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

	The relation of the pharmacist in the P0016-22-AM outpatient department cataract surgery and future problem 吉田尚子1), 多田亜矢1), 目良りか4), 沼慎一郎3), 松井孝明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

	Efforts and usefulness evaluation of the doubt inquiry based on the P0017-21-PM renal function evaluation 青木健祐, 夏目義明, 齊藤政利, 渡辺重雄, 柄沢一弘, 中條睦子, 藤田真一, 美濃川香世子, 星野貴子, 田邉梨恵, 水澤彩乃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

	The situation and analysis of the doubt inquiry in the P0018-22-AM health insurance pharmacy 中島由香里1), 石川道佳1), 松尾浩民2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2015.

	The effect that a test value mention gives to doubt inquiry contents on P0019-21-PM outside Parliament prescription 野口亜樹, 山崎美保, 中下愛, 木村竜司, 今津智子, 西園寺真二, 松本篤, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

	The utilization situation and problem about the test value indication to P0020-22-AM outside Parliament prescription 齊藤美聡, 横山威一郎, 山口洪樹, 山崎香織, 橋本杏里, 新井さやか, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

	Construction and evaluation of the formulations medicine inspection system which utilized bar code indication of the P0021-21-PM drug for external use 小野祐志, 赤羽美樹子, 大江彰彦, 村田充弘, 新家恵子, 栗谷良孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

	Dispensing error prevention by the P0022-22-AM image inspection support system introduction effect 硲真悟, 新嶋茂正, 松橋裕子, 阿部宏志, 神谷友理子, 大塚一興, 町島浩, 伊藤由香, 坂上逸孝, 増原慶壮, 横山美恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

	The error decrease effect with the P0023-21-PM newly automatic tablet formulations system and examination of the formulations speed 小林武志, 高橋修二, 須藤将裕, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

About construction and the trial situation of the formulations medicine inspection image recording system using P0024-22-AM Web camera
赤羽美樹子, 小野祐志, 徳山絵生, 上野ひとみ, 上ノ山江利子, 大江彰彦, 竹中智子, 村田充弘, 新家恵子, 栗谷良孝
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2015.

	The way of a factor investigation and preventive measures to lead to P0025-21-PM normalization bias against future blunders 山田和正1), 高橋志朗1), 井上幹雄2), 小林範博3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

	In the P0026-22-AM dispensary take; the fact-finding of the mistake 鮫島絵莉子, 進健司, 梅田勇一, 内田守次, 橋本政弘, 金澤康範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

Inspection ... of the appropriate crush degree of the drug which is hard to collapse which we saw from efforts - nurse questionnaire for the problems improvement of the P0027-21-PM simple suspension method
松原満裕, 川崎奈美江, 岸脇由衣, 天生浩子, 竹内祐介, 安田光都子, 根来早紀子, 西井有希, 木村初, 小泉祐一, 野村真美
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

	Usefulness of the personal digital assistant (PDA) in P0028-22-AM calculation compounding of medicines duties 小沼利光, 神崎浩孝, 天野杏, 金聖暎, 西宮祐輔, 丸尾陽成, 田中雄太, 定金典明, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

	About the stability of isosorbide dinitrate tablets in the P0029-21-PM automatic packeted plane rotor cassette 林真優1), 高橋謙太1), 沼尻幸彦1), 大島新司1), 新津勝1), 古地壯光1), 小林大介1), 秋山滋男2), 礒野淳一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

	It is an effect of the introduction by P0030-22-AM drug management system (Narcotic Stage) 谷口公章, 北村仁, 伊藤ちか恵, 鶴田瑛典, 宮明洋一郎, 佐々木達也, 海部真代, 甲斐章裕, 力武隆浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2015.

	Efforts to generic medicine introduction for the contribution to P0031-21-PM Hospital management 本郷知世, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

	Comparison between the stable preparation becoming durability of P0032-22-AM magnesium oxide tablets and one 里加代子, 稲岡奈津子, 松本章, 佐々木均, 北原隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

	Change efforts to a product (domestic product) derived from domestic blood donation of the isotonicity albumin preparation in conformity with a basic idea, basic policy of P0033-21-PM Blood Law 本田義輝, 齋藤秀之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

	The effect that temperature of the warm water to use at the P0034-22-AM simple suspension method enforcement gives to Cravit tablets collapse 石田志朗1), 原隆志1), 山川和宣1), 渡辺智康2), 安藤哲信2), 新井克明3), 岡野善郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

	Through P0035-21-PM enteral feeding tube a Valproic Acid infinitesimal grain a throw pre-; a workaround of the obstruction to occur when did it 浜田茂明1), 石田志朗2), 岡田清花2), 山川和宣2), 森本真仁1), 鈴江朋子3), 岡野善郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

	Intervention ... to operating room intervention example report - PCA germfree preparation duties of the pharmacist in the scale hospital out of P0036-22-AM 栗崎貴啓1), 園田美智代2), 相方靖史3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2015.

	It is ... as part of review ... ward drug duties of the P0037-21-PM ward fixed number medicine 十文字菜穂, 矢作栄男, 小林庸子, 中山英明, 長澤知徳, 泉亮介, 辻健作, 安齋枝里, 篠原高雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

	About efforts to pharmaceutical products management adequacy with the operating room permanent residence of the P0038-22-AM pharmacist 猪狩賢蔵, 鈴木信也, 野村嘉奈子, 林誠一, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

	Introduction of the drug, locking management medicine automatic withdrawal device (Inteligent-Cabinet SYSTEM(R)) in the P0039-21-PM surgery part 長屋美香子, 只見智恵子, 山口芳幸, 林勇輔, 森敬子, 坂丹波礼子, 高橋賢成, 木村利美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

	Efficiency of the duties by the review of P0040-22-AM inventory control duties 鈴田浩孝1), 大久保嘉則2), 三砂義敬2), 床島英雄2), 加茂章弘1), 仲村早紀1), 小迫晶寛1), 小薮真紀子1), 草葉一友2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

It is ... for the realization of ... imagination cassette about usefulness by the introduction of the P0041-21-PM returned goods medicine withdrawal machine
高橋功一, 樋口和子, 山口佳津騎, 水川奈己, 立道貴清, 野崎孝徒, 篠原尚樹, 小坂信二, 芳地一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

	Examination about the effect when we changed the P0042-22-AM pharmaceutical products purchase to a little packing 角山政之1), 冨永雅枝2), 柳田徳栄2), 垰越崇範2), 松尾裕彰2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2015.

	Match a sublingual tablet with P0043-21-PM fentanyl buccal tablet; risk management at adoption 宮崎あゆみ, 原祐輔, 板井進悟, 高林真貴子, 平原佑季子, 嶋田努, 崔吉道 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

	About unification of the pharmaceutical products temperature management using P0044-22-AM network 鈴木薫, 濱田武, 坂本朱里, 西原雅美, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

	Management such as a drug, the poison in the P0045-21-PM operating room, relation of the pharmacist to operation 小出哲朗1), 山野惣平1), 吉野正康1), 西川佐喜代2), 藤代陽子2), 伊澤英次3), 玉置秀成1), 松原史典1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

	Efforts in our hospital for P0046-22-AM Abstral sublingual tablet proper use 徳田憲治1),2), 西村絵実1),3), 川原成一2), 貴島文雄1),4), 小野原信一1),5), 柳政行1),4), 古川いづみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

	Anesthesia set management in the operating room by the cooperation with the P0047-21-PM anesthesiologist 坂本有加1),2), 田中陽一郎1), 今成得恵1), 櫻井雄太1), 湯野川隻2), 武田昌子2), 郡彰一2), 松川公一2), 中村裕義1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

	Efforts to reduction of the immovable stock in the scale hospital out of P0048-22-AM and the significance 唐橋久恵, 藤島ひとみ, 平尾尚之, 佐藤直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2015.

	Efforts to pharmaceutical products inventory control efficiency in the P0049-21-PM Tsuchiura practice medical examination center 宇津木敦子, 伊藤春子, 阿部加奈子, 小野崎昌史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

	Inspection of the effect after the P0050-22-AM pharmaceutical products digestion payment system introduction 深見徹郎, 岡亜矢子, 久原紀子, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

	Examination and preparation stability evaluation of the formula of P0051-21-PM hospital preparation 0.033% PA, iodine eye drops 西川満則, 中村歩, 八木裕太, 細川祐岐, 森本啓太, 田邉沙織, 百崎久恵, 勝浦正人, 門脇裕子, 三輪芳弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

Examination second report of the Mitsuyasu qualitative analysis of P0052-22-AM Lambert-Eaton myasthenic syndrome therapeutic drug 3,4-diaminopyridine and photodegradation thing
小林恵里奈1), 上田真理1), 内山正彦2), 福吉修一3), 石田奈津子1), 舟木弘1), 松下良3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

	Examination of the infusion preparation using P0053-21-PM KOACH C645-F 長岡匠, 鈴木理穂, 越川千秋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

	Examination of the pharmaceutics of the new stomatitis therapeutic drug using P0054-22-AM mesalazine 石破佳永子, 下村斉, 河野弥生, 花輪剛久, 青山隆夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2015.

	The use situation of the Yokukansan suppository which we gave at surgery for the purpose of the delirium prevention after P0055-21-PM technique 京由美子, 吉岡亮, 乾有希子, 池田久雄, 野村浩英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

Examination of stability and the usefulness of the sterilization 5% iodine stain used in P0056-22-AM gynecology at uterine cervix cancer surgery
渋谷文則1), 巣山郁子1), 村上瑛莉香1), 江藤壮志1), 内藤梨奈1), 八巻俊哉1), 高橋信1), 廣井順子2), 池田さやか3), 工藤一弥3), 櫻庭瑛4), 山口翔平4), 工藤敏之4), 伊藤清美4), 内川清次1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

	Examination about the usefulness for stomatitis with chemistry, the radiotherapy of the P0057-21-PM hospital preparation HACHIAZULE professional Mac D Xylocaine mouth wash 吉元公一1),2), 峰島宏枝1), 輿石徹1), 塚原清彰2), 小川恭生2), 奥山清1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

	Examination about preparation properties of the P0058-22-AM polyvinyl alcohol addition oral mucosa adhesion lock 戸田紗衣1), 池内由里1), 石原千津子2), 伴孝仁1), 三浦英里佳1), 大西啓1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

Basic pharmaceutical properties of matter evaluation - of the study on P0059-21-PM Mohs' paste (the tenth report) - prescription improved Mohs' paste
田口真穂1),3), 伊東奈保美2), 小川法子2), 高橋知里2), 村田実希郎1), 礒部隆史1), 埴岡伸光1), 重山昌人1), 山本浩充2), 寺町ひとみ3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

	The establishment of the Mohs paste use protocol in P0060-22-AM this museum and 1 case 西村美里, 宮原強, 松永尚, 竹内恵, 黒部健太郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2015.

	One case that used P0061-21-PM polymyxin B inhalation therapy to multidrug-resistant Pseudomonas aeruginosa pneumonia of the patients in the maintenance dialysis 村津圭治1), 橘憲2), 大津幸1), 佐光留美1), 覺野律1), 本田芳久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

	Examination of the preparation method of the P0062-22-AM hospital preparation selenium injection 若月淳一郎, 松本香織, 向山明彦, 南貴之, 長谷川美雪, 中根優, 花輪和己, 磯部克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

	It is evaluated the rheological property of the xyloglucan solution P0063-21-PM emulsion 下山哲哉, 宇野早也香, 小野夏実, 佐藤倫亮, 伊藤邦彦, 小林道也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

	A preparation and preparation properties of the gelation preparation of the P0064-22-AM hinokitiol 釣みずき, 鈴木莉奈, 村田勇, 井上裕, 金本郁男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

	The effect that P0065-21-PM acceleration condition gives to an elution rate of the indomethacin capsule 栗林和美, 阿部麻衣, 関場美香, 山本佳久, 水野恵司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

	Comparison of the P0066-22-AM magnesium oxide tablets generic medicine 遠藤裕司, 丘龍祥, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2015.

	Competitive review of inside the hospital about the property of the ointment preparation for the P0067-21-PM oral cavity and the outside Parliament drugstore 牧田久美子, 石道陽子, 星子謙, 原澤秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

	Comparison evaluation of the physicochemical property of the P0068-22-AM acetaminophen preparation 井上裕, 鈴木健吾, 池田貴司, 角田結菜, 小野田弘崇, 菅原光希, 土屋侑瑛, 釣みずき, 恵沢敏成, 金本郁男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

	Diachronic examination about the peroxide generation in the lipid microsphere for the P0069-21-PM IV infusion 北小路学1), 林智洋2), 三島裕彦2), 大鳥徹1), 松山賢治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

	It is examined the storage container for the purpose of the prevention of moisture absorption of the formulations medicine P0070-22-AM package 脇屋義文, 渡部文菜, 平野匡哉, 梅村雅之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

	P0071-21-PM Mechanism of moisture stabilization and its stabilization mechanism of OPALMON tablets meeting the needs of dispensing medicines at medical sites 関屋昇1), 井上靖雄2), 片山和格2), 鳴瀧壮二2), 山本政信1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

	Effect - with examination - PTP of the color change of pharmaceutical products under a lot of P0072-22-AM lighting 山下修司1),2), 井口和弘1),2), 野口義紘1),2), 堺千紘1),2), 伊野陽子1),2), 中村光浩1),2), 寺町ひとみ1),2), 杉山正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2015.

	Intervention effect to the administration duties by the ward pharmacist in the P0073-21-PM medical treatment ward 安藝智子1), 小原麻由1), 溝口千鶴2), 田平潤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

	A trial and evaluation of the prior confirmation of the appointed hour prescription by the P0074-22-AM ward permanent residence pharmacist 藤田早織1), 早船彩花1), 竹節七美1), 永田将司1), 高橋弘充1), 安原眞人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

	Approach report of the internal use self-care support that cooperated with P0075-21-PM nurse 伊藤知行1), 陰山敦美1), 島岡藍1), 日谷直子1), 宮原由香里1), 太田哲徳1), 鈴木智子2), 市川典子2), 細谷仁美2), 山崎千絵2), 高木恵子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

	Inspection of introduction and the usefulness of the medicine calendar in the P0076-22-AM stroke department ward 塚田藍, 西村英子, 石塚友一, 塩川満 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

	Efforts for the safe use of the P0077-21-PM Mohs ointment 小角麻衣1), 瀬名波宏昌1), 田代美佳1), 大河万顕1), 冨田由美1), 名徳倫明2), 川口進一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

	Present conditions investigation about the prescription participation in planning by P0078-22-AM ward drug duties 宮内秀典, 野口周作, 宮田広樹, 若城由美子, 笠原英城 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2015.

	A present conditions report and outcome evaluation of P0079-21-PM ward drug duties 吉田仁志, 秋山滋男, 礒野淳一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

P0080-22-AM About the present condition and evaluation of ward drug business in Kitakyushu General Hospital 2nd report: What I saw from the ward drug service daily
今村陽子, 中島一, 大治万喜子, 堂薗吉彬, 鮫島恵介, 福田恭輔, 岡仁美, 松尾麻美, 坂井蘭, 大石貴裕, 池田浩和, 高橋浩二郎
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

	About the efforts of the ward drug duties in the P0081-21-PM neonates treatment ridge 米田奈美, 木原理恵, 鶴崎泰史, 高島伸也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

	The enforcement situation of the prescription intervention in P0082-22-AM ward duties and clinical outcome 福島史織, 星野輝彦, 松本健吾, 塩津和則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

	Effect of the pharmacist intervention in the P0083-21-PM intensive care unit 河野洋平, 浦田修平, 外山智章, 田崎智也, 大野梨絵, 関屋裕史, 岩切智美, 奥村学, 有森和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

	Relation of the pharmacist for the patients who did a change ridge in a regular hospital from the P0084-22-AM ICU 安井一正, 高橋弘泰, 大谷寧次郎, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2015.

	P0085-21-PM NICU, pharmacist duties in GCU 田中庸, 富樫敦子, 阿部和人, 鎌田敬志, 庄司知摩, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

	Efforts of ward drug duties in P0086-22-AM NICU, GCU 田中翔子, 久本佳奈, 山田美穂, 日野千恵子, 水津知葉, 廣實清司, 古川裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

About efforts for the promotion of the pharmaceutical instruction in the P0087-21-PM Osaka railroad hospital pharmacy correspondence - to 2 of - Pharmacist Law Article 25
小牟田豊, 辻本亜理沙, 衛藤広士, 吉田友里, 河野有希, 古谷真依子, 中井優作, 福田晴美, 八代哲也, 東海秀吉
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

It is efforts in our hospital to the pharmaceutical products with mention about the examination that is periodical in a warning column of the P0088-22-AM package insert
澤口友紀, 合田さやか, 亀岡喬, 鹿沼奈央, 足立雅, 盆子原唯, 川村大輔, 大荒政志, 浜野憲子, 平野真衣, 久岡清子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

	Ward activity in the P0089-21-PM ward drug duties enforcement addition non-calculation institution 清川明慶, 西川眞佐人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

Evaluation - of the usefulness of the internal use commuter pass prescription representation input in practice - orthopedics ward of PBPM in the hospital attached to the P0090-22-AM Nagoya University faculty of medicine
田上聖実1), 濱田恭2), 千崎康司1), 宮崎典子1), 久米初枝1), 杉本亜弥1), 矢野亨治1), 酒井忠博3), 西田佳弘3), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2015.

	Construction of the aspiration pneumonia protocol in the P0091-21-PM neurosurgery ward 佐藤悠太1), 木村正行1), 藤原斉1), 太田原康成2), 遠藤英彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

	Efforts (the first report) before and after the surgery by the pharmacist in the P0092-22-AM autoregulation pain relief out of the endocranium 平田一耕1), 鎌野公実1), 鈴木正論1), 永井淳子1), 吉沼裕美2), 舟越亮寛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

	Efforts of ward drug duties in the P0093-21-PM our hospital 佐藤佳華1), 藤原陽子1), 堀金妙子1), 遠藤麻紀1), 日下部鮎子1), 菊池一樹1), 明田克之2), 江副英理3), 八十島隆博3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

	Efforts in the discharge support conference in the P0094-22-AM synthesis clinical department ward 福島奈津美, 櫻井登代子, 伴具也, 福田亜矢, 菱田啓介, 三浦誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

	Construction and efforts of the training program for the purpose of the improvement of the quality of P0095-21-PM ward drug duties 花澤迪子, 片山皓希, 渡邉暁洋, 福田恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

	Duties reform of the small and medium size hospital which aimed at the improvement of P0096-22-AM clinical drug duties 横山敏紀1), 大森恭子1), 中村宜央1), 江口美夏1), 吉玉幸弘3), 五十嵐知文2), 中島茂夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2015.

	Change after the working full time pharmacist placement in P0097-21-PM ward drug duties 高儀佳代子, 谷浩成, 安藤智美, 清水圭子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

	Analysis of the pharmaceutical intervention by the P0098-22-AM ward charge pharmacist 鵜飼麻由, 松本茂, 山田哲也, 鷹見繁宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

Ward drug log book making system in 1 new system introduction electronic chart with the P0099-21-PM ward drug duties enforcement addition calculation
村田七海, 島崎良知, 甲斐田浩輔, 早舩美保子, 瀧川正紀, 田中達郎, 前田陽平, 深野光司, 横井妙子, 森淑子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

	Examination of the usefulness in the doubt inquiry item addition of 2 new system introduction ward log book systems with the P0100-22-AM ward drug duties enforcement addition calculation 早舩美保子, 深野光司, 瀧川正紀, 島崎良知, 横井妙子, 森淑子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

Construction of 3 new system introduction pharmaceutical products "information sharing systems" with the P0101-21-PM ward drug duties enforcement addition calculation
田中達郎, 瀧川正紀, 甲斐田浩輔, 早舩美保子, 村田七海, 前田陽平, 深野光司, 島崎良知, 横井妙子, 森淑子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

Construction of the drug duties support system which utilized P0102-22-AM tablet terminal
村田久枝, 寺本有里, 大井美和, 高木友莉, 林田佳愛, 長山優介, 北村美穂, 藤波舞, 廣本早紀, 秋田幸子, 駒井千穂, 前田英加, 益田敦美, 浅場幸子, 北口剛吉, 藤吉徹也, 山本克己
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2015.

	Pharmacist in ward duties of the P0103-21-PM our hospital, practice nurse, the present conditions of the joint participation in planning of the nurse 渡邊由梨香, 筑井菜々子, 枦秀樹, 太田哲徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

	Construction of the side effect monitoring system of the high-risk medicine which utilized P0104-22-AM FileMaker (R) 小土井亮介1), 河原光1), 酒井照美1), 西塚亨1), 渡辺智康2), 安藤哲信2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

About the present conditions of ward drug duties in the P0105-21-PM our hospital and the evaluation
古賀清弘, 江崎舞, 天野佳奈, 池綾子, 大竹由希子, 町田梨絵子, 五反田智恵, 竹永早百合, 原友子, 松下尚弘, 石丸隆之, 藤田誠二, 野中敏治
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

	Construction of the P0106-22-AM ward drug duties support system 須田泰記, 中村安孝, 信田佳克, 西川武司, 永山勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

	Result of the pre-Abo id report promotion in the P0107-21-PM Yokohama medical center 石川紗耶香, 神長雅浩, 西村富啓, 佐橋幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

	Efforts of the drug instruction about driving attention, the prohibition of the car in our hospital with the P0108-22-AM revision Pharmacist Law 舌間清晃1),2), 安部有香1), 光安靖子1), 藤田あゆ美1), 長岡麻由1), 藤啓子1), 江崎信子1), 小池城司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2015.

P0109-21-PM Kagawa University nose and ears pharynx department, dermatology, plastic surgery, questionnaire for ward drug duties in dentistry
田井達也, 山口佳津騎, 山本高成, 加地雅人, 篠原尚樹, 水岡大策, 越野優希, 冨田淳子, 立道貴清, 小坂信二, 芳地一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

	Questionary survey to the nurse about P0110-22-AM ward drug duties 吉川慧, 村井華代, 荒川裕明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

	Relation of the pharmacist for patients with rheumatoid arthritis in the P0111-21-PM Kurume University Hospital 野口朱美, 堤一貴, 田中和江, 中垣春美, 有馬千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

Relative - with present conditions - ward sojourn time and the pharmaceutical products proper use of the P0112-22-AM ward drug duties enforcement addition acquisition institution
瀧本淳1),2), 濃沼政美1),3), 前田拓哉1), 藤原久登1),4), 小林求1), 湯本哲郎1),5), 綾部由紀乃1), 金田光正1), 笠原英城1), 宮崎美子1), 高尾良洋1), 佐藤透1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

	The use fact-finding of the P0113-21-PM bisoprolol patch and proper use 武石愛子, 植草秀介, 千葉達夫, 木村麗砂, 酒井正博, 小林秀樹, 加藤裕芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

Approach for an evaluation and the problem from a physician, the nurse for P0114-22-AM ward pharmacist duties
神崎浩孝, 小沼利光, 森下陽介, 村川公央, 槇田崇志, 正岡康幸, 田中雄太, 天野杏, 金聖暎, 西宮祐輔, 定金典明, 北村佳久, 千堂年昭
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2015.

	Evaluation of a physician for the P0115-21-PM ward drug duties enforcement and the nurse 長崎志津, 森田靖代, 小松仁美, 西雅恵, 岡崎萌水, 橋田和佳, 野村政孝, 常風興平, 門田亜紀, 横田淳子, 宮村充彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

	Change of the role in ward duties in the P0116-22-AM our hospital 古浜健一1), 小林求1), 河野健1), 湯本哲郎1),2), 稲葉健二郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

	The future problem that we were able to see from the fact-finding of the prescription suggestion example in P0117-21-PM ward duties 平田やよい, 松田理美, 宮里弥篤, 佐次田頌, 翁長真一郎, 比嘉保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

	We correspond to the pharmacist duties in the P0118-22-AM ward, and it is evaluated by the type of job 井上稚枝子, 高田星羅, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

	Efforts to a rise in contribution degree for the medical treatment by the P0119-21-PM ward drug duties start 鈴木博晃, 野村理恵, 内田里香, 長濱貴恵, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

Fact-finding about the consistency of a practice reporting book and the bringing medicine by the P0120-22-AM ward exclusive duty pharmacist
新貝弘明1), 阿部真也1), 小林義和1), 藤岡貴光1), 斎藤太寿1), 小林彦登1), 高野照子1), 町田美香1), 齋藤雅俊1), 松原肇1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2015.

	P0121-21-PM third emergency designation, stocktaking of ward drug duties in the local cancer practice cooperation base Hospital 陸丸幹男, 河村聡志, 末延道太, 柴田七奈, 菅田佳子, 佐藤史織, 重松明美, 森一生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

	Start relation - ward drug duties of the pharmacist until a discharge before the hospitalization to patients with P0122-22-AM cataract surgery plan; and - 野村理恵, 内田里香, 岩村瞳, 赤木圭太, 長濱貴恵, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

	Bringing medicine discriminant positioning in P0123-21-PM ward drug duties 長濱貴恵, 野村理恵, 内田里香, 鈴木博晃, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

	Efforts for safety management and the proper use of the P0124-22-AM bringing medicine 永井亜美, 寺沢匡史, 中村翔吾, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

	The efforts of ward drug duties in the P0125-21-PM our hospital and future problem 木藤貴弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

	Intervention to the medical therapy of the pharmacist in the P0126-22-AM orthopedics ward 中出奈津子, 東昌代, 梅元晃美, 中村美紀, 多保田千佳子, 高畠恵美, 道下孝恒, 石田美由紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2015.

	The efforts which contributed to an omission of special diet calculation of the P0127-21-PM pharmacist 山脇聡, 渡部寿康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

	Efforts for the P0128-22-AM ward drug duties enhancement 小坂井加奈, 古川裕美子, 岩崎明子, 三輪耕次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

Medicine management after the pharmacist intervention in the P0129-21-PM operating room and adequacy of the cost
北森翔子, 井上美穂, 今市沙有美, 岡紗智子, 二見早希, 石田あい, 上田華世, 松下比奈子, 藤本智大, 久保智士, 山崎瑞貴, 松尾多恵, 鶴崎亮, 青木美沙, 松谷和子, 三嶋仁美, 木村真策
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

	What is found in other types of job on the treatment intervention of the P0130-22-AM ICU ward pharmacist 飯田遥, 男全昭紀, 井口恵美子, 猪股克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

	The present conditions in the viewpoint of ward drug duties in the hypothermia therapy management after the P0131-21-PM cardiopulmonary arrest revival 田中大輔, 草島宏平, 佐藤拓也, 石川大介, 阿部和人, 鎌田敬志, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

	About the efforts of the ward drug duties in the P0132-22-AM ICU ward 上ノ山和弥, 高橋有, 三井克巳, 三宅麻文, 河原宏之, 石川弘子, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2015.

	Findings by the introduction of the delirium evaluation in the P0133-21-PM ICU and the evaluation 福田聖啓1), 水井貴詞1), 大橋洵1), 大野佑城1), 吉田南2), 長谷川直美2), 青山智1), 安田昌宏1), 大畠博人3), 後藤千寿1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

	Reporting about the antimicrobial in the P0134-22-AM our hospital critical care center 西島正人, 植原佳代子, 宇佐美千佳子, 齋藤俊郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

	1 case that a plasma exchange was thought to influence to blood sodium valproate levels of patients with P0135-21-PM thrombotic thrombocytopenic purpura 山口美紗子1), 久保陽平1), 祖川倫太郎1), 今長谷尚史2), 進藤岳郎3), 原英夫4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

	Intervention example of the pharmacist in the P0136-22-AM North America type ER first aid practice 利根川小春, 原直己, 金明俊, 高梨愛, 加瀬和也, 永嶋一貴, 内田佳菜子, 松田俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

	About the pharmacist duties in the ICU of the P0137-21-PM children special hospital 石賀圭, 日野洋明, 中井啓, 二木彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

	Enforcement and evaluation of the pharmaceutical management in P0138-22-AM NICU, GCU 横山智子, 尾栢有美, 鈴木えり子, 山西由里子, 加藤有香, 越川一誠, 飯久保尚, 小杉隆祥, 西澤健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2015.

	Record style of ward drug duties and drug control instruction charges 1 in P0139-21-PM our hospital HCU 渡邉悦子, 佐野邦明, 高木雄一, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

	Fact-finding of the delirium patients in the P0140-22-AM ICU 赤崎瞳, 浜元善仁, 翁長真一郎, 比嘉保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

	Role of the pharmacist in the drug information offer of the P0141-21-PM our hospital intensive care unit 内藤久志1), 尾崎昌大1), 北村渉1), 坂和園子1), 添田真司1), 松陰崇2), 渡邊昌之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

	Objective evaluation of the ward drug duties in the P0142-22-AM NICU/GCU ward 山辺雄太, 宮本晋治, 本田義輝, 齋藤秀之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

	One case that the P0143-21-PM Nasal high flow refusal patients were able to evade intubation using dexmedetomidine 中村敬之, 市川照文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

	Construction of pharmacist duties in the perioperative period when we cooperated with P0144-22-AM anesthesiologist 古谷一平, 土川拓也, 山里久子, 平下智之, 谷沢克弥, 遠藤秀治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2015.

	Efforts by inspection and the team of the pharmaceutical background for patients with P0145-21-PM stroke 高森智敬, 安尾哲郎, 滝波昇悟, 井上剛, 監物英男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

	Fact-finding of the patients whom it presented a hyperglycemia state in the P0146-22-AM second emergency designated hospital and was conveyed first aid to 昆貴志1), 森雅之1), 橋本貴尚1), 茂泉善政2), 栃窪克行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

	Usefulness evaluation of the sustained sedative medicinal solution preparation in the operation by the P0147-21-PM pharmacist 柴田みづほ, 小林由佳, 川口真由子, 橋本杏里, 渡辺健太, 新部陽子, 新井健一, 中村貴子, 鈴木貴明, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

	Efforts ... of risk management - pharmacist resident in P0148-22-AM ICU, CCU 根来加菜子1), 岡田美香1), 田内千賀1), 横山晶子1), 大城靖1), 荒川隆太郎1), 丈達泰史1), 宮崎哲郎2), 稲田英一3), 天野篤4), 代田浩之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

	Fact-finding report of the suicide attempt patients who had P0149-21-PM acute intoxication 末延道太1), 上野悦子1), 佐藤史織1), 麻生真由美1), 重松明美1), 中島竜太2), 稲垣伸洋2), 森一生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

Present conditions of duties that it passes after process, opening of a Diet session until setup - opening of a Diet session of a critical care center, the intensive care section of the P0150-22-AM new hospital for one year and future problem ...
五味知之1), 渡部修2), 岡田邦彦2), 竹村隆広3), 斉藤まゆみ4), 由井俊文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2015.

	Examination to stocktaking of the inhalational instruction to P0151-21-PM outpatient and the construction of the instruction system 堀場さゆり1), 葛谷真理1), 今高多佳子1), 青山智彦1), 小笠原智彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

Examination ... of the storage of the instruction record with the present conditions report of the medication counseling record to an outpatient in the P0152-22-AM our hospital and 2 revisions of future fine-view - Pharmacist Law Article 25
大久保淳史1), 森本景子1), 高橋信矢1), 立沢正臣1), 下嶋和代1), 宮崎招久1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

	Efforts to instruction based on the pharmaceutical knowledge for the P0153-21-PM outpatient 宮崎衛江, 大澤千鶴子, 芦埜和幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

	Efforts of the discontinuation instruction in the P0154-22-AM our hospital heart blood vessel center 神戸千紘1), 石井有紀1), 宮崎雄紀1), 網野一真1), 跡部治1), 山本高照2), 高橋耕平2), 河野哲也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

	Active intervention to the pharmaceutical management of the perioperative patients in the P0155-21-PM our hospital 山田奈緒1), 左右田和恵1), 太田久美子1), 田村睦弘2), 金澤美也子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

Efforts (the first report) to establishment and the duties burden on ward pharmacist reduction of the pharmacist duties of the P0156-22-AM admitting department
柴田大地, 木下照常, 北川加寿子, 高橋詩織, 渡邉彰己, 菅原志穂, 杉浦友美, 近藤洋一, 滝本典夫, 杉浦充, 足立守
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2015.

Questionary survey about drug explanation, instruction duties in the P0157-21-PM outpatient department
鵜池敏令, 泉谷悟, 岡本直樹, 笠原庸子, 柴田ゆうか, 常友盛勝, 松本俊治, 光廣貴紀, 新井茂昭, 荒川隆之, 佐々木雄啓, 谷口雅敏, 日浦和徳, 中村徹志, 木平健治
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

It is ... through efforts - pharmacist outpatient department establishment of our hospital in the P0158-22-AM pharmacist outpatient department
神田英一郎, 鹿浦香織, 野田能成, 大坪達弥, 加藤良隆, 中川ゆかり, 小川博史, 小林大祐, 福田喬士, 藤田敦夫, 友金幹視, 三上正
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

	About P0159-21-PM Daclatasvir, the pharmacist outpatient department introduction for patients who received Asunaprevir combination therapy 中島瑶子1), 松崎貴志1), 松村泰斗1), 有木宏宗1), 石井俊哉2), 佐藤明2), 横山美恵子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

	Thing - Okayama fine weather fine weather DOTS notebook operation ... which we saw from efforts of P0160-22-AM area DOTS 佐藤可奈1), 福島さやか1), 亀井健人1), 橋本徹2), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

P0161-21-PM Drug status survey of Daclatasvir (Daklinza(R)), Asunaprevir (Sunvepra(R)) at our hospital
隅田英幸1), 伏見友里1), 藤井悠1), 岸田佳恵1), 高井美和1), 高橋沙希1), 玉井恭子1), 二宮洋子1), 勝村登美子1), 小野眞代1), 日野啓輔2), 仁科惣治2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

	Efforts to fact-finding and the adequacy of the polypharmacy patients in the P0162-22-AM outpatient department 上野良夫1), 三枝貢1), 浅田智哉1), 眞鍋伸次1), 前田剛2), 森由弘2), 厚井文一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2015.

	In P0163-21-PM outpatient department pharmacist duties is going to be hospitalized; the present conditions and a problem of the bringing medicine for patients confirmation 菊池大輔, 大内竜介, 早川幸子, 布施克浩, 畑中貞雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

Efforts of the pharmacist in the P0164-22-AM Saiseikai Fukuoka General Hospital hospitalization support center
阿曽沼伸一, 入江徳俊, 由井薗陽一, 二神咲子, 眞弓志乃, 五反田利恵, 住田愛, 阿部聡子, 池田宗彦, 圓福優子, 松下祥子, 山田正紀, 槇林智子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

	Efforts of the common use medicine confirmation (bringing medicine outpatient department) in the P0165-21-PM our hospital and the evaluation 新島大輔1), 高橋郷1), 宮野早苗1), 矢田部恵1), 岩崎景子1), 赤木祐貴2), 勝海学1), 千田昌之1), 谷地豊1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

	Intervention significance before hospitalization to the perioperative patients in the P0166-22-AM our hospital pre-operative examination center 藏本裕信, 粂裕子, 山本麻央, 山口沙織, 長谷川豊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

	Role of the pharmacist in the center before P0167-21-PM hospitalization 川柳大翔, 岩崎明子, 澤田佳克, 三輪耕次 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

Confirmation and instruction ... of confirmation - hospitalization previous cancellation medicine of the common use medicine by the pharmacist in the P0168-22-AM outpatient department
片山智章, 木村智美, 辰巳典子, 廣田麻衣子, 中村有理, 内本典子, 北山尚子, 寺沢匡史, 内山ひとみ
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2015.

Efforts of the pharmacist outpatient department in P0169-21-PM chronic hepatitis C treatment and intervention ... to case report - Daclatasvir Asunaprevir combination therapy
河南有友子, 吉田純也, 丹羽しおり, 平塚愛加, 橋本さや香, 宮本裕子, 新嶋茂正, 大塚一興, 伊藤由香, 坂上逸孝, 増原慶壮, 横山美恵子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

	An advantage and problem of the pharmacist outpatient department before the medical examination for the use of P0170-22-AM outpatient department chemotherapy room patients 伴晶子1), 岡戸洋1), 佐藤知香1), 吉岡祐貴1), 小林義和1), 小島義博1), 生田宏次2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

Practice - pharmacist of the team approach in medical care to support patients with P0171-21-PM outpatient department cancer is foreign, and establish cancer nursing outpatient department at the same time; and ...
浅川由希子1),2), 宮崎美佳1), 古川順章1), 飯田幸恵2), 内藤潤2), 手塚健志3), 所昭宏4), 安宅信二5), 小林勝昭1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

It is ... through the cooperation between usefulness - pharmacists of by medical examination front of the pharmacist outpatient department in the treatment with P0172-22-AM Aki Shichi nib case
鹿浦香織1), 加藤良隆1), 神田英一郎1), 野田能成1), 中村雄一2), 伊藤吉三2), 友金幹視1), 三上正1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

	The present conditions and problem of the cancer instruction to patient management charges 3 calculation acquisition in the P0173-21-PM JCHO Kyushu Hospital 上津沙織, 桑村恒夫, 吉国健司, 末松文博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

Medication counseling and side effect monitoring to the internal use anticancer agent remedy patients in the P0174-22-AM outpatient department
田中庸一1),2), 瀬川聖奈1), 青木学一1),2), 塩見めぐみ1),2), 渋谷清1),2), 田村実紀2), 久保田理恵1),2), 小宮山貴子1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2015.

	Grasp of efforts and problems of the drug control instruction to P0175-21-PM outpatient department cancer chemotherapy patients 宮脇未来1),2), 藤井千賀1),2), 柳下祐貴子1), 安井友佳子1), 神垣俊二2), 木村豊2), 石坂敏彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

	Efforts to side effect evaluation and the pharmacist outpatient department introduction of P0176-22-AM outpatient department chemotherapy patients 桝茂典, 岡田悠美, 櫻井彩乃, 中川隼一, 上村苑子, 高橋真一, 鈴木由依, 蔭山博之, 村上敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

	The present conditions and problem of the P0177-21-PM "cancer support outpatient department" 牧智恵子, 後藤愛実, 細見誠, 花房加奈恵, 早坂大, 片岡憲昭, 西原雅美, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

	Effect of the pharmaceutical management that hospital pharmacist performs in P0178-22-AM diabetes outpatient 一木裕子1),2), 是木一也2), 大園沙保子1), 小林大介1), 窪田敏夫1), 島添隆雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

	It is the participation of the pharmacist in the instruction management in patients after P0179-21-PM transplant 宮坂優人1), 小林昌宏1), 稲野寛1), 吉田一成2), 石井大輔3), 竹内康雄4), 池田成江5), 野口文乃5), 田中美樹5), 厚田幸一郎1),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

	P0180-22-AM Relationship between LINQ questionnaire and inhalation technique degree of acquisition, adherence in Breezhaler type inhaled medicine 高橋光明1), 中西大介1), 畑地治2), 柳川泰裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2015.

	The case that treatment-resistant hyperuricaemia improved by the living guidance by the P0181-21-PM pharmacist 大久保七枝1), 大久保正2), 田中真理子3), 大久保節子4), 阿部慧5), 大久保美穂5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

	Attempt to the pharmacist outpatient department in the P0182-22-AM orthopedics outpatient department 高橋えりか1), 亀田敬子1), 木本信介1), 山田周平1), 西田直史1), 初田輝1), 山下敦志1), 大西英生2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

P0183-21-PM pharmacist foreign establishment and usefulness consideration aiming at introduction of the smooth hepatitis C therapeutic drug
家永嘉子1), 萱野勇一郎1), 杉本充弘1), 吉田優子1), 山本崇1), 野口葉子1), 今井哲司1), 深津祥央1), 石塚良子1), 矢野育子1), 上田佳秀2), 丸澤宏之2), 松原和夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

	Investigation about the number of investigations before surgery in the P0184-22-AM outpatient department and the presence or absence of surgery postponement 牧なつみ, 沢田俊朗, 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

	Analysis using the technique of the text mining of the patients information hearing by the many types of job in the P0185-21-PM pain center 西村明子1),2), 今井徹1), 鈴木慎一郎1), 早坂正敏1), 吉田善一1), 加藤実2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

	Efforts of the pharmacist in vaccination duties in the P0186-22-AM pediatrics outpatient department 有本忍, 森睦, 尾野由佳子, 中濱美恵, 森佳恵, 白木幸子, 宮崎千尋, 魚住有沙美, 横野祐未, 宮川明宏, 山本ひとみ, 石見淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2015.

	The delirium prophylactic protocol making in patients with P0187-21-PM stroke and the evaluation 川田敬1), 太田剛史2), 山崎好恵1), 端茉美1), 高平豊1), 田中聡1), 山本創一1), 森本雅徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

	Result and problem of the joint medical treatment management (CDTM) introduction in the P0188-22-AM Taketa synthesis hospital 熊谷修一, 木本真司, 安達亮平, 河原史明, 香内綾, 安齊泰裕, 大竹伸知, 外島真, 遠宮賢二, 塩川秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

	Attempt of the inhalational instruction using the P0189-21-PM "examination by a stethoscope breath sounds that we visualized" 田代千明1), 福田萌美1), 平田周祐1), 井口恵美子1), 猪股克彦1), 河崎勉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

Medication support in the institution using the use change protocol by P0190-22-AM CDTM
小川壮寛1),2), 松下明3), 井口千恵美4), 守安洋子1), 福嶋寛子1), 佐々木萌子1), 中西由恵1), 河南真依1), 藤谷直明5), 賀來敦3), 島田憲一2), 江川孝2), 高見陽一郎2), 高橋正志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

Input support of the periodical prescription of the oral medicine by the P0191-21-PM pharmacist: Enforcement and the evaluation
細野智美1), 井坂由佳1), 井坂江吏香1), 横田裕之1), 三木俊一郎2), 山本哲哉2), 塚本俊太郎3), 原明弘3), 福永潔3), 神林泰行1), 土岐浩介1), 大河内信弘3), 松村明2), 本間真人1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

	Hold ... "meeting learning physical assessment" about the physical assessment class to P0192-22-AM pharmacist; and ... 浅野志津1), 大道淳二1), 石橋真実1), 諏訪耕三1), 藤原孝子2), 河原宣裕2), 磯村治樹2), 松山哲史3), 齋藤博則4), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2015.

	The use situation and problems of the P0193-21-PM adrenalin self injection drug (Epinephrine autoinjector) 野澤彰1), 野村良子1), 野澤玲子2), 高橋治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

	About a proper use investigation of P0194-22-AM new oral anticoagulant drug (NOAC) 西村文宏, 牛島智子, 宮村重幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

	Importance of the warfarin control in patients with P0195-21-PM atrial fibrillation 本田哲也, 吉原郁夫, 渡部善博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

The use situation and clinical response of the tolvaptan for the fluid retention in the P0196-22-AM heart failure
坂元優太, 中島誠, 野間口寛, 桐野玲子, 瀧下恭子, 高橋武士, 中木原由佳, 新上香奈子, 平松さやか, 福元裕介, 池ノ上知世, 平田りか, 寺師守彦
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

	Examination of the albumin consumption by the P0197-21-PM Hydroxyethylated starch infusion 6% introduction 舩越真理1), 原田益宏1), 津田正博1), 平田学2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

	Way ... of the drug control instruction to be understood from ... patients questionnaire to reconsider P0198-22-AM drug control instruction 中埜梓, 矢沢麻貴, 荒井早穂, 林千麗, 吉村尋典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2015.

	Led by a relation and the patients of the pharmacist in the use of edoxaban after the P0199-21-PM orthopedics lower limbs surgery with safe examination - impaired renal function - 小岩まの, 永野浩之, 伊藤護之, 北澤貴樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

	P0200-22-AM On the Usage of Phosribbon(R) for Prematurity Metabolic Bone Disease (MBD) in Our College 楠川侑吾1), 大橋正和1), 三松史野1), 村田龍宣1), 塩見梢2), 村岡淳二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

	Examination about the nicardipine injection proper use to be used for P0201-21-PM sustained depression 春日井理恵1), 柴田隼人1), 酒井欣嗣2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

Research about the confirmation technique of the P0202-22-AM medication amount of drinking
家治川真代1), 小北純也1), 藤田知子1), 中嶋香里2), 東川伸一2), 西村奈緒恵3), 榎本初音3), 立木秀尚3), 宮崎珠美4), 小森浩二4), 首藤誠4), 山下伸二4), 恩田光子5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

	Present conditions investigation about the medication counseling of the P0203-21-PM NSAIDs patch 松浦誠1), 野舘敬直2), 畠山和也2), 佐塚泰之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

	Patients attitude survey about the prescription change to P0204-22-AM non-vitamin K inhibition oral anticoagulant drug (NOAC) 柴山紗貴子1), 藤井洋介2), 福田喜彦3), 藤枝正輝2), 中澤祐輔2), 長谷川佳孝2), 月岡良太2), 森澤あずさ2), 大石美也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2015.

	About efforts of the generic name prescription in the P0205-21-PM Okinawa Hospital 小迫晶寛1), 加茂章弘1), 仲村早紀1), 小薮真紀子1), 鈴田浩孝1), 大嶺彩3), 八木秀明2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

	Competitive review of the P0206-22-AM "application (electronic edition medicine notebook common throughout the whole country) for the patients to manage the health by oneself" 田代朋子1), 本田卓也1), 折井孝男2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

The use situation and problem extraction of the English drug reporting document for P0207-21-PM foreigner patients
上市敦子1), 神宮寺秀幸1), 瀧裕子1), 吉野翠1), 田代和子1), 西澤満里子2), 長谷川佳孝2), 月岡良太2), 森澤あずさ2), 大石美也2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

	Change third report of the number of the combination drugs with the antihypertensive medications combination drug judging from the prescription fact-finding of P0208-22-AM antihypertensive medications 若林進1), 篠原高雄1), 岡本晋2), 林潤一2), 山本実2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

	Investigation about the acquisition situation of the pharmaceutical products safety information in the P0209-21-PM medical institution 星野絵里, 中常恵美, 平松彩佳, 鳥井真由美, 近藤恵美子, 俵木登美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

Investigation second report of the pharmacoepidemiology by the changes from the antihypertensive medications which assume valsartan in the P0210-22-AM Sapporo Tokushukai Hospital an active ingredient to other antihypertensive medications
田中正臣, 田中彰一, 杉村ゆかり, 高橋秀聡, 前田健太, 後藤圭介, 武田瑛司, 星貴薫, 水戸麻未, 宮越貴之
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2015.

	In prescription situation - new taking oral anticoagulant drug start cases for patients with P0211-21-PM cerebral infarction - 白石貴寿, 田口みどり, 中山久美子, 栗原江未, 安河内寿成, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

Use fact-finding of the albumin preparation in the surgery of heart, great vessels after the P0212-22-AM hydroxyethylated starch preparation adoption origin
谷口仁孝1), 徳村博子1), 田中美智子1), 山本彩佳1), 猪山友香1), 千葉恵美子1), 渡邉美樹1), 小原祐子1), 谷口和孝2), 加納みゆき1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

	Consideration about the change of prescription reason of the P0213-21-PM oral anticoagulant drug and the patients background 宇都宮奈々, 白石貴寿, 中山久美子, 植中英恵, 臼井和明, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

Comparative study of the effect that P0214-22-AM generic name prescription and generic medicine prescription give to formulations of the health insurance pharmacy
越塚宏美, 宮野正広, 八木仁史, 遠藤美緒, 屋城由樹, 大村恵, 高橋あい理, 山田えり, 渡邊徹, 佐々木忠徳
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

Present conditions investigation about the taking oral medicine situation in the case that had a diagnosis of peptic ulcer by P0215-21-PM endoscopy upper gastrointestinal tract
栗原江未1), 長谷川将1), 白石貴寿1), 宗本佐知子1), 近藤真由1), 今村寿宏2), 中村宏1), 面田恵1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

	Subjective sleep evaluation to the case that we changed from P0216-22-AM zopiclone to S zopiclone 福田翔一1), 雪田拓1), 田中宏尚1), 安土菜美1), 樋浦一哉2), 今井隆人1), 小原郁司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2015.

	The use situation of the peg filgrastim in the P0217-21-PM our hospital 實光由香, 本多伸二, 浜田久美子, 荒田美帆子, 三松史野, 目黒裕史, 大野恵一, 村田龍宣, 寸田靖, 村岡淳二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

	Prescription fact-finding of various opioid preparation in the P0218-22-AM Higashisapporo Hospital 日置陽子1), 加藤遥平1), 中脇誠一1), 照井健2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

	Investigation of the use situation and the adverse event of the sorafenib in the P0219-21-PM hepatocellular carcinoma 陣内優, 畑瀬圭佐, 西田修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

Comparison ... with the use fact-finding results in 18 hospitals attached to use of antimicrobial situation - private institution dental college in the hospital attached to the P0220-22-AM Ohu University school of dentistry
緑川信幸1),2), 長嶋友美1),2), 浅倉聖岳1),2), 中村郁子1),2), 東海林徹3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

	Evaluation of our hospital antimicrobial consumption by P0221-21-PM Defined daily dose (DDD) and days of therapy (DOT) 平川尚宏, 石原義久, 渡部由起, 柿元郁代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

	Use of antimicrobial situation investigation using DPC data for the P0222-22-AM antimicrobial proper use 杉井麻耶1), 大迫朗子1), 鶴見彩1), 萩原奈央1), 八田部良子1), 相曽啓史1), 森美奈子1), 永田将司1), 高橋弘充1), 安原眞人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2015.

	DPC data utilization to a use of P0223-21-PM antimicrobial situation investigation 佐瀬裕子1), 相曽啓史2), 鳥羽三佳代1), 森脇睦子1), 貫井陽子3), 高橋弘充2), 伏見清秀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

	Nutrient preparation Heine E gel and drug combination in the P0224-22-AM medical treatment ward 土元研史, 安田礼子, 三代貴康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

	Investigation about the change of the quantity of prescription of an antianxiety drug in the P0225-21-PM our hospital and the sleeping drug 田代佳生, 木苗佑介, 浅井萌子, 浅倉侯子, 名倉基雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

	Use fact-finding of the selective SGLT2 inhibitor in all P0226-22-AM Yokohama municipal institutions and the Red Cross hospital 男全昭紀1),2), 飯田遥1), 井口恵美子1), 猪股克彦1), 澤口達也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

	The use situation of the oral anticoagulant drug in the P0227-21-PM our hospital 向井弘恵1), 岡田昌浩1), 星野祥儀1), 池亀芳野1), 岡本伸也1), 神垣江里奈1), 烏尾和恵1), 村上史承1), 杉原弘記1), 竹井英介1), 岩崎淳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

	Efforts for the P0228-22-AM eldecalcitol proper use 三木芳晃1), 塚本啓介1), 奥村裕英1), 桑井幸雄1), 嶋津啓二2), 田中敬雄2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2015.

	Examination about the estimate of the incidence that we applied Poisson distribution to about serious dermatopathy from adverse event spontaneous report database (JADER) of P0229-21-PM Japan 四釜亮太, 松本直人, 曽根原亘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

	Result and problem - of practice - introduction second year of the drugstore management using balun strike scorecard (BSC) in the P0230-22-AM Kushiro Red Cross hospital 渡邊清人, 近江令司, 澁谷基宏, 田中康裕, 元木孝, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

Evaluation of construction and the outcome of the information sharing system about the pharmaceutical intervention in P0231-21-PM Hospital and the health insurance pharmacy
田坂祐一1),2), 安永大輝1),2), 田中守1),2),3), 田中亮裕1),2),3), 浅川隆重2),3), 堀尾郁夫3), 宮内芳郎3), 荒木博陽1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

Search of the pharmacoepidemiology of the private business pharmaceutical products which there is possibility of the becoming severe of the drug-related adverse event in P0232-22-AM elderly people in
野口義紘, 杉田郁人, 林勇汰, 吉田阿希, 江崎宏樹, 齊藤康介, 臼井一将, 加藤未紗, 舘知也, 寺町ひとみ
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

	Examination about the cost effectiveness according to the drug which we used for initial treatment for P0233-21-PM community-acquired pneumonia 山田英紀, 荒木良介, 山村翔, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

	Figure of the drugstore for community medical care promotion judging from P0234-22-AM geographical information and institution standard 吉原幹詞1), 倉田香織2), 山浦克典1), 岸本桂子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2015.

	Medical economic evaluation of the P0235-21-PM new hyperactivity bladder therapeutic agent Mirabegron 山西由里子1),2), 山西友典3), 田島博樹4), 池田俊也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

	Efforts of the prescription suggestion by the electronic chart representation input for appropriate hospitalization prescription shifts of the P0236-22-AM bringing medicine 西迫多重, 齋藤茉梨絵, 猪股育夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

	Construction of bringing medicine differentiation, the prescription instructions system in the P0237-21-PM electronic chart introduction 田口みどり1), 森田佳博1), 白石貴寿1), 上地純子1), 大石丸美1), 平岡剛2), 神原昇3), 中村宏1), 面田恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

	The problem that was seen from bringing medicine differentiation and the medicine notebook bringing rate for all inpatients in the P0238-22-AM size scale hospital 多賀允俊, 丹羽修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

	The development of the prescription input support function using P0239-21-PM common use medicine information and investigation about the usefulness 石原裕介, 安食健一, 横手克樹, 園山智宏, 平野榮作, 竹下和男, 小阪真二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

	Approach in our hospital to connect P0240-22-AM bringing medicine with inpatient care appropriately 鶴崎泰史1), 松島薫1), 副島啓司2), 高島伸也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2015.

Safety management of the bringing medicine using P0241-21-PM oral medicine prescription calendar function
新崎孝夫, 弥山秀芳, 氏家玲奈, 澤井綾佳, 矢野裕子, 岡田玲子, 若原由佳, 西田さやか, 米田篤司, 久保悦子, 安永浩子, 阪口博保, 富田浩
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

	Compliance investigation of the bringing medicine in the patients admitted to the P0242-22-AM lifesaving emergency ward 倉田歩, 藤裕美, 岩内大佑, 山口佳代, 三浦誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

Evaluation - second report ... from an attempt and a physician of the bringing medicine bottle power support by the P0243-21-PM pharmacist
村上理沙子, 江川裕之, 矢野裕士, 吉澤美香, 中丸沙弥香, 岡本祐二, 佐藤千比呂, 高橋和紗, 江崎さやか, 鈴木優司
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

Relation of the ward pharmacist to bringing medicine operation in the P0244-22-AM Kitakyusyu General Hospital
鮫島恵介, 今村陽子, 中島一, 堂薗吉彬, 大治万喜子, 福田恭輔, 岡仁美, 坂井蘭, 松尾麻美, 小橋亮, 柏田匡広, 大石貴裕, 池田浩和, 高橋浩二郎
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

Making and operation of the protocol that a ward pharmacist judges cancellation, the continuation for the bringing medicine of the P0245-21-PM planned inpatient
日下部華子, 福崎由里絵, 植竹緑, 西本悦美, 林憲子, 青柳京子, 中島みゆき, 森美奈子, 金内幸子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

	Role of the P0246-22-AM outpatient department bringing medicine discriminant introduction and pharmacist 中野有瑛1), 中居肇2), 青山崇1), 工藤香澄1), 佐々木友見1), 中村一成1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2015.

	Investigation about bringing medicine management room duties in the P0247-21-PM Saku medical center 畠山裕実子, 堀内賢一, 田中美和, 清水彩子, 橋詰さやか, 由井俊文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

Efforts of the bringing medicine management using the cooperation system that the bringing medicine management in the P0248-22-AM electronic chart is soft
原栄子, 近藤喜代子, 高橋貴子, 松林瑠美, 吉田雄一, 後藤友里, 宮下和也, 安田カオル, 齋藤真司, 川島優花
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

	Construction and evaluation of the bringing medicine probate system which we incorporated in P0249-21-PM electronic chart 増田由香, 平田淑子, 小澤和子, 加藤純, 林豊, 小野田千晴, 名倉理央, 池谷延房 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

	Development and usefulness of the P0250-22-AM bringing medicine management system (medicine fast for Windows) 木村真也, 木村敦, 逢坂智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

	Fact-finding about the P0251-21-PM preoperation cancellation medicine 中村俊貴1), 小林由布子1), 八木澤啓司1), 左右田和枝1), 宮下博幸1), 柴田壮一1), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

The effect that P0252-22-AM medicine notebook gives to confirmation duties of the bringing medicine, use medicine at admission
舘知也1),2), 齊藤康介1), 林勇汰1), 吉田阿希1), 杉田郁人1), 江崎宏樹1), 加藤未紗1), 臼井一将1), 野口義紘1), 福田聖啓2), 安田昌宏2), 水井貴詞2), 後藤千寿2), 寺町ひとみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2015.

	It is an attempt of becoming it the on admission bringing medicine reduction in P0253-21-PM elderly patients 河上卓弥, 松谷洋, 石本敬三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

	Efforts and evaluation of the bringing medicine investigation in the P0254-22-AM our hospital 出水睦子, 千原里美, 上田宏, 五十嵐努 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

	Bringing medicine information management in the P0255-21-PM district acute phase hospital 田中敏, 佐藤益男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

	Hypertensive management - excessive depression ... after the P0256-22-AM femoral neck fracture surgery 麻生美佐子1), 宇夛裕基2), 河原昌美2), 辻未希子1), 中野正人3), 浜手ひとみ1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

	To do P0257-21-PM bringing medicine management appropriately more safely 馬場礼治, 鮎川美奈子, 永田和美, 小笹朝美, 屋久直紀, 小原優佳, 伊集院聖司, 寺澤麻梨恵, 柿元美乃, 益田宏代, 田中和子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

	Investigation about efforts and the blunder of our hospital at the change checking prescription from P0258-22-AM bringing medicine 浅川唯, 前田剛司, 沢田俊朗, 稲垣由加利, 水草博希, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2015.

	Efforts and problems to bringing medicine check duties in the P0259-21-PM Iizuka Hospital 内田守次, 岡松沙哉佳, 小野貴絵, 川崎千尋, 川波宏隆, 鮫島美里, 野間口順哉, 橋本政弘, 古市佳奈, 進健司, 梅田勇一, 金澤康範, 竹本伸輔 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

	The construction of the bringing medicine management system in the P0260-22-AM our hospital and the result 泉雄介, 栗本美里, 行木晃洋, 目連里江, 加藤幸三, 鮫島美和, 伊東美歩, 平原一也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

	Doxorubicin hepatotoxic reduction by the P0261-21-PM theanine combination 長井克仁, 福野修平, 小田彩乃, 小西廣己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

	Effect of pravastatin and the chitosan on P0262-22-AM blood cholesterol and liver weight 岩崎綾乃, 片山雄貴, 矢野広将, 吉野祐太郎, 今井公江 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

	Development of the application for iPad supporting the proper use of herbal medicinal products for the P0263-21-PM public 浅野孝1), 岡崎光洋2), 橋口正行3), 藤井勲1), 望月眞弓3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

	About the role that an insurance pharmacist should fulfil at P0264-22-AM OTC sale 伊藤学1), 佐々木奈那1), 井上幹雄2), 小林範博3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2015.

	Participation of the pharmacist in consumers to consider from the effect that P0265-21-PM OTC medicine television CM gives 岸本桂子1), 福島紀子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

	Attitude survey for the self-medication of P0266-22-AM area inhabitants 村上美穂, 今川尚美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

	Attitude survey for the smoking cessation support of the P0267-21-PM drugstore pharmacist 葛城静菜1), 恩田光子1), 堀口道子2), 小林春菜1), 吉川洸平1), 荒川行生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

	Examination about the knowledge of the drugstore pharmacist for the P0268-22-AM smoking cessation support and the associated factor 森元李早1), 恩田光子1), 堀口道子2), 永田祥子1), 隅田侑希1), 荒川行生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

	Fact-finding for problem extraction for P0269-21-PM "smoking cessation support promotion" 堀口道子1),2), 恩田光子2), 斉藤由里2), 荒川行生2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

	Investigation of the side effect of P0270-22-AM contrast media expression situation 臼井和明1), 田口みどり1), 宗本佐知子1), 沖田健太郎1), 吉田悦朗1), 松田裕一郎2), 守屋雅光2), 中村宏1), 面田恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2015.

The experience of patients with myasthenia gravis with suspected respiratory failure by the P0271-21-PM cibenzoline and consideration from literatures
宮本明希1), 榎屋友幸1), 石川英洋2), 島田拓弥2), 谷口彰2), 岡本隆二3), 村木優一1), 岩本卓也1), 奥田真弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

	It is ... through side effect investigation - ward pharmacist duties in the P0272-22-AM pentamidine inhalation 久保嘉靖, 奥野昌宏, 中田学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

	Example that changes from warfarin in P0273-21-PM venous thromboembolism treatment to edoxaban were effective 岩崎景子1), 大橋養賢1), 勝海学1), 千田昌之1), 金宇慶2), 森田陽子2), 谷地豊1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

	One case with suspected drug evocation-related insulin autoimmune syndrome with P0274-22-AM clopidogrel 砂川恵子, 木村和美, 飯島由美子, 細田宏美, 坂下可奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

	One patient whom rhabdomyolysis developed in during P0275-21-PM levetiracetam remedy 小西敦子, 飯沼公英, 田中あゆみ, 岸本歩, 吉野宗宏, 田中三晶 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

Investigation about side effect expression and the risk factor of the fentanyl sustained intravenous administration for the P0276-22-AM postoperative pain
政賢悟1), 堀尾桃子1), 大島壽和子1), 橋口ゆみ1), 尾田一貴1), 前田克史1), 相澤実里1), 田上直美1), 西村千恵美2), 本田義輝1), 笠岡俊志3), 齋藤秀之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2015.

	It is one patient with suspected rhabdomyolysis onset after a change to atorvastatin from P0277-21-PM rosuvastatin 植村太志, 伊藤和幸, 河井和子, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

7 cases that was able to intervene in drug-related liver damage suspicion in P0278-22-AM ward drug duties
千場美奈1), 諌見圭佑1), 田川幸1), 吉本有里1), 竹内小百合1), 山部美千子1), 塩田喜美子1), 小園亜希1), 花田聖典3), 中川義浩2), 津曲恭一1), 山道研1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

	Analysis of the paradoxical response expression risk factor by the midazolam in P0279-21-PM neonates, infants 櫻井愛1), 本間雅2), 雨宮貴洋1), 田中陽子1), 長瀬幸恵1), 鈴木洋史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

	Examination of the factor influencing P0280-22-AM Daclatasvir, onset of hepatic dysfunction in the use of Asunaprevir patients 松崎貴志1), 有木宏宗1), 中島瑶子1), 松村泰斗1), 石井俊哉2), 佐藤明2), 横山美恵子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

It is ... for a case with examination - diclofenac local site cutaneous administration preparation about the expression tendency of the side effect in the different local cutaneous administration preparation of the P0281-21-PM dosage form
大山勝宏1),2), 高橋真二2), 井上みち子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

	The actual situation of the lamotrigine adverse event using P0282-22-AM adverse drug reaction database (JADER) 黒田裕子, 安藤剛, 伊藤基泰, 坂本和紀, 西野夏希峰, 土生章太郎, 飛田悠里加, 横野加那子, 吉村拓音, 松元一明, 木津純子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2015.

	Fact-finding ... based on information of change - PMDA of the side effect report with the consumption increase of the P0283-21-PM Chinese medicine 松本すずか1), 加藤鈴1), 山本伸一2), 湯本哲郎1),3), 稲葉健二郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

	Search of the symptom for a risk factor and early detection of the P0284-22-AM drug-related dysfunction thyroid 杉山菜々1), 大津史子1), 矢野玲子3), 榊原仁作1), 後藤伸之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

	Search of the symptom for a risk factor and early detection of the P0285-21-PM drug induced hepatic injury 岡田侑子1), 大津史子1), 矢野玲子2), 榊原仁作1), 後藤伸之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

	Examination about the effect factor of the treatment with P0286-22-AM rivastigmine patch continuation 寺澤真理子1), 安高勇気1),2), 合馬慎二3), 今給黎修1),2), 鷲山厚司1), 坪井義夫3), 二神幸次郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

	Fact-finding of hepatic dysfunction in the P0287-21-PM Daclatasvir Asunaprevir combination therapy 松川雅子1), 福野和治1), 西部幸一1), 今井桂子1), 古家乾2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

	The use situation of new oral anticoagulant drug (NOACs) in the P0288-22-AM our hospital and the side effect expression situation 佐藤伸輔1), 櫻井淳二1), 笹森友理恵2), 岡田優1), 佐藤昌子1), 阿部順1), 石澤文章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2015.

	Safe investigation of the Juzentaihoto in the P0289-21-PM child surgery patients 宮原由香里1), 草深純一2), 太田哲徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

	Effective and safe examination of the edoxaban low dose administration in the P0290-22-AM Total Hip Arthroplasty 奥田直之, 梅原玲緒奈, 朴井三矢, 土井敏行, 上野裕之, 山崎邦夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

	Analysis of the hearing investigation contents which went in the case of an inquiry about the extravasation of the P0291-21-PM infusion 岩原良晴, 堀越由里, 竹林佑花, 津田朋枝, 吉岡小都子, 佐々木美由紀, 福田まゆみ, 星泉, 河野裕則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

	Use situation investigation of the tolvaptan in P0292-22-AM children 石原彩, 藤川景子, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

One case that an erethism-like symptom developed at the P0293-21-PM steroid pulse therapy enforcement, but was able to accomplish treatment without reaching it by the participation of the pharmacist seriously
渡邉雄貴1), 田窪桜子1), 伊藤瑞規2), 祖父江元2), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

	Use fact-finding (the second report) of the nitric acid agent in patients with P0294-22-AM prostatic hypertrophy or the nitric oxide grant agent 甲田明英, 梅田道, 大澤友裕, 大野佑城, 馬淵温子, 青山智, 安田昌宏, 水井貴詞, 後藤千寿 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2015.

	Study on human liver damage risk prediction of the anticancer agent using the P0295-21-PM T-LEX(R) method 西村奈緒恵1), 榎本初音1),4), 立木秀尚1), 島田卓2), 長塚伸一郎3), 中嶋幹郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

	The analysis of the epithelium mesenchyma conversion trigger mechanism by the P0296-22-AM methotrexate and search of the defense target of the drug-related pulmonary disorder based on it 原林六華1), 宮本未緒花2), 川見昌史2), 湯元良子2), 高野幹久2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

	Bradycardia with the P0297-21-PM phenytoin administration, 1 case with suspected cardiac arrest 橋本貴広, 大森俊和, 太田裕, 藤村一軌, 仲鉢英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

	One case that taste perversion developed after P0298-22-AM linezolid administration 松井侑子1), 田中雅幸1),2), 打谷和記1), 廣田育彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

	Dangerously ill low Na blood symptom with P0299-21-PM thiazide and the duloxetine combination 森実優1), 小出哲朗2), 今西義紀1), 松井佑梨世3), 松田理3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

	One case that dermatopathy and rhabdomyolysis were thought to complicate by P0300-22-AM lamotrigine 藤井晶子, 近藤あゆみ, 村田義明, 築山郁人, 松浦克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2015.

	Adverse event investigation in the proper use of the P0301-21-PM lamotrigine 佐藤菜月1), 井上裕貴1), 林誠1), 竹内正紀1), 松本修一1), 小林麗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

	Side effect investigation of the P0302-22-AM chronic hepatitis C therapeutic drug protease inhibitor 土田美奈子, 岩瀬裕治, 鯨明美, 丹羽直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

	Correspondence to circulation inhibition by the dexmedetomidine at P0303-21-PM large intestine ESD 稲田寛之1), 川上香恵2), 増山静代2), 廣島良規3), 間宮孝4), 関利一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

	Pharmaceutical consideration for the case that developed disturbance of consciousness after P0304-22-AM famciclovir internal use 宮内綾子1), 平出耕石1), 今関孝子1), 加藤武司1), 小山純司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

	Effect of the silver sulfadiazine giving it to an internal change of the P0305-21-PM cisplatin 小田祐一郎1), 日高宗明1), 大小田晃2), 土肥聡子2), 大橋あゆみ2), 鈴木彰人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

	Effect of lithium giving it to P0306-22-AM kidney existence machine anion transportation system 上井優一, 柘植みさと, 東海雄太, 川嵜達也, 鍋倉智裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2015.

	Effect of the deoxycytidine kinase knockdown on deoxycytidine uptake in P0307-21-PM humans colon cancer cell line HCT116 cells 枡田文沙, 金原未佳, 細川美香, 上田久美子, 岩川精吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

	Examination about the solubility of the fexofenadine hydrochloride in the P0308-22-AM apple juice 岩永一範, 池田光, 宮崎誠, 永井純也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

	Diagnosis before administration to predict a diuresis effect of furosemide using the P0309-21-PM nephrosis rat 黒田浩昭1), 緒方賢次1), 内田光祐1), 徳永仁1), 瀬戸口奈央1), 小川修2), 高村徳人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

	Problems about rat serum vancomycin densitometry using the P0310-22-AM enzyme immunoassay and the solution 小西廣己1), 福野修平1), 地村拓也1), 伊賀幾美1),2), 長井克仁1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

	Examination ... in effect - clinical density of aldehyde oxidase activity to give it to allopurinol metabolism in P0311-21-PM rat in vivo 田山剛崇1), 杉原数美1), 三宅勝志1), 北村繁幸2), 太田茂3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

	Effect of the Bakumondoto giving it to P0312-22-AM drug metabolizing enzyme activity 柏木健宏1), 安原昌子1),2), 田山剛崇1), 佐和章弘1), 三宅勝志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2015.

	Study on internal change of diuretics furosemide in the P0313-21-PM ascitic fluid liver cancer rat 内田光祐, 緒方賢次, 黒田浩昭, 徳永仁, 瀬戸口奈央, 高村徳人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

	About correspondence to on admission patients bringing medicine of P0314-22-AM NOAC 三島裕彦, 林智洋, 中澤百合子, 松元一隆, 孫栄淑, 西川美香, 黒田陽子, 水野彩里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

	Comparison of the blood level change by the genetic polymorphism of the Aki Shichi nib for patients with P0315-21-PM progress-related renal cell carcinoma 加藤博史1), 佐々直人2), 宮崎雅之1), 竹内美緒3), 浅井美穂3), 岩井茜3), 野田幸裕3), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

	The pharmacokinetic prediction in P0316-22-AM children: Antiepileptic drug phenytoin as a case 中山哲1), 杉山雄一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

	Establishment of the simultaneous assay of paclitaxel for pharmacokinetic analysis in P0317-21-PM oil xanthan gum treated patients and the main metabolites 友田麻耶1), 田井紀江1), 前田真一郎1),2), 木島貴志3), 安田宗一郎1),2), 三輪芳弘2), 藤尾慈1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

	Investigation about the effectiveness and the renal failure frequencies that assumed AUC/MIC of P0318-22-AM vancomycin hydrochloride (VCM) an index 高橋愛加1), 伊藤正輝1), 鈴木正論1), 舟越亮寛1), 佐々木忠徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2015.

	Comparison between P0319-21-PM lanthanum carbonate chewable tablet and citric acid second iron tablets 佐野祐子1), 望月真太郎1), 須田智1), 村松望美1), 海江田由樹子1), 山内拓1), 内田光一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

	P0320-22-AM Factor Xa inhibitor Edoxaban reduces active factor VII in the trough phase and potentiates anticoagulant action 畑中由香子1), 根本禎久2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

	The drug interactions check in the P0321-21-PM order ring system: The setting that is contraindicated to the combination in AUC regulation indication and the institution 伊藤哲也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

	The antimicrobial activity in reaction products of P0322-22-AM meropenem hydrate and the L-cysteine and cytotoxic examination 中川幸子, 板垣文雄, 飯島亮介, 山本瑠璃子, 油井聡, 渡邊真知子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

	Stability of pharmaceutical products at nutrient for intestinal administration combination in the P0323-21-PM simple suspension method 田中扶美1), 藤原由梨2), 綿本有希子2), 豊原朋子1), 桑原晶子1),2), 上田幹子3), 片岡和三郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

	One patient who worked on P0324-22-AM vincristine and the management of drug interactions with voriconazole 堀井麻衣1), 安武夫1), 黒川陽介1), 川俣豊隆2), 大野伸広2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2015.

	Examination of the background factor of the case that a rise of PT-INR was found in during P0325-21-PM warfarin remedy 吉田悦朗, 白石貴寿, 沖田健太郎, 宇都宮奈々, 近藤真由, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

	Investigation about the combination of cyclosporin A and HMGCoA inverting ferment inhibitor case in the P0326-22-AM Iwata City general hospital 河村美弥子, 広瀬和昭, 松原大祐, 上甲佳奈, 正木銀三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

	Evaluation using DIPS for 2 cases with suspected interaction of P0327-21-PM azithromycin single dose preparation and the warfarin 相馬直記, 留守克之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

Structure to give it to the interaction with P0328-22-AM new quinolone antibacterial and the metal cation-containing supplement
岡崎大祐1), 高見陽一郎1), 松岡哲史1), 佐藤展子1), 小川壮寛1),2), 酒井将弘1), 中川碧1), 森翔馬1), 島田憲一1), 江川孝1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

	2 cases that accepted cerebral infarction and intraatrial thrombus by interaction with the P0329-21-PM warfarin 大野凜太郎1), 新井隆之2), 斎藤和悦1), 渡部義和1), 小林義美1), 戸邉豊総2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

	Examination about the effect that antimicrobial gives to a P0330-22-AM PT-INR level 小西麻美子, 澤田真嗣, 折笠奈津希, 藤田敦夫, 友金幹視, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2015.

Effect and retrospective study investigation (the second report) of the proton pump inhibitor about the excretion delay of the methotrexate in the P0331-21-PM Miyakonojo medical center
西村尚芳1),2),3), 福石和久1), 津曲恭一2), 田中基稔3), 大津貴寛1), 吉田裕生1), 末永亘1), 戸切祥恵1), 古里あかね1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

	Effect of metronidazole giving it to mRNA expression of cytochrome P450 in P0332-22-AM humans hepatocytes and tinidazole 工藤敏之, 木林英彦, 遠藤由実子, 谷津雅美, 伊藤清美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

	Examination of the interaction with P0333-21-PM methotrexate and the glycyrrhizic acid 中野智尋1), 石崎純子1), 北川佳奈1), 三坂恒1),2), 菅幸生1), 崔吉道2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

	Examination about the interaction of P0334-22-AM rifampicin and the antacids containing the metal cation 茂野絢子1), 下村斉1), 島田洋輔2), 後藤了2), 青山隆夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

	A prediction of the drug interaction at the P0335-21-PM impaired renal function: DPP-4 inhibitor Tenelia as a case 清水秀俊1), 仲丸善喜1),2), 山崎浩史2), 久米俊行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

1 case that was able to control PT-INR under warfarin, bucolome, amiodarone combination for metabolism enzyme induction with P0336-22-AM rifampicin
高瀬友貴1), 土肥麻貴子1), 藤原秀敏1), 登佳寿子1), 森本茂文1), 早坂朋彦2), 植田浩司2), 池村舞3), 橋田亨1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2015.

	P0337-21-PM morphine and sedative adjuvant, prediction of the interaction with NSAIDs 柴田実香1), 無量井昂樹1), 木村嘉明2), 尾崎紀之3), 荒井國三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

	1 case that evaluated cyclosporine and drug interaction of the miconazole gel in P0338-22-AM children 南智香子1), 祖川倫太郎1), 大塚泰史2), 持永早希子1), 田崎正信1), 松尾宗明2), 原英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

	Examination about drug interactions of P0339-21-PM warfarin and tramadol 溝口夏海1), 宮原強1), 塩川裕美1), 植松大智1), 小杉寿文2), 松永尚1), 佐藤英俊3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

	It is ... about three-drug combination of 1 case - phenytoin, warfarin and 5-fluorouracil with suspected drug interaction during the P0340-22-AM chemotherapy enforcement 西川豊, 梶田貴司, 山下加那子, 和田彩, 堀内映里, 黒松誠, 雪矢良輔, 上田睦明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

	The case that PT-INR fluctuated by P0341-21-PM TS-1 and warfarin combination 高松竜一1), 安部一秀1), 佐藤和則2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

	1 case that showed a significant neutropenia by paclitaxel for the P0342-22-AM double cancer and interaction of the letrozole combination 徳島英明1), 持永早希子1), 江越正芳1), 細矢和久1), 江本晶子1), 田崎正信1), 原英夫1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2015.

	We analyze the side effect of 5 cases receiving the sorafenib for patients with P0343-21-PM thyroid cancer 須藤宏文1), 岡本明大1), 濱口直美1), 佐々木典子1), 西田幸平2), 竹内万彦2), 村木優一1), 岩本卓也1), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

Examination about drug interactions at Caspofungin and calcineurin inhibitor combination in the P0344-22-AM same kind hematopoietic stem cell transplantation and the safety
徳和目篤史1), 西本光孝2), 高橋正也1), 中村安孝1), 康秀男2), 中前博久2), 西川武司1), 日野雅之2), 永山勝也1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

	About the decrease in PTINR level by the combination of P0345- 21-PM warfarin and intravenous lipid microsphere 黒川建吾1), 汐見紘明2), 湊聖一郎1), 松野純男2), 北小路学2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

Rearward medical record investigation about the effect on phosphorus level inorganic in blood by the gastric-acid secretion antagonist combination in haemodialysis patients during P0346-22-AM calcium carbonate preparation remedy
立沢正臣1), 小川竜一2), 大久保淳史1), 前田国見3), 下嶋和代1), 宮崎招久1),4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

	Rearward observational study about the drug interaction of P0347-21-PM rifampicin and amlodipine 櫻井健史1), 平井啓太2), 杉山慎一1), 伊藤邦彦2), 角入壽彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

	Drug interactions of ezetimibe and the warfarin through the absorption inhibition of P0348-22-AM vitamin K 高田龍平, 山梨義英, 山本武人, 豊田優, 山本英明, 田中悠介, 小峰瞳子, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2015.

	Basic examination about the effect of the high phosphorus blood symptom therapeutic drug in lipid dysbolism treatment of patients with P0349-21-PM chronic renal failure 小田雅子, 星麻美子, 村上柚季, 市村祐一, 齊藤浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

	The case that blood cyclosporine concentrations decreased by P0350-22-AM Caspofungin combination 伊藤あゆみ, 中川隼一, 高橋真一, 桝茂典, 岡田悠美, 蔭山博之, 村上敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

Examination of the usefulness of the new disease activity evaluation MBDA score in the P0351-21-PM early rheumatoid arthritis diagnosis, effect of treatment judgment
樋浦一哉1), 皆上翔太郎2), 新穂彩2), 浅山りん2), 城田愛理2), 宮川千珠2), 伊藤萌子2), 竹田剛3), 渡辺浩明1), 渡辺泰裕2), 江川 (岩城) 祥子2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

	A use situation investigation of vancomycin for the P0352-22-AM injection and future problem 窪田真弓, 三谷和恵, 波多晶子, 中澤美樹子, 鶴居勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

	Intervention ... of the pharmacist through examination - testing order representation about TDM duties in the P0353-21-PM our hospital 秋場孝則, 森村春菜, 米岡祐貴, 中野一男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

	Risk ... of the blood use experience - phenytoin levels drop of fosphenytoin for patients with P0354-22-AM children status epilepticus 宮津大輔, 田中博和, 後藤貴央, 立石裕樹, 平川雅章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2015.

	Efforts about the TDM enforcement in the P0355-21-PM outpatient 鎌滝真永, 加藤幸三, 平原和也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

	About the efforts of antimicrobial representation order duties targeted for the TDM by the P0356-22-AM pharmacist 須貝瑶子1), 松本浩1), 宿谷光則1), 坪谷綾子1), 濱野公俊1), 坂下裕子1), 増原慶壮2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

	Improvement of the multiple drug simultaneous assay of plasma antiphthisic drug by P0357-21-PM LC-MS 伊藤瑚乃美1), 深澤弘樹1), 宮下真美1), 西村麻由1), 鈴木純子2), 松井弘稔2), 蛇澤晶2), 吉田久博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

Possibility ... of basic examination - sustained administration about the meropenem resistant bacteria onset inhibition strategy using the P0358-22-AM Monte Carlo method
尾田一貴1), 堀尾桃子1), 橋口ゆみ1), 田上直美1), 本田義輝1), 城野博史1),2), 齋藤秀之1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

	A prediction and inspection of the vancomycin clearance using the glomerular filtration rate that we derived than the serum creatinine level in P0359-21-PM children 齊藤順平, 小村誠, 寺門浩之, 石川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

	Administration plan based on the blood level of the P0360-22-AM dabigatran and examination of the blood level change factor 松田翔平1),2), 今津智子1), 浜崎浩一1), 中村護1), 松本篤1), 村上照夫2), 前田頼伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2015.

	Population pharmacokinetics analysis of vancomycin note (VCM) in P0361-21-PM children 浦田由紀乃1), 小野達昌2), 平田憲史郎1), 猿渡淳二2), 陣上祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

	Examination of the drawing blood method to medication method of the P0362-22-AM cyclosporine 久保拓己1), 高山寿里1), 徳永秀美1), 寺門浩之1), 中澤裕美子2), 後藤文洋2), 河合利尚2), 小野寺雅史2), 石川洋一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

	Examination about the factor affecting P0363-21-PM amiodarone metabolite concentrations 山本舞, 井上健, 坪井伸治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

An example of patients with renal cell carcinoma which the blood level of the P0364-22-AM Aki Shichi nib did not increase
野田あおい1), 田中雅樹1), 高崎新也1), 鈴木裕之1), 菊地正史1), 川崎芳英2), 伊藤明宏2), 久道周彦1), 山口浩明1), 荒井陽一2), 眞野成康1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

	Evaluation of the blood tacrolimus levels assay of dimension Xpand Plus-HM using the P0365-21-PM new reagent 水谷栄梨, 岩本卓也, 小田都紀子, 村木優一, 奥田真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

	Application effect of the generalization linear mixed effect model in the initial administration plan of P0366-22-AM vancomycin 興梠靖幸1),2), 緒方賢次2),3), 田中恵美1), 甲斐晃弘1), 徳永仁2),3), 瀬戸口奈央3), 千代反田晋1), 高村徳人2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2015.

	About usefulness of blood busulfan levels monitoring - low dose trial administration in P0367-21-PM children - 石渡泰芳1), 永田将司1), 瀧川加奈子1), 高橋弘充1), 今井耕輔2), 高木正稔2), 金兼弘和2), 森尾友宏2), 安原眞人3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

Search of the Cpeak arrival time for aminoglycoside derivative antimicrobial by the 2-compartment model using the P0368-22-AM Easy TDM
山口佳津騎1), 阿部武由2), 渡邊政博3), 竹内敏己4), 土屋浩一郎5), 高橋功一1), 元木貴大1), 田中裕章1), 朝倉正登1), 小坂信二1), 芳地一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

	Suggestion at the time of the recommended drawing blood at population pharmacokinetics analysis and TDM measurement of P0369-21-PM vancomycin 金丸達哉1), 松村千佳子1), 塩田智子2), 高橋一栄2), 矢野義孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

	Usefulness of the institution original population parameter facing P0370-22-AM TDM enforcement 岡田章1), 上野幹生1), 金森美咲1), 小阪直史2), 国府孝敏3), 牛込秀隆4), 吉村了勇4), 笠井英史5), 福島恵造1), 杉岡信幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

Search of the factor contributing to onset of hepatic dysfunction with the voriconazole administration in patients with P0371-21-PM blood malignant disorder
森永裕子1), 鈴木陽介1),2), 時松一成3), 田中遼大1),2), 佐藤雄己1),2), 緒方正男4), 平松和史2), 伊東弘樹1), 門田淳一2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

	Examination of an IV infusion, the oral voriconazole optimum dose in P0372-22-AM children 茂見茜里1), 渡辺英里香1), 松元一明2), 横山雄太3), 猪川和朗3), 金澤直子1), 梅崎靖弘1), 竹下鮎美1), 池田龍二1), 森川則文3), 武田泰生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2015.

	Evaluation of the blood tacrolimus levels measurement using the P0373-21-PM new ACMIA method 田渕祐輔, 牧野洸太朗, 越智尚子, 小阪直史, 四方敬介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

	Inspection of the usefulness of the point of recommended drawing blood chart at the P0374-22-AM vancomycin TDM measurement 塩田智子1), 松村千佳子2), 谷長美菜子1), 金丸達哉2), 矢野義孝2), 高橋一栄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

Two cases of patients with lymph vessels myoma symptom that a trough level of sirolimus showed high level by combination of P0375-21-PM itraconazole
菊地正史1), 野田あおい1), 田中雅樹1), 高橋阿希子1), 松田安史2), 星川康2), 久道周彦1), 山口浩明1), 岡田克典2), 眞野成康1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

Intervention effect to vancomycin initial administration plan by the P0376-22-AM ward permanent residence pharmacist
水岡大策, 山口佳津騎, 馬場亨, 久保裕香理, 河野真梨, 立道貴清, 田井達也, 一瀬ひろみ, 住吉健太, 冨田淳子, 小坂信二, 芳地一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

Examination of the diarrhea expression risk factor early after transplant with mycophenolic acid in the P0377-21-PM lung transplantation patients
伊藤雄大1), 須野学1),2), 坂本健太1), 吉崎祐太1), 川西秀明3), 千堂年昭3), 三好健太郎4), 山根正修4), 杉本誠一郎4), 大藤剛宏4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

	Application to the Viva-E system of the P0378-22-AM nano peer (R) eTDM methotrexate measurement kit 松下尚弘, 谷川昇, 大竹由希子, 竹永早百合, 安藤千裕, 青柳裕美, 江崎舞, 古賀清弘, 石丸隆之, 野中敏治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2015.

Comparison between antigen antibody immune reaction assay and traditional approach using the My5-FU reagent in blood 5-FU densitometry in P0379-21-PM TS-1 treated patients
野田哲史1), 稲富理2), 平大樹1), 池田義人1), 赤羽理也1), 安藤朗2), 森田真也1), 寺田智祐1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

	Examination of the initial administration plan method using the vancomycin parameter varying in P0380-22-AM 鈴木伸志, 井田真仁, 佐野邦明, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

	Examination of the decreased renal function frequency according to the renal function in the P0381-21-PM vancomycin administration 杉慎介, 大石泰也, 川野昭, 東めぐみ, 鷲見理恵, 西村紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

Decision of the treatment strategy based on a characteristic of the vancomycin TDM analysis software which paid its attention to P0382-22-AM renal function
春木祐人1), 広本篤2), 毎熊隆誉2),3), 岡泰江1), 春木麻衣1), 増田展年4), 杉山哲大1), 手嶋大輔2),3), 近藤祥代1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

	Nephropathic risk factor analysis with the P0383-21-PM vancomycin hydrochloride administration 薗田晃弘, 中尾承司, 岩崎公美, 桑鶴麻代, 川畑綾, 永田春香, 高田侑那, 浜園龍, 宝来留美, 岩下佳敬, 石田和久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

	Examination of the nephropathic expression situation and risk factor in the P0384-22-AM vancomycin administration 只佐宣子1), 梶谷真也1), 徳本和哉1), 要田芳代1), 川上恵子1), 三島基靖1), 竹増まゆみ1), 只佐正嗣1), 堀川俊二2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2015.

	Role of introduction and the pharmacist of PBPM for P0385-21-PM antiMRSA medicine proper use 渡邊卓嗣, 田村彩, 伊藤亮太, 中居肇, 伊藤功治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

Examination of the usefulness of the VCM, TEIC initial administration plan using the P0386-22-AM TDM implementation manual
久保智士, 二見早希, 今市沙有美, 岡紗智子, 井上美穂, 松下比奈子, 石田あい, 松尾多恵, 藤本智大, 山崎瑞貴, 鶴崎亮, 北森翔子, 青木美沙, 松谷和子, 三嶋仁美, 木村真策
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

Factor - of consideration - initial administration plan deviation of the case that deviated from a therapeutic range from initial administration plan of P0387-21-PM vancomycin
高橋静香1), 松村直樹2), 横濱妙子1), 高松謙1), 渡邊卓嗣1), 長島章3), 中居肇1), 伊藤功治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

	Comparison of the pharmacokinetic parameter at the vancomycin hydrochloride infusion between the P0388-22-AM cancer species 大塚亮, 中島寿久, 小井土啓一, 佐野智望, 西垣玲奈, 橋本浩伸, 大塚知信, 林憲一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

	Association between blood vancomycin levels and effect of treatment in P0389-21-PM children 近藤美貴, 中川俊作, 米澤淳, 矢野育子, 中川貴之, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

	1 case that was given continuous infusions of vancomycin for the bacterial meningitis of P0390-22-AM children 喜多岡洋樹1), 後藤由起子1), 山室蕗子1), 末吉栄志1), 近藤元三1), 久冨雄一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2015.

	The effectiveness and problems of the arbekacin administration plan based on P0391-21-PM antimicrobial TDM guidelines 杉田裕貴, 田中絵美, 細見健悟, 小牧佐知子, 稲田智子, 高子優子, 増本憲生, 大槻裕朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

	Future problem in the TDM of P0392-22-AM VCM 堀本厚子, 組橋由記, 大久保真由美, 鈴江朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

	Examination about the vancomycin administration plan during the P0393-21-PM sustained hemofiltration dialysis enforcement 溝田繁治, 下澤那津, 花田聖典, 谷口潤, 東島彰人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

	Examination of the blood vancomycin levels optimum measurement interval in the adult case except the P0394-22-AM special condition of a patient 坂倉広大1),2), 中蔵伊知郎1),2), 土井敏行1), 上野裕之1), 山崎邦夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

	Operation of the vancomycin TDM duties flow by P0395-21-PM ward charge pharmacist and the TDM charge pharmacist 佐藤浩太郎, 古川早矢香, 飯田遥, 梶野哲, 岩崎希, 井口恵美子, 猪股克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

	Renal function evaluation using predictive precision and cystatin C in the P0396-22-AM vancomycin doses design 塩田喜美子, 吉本有里, 田川幸, 諌見圭佑, 千場美奈, 竹内小百合, 山部美千子, 小園亜希, 津曲恭一, 山道研 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2015.

	One case that we intervened in pharmaceutical to the patients that P0397-21-PM MRSA was detected 千原亜紀子, 池田久雄, 平田貴宏, 岡安唯, 野村浩英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

	Examination about the contribution degree to the medical care by the in-hospital measurement shift of blood drug levels in the cottage-hospital out of P0398-22-AM 鳥羽英理子, 藺上圭子, 宇夛裕基, 山島糸, 河原昌美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

	The administration method of vancomycin for P0399-21-PM haemodialysis patients and the clinical evaluations 大仁田哲修, 石原慎之, 岡崎美香, 井上昌樹, 玉木宏樹, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

	Population efficacy change model analysis of the febuxostat using the P0400-22-AM daily life clinical data (electronic chart) 森木邦明1), 高根浩1), 重松沙希2), 深江真登2), 加唐誠剛東2), 島田美樹1), 家入一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

	Insurance examination assessment situation investigation of Teiko plastic Nin in the P0401-21-PM Nagasaki University Hospital 松永典子, 森塚暁裕, 吉永萌, 里加代子, 北原隆志, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

	Fact-finding ... to an attitude survey and a practitioner to Mayor of TDM questionnaire survey - section in P0402-22-AM Kanagawa 蛭田剛俊1),3), 濃沼政美2),4), 佐村優3), 樋島学3), 小村裕子3), 井上順博3), 佐藤透4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2015.

	P0403-21-PM Asian, blacks, population pharmacokinetics analysis of the warfarin for whites and evaluation of the administration algorithm 久保佳奈1), 大原みなみ1), Cavallari LH2), Lee MTM3), Scordo MG4), 宮嶋篤志1), 高橋晴美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

	Study on blood tramadol optical isomer levels and clinical response according to the P0404-22-AM CYP2D6 genetic polymorphism 須野学1), 伊藤雄大2), 山本健人2), 吉崎祐太2), 中西里佳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

Search of the risk factor for chemotherapy-induced retching, vomiting in patients with P0405-21-PM AC therapy enforcement breast cancer
幕田龍1), 辻大樹1), 金容壱2), 山本圭祐3), 横井茉里1), 大嶽亜季1), 中森春美1), 井上和幸1), 平井啓太1), 中道秀徳3), 塩川満3), 伊藤邦彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

About the platelet function measurement in the P0406-22-AM our hospital and the choice of the antithrombocytic agent using the CYP2C19 genetic polymorphism
廣田あゆ子1), 浅野志津1), 松本和也1), 山本梓2), 金井美緒1), 花房伸幸1), 難波悠介3), 福家聡一郎3), 佐藤哲也3), 森英樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

	FCGR3A gene -158V/F polymorphic frequency analysis in the P0407-21-PM Japanese 木村耕二, 小林大悟, 横山晴子, 高柳理早, 山田安彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

	The construction of the cancer chemotherapy management system using the P0408-22-AM frequent use database software and the evaluation 木津茂, 米川恭史, 光家勉, 太田正美, 渡部なおみ, 富田国男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2015.

	Development of the explanation documentation system which established a viewpoint for the comparison of the P0409-21-PM breast cancer regimen 広田瑞季, 大西優香里, 鈴木信世, 松井布美, 石井杏奈, 西岡佐和子, 河原栞, 小茂田昌代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

	Construction of the regimen system including the oral medicine by the P0410-22-AM electronic chart 金子誠1), 山崎博之2), 松井孝之1), 今井弘之1), 赤沼浩明1), 石川靖治3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

	Safety Management and convenience of the chemotherapy treatment planning form that practiced medical treatment management (PBPM) based on P0411-21-PM protocol 齋藤裕子, 菊池大輔, 齊藤美帆, 高橋透, 畑中貞雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

	About making and the operation of the management sheet for P0412-22-AM anticancer agent proper use 龍官真生子1), 吉岡奈津恵1), 尾崎智規1), 北村芽衣子2), 小林真也3), 渡辺明彦4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

	Enforcement of the UGT1A1 genetic screening in the P0413-21-PM irinotecan administration and fact-finding about the dose 久枝真一郎1), 西口幸代2), 浜野峰子1), 宗広樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

Evaluation of hepatitis B reactivation measures at chemotherapy start in the P0414-22-AM our hospital
林豊1), 富野浩光1), 名倉理央1), 小野田千晴1), 加藤純1), 小澤和子1), 増田由香1), 平田淑子1), 増田仁美1), 後藤治子1), 池谷延房1), 小平誠2), 平松毅幸3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2015.

	Evaluation after the hydration unification of the cisplatin regimen in the P0415-21-PM Beppu medical center 鶴田南奈子1), 鳥山陽子1), 梅野なるみ2), 橋本典也3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

	A problem and the remedy that we were able to see from doubt inquiry about the clinical test value in the P0416-22-AM cancer chemotherapy 高橋透, 齋藤裕子, 齊藤美帆, 菊池大輔, 畑中貞雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

Usefulness by the electronic order system registration of the P0417-21-PM childhood cancer chemotherapy regimen
渡邉美菜子1), 丹羽洋介1), 矢田郁実1), 冨安真史1), 大庭真弓1), 伊藤槙智子1), 野村英宏1), 鳥本真由美1), 森智子1), 村松秀城2), 高橋義行2), 小島勢二2), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

	Efficiency of the anticancer agent regimen inspection using P0418-22-AM Microsoft Excel 瀧平純一, 島田惇司, 岡田和博, 金子知由, 大塚淳一, 伊藤やす江, 安間浩子, 長塚さおり, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

Significance in the electronic order ring systems construction of the P0419-21-PM childhood cancer chemotherapy regimen and the medical security
冨安真史1), 丹羽洋介1), 森智子1), 渡邉美菜子1), 大庭真弓1), 伊藤槙智子1), 矢田郁実1), 野村英宏1), 石塚雅子1), 鳥本真由美1), 村松秀城2), 高橋義行2), 小島勢二2), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

	An evaluation and improvement for the P0420-22-AM inside the hospital adoption anticancer agent table 水木麻里, 寺内さつき, 中山真知, 長江萌菜美, 富田かおり, 柏木優香, 鈴江香織, 岡峰亜希菜, 大村ふみ, 森吉雅代, 中川朱美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2015.

	Introduction of by encounter front by the pharmacist for the P0421-21-PM oral anticancer agent 杉野善彦1), 前川由佳2), 小島圭太郎1), 蓑島謙一3), 山羽正義2), 堀江正宣2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

	Efforts to oral anticancer agent therapy support for the outpatient in the P0422-22-AM Itabashi Chuo General Hospital 目黒聡子1), 高山裕子2), 酒井由希子1), 岡山和広1), 山内泰一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

Role of the foreign chemotherapy conference by the P0423-21-PM pharmacist leadership
山室蕗子1),2), 後藤由起子1),2), 喜多岡洋樹1), 楠本将裕1), 吉田愛1), 田中泉1), 末吉栄志1), 近藤元三1), 辻隆宏2), 奥村恭博2), 岸裕人2), 山崎浩2), 津田弘之2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

	Efforts to cancer instruction to patient management charges 3 in the P0424-22-AM our hospital 古林園子1), 小沼大祐1), 岩村瞳1), 伊藤博1), 中野茂治2), 鈴木正人2), 加藤一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

P0425-21-PM AC, fact-finding of the foreign chemotherapy hot line consultation from patients with CEF therapy enforcement breast cancer
原茉梨絵1), 橋本浩伸1), 文靖子1), 近藤俊輔2), 上原智子3), 矢野美穂3), 朝鍋美保子3), 田村研治4), 大塚知信1), 林憲一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

1 case that the opioid continuous intravenous infusion introduction with the P0426-22-AM PCA pump allowed home discharge
高橋晶子1),2),3),4), 藤谷竜磨1), 岡嶋絵里香1), 赤嶺千秋1), 藤屋華織2), 藤本和美2), 浦野美雪2), 熊倉佐代子2), 片岡学4), 高田淳子3), 越田晃1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2015.

Efforts for quality and safety improvement of the cancer chemotherapy that we followed for the PDCA cycle by the P0427-21-PM chemotherapy team
日比聡1), 井上博貴1),5), 城川優子2),5), 壁谷めぐみ5), 長岡雅敏1), 横井沙緒里1), 鈴木彩香1), 丹羽絵梨奈1), 松浦三恵子3), 伊奈研次4), 湯浅周1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

	Patients intelligence using the patients with cancer screening in the P0428-22-AM outpatient department chemotherapy center 宮松洋信1), 東加奈子1), 鮎原秀明1), 宮里明芽1), 夏目真紀1), 川島美由紀2), 鈴木康予2), 明石貴雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

	Relation of the drug department in the P0429-21-PM cancer board 大原正之, 小川信二, 藤原斉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

	Efforts to the emergency consultation of the cancer chemotherapy enforcement patients in the P0430-22-AM City Nagahama Hospital 大岡千寿子, 野洌孝二, 寺村早貴, 池田遼太, 元持正樹, 多賀俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

	Construction of the local medicine medicine cooperation system in the P0431-21-PM breast cancer adjuvant postoperative treatment 松原怜, 鈴木大吾, 田中伸明, 鈴木敦詞, 牧なつみ, 稲垣史郎, 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

The examination of the preparation method of the allopurinol gargle agent and the effect on stomatitis with the P0432-22-AM cancer chemotherapy
藤井芳範1), 長谷部忍1), 山浦佳子1), 小田泰弘1), 内田ゆみ子1), 五十嵐正博1), 伊藤忠明1), 宇田川晴司2), 林昌洋1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2015.

	Effect of the renal function on side effect frequencies in the P0433-21-PM Ron surf (R) treatment 角川幸男, 高橋靖治, 石床知佐江, 岩西雄大, 高橋幸三, 澤井祐樹, 杉本貴洋, 清水克次, 望月千枝, 中多陽子, 福島宣久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

	The effectiveness, safe examination of the peg filgrastim in the P0434-22-AM malignant lymphoma R-CHOP therapy 櫻井淳二, 宮内康夫, 佐藤伸輔, 野上佳奈子, 武者栄美子, 石澤文章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

	P0435-21-PM peg filgrastim subcutaneous injection proper use and investigation of the effectiveness 仁田美保子, 中林真紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

	Study on venous thrombosis and patients background by P0436-22-AM Bevacizumab 早川裕二1), 小山一子1), 森下拓也2), 小林智晴1), 大津史子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

	Fact-finding of acute renal failure (AKI) in the P0437-21-PM cisplatin (CDDP) combination chemotherapy and search of the risk factor 阿部真紀, 吉野真樹, 山下弘毅, 田中克幸, 佐々木奈穂, 田川千明, 田中佳美, 加藤克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

An evaluation of the prophylaxis of the vascular pain with P0438-22-AM oxaliplatin and analysis of the risk factor
池田菜々1), 菅幸生1), 前田真奈美1), 岡田守弘2), 桂英之3), 北出紘規4), 米澤美和5), 石崎純子1), 嶋田努6), 柏原宏暢5), 崔吉道6), 松下良1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2015.

	Examination of the onset of hypomagnesemia situation by the P0439-21-PM panitumumab 平池美香子, 林稔展, 西野隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

	We look at the use situation for the second prevention of the P0440-22-AM peg filgrastim and the rear about the onset of pyrogenic neutropenia and investigate a mark 櫻下弘志1), 佐伯康之1), 畝井浩子1), 杉山一彦2), 松尾裕彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

	Examination about the effect of treatment of the irsogladine maleate for the P0441-21-PM acetic acid-induced stomatitis model 佐藤光利1), 赤石美生1), 今村綾乃2), 河野弥生2), 花輪剛久2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

	Of the prophylaxis of the sustained G-CSF preparation for the P0442-22-AM head and neck cancer TPF therapy, actually 平田力1), 北山秀則1), 村紗苗1), 出町拓也1), 佐藤佑一朗1), 芦崎雅之1), 早坂州生1), 竹内公美1), 渡邉昭仁2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

It is the actual situation of peripheral neuropathy in the adjuvant chemotherapy Capecitabine/Oxaliplatin combination (XELOX) therapy after colon cancer technique using the evaluation tool of plural P0443-21-PM
杉崎崇人1), 川上和宜1), 横川貴志1), 瀧口友美1), 杉田一男1), 中本恵理1), 末永光邦2), 水沼伸行2), 山口俊晴2), 濱敏弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

	The nephrotoxic evaluation of the short hydration method at the P0444-22-AM cisplatin administration and examination of the tolerability 高山智行, 田邉直人, 田沼道也, 高野浩彦, 折井孝男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2015.

	Effect of "the paclitaxel to preload" giving it to P0445-21-PM "vascular pain during Carboplatin administration" 堀部正記, 池井健, 大谷仁士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

	Investigation of the adverse event with the trastuzumab M tongue Shin administration in patients with P0446-22-AM HER2-positive breast cancer 須川涼, 泉谷悟, 西垣内亮, 垰越崇範, 佐伯康之, 畝井浩子, 松尾裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

	About plasma platinum concentrations in the P0447-21-PM Weekly cisplatin combination concurrent chemoradiotherapy and acute nephropathic association 山本健人1), 須野学1),2), 浅野匡彦1), 伊藤雄大1), 中西里佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

It is ... about examination - small-cell lung cancer CDDP+CPT-11 therapy of the risk factor about dose regulation factor of P0448-22-AM irinotecan
椎名俊介1),2), 平井成和2), 渡辺和美3), 土井啓員2), 増田雅行2), 佐野君芳2), 田中芳夫1), 真坂亙2), 石井敏浩4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

	The HBV reactivation measures that utilized a regimen sheet in the P0449-21-PM cancer chemotherapy 米北浩人1), 黒津愛奈美2), 森健治3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

	Effect to hepatitis B reactivation risk reduction by the pharmacist inspection at the P0450-22-AM cancer chemotherapy enforcement 藤岡美穂, 中西敏博, 桂川健司, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2015.

	Examination of the renal failure protective efficacy with the Mg administration in the P0451-21-PM cancer of the esophagus FP therapy 藤川翠1), 宮原強1), 嬉野紀夫2), 松永尚1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

	The onset of hypomagnesemia situation and intervention effect in the P0452-22-AM cetuximab panitumumab 杉浦央, 斎藤由起子, 加藤ゆか, 近藤覚也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

	One case that came by treatment continuation by correspondence such as the weight loss for hepatic dysfunction of the P0453-21-PM that mouth nib 楠本将裕1), 山室蕗子1), 喜多岡洋樹1), 後藤由起子1), 末吉栄志1), 近藤元三1), 岸裕人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

	One patient who presented with sex hypersensitivity from delayed type hypersensitivity by P0454-22-AM oxaliplatin immediately 青孝明, 近藤智彦, 山川恵子, 木村匡男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

	Efforts for the establishment of the side effect expression situation and the supportive care by the P0455-21-PM Afatinib 越野優希, 立道貴清, 冨田淳子, 久保裕香里, 河野真梨, 馬場亨, 田井達也, 水岡大策, 田中裕章, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

	We look at the rear about the side effect of P0456-22-AM clofarabine expression and investigate a mark 疋田絵梨1), 清美奈1), 米窪恭子1), 大橋一輝2), 白石範子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2015.

	Evaluation of the expression situation and measures of the dermatopathy by P0457-21-PM cetuximab and the panitumumab 斎藤由起子, 杉浦央, 加藤ゆか, 菅野崇淑, 近藤覚也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

	The use situation and side effect management of the P0458-22-AM Afatinib 櫻井登代子1), 伴具也1), 坂口才2), 土谷美知子2), 三浦誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

	Choice of the appropriate supportive care for the P0459-21-PM FOLFIRINOX therapy and the case that was thereby available for long-term treatment 金田典子, 山下剛史郎, 廣瀬孝一, 高田宏文, 馬島務, 丸尾栄次, 北村瑞穂, 角田誠一, 南橋薫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

Differences between P0460-22-AM docetaxel, trastuzumab combination therapy and infusion reaction frequencies by the trastuzumab monotherapy
中嶋陽一1),2), 柿原圭佑1), 葉田昌生1), 松崎雄1), 白石亘1), 佐伯衣里佳1), 米倉博知1), 三上忠司1), 野瀬育宏2), 田中眞紀2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

	The effect that the nutritional status at P0461-21-PM Eribulin administration start gives to intensity of treatment 横山雄一1),3), 今井一輝2),3), 矢野亨治3), 杉原輝洋1), 井上潔1), 今村健郎3), 篠原義剛1), 日高博司1), 山田清文3), 浅原稔生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

The effect that a characteristic and the difference in regimen using the high-dose cisplatin in the P0462-22-AM each clinical department give to renal function, volume of urine, onset of side effect
杉原輝洋, 横山雄一, 井上潔, 今村健郎, 篠原義剛, 日高博司, 浅原稔生
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2015.

	The effect that the low-dose cisplatin administration in P0463-21-PM outpatient department chemotherapy patients gives to renal function 今村健郎, 横山雄一, 杉原輝洋, 井上潔, 篠原義剛, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

	Effect to give to protective efficacy and Dose Intensity of the febrile neutropenia with the P0464-22-AM peg filgrastim administration 井上潔, 横山雄一, 杉原輝洋, 篠原義剛, 日高博司, 浅原稔生, 今村健郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

	Examination of the durability density for normal humans of gargle water using the P0465-21-PM tricyclic antidepressant (amitriptyline) 江口智子1), 佐々木寿子2), 国分秀也2), 坂本真依子1),3), 矢島愛理1), 尾鳥勝也1), 厚田幸一郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

	Vascular pain measures of the P0466-22-AM Fosaprepitant and the evaluation 藤井友和, 西川隆一, 澤柳直樹, 荒木寛也, 坂柳悦章, 辻博幸, 塚本久之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

	1 case that was given hyposensitization of P0467-21-PM oxaliplatin 山際一也1), 三浦華歩2), 二瓶大輔1), 五味祐介1), 高田みゆき1), 地引綾2), 中村智徳2), 山本聖一郎3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

Analysis of the risk factor about the thrombocytopenia of patients receiving P0468-22-AM lenalidomide
安田昌宏1),2), 舘知也2), 梅田道1), 長屋雄大1), 大澤友裕1), 川島あずさ1), 牧野哲平1), 甲田明英1), 市橋厚司1), 後藤英子3), 笠原千嗣3), 高橋健3), 後藤千寿1), 寺町ひとみ2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2015.

	It is examined the need of the serum electrolyte monitoring until eight weeks after administration cancellation in the P0469-21-PM antiEGFR antibody preparation 桜田宏明, 川瀬洋次, 浅野寿規, 染原渉, 伊藤弘美, 山村益己 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

	One patient who presented with hyperammonemia after a change from P0470-22-AM FOLFOX4 to mFOLFOX6 古田知子1), 高橋有和2), 中嶋早苗2), 久米真2), 岡安伸二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

About the need of the specimen cooling in the uric acid level measurement after the P0471-21-PM rasburicase administration (the second report)
大坪達弥1),2),3), 杉山忠章2), 眞釼彩子1), 中川ゆかり1), 友金幹視1), 藤田敦夫1), 魚嶋伸彦3), 小林裕3), 三上正1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

	The effect that a merger of the P0472-22-AM heart disease gives to cisplatin renal failure 三好孝法1), 三角紳博2), 平池美香子3), 三原由記4), 平木洋一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

	New predictor of nail disorder expression time by P0473-21-PM Docetaxel and the becoming severe 高畑英信1),2),3), 田辺公一4),5), 高木昭佳3), 久田勢津子1), 山之内恒昭3), 三村泰彦3), 新田淳美2), 安田初奈4), 菓子井達彦4), 足立伊佐雄3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

	Efforts for the hepatitis B reactivation in the P0474-22-AM our hospital and future problem 山中義裕1), 横山正人1), 佐竹路子1), 野竹秀幸1), 西山雅善1), 朝日恵美2), 日比知志3), 竹内隆浩4), 田村圭浩5), 岡本好史6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2015.

	It is a 2 case receiving the Afatinib for patients with non-small cell lung cancer with a history of the liver damage by P0475-21-PM EGFR-TKI 中西大介1), 出口綾子1), 畑地治2), 柳川泰裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

	Examination of the usefulness of the G-CSF preparation prophylactic administration in the P0476-22-AM outpatient department chemotherapy 岩坪沙奈恵, 樋口美奈子, 佐々木好美, 和田依子, 山口竜一, 中野行孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

	Protective efficacy of magnesium for the renal failure at the cisplatin administration in patients with P0477-21-PM progress recurrent lung cancer 牛島知実1), 三好孝法2), 山脇一浩1), 林稔展1), 西野隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

Example that secondary prophylaxis of the P0478-22-AM peg filgrastim prevented neutropenia during the progress cancer of endometrium DC therapy enforcement for stage 3, and contributed to burden on patients reduction
山下悟史, 岸川春樹, 長谷悠紀, 曽我弘道, 平野真健, 町田聖治, 入江利行
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

The participation of the pharmacist in marker screening for the HBV reactivation prevention during P0479-21-PM cancer chemotherapy and the result
川畑綾, 岩下佳敬, 薗田晃弘, 中尾承司, 岩崎公美, 桑鶴麻代, 永田春香, 高田侑那, 浜園龍, 宝来留美, 石田和久
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

The possibility that the dosage of Pregabalin reinforces improvement and an effect of Chlorpromazine for intractable hiccups with the P0480-22-AM cancer chemotherapy
鈴木毅1), 柴田馨日1), 下地滋子2), 石井岳夫1), 難波有智1), 若松菜摘1), 外間惟夫1), 中村克徳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2015.

	1 case that a platelet suddenly decreased after P0481-21-PM Oxaliplatin administration 本多伸二1),2), 大野恵一1), 三松史野1), 浜田久美子1), 荒田美帆子1), 實光由香1), 目黒裕史1), 村田龍宣1), 寸田靖1), 伊藤鉄夫2), 村岡淳二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

	Examination - about the adsorption of the anticancer agent for development - infusion set of the simple assay of pharmaceutical products using P0482-22-AM 1H-NMR 梅村雅之, 新倉伶奈, 吉松昂大, 岩井香穂, 松尾はるか, 松村美紀, 平野匡哉, 脇屋義文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

	Investigation of the hepatitis B screening enforcement situation using P0483-21-PM DWH and Microsoft Access 廣岡賢輔1),2),3), 松岡聡2), 清水浩幸1), 國森公明1), 満田朱理3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

	Inspection of the usefulness of the drug costs calculation tool in the P0484-22-AM breast cancer medical therapy 橋本浩季1), 村上通康1), 篠崎恭子3), 川口英俊2), 西崎隆4), 仙波昌三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

Present conditions investigation of the quantity of disposal of anticancer agent in the P0485-21-PM our hospital
森田美江子, 岩瀬利康, 坂本鉄弥, 野澤孝章, 瀧山慈絵, 大澤千恵, 池田真菜美, 小山朋子, 木村美貴, 星野浩一, 宮川潤子, 大塚敏弘, 伊藤好夫, 越川千秋
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

	Examination about the effectiveness and the safety of the starting pharmaceutical products and generic medicine in the P0486-22-AM breast cancer chemotherapy 山崎美保1), 野口亜樹1), 中下愛1), 木村竜司1), 松本篤1), 高橋護2), 前田頼伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2015.

	Examination of the high blood pressure of the P0487-21-PM Bevacizumab administration case, the onset of thromboembolism situation and the d-dimer level 丸山昌広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

The chemotherapy-induced neutropenia in patients with gemcitabine enforcement pancreatic cancer with the P0488-22-AM distant metastasis and related examination with the survival period
大嶽亜季1), 辻大樹1), 多久佳成2), 幕田龍1), 横井茉里1), 中森春美1), 井上和幸1), 平井啓太1), 伊藤邦彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

	Safety of the TPF therapy in P0489-21-PM head and neck cancer 小池麻由, 平岩歳久, 家田浩美, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

	Frequencies of infusion reaction by the difference in dilution level of P0490-22-AM rituximab and safe examination 細見誠1), 稲野祥子1), 早坂大1), 後藤愛実1), 西原雅美1), 横手耐冶2), 勝間田敬弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

	P0491-21-PM Study on the effect of kidney function on the incidence of hypocalcemia in patients receiving RANMARK(R) in combination with DENOTAS(R) 橋爪孝弘, 篠道弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

	About mLSG15 therapy for P0492-22-AM 70 years old or more 戸切祥恵, 福石和久, 尾之江剛樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2015.

	Risk factor analysis of the low Ca blood symptom by the P0493-21-PM denosumab 植村隆1), 下澤那津1), 高田正温1), 田中誠2), 東島彰人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

	Participation of deoxycytidine kinase in effect of decitabine in P0494-22-AM colon cancer cells 池田奈津希, 細川美香, 上田久美子, 岩川精吾 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

	Combination of P0495-21-PM Erlotinib and gastric-acid secretion antagonist fact-finding 山口竜司1), 樋口美奈子1), 佐々木好美1), 和田依子1), 岩坪沙奈恵1), 古藤洋2), 松尾宏一3), 中野行孝1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

	The effect that antacids give for EGFR tyrosine kinase inhibitor effect of treatment in the P0496-22-AM non-small cell lung cancer 酒井鉄平1), 小井戸啓一2), 牧原玲子2), 橋本浩伸2), 大塚知信2), 林憲一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

	Examination - of the effect by lenalidomide administration - renal function on patients with P0497-21-PM multiple myeloma 山本圭城1),3), 安井友佳子1), 上島悦子3), 石坂敏彦1), 柴野賢2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

	Examination about the excretion delay factor at the P0498-22-AM large quantities methotrexate administration 片岡達夫, 櫻下弘志, 垰越崇範, 西垣内亮, 村瀬哲也, 泉谷悟, 佐伯康之, 畝井浩子, 松尾裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2015.

Use experience of the Docetaxel (TXT) + Bevacizumab (BV) combination therapy for the P0499-21-PM progress non-small cell lung cancer
相澤佑佳1),2), 大西涼子2), 浅野幸市2), 鱸稔隆2), 安田成雄2), 佐野公泰2), 加藤達雄2), 梅村実希1), 梶田実穂1), 大島由莉1), 横田智香1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

	Use case of the denosumab note for hypercalcemia in the P0500-22-AM our hospital 越智良明1), 根岸大輔1), 石井弘幸1), 舟越亮寛3), 大渕徹2), 雨宮厚2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

	Two patients who presented with impaired renal function by P0501-21-PM high dose cisplatin (100 mg/m2) administration 大園ゆかり1), 川俣洋生1), 吉永里香子1), 山口泰弘1), 林淳一郎1), 松崎勉2), 西元謙吾2), 吉福考介2), 平山俊一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

	It is the effect in S-1 treated patients by the test value repousse introduction to P0502-22-AM prescription 向井光一朗, 羽田野桂史, 亀丸明莉, 松井法子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

	The present conditions of the FOLFIRINOX therapy in the P0503-21-PM our hospital 白井敦史1), 埋橋賢吾1), 藪田ゆみ1), 山崎貴司1), 中島恵子1), 橋本佳浩1), 藤本佳史2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

	Research about the present conditions of the disposal of anticancer agent in the P0504-22-AM healthcare setting and the economic loss 元山瞳1), 大津史子1), 佐々木忠徳2), 濱宏仁3), 原田幸子4), 松浦克彦5), 山川雅之6), 渡辺享平7), 後藤伸之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2015.

Investigation, analysis of doubt inquiry contents in the P0505-21-PM cancer chemotherapy
濱武清範1), 小島一晃1), 美和孝之1), 仲忠士1), 松本弘誠1), 奥村優介1), 小西史子1), 飯田有香1), 足立那々緒1), 酒井ちひろ1), 福井美礼1), 千葉渉1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

Efforts of the pharmacist for the P0506-22-AM cancer instruction to patient management charges 3 calculation
田尾勇治, 香川千春, 上田裕子, 高田健司, 甲斐千晴, 藤原央樹, 内橋宣裕, 衛藤里沙, 小本晴香, 小田代知佐美, 高倉千晶, 宝諸あい, 熊谷美香, 前川文乃, 沢崎高志
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

	Efforts of the excretion instruction during P0507-21-PM colon cancer chemotherapy 小山拓弥1), 下川福子1), 南原誠1), 賀川義規2), 弘岡貴子3), 立原敦美3), 船越幸代1), 池上英文1), 加藤健志2), 田村茂行2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

	Efforts ... in the cottage-hospital out of intervention ... to the foreign cancer chemotherapy that utilized P0508-22-AM electronic chart 原竜太郎, 戸鹿野美織, 橘淳, 濱浦睦雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

Inspection of an evaluation and the intervention effect by the round before chemotherapy of the pharmacist in the P0509-21-PM blood tumor internal medicine
加瀬くりみ1), 桝田浩司1), 安室修1), 伊勢崎竜也1), 川名晶子1), 鈴木正論1), 石塚寛和1), 永井淳子1), 舟越亮寛1), 末永孝生2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

	About the standardization of the intravenous feeding route assembling method in the P0510-22-AM cancer chemotherapy 大野裕之, 渡部実咲, 平下智之, 谷沢克弥, 遠藤秀治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2015.

Analysis - of the questionnaire results at the joint symposium with present conditions of the anticancer medicine preparation in the P0511-21-PM healthcare setting and pharmaceutic problem 1 - Academy of Pharmaceutical Science and Technology, Japan
荻原琢男1), 石田竜弘2), 河原昌美3), 宇都口直樹4), 大槻純男5), 宮本祐司6), 中田雄一郎7), 岩本卓也8)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

Receive the present conditions of the anticancer agent preparation in the P0512-22-AM healthcare setting and the enforcement of the roundtable session in pharmaceutic problem 2 - Academy of Pharmaceutical Science and Technology, Japan annual convention; and -
石田竜弘1), 河原昌美2), 宮本祐司3), 荻原琢男4), 大槻純男5), 宇都口直樹6), 中田雄一郎7), 岩本卓也8)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

Examination of the antineoplastic administration using P0513-21-PM syringe pump
川崎智子, 成川祥子, 高橋恭子, 勝田良子, 新穂祐子, 渡辺孔明, 吉澤雅恵, 風岡真実, 小野妙子, 佐藤綾子, 島盛一郎, 吉田有貴子, 山内たきよ, 上村彩子, 中嶋一恵, 桜井美杏, 佐野文香, 湯浅智恵, 今村涼子, 長澤宏之
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

	The effectiveness in the change cases from P0514-22-AM zoledronic acid note to a denosumab note and safe evaluation 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

	Patients satisfaction investigation of the pharmacist concerned with P0515-21-PM "cancer instruction to patient management charges 3" 田村悟, 小森谷友宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

	The use situation of the oil xanthan gum /GEM combination therapy in the P0516-22-AM our hospital 小阪圭治, 土谷有美, 井岡真佐夫, 塚本真裕子, 大林巧志, 津田正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2015.

	Evaluation of pharmacist duties in the P0517-21-PM outpatient department chemotherapy 伊藤実里, 阪田安彦, 阿部圭輔, 村上礼隆, 岡崎夏実, 菅原隆文, 北本真一, 開浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

	Use experience of the Ron surf (R) combination lock in the P0518-22-AM our hospital 田島博樹1), 加藤秀明2), 伊藤錬磨3), 竹内恵美1), 山田裕之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

	Investigation about the use situation and the side effect expression of regorafenib for P0519-21-PM colon cancer 竹内玲奈, 若林雅人, 矢嶋明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

	P0520-22-AM Survey on the use situation and side effects of trifluridine, tipyirasyl hydrochloride and pharmacist's approach 樋口弓都, 若林雅人, 矢嶋明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

	The case that was daptomycin refractoriness for the revival of the P0521-21-PM MRSA infection 藤田将輝, 澤田真嗣, 中西裕明, 友金幹視, 藤田敦夫, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

	Efforts to a use situation investigation and the proper use of the P0522-22-AM Clostridium difficile association loose bowels therapeutic drug 長橋かよ子1),2), 植田正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2015.

Cooperation with use of antimicrobial situation investigation after the P0523-21-PM infection internal medicine setting and drug department and the hospital infection measures team
鈴木朋克1),2), 大森美里1),2), 山本泰子1),2), 岡英昭2),3), 黒川正美2),4), 田中慶彦1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

	Examination about antimicrobial consumption in the P0524-22-AM our hospital and the Pseudomonas aeruginosa-resistant rate 遠山泰崇1), 尾野恵2), 甲斐誠美2), 木元亜里沙2), 伊東佳子2), 後藤忍2), 井上真1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

	Effect of the renal function to give to the platelet level of P0525-21-PM linezolid treated patients 久保悠1),2), 多田知弘1), 小財弘己1), 今田深雪1), 今田愛也2), 猪爪信夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

	The side effect assessment that developed in a use of P0526-22-AM antimicrobial aptitude case 高橋知孝1), 東佑輔1), 山本みどり1), 岸本靜佳1), 鹿島孝子1), 兵頭純子1), 西村翔2), 松尾裕央3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

	The effect of the Clostridium difficile infection treatment manual of the P0527-21-PM our hospital and safe examination 柳橋秀行, 都築はる奈, 林昭子, 宮内智行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

	The change of prescription situation by TDM analysis of vancomycin hydrochloride (VCM) by the P0528-22-AM ward pharmacist and the administration suggestion 伊藤嘉英1), 清水智也1), 長谷川雅哉1), 中尾彰宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2015.

	The observance of the use of vancomycin hydrochloride (VCM) registration system using P0529-21-PM electronic chart system and investigation of the use of VCM situation 清水智也1), 伊藤嘉英1), 長谷川雅哉1), 中尾彰宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

	The best consideration about the effect that the difference of P0530-22-AM children, adults gives thrombocytopenia derived from linezolid 平田憲史郎, 浦田由紀乃, 四郎園巧, 合澤啓二, 陣上祥子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

	Examination about the appropriate administration method of the vancomycin hydrochloride for the purpose of the P0531-21-PM SSI prevention 宮田慎也1), 今浦将治1), 高橋宏行2), 伊藤努3), 菅野浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

An example of an iliopsoas muscle abscess and the vertebral body discitis due to M. fortuitum which secured aim concentrations, and was treated with the amikacin administration before the P0532-22-AM dialysis start
加藤智之1), 鳴島智子1), 古川早矢香2), 本郷偉元3), 丹羽一貴4), 有馬丈洋5), 都倉広子6), 堀治1), 山崎隆志7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

	A CK rise with the P0533-21-PM daptomycin administration and examination about the plasma concentration 平野淳1), 井上裕貴1), 間瀬弘樹2), 高橋昌明3), 柴田雅章4), 稲吉隆行1), 後藤拓也1), 垣越咲穂5), 林誠1), 山谷明正6), 松本修一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

	We look at the rear of the P0534-22-AM sustained MRSA bacteremia and examine a mark 宗佐博子1),2), 加藤英明2), 杉山嘉史2), 橋本真也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2015.

	Daily doses of the P0535-21-PMβ lactam system wide area antimicrobial, the number of administration, examination of AUD 内木義泰1), 征矢佳輔2), 矢野博之2), 伊藤新司1), 坂井孝行1), 竹内信道3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

	A doubt inquiry rate change and the present conditions by the ICT intervention method change to the use of P0536-22-AM daptomycin patients 岡冨大輔1),4), 宅江良隼1),4), 山西紀子1),4), 谷口雅敏1),4), 明見能成2),4), 許泰一3),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

	Examination about P0537-21-PM Staphylococcus aureus bacteremia treatment 池田浩幸1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

Mortality comparison of meropenem administration and the cefmetazole administration for patients with P0538-22-AM ESBL-producing Escherichia coli bacteremia
高野尊行1), 小林由香1), 倉井岳史1), 中丸朗1), 薄井啓一郎2), 百瀬薫2), 藤田明美3), 仲澤恵3), 池野義彦4), 阿久津郁夫5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

	One case that we showed improvement by having suggested antimicrobial according to P0539-21-PM principle and stopped 津曲恭一1), 有村真一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

Than the questionnaire findings to a member of present conditions - Wakayama hospital pharmacist society institution of the antiinfluenza medicine prophylaxis at the P0540-22-AM inside the hospital outbreak ...
木村真1), 阪口勝彦1), 崎山晃宏1), 赤木和由1), 中西町代1), 小山貴久1), 阪野和重1), 中山博文1), 満田正樹1), 野口恵子1), 柏木秀美1), 加藤渓1), 那須明弘2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2015.

	P0541-21-PM A study on the dose of Vancomycin hydrochloride administered to Clostridium difficile related diarrhea in our hospital 加戸義大, 奥村佳史, 山田浩一, 熊代桂子, 森田孝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

	Use fact-finding of the ganciclovir note in the P0542-22-AM our hospital 沢仁美, 山本真史, 浅野智央, 野口泰菜 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

Fact-finding (2) of Clostridium difficile enterocolitis treatment in the hospital attached to P0543-21-PM Sapporo Medical University - Change after the intervention of the pharmacist and effect -
藤居賢, 國本雄介, 益子寛之, 山崎紀恵子, 中田浩雅, 野田師正, 宮本篤
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

	The present conditions of the antibiotic exposure for P0544-22-AM ESBL-producing Escherichia coli bloodstream infections 石田茂伸1),2), 楠本茂雅2), 太田真希2), 笹谷純平2),3), 浅野里枝1),2), 星育子1), 中井由佳1), 川村真代2),3), 大島利夫2),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

Introduction of the multicenter antimicrobial surveillance using ATC/DDDsystem in P0545-21-PM Toyama
舘美幸1), 飯尾志帆1), 高野雄介1), 高橋慎太郎1), 脇田真之1), 船本哲生1), 守内匡1), 加藤貴子1), 窪田佳代子1), 杉田真理子1), 福島恵1), 河井良智1), 辻泰弘2), 山本善裕3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

	Safety assessment of the Atovaquone for the P0546-22-AM pneumocystis pneumonia 常友盛勝1), 菅原隆文1), 壁村嘉恵1), 開浩一1), 辻泰弘2), 神村英利3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2015.

	Usefulness of the empiric administration of Micafungin sodium in the P0547-21-PM antifungal prophylaxis patients 菊池光太, 工藤晋, 丹代恭太, 蒲澤一行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

	Examination of 2 cases that daptomycin-resistant MRSA was detected in P0548-22-AM our hospital 小池彩子1),5), 花房伸幸1),5), 廣田あゆ子1),5), 小原香那1),5), 岡崎忠治2),5), 大山智之2),5), 小川一恵3),5), 奥格4),5), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

	Examination of the clinical usefulness at the azithromycin administration under the treatment with P0549-21-PM low dose macrolide 小薮真紀子, 小迫晶寛, 仲村早紀, 加茂章弘, 鈴田浩孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

	An example of sepsis by Edwardsiella tarda which responded to P0550-22-AM tazobactam / piperacillin well 田子尚史, 森田淳介, 國分真理, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

	Effect on antimicrobial consumption and Pseudomonas aeruginosa chemosensitivity by the rearranging of the P0551-21-PM adoption injection antimicrobial 藤原信二1), 綺田尚久1), 速水亮一2), 西村さとみ2), 中川文一2), 中村忠之3), 原田吉将4), 西嶋長1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

	Intervention effect by the ward exclusive duty pharmacist based on the protocol on Clostridium difficile infection that occurred after P0552-22-AM antibiotic start 山村亮太, 山崎悠, 脇田翔子, 柴田麻美, 菅田哲治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2015.

	It is efforts to the qualitative improvement of ward duties by becoming it PBPM of the use of P0553-21-PM identification antimicrobial registration system 岩崎希, 古川早矢香, 井口恵美子, 猪股克彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

	Examination about the medical application of the P0554-22-AM cleanliness space formation device (table coach) 佐伯康弘, 藤澤宗央, 加藤雄也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

Consumption investigation ... of the visualization of the contact part using practice - fluorescent paint of contact infection measures in P0555-21-PM ward drug duties and the mobile finger disinfectant
中谷亮介, 満田正樹, 野際俊希, 楠本梨賀, 佐向美帆子, 稲葉静香, 石本昌裕
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

	Fact-finding of the treatment suggestion associated with the P0556-22-AM antimicrobial 佐藤誠太郎, 中山貴美子, 澤口和代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

	Evaluation - using effect - Defined daily dose (DDD) and days of therapy (DOT) of the decreased renal function patients in the P0557-21-PM antimicrobial consumption count 浦田元樹1),2), 永田眞美2), 姜裕2), 北村芳子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

	About efforts for the proper use of the antimicrobial in the P0558-22-AM emergency visit 島村竜也, 饗庭孝一, 北村卓磨, 岡平将志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2015.

	Use investigation of the ST medical mixture for the purpose of the PCP prophylaxis to the immunodepression patients in the P0559-21-PM Himeji medical center respiratory organs internal medicine 中西剛志, 山口崇臣, 岸本歩, 吉野宗宏, 田中三晶 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

	Intervention and effect with the medicine notebook to the P0560-22-AM antimicrobial remedy patients 池増鮎美1), 中島理恵1), 中村有莉恵1), 赤星真広1), 上原友美1), 石神誠子1), 神門孝典1), 佐多照正1), 宮脇武徳2), 前之原茂穂3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

The effect that the P0561-21-PM "preventive measures against infection addition" gives to a management cost price and a quality (safely) standard and a total quality cost price
小林義和1),5), 吉岡祐貴1),5), 山田昌矢2),5), 織田元3),5), 生田宏次4),5), 浅野昌彦4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

	Examination of introduction and the effect of the antimicrobial round for the P0562-22-AM antimicrobial proper use 杢保貴幸1), 徳竹裕貴1), 石井康友2), 植田宏治3), 松岡裕士4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

	Effect on MEPM consumption, sensitivity rate by the P0563-21-PM ICT intervention 石川智子1), 野澤寿吉1), 加藤由香里1), 網谷智輝1), 舟瀬和美1), 稲生隆行1), 百石祐一朗2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

	One case that affected infection control of the P0564-22-AM intractable MRSA from pharmaceutical approach 伊藤貴史1), 正木智久1), 川上浩基2), 岩崎吉津3), 近藤正子3), 田島崇4),5), 寶亀登4), 鈴木正彦1),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2015.

	Questionary survey of the staff prophylaxis of oseltamivir phosphate for P0565-21-PM influenza 後藤義之, 増林千尋, 西上真, 深見聖也, 若林奈織子, 鈴木里佳子, 本田太朗, 永森理美, 石崎真由美, 岡田久美, 角紀一郎, 森戸敏志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

	Intervention to the antimicrobial proper use that P0566-22-AM small and medium size hospital pharmacist is available for 坪内理恵子, 大倉輝明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

	Antimicrobial stewardship team activity in the P0567-21-PM our hospital 山口景子1), 島田侯陛1), 川上剛明2), 宗村盛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

	About increase of the clinical intervention of the pharmacist obtained by the cooperation with the specialist in P0568-22-AM infection 井出和男1), 加藤英明2), 西村富啓1), 佐橋幸子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

	Wastage and extinction of P0569-21-PM antimicrobial resistance Pseudomonas aeruginosa 山田陽一1), 森下博史2), 桑元愛衣2), 石角彩2), 谷口愛2), 塩田澄子1), 土屋友房2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

	Efforts - pharmacist sectional meeting activity report ... to local infection measures in the P0570-22-AM KAWASAKI area infection control council 野口周作1),6), 濱野公俊2),6), 小林加寿夫3),6), 小林岳4),6), 向山雅士5),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2015.

Investigation ... about the adoption situation of antibacterial chemotherapy duties fact-finding report - antimicrobial in the P0571-21-PM KAWASAKI area infection control council member institution
松本浩1),5), 濱野公俊1),5), 吉田純也2),5), 向山雅士3),5), 野崎惠4),5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

	It is ... about antibacterial chemotherapy duties fact-finding report - identification antimicrobial surveillance in the P0572-22-AM KAWASAKI area infection control council member institution 内田裕之1),5), 小林加寿夫2),5), 長井美知子3),5), 野口周作4),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

It is ... about use and application of the use of antibacterial chemotherapy duties fact-finding report - antimicrobial density in the P0573-21-PM KAWASAKI area infection control council member institution
安次嶺ゆか1),6), 岡田紳哉2),6), 小林岳3),6), 佐藤樹里4),6), 沢辺正和5),6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

	Use turn of eventss of the designated antimicrobial in the P0574-22-AM City Tonami General Hospital 旭美樹1), 舘美幸1), 酒井由貴江1), 釣真之1), がけ晋太郎1), 坂本歩美1), 高畑英信1), 山本知代美2), 村本由子3), 又野禎也3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

	P0575-21-PM surgical-site infections and perioperative antimicrobial proper use 竹内都子1), 池崎友明2), 村上真樹2), 山谷香織2), 北澤英徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

	About the change of use antimicrobial in the P0576-22-AM our hospital and the anti-biogram 笹木範子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2015.

	Association of PPI to the Clostridium difficile-related enterocolitis onset in the P0577-21-PM Yasuo society Takeda Hospital and the H2 blocker 酒井果林1),2), 松尾史1),2), 桑原宏臣2), 藤井香緒利2), 神谷一利2), 林千麗1), 吉村尋典1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

Examination of the intervention method for construction and the proper use of the antimicrobial report system for the P0578-22-AM injection
加藤善章1), 山本雅人1), 稲垣孝行1), 手塚宜行2), 森岡悠2), 平林亜希2), 井口光孝2), 加藤大三2), 冨田ゆうか2), 八木哲也2), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

	Intervention and use of antimicrobial trend of the antimicrobial usage in the P0579-21-PM clinical department conference, evaluation of the effect on resistant bacteria generating 太田登志子1), 白根尚子1), 大塚昌信2), 中山晴雄2), 小林秀樹1), 加藤裕芳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

	Examination about the usefulness of long-term use surveillance duties of the specific antimicrobial in the P0580-22-AM our hospital 川田彰彦, 伊藤貴亮, 佐藤圭吾, 高橋直希, 菅野和, 早坂昭一, 佐賀利英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

Local duties support - Hokkaido, efforts ... in the Eastern Hokkaido district of the P0581-21-PM hospital pharmacist
佐賀美裕樹1), 佐々木千花1), 石成凌1), 岩崎正宏1), 天童有香1), 森村あゆみ1), 若林麻衣1), 大村侑平1), 粟澤一聖1), 平野あゆみ1), 太田明秀1), 川上麻衣子1), 清水勇基1), 北島彩郁1), 森山真実1), 伊藤桂子1), 坂本和央1), 重成大介1), 岡野翔1), 石田恵理2), 速水章一1), 大江利治3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

	Relation (the second report) to the PD duties by the P0582-22-AM pharmacist 酒井理予, 尾崎昌大, 添田真司, 渡邊昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2015.

	GIS analysis (the Kanto Koshinnetsu district) about the appropriate placement of the drugstore with the P0583-21-PM health station function 倉田香織1), 岸本桂子2), 土橋朗1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

An attitude survey about the COPD with the P0584-22-AM lungs age measurement and evaluation of the COPD-related risk factor
西尾廣昭1), 土谷大樹2), 小嶋英二朗1), 田中哲郎1), 数野博3), 福田豊4), 尾上洋4), 谷田恭洋4), 森広亜紀5), 山田真弘4), 岡田昌浩6), 徳毛孝至7), 横田いつ子8), 荒川隆之9), 大森亮太10), 瀬尾誠1), 上敷領淳1), 杉原成美1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

Fact-finding of the person of next situation consultation in the P0585-21-PM local health insurance drugstore
宮田祥一1), 岡田賢二2), 井上朋法1), 幸地拓也1), 執行俊彦1), 堤一晃1), 藤原三沙子1), 宮田英理1), 山上千子1), 山本雅裕1), 藤原英憲1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

	Development of the lifestyle swing return marks instruction using the check sheet at the P0586-22-AM drugstore and the usefulness inspection 藤田直希1), 井上渉1), 菊池千草1), 渡邉幹哉2), 高尾雅春3), 鍋谷伸子4), 田中美葉子5), 鈴木匡1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

	1 case - that we caused depressed level of consciousness by efforts - instruction of the home care patient visit drug control instruction in the P0587-21-PM our hospital 福森和俊1), 越智麻有1), 猪田幸邦1), 小澤一夫1), 光根緑2), 築田恵2), 宮本美千代2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

	Evaluation experiment in elderly persons living at home and the welfare institution of the P0588-22-AM medication support equipment 鈴木亮二1), 武政文彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2015.

	Qualitative study on psychological process in the P0589-21-PM end-of-life care 大和田真未, 有田悦子, 荒井きより, 池谷博美, 田辺記子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

	About physical assessment and the need practicing by P0590-22-AM visit drug instruction 長友孝純, 的場つかさ, 楠本結香, 高橋唯, 森江遥, 平田有佳理 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

	The present conditions and problem of P0591-21-PM at-home pharmacist duties 八木澤啓司1), 岩田耕一郎1), 宮下博幸1), 左右田和枝1), 中村俊貴1), 小林由布子1), 柴田壮一1), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

	At first it is one step of ... to practice - pressure sore team approach in medical care of the ad usum externum therapy in being at home P0592-22-AM 舛甚路子, 阿部恵, 西村美和, 李沢敏明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

Pharmaceutical cooperation of osteoporosis treatment that we applied P0593-21-PM health insurance pharmacy in
荒井國三1), 山本憲男2), 正源寺美穂3), 杉原信4), 石野洋4), 今庄恵子5), 綿谷敏彦5), 兼田春生5), 木村嘉明1), 柴田実香1), 吉田綾乃1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

	Understanding degree investigation for the treatment at home of the P0594-22-AM patients 高島敬子1), 吉川泰博2), 北小路学2), 奥村隆司1), 田辺博章1), 奥村兼三1), 大鳥徹2), 松山賢治2), 小田典央1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2015.

	Hold a study session thinking about P0595-21-PM treatment at home by regional alliances 後藤千寿, 安田昌宏, 土田陽子, 説田英利子, 川島あずさ, 甲田明英, 長屋雄大, 水井貴詞 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

An example of the home medical treatment management instruction of the Parkinson's disease patients who cooperated with P0596-22-AM health visitor
榊原ゆかり1),2), 片山広美1), 鈴木めぐみ1), 鈴木厚志1), 黒田信行1), 天野哲史1), 鈴木裕之1), 松本薫1), 土井英樹2), 板倉由縁1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

	An approach and evaluation of the vital sign monitoring by the drugstore pharmacist after the P0597-21-PM vital sign training 武井政陛1), 長谷川フジ子1),2), 池田俊也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

	About the present conditions of the pharmaceutical cooperation with the neighborhood clinic in P0598-22-AM horsetail ethical pharmacy Akutami store 森厚司1), 丹羽知恵子1), 丹羽良子1), 吉田和美1), 山本有人1), 内田眞一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

	Present conditions investigation - of the treatment at home of the health insurance pharmacy in efforts - Ishikawa for the P0599-21-PM treatment at home promotion 興村桂子1), 大柳賀津夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

	The example that health insurance pharmacy pharmacist worked on toward P0600-22-AM area inclusion care 高橋康晃, 川添翼, 黒澤幸太郎, 田村多真美, 小坂浩之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2015.

	Investigation about the request of the consciousness to the at-home duties of the health insurance pharmacy pharmacist resident in P0601-21-PM Hokkaido and the postgraduate education support 柳本ひとみ1), 梅田純代2), 古田精一1), 黒澤菜穂子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

	Attitude survey about "the discharge clothing characteristic of an age medicine teachers' textbook" to the P0602-22-AM pharmacy service under health insurance drugstore 角田健, 小室治孝, 宇賀神咲美, 瀬川亮, 喜古康博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

Efforts based on medicine - medicine cooperation in the oral dual therapy for P0603-21-PM chronic hepatitis C
守屋真美1), 沼田恵実1), 王泰範1), 湯浅友美1), 出口由紀子1), 村田恵美2), 山田元3), 長谷川豊4), 平野泰健4), 岩出賢太郎5), 下路静佳5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

Questionary survey for fact-finding and application of medicine for patients who received cancer chemotherapy notebook direction for uses in the P0604-22-AM Tokachi district
村上智香, 門野冴美, 大平英美, 斉藤芳敬, 石田陽美, 谷口雄人, 船木映二, 和泉秀明, 橋本義宏, 小森均
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

	Efforts aiming at bringing rate improvement of the P0605-21-PM medicine notebook 伊藤緑, 佃晶子, 平井成和, 原敬一, 増田雅行, 佐野君芳, 真坂亙 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

	About the efforts of injection anticancer agent administration contents mention in P0606-22-AM regional alliances 安樂早希, 熊谷範之, 宮本亜希, 鈴木正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2015.

Usefulness evaluation of the new pharmaceutical medicine cooperation model who introduced side effect of P0607-21-PM telephone monitoring
住吉加江1), 牧原玲子1), 橋本浩伸1), 佐藤洋子3), 波田野小百合4), 小原茜4), 渡辺典子5), 吉野麻結5), 飯田左知5), 三木晶子2), 牧野好倫1), 大塚知信1), 林憲一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

	Questionnaire findings report about the internal use anticancer agent that we conducted by P0608-22-AM cancer chemotherapeutic drug medicine cooperation ordinary assembly 中山和彦, 増野貴司, 堀口裕之, 小幡輝夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

	Inventive idea to make a P0609-21-PM injection anticancer medicine medicine notebook seal issued automatically 福本真利江, 香取哲哉, 出雲貴文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

	The present conditions and problem about the efforts to oral anticancer agent proper use by the P0610-22-AM medicine medicine cooperation 武田智子1), 長谷川晃司1), 小林篤史2), 秋葉由華2), 乙黒万喜子3), 古曽部毅4), 蓑輪圭一郎5), 和田淳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

	We help medicine medicine for the side effect management in the P0611-21-PM oral anticancer agent and are built the cooperation 鈴木智博1), 町島由美2), 菅野友美3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

	1 case that medicine medicine cooperation functioned for a shift to P0612-22-AM at-home mild medical care effectively 樋口眞宏1),2), 鈴木恵美子1), 八木聖子1),2), 山田圭子3), 武田絵里子2),3), 松川香織2), 西村豊4), 宇野敦子1), 野村一之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2015.

	Problems extraction and illness medicine cooperation seminar holding - that efforts - health insurance pharmacy to illness medicine cooperation in the P0613-21-PM relaxation medical therapy has it 田中里佳1), 中村豪志2), 田中邦佳2), 室親明2), 木村健2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

Efforts medication counseling present conditions investigation of the illness medicine cooperation to the medication counseling improvement of the palliative care domain in the P0614-22-AM Saku, Nagano area
畠山浩明1), 篠原佳祐2), 杉山昌秀2), 三浦篤史2), 中尾美香3), 清水誠4), 井出香織4), 井上南4), 大森健4), 小林潤5), 小松富美男5), 市川輝幸1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

	Investigation about the patients contribution of the patients information sheet to the hospital from the P0615-21-PM health insurance pharmacy 菅野里美1), 吉田丘2), 紺野恵1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

	About an evaluation, improvement for the practical use of "my treatment notebook" which we made in P0616-22-AM our hospital 藤本愛理, 伊藤政祥, 西本辰徳, 橋本崇広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

	Efforts of medicine - medicine cooperation that realized interactive reporting in the P0617-21-PM foreign oral anticancer medicine prescription 川原裕, 西塔志織, 九鬼亜衣子, 衞藤麻里子, 中尾佳人, 宮崎宏美, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

	Promotion of the medicine medicine cooperation in the foreign cancer chemotherapy using the P0618-22-AM medicine notebook 山口恭平, 橋本浩季, 村上通康, 仙波昌三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2015.

Investigation about reporting contents between a hospital and the health insurance pharmacy in the P0619-21-PM colon cancer medicine medicine cooperation
鈴木大吾, 石井秀明, 松原怜, 伊東和真, 浅野嘉之, 鈴木敦詞, 村山まりこ, 栗本夕夏, 奥田ユミ, 前田剛司, 坂田洋
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

	Promotion of the medicine medicine cooperation using the P0620-22-AM anticancer agent side effect monitoring sheet 羽生智宏, 尾形美絵, 嶋崎千絵, 長澤欣弘, 森山亜矢子, 田村和彦, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

Thing ... which we saw from ... attitude survey for further development of P0621-21-PM medicine, the medicine cooperation
中村敏史1), 伊藤稔宏1), 新井孝文1), 牛膓沙織1), 上原有夏2), 福岡一貴2), 大川哲司2), 高橋典男2), 吉田昌則2), 池上信昭1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

	Efforts based on medicine - medicine cooperation in the oral dual therapy for P0622-22-AM chronic hepatitis C 長谷川豊1), 村田恵美2), 守屋真美3), 平野泰健1), 山田元4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

	Examination of the usefulness of the medicine medicine cooperation with P0623-21-PM hospital pharmacist and the drugstore pharmacist instructing between the at-home visit drug 高柳論也, 須貝壮衆, 渡邉基之, 小林恵美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

	Examine P0624-22-AM disease; an investigation about the medicine notebook information inflection of the medical institution classification in the medicine cooperation 伊藤明人1), 千葉俊介2), 伊藤嵩1), 高橋道子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2015.

	About efforts of the local medicine, medicine cooperation in the oak hospital pharmacy attached to the P0625-21-PM Jikei University School of Medicine 長郷千香子, 渡邊譲, 松本明子, 長塚さおり, 島崎博士, 勝俣はるみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

	Fact-finding of the health insurance pharmacy cooperation in the P0626-22-AM community medical care cooperation system 小川充恵1),2), 植田真理1), 山崎肇1), 小枝伸行2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

	Attempt ... of the clinical test value indication to medicine medicine cooperation - outside Parliament prescription aiming at P0627-21-PM pharmaceutical products proper use 佐藤友美, 荒木隆一, 藤長宏昌, 西島勝之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

Efforts of the Okayama pharmacist society aiming at promotion of medicine, the medicine cooperation for P0628-22-AM young person pharmacists
加地弘明1),2), 森英樹1),3), 松山哲史1),4), 鍛治園誠1),5), 名賀石繁1),6), 藤原孝子1),7), 小笠原加代8), 千堂年昭8), 大森宏真8), 石井美江8), 三宅修8), 赤澤昌樹8)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

	About the relation of the ward pharmacist in the instruction joint at a P0629-21-PM discharge 金井知子1), 坪谷綾子1), 竹田桂子1), 東しずか1), 濱野公俊1), 坂下裕子1), 増原慶壮3), 岡田みちよ2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

	Efforts to the medicine medicine cooperation with the P0630-22-AM Gunma Prefectural heart blood vessel center and local health insurance drugstore 木村和美, 砂川恵子, 飯島由美子, 細田宏美, 坂下可奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2015.

	Introduction of the municipal Ikeda Hospital community medical care network system enabling P0631-21-PM medicine medicine cooperation 大河万顕1),2), 下村一徳1), 梶本幸彦2), 藤本智裕2), 川口進一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

	About the start of the medicine medicine cooperation meeting for the study in the P0632-22-AM Saga Hospital 渡辺健二, 中溝卓, 鶴崎泰史, 高島伸也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

	The establishment and activity report of the P0633-21-PM North Saitama medicine medicine cooperation council 須賀宏之, 内田宜伯, 麻生一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

	Examine the illness using the P0634-22-AM medicine notebook; efforts to medicine cooperation 田村和彦, 嶋崎千絵, 長澤欣弘, 羽生智宏, 森山亜矢子, 尾形美絵, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

	Investigation about the effect that the clinical test value publication in the P0635-21-PM outside Parliament prescription gives to the proper use of pharmaceutical products 権平由貴, 瀧本淳, 石福奈々, 永瀬怜司, 今浦将治, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

	Than questionary survey to evaluation - neighborhood health insurance pharmacy of the outside Parliament prescription which described P0636-22-AM test value ... 菱田栄子, 浦崎圭太, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2015.

	For medicine reporting and the regional alliances that are better than - about the education for patients about the P0637-21-PM medicine notebook and the availability ratio - 樋口純一, 青山乃莉子, 阿曽沼和代, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

Examination of the medical expenses reduction effect by the Residual medicine adjustment in the P0638-22-AM regional alliances hospital
森朝紀文1), 中川直樹1), 泉原里絵1), 西井拓人1), 松山達登1), 中川貴弘1), 野上浩實2), 南尚孝3), 土井義仁3), 池喜章4), 梅田卓也4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

It is ... for the inhalational instruction that is better than examination ... from questionnaire results about the P0639-21-PM inhalational instruction
平田備子1), 渡辺真穂1), 宮本敬子1), 大前由香利7), 北畑香里6), 鷲見佳子5), 梅澤佳乃子4), 西馬照明3), 大西尚2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

It is efforts ... to construction and the spread of communalization of the patients information such as ... test results for promotion of the local team approach in medical care by the P0640-22-AM patients participation type
大木稔也1), 富岡佳久2), 庄野あい子3), 山内泰一4), 平野道夫5), 金親正知6), 今井博久7), 佐藤秀昭1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

Fact-finding ... to effect on P0641-21-PM outside Parliament prescription - neighborhood health insurance pharmacy by the clinical test value indication
土師日香里1), 坪谷綾子1), 小宮詠子1), 松本浩1), 浅見妥江1), 濱野公俊1), 坂下裕子1), 増原慶壮2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

	Efforts of the pharmacist in the P0642-22-AM Chiba joint ownership stroke community medical care cooperation pass 太田洋貴, 生島五郎, 高橋憲二, 干川克己, 帰山由紀子, 上野朱里, 武田澄香, 鈴木乃乃子, 井上佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2015.

	The effect that one application formulations rate of use improvement of the P0643-21-PM injection drug gives in an incident report 浅田留奈, 加藤善章, 服部亜衣, 北原裕子, 清水久美子, 玉置紀子, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

	It is ... to zero by tablet filling mismeasures ... false filling using P0644-22-AM Excel limitlessly 新舍美貴, 大内一希, 岩田裕貴, 佐藤康雄, 舟橋智広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

Introduction ... of construction and usefulness - Mediceo Hospital Innovative Logistics (McHIL) of the safely appropriate management system of P0645-21-PM pharmaceutical products
小菅健志1), 平嶋志穂1), 大塚幸彦1), 佐藤純一4), 若林明4), 中田芳秋4), 鈴木寛子3), 向後麻里1),2), 佐々木忠徳2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

Preventive measures against dispensing errors ... using construction and usefulness - bar code of security, the appropriate management system of P0646-22-AM pharmaceutical products
平嶋志穂1), 小菅健志1), 大塚幸彦1), 佐藤純一4), 若林明4), 中田芳秋4), 鈴木寛子3), 向後麻里1),2), 佐々木忠徳2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

	Role of the pharmacist in the P0647-21-PM clinical practice designation hospital 浦崎圭太1), 菱田栄子1), 河井和子1), 伊藤和幸1), 磯谷聡1), 露木幹人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

	Investigation of the dispensing error with the P0648-22-AM outside Parliament outpatient department prescription issuance 添田真司, 倉野恵美, 渡邊昌之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2015.

	It is ... to development ... information to come because we tell of "TO DO CARD" in P0649-21-PM drug duties 越智文也, 高砂美和子, 吉本久子, 廣實清司, 古川裕之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

	Efforts toward the medicine unionization of the P0650-22-AM emergency cart 柘植麻里奈1), 杉本恵理1), 堀部緑1), 寺田雄亮2), 山川恵子1), 青孝明1), 木村匡男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

Receive the incident about all P0651-21-PM automatic tablet packaging machines
谷田有花, 佐賀嘉英, 門脇隼也, 小田智晴, 塩見明日香, 藤本華衣, 芦田理沙, 足立圭司, 村上由樹, 川見里奈, 堀雅博, 足垣亮介, 宮谷正哉, 勝井靖, 山本真世, 立道直美
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

	The enforcement situation of the drug training for the P0652-22-AM nurse 上田温子, 田山理恵, 星野輝彦, 塩津和則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

	Effect by the ward permanent residence that we were able to see from an incident report in the P0653-21-PM Saiseikai Futsukaichi Hospital 蓮輪博嗣, 深見徹郎, 大竹野久雄, 北村憲雅, 中野祐樹, 辻村啓史, 横尾賢乗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

	About the effect of the introduction of the P0654-22-AM Distribution of medicine cart and the Distribution of medicine contents check by the ward pharmacist 渡邉武明, 今井洋志, 町田洋平, 川尻尚子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2015.

	The present conditions of the failure example in the P0655-21-PM discontinuation instruction 和地徹1), 藤井梨紗1), 千葉里菜1), 川田彰彦1), 伊藤貴亮1), 佐藤圭吾1), 追木正人1), 遊佐洋子1), 西和哉1), 阿部浩幸1), 小原拓2),3), 佐賀利英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

	To quantity of P0656-22-AM one time prescription about the change of doubt inquiry contents of the outside Parliament prescription with the shift 山足敏昭, 才野壽子, 吉井加奈子, 柏木明美, 森田みどり, 佐々木亜也, 大井康史, 八本久仁子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

The introduction of the child dose check function for the prevention of false prescription by the quantity of P0657-21-PM one time prescription introduction and the evaluation
安達真紀子1), 椎木芳和1), 小川勝弘1), 金田達也1), 森木邦明1), 井上和子1), 門脇美智子1), 足塚則子2), 齋藤憲輝2), 池口正英2), 高根浩1), 島田美樹1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

	About the investigation of HBV reactivation measures using the coding of examination for P0658-22-AM data 長坂篤志1), 村井宏通1),2), 佐藤力哉1),2), 加藤修1), 伊藤友一3), 辻健史2),4), 浅岡峰雄2),5), 小林伸三1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

	Efforts second report to risk management by the child dose check system introduction in the P0659-21-PM Kitasato University Hospital 八木宏樹1), 友田明子1), 坂本かおり1), 松本圭祐1), 椎崇1), 近藤留美子1), 岩崎俊之2), 厚田幸一郎1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

	Communalization of efforts - information to P0660-22-AM risk management and utilization ... 大久保淑子1), 長谷弘子1), 大野弘貴1), 斎藤大佑1), 松永静恵2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2015.

	Efforts associated with the medicine explanation that P0661-21-PM driving is prohibited in it 田原雅子1),2), 平昭圭介1), 花田徳子2), 新谷茂之1), 中村亮1), 大知正典2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

	Fact-finding of the instructions record about the rate of application of the P0662-22-AM injection drug 臼窪一平, 中村友香, 橋亮介, 下山あさ子, 亀井浩二郎, 嘉屋則子, 稲垣育宏, 小寺隆二, 妻木良二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

	The pre-Abo id report situation of our hospital which we compared from P0663-21-PM Japanese Society of Hospital Pharmacists report example 日野亜莉沙, 小林理栄, 熊倉裕昌, 新井亘, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

	It is ... using patients of efforts - electronic chart profile avoiding P0664-22-AM warfarin and interaction of the natto 高橋望月, 岩佐千尋, 田中嘉一, 濱田潤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

	Examination of the usefulness of the pharmaceutical products security workshop by the P0665-21-PM pharmacist 上村円香, 喜多香菜, 田畑寛明, 杉村奈美, 猿谷淳, 向一美, 地野幹子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

	Examination about the effect to give to the fall of P0666-22-AM cardiovascular system disease and the therapeutic drug 河内正二1), 三角ひかる1), 藤井信大郎2), 福田英克3), 南波勝栄3), 濱口常男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2015.

	The activity of the fall fall measures team in the P0667-21-PM Kanazawa Red Cross hospital and participation (the second report) of the pharmacist 高橋怜史1), 大川浩子1), 枝廣茂樹1), 山口亜矢2), 川原繁2),3), 西村泰行2),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

	Efforts of the experience-based safety measures workshop for P0668-22-AM personnels 星子謙1),2), 礒部隆史2), 宮本智行2),3), 竹内周平4), 深山治久2),3), 原澤秀樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

	Examination about the relations of P0669-21-PM sleeping drug remedy and a fall, the fall 石郷友之, 高田遼, 中野敬太, 野々山雅俊, 藤居賢, 山崎紀恵子, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

	Introduction of the medical treatment management based on the P0670-22-AM protocol and the effect 浜崎浩一, 山崎美保, 福原伸治, 福澤正隆, 大野静子, 脇泰見, 松本篤, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

Reach efforts - high risk drug workshop ninth year of the medical security in the P0671-21-PM Nankai medical center; ...
甲斐章裕1), 北村仁1), 伊藤ちか恵1), 鶴田瑛典1), 宮明洋一郎1), 佐々木達也1), 海部真代1), 谷口公章1), 梅木正純2), 渡邉薫3), 力武隆浩1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

Duties fact-finding of "the pharmaceutical products security administrator" in the P0672-22-AM Osaka hospital pharmacist society
田中義人1),9), 菊田裕規2),9), 中林真紀3),9), 梅永真弓4),9), 西原雅美5),9), 高尾知佳6),9), 渡邉幸子7),9), 河瀬留美8),9), 但馬重俊10)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2015.

	About the contribution to medical security and compounding of medicines duties by the database compilation of P0673-21-PM doubt inquiry 井上博貴1), 壁谷めぐみ1), 坂口麻貴1), 湯浅周1), 竹口恵2), 松島真弓2), 松浦三恵子3), 石川尚武3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

	Efforts for the prevention of malpractice of the P0674-22-AM infusion preparation council 藤冨徹, 早田和生, 福岡誠次, 田中修一, 多田義孝, 籾井明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

	Measures in our hospital in the adverse event that resulted from combination of P0675-21-PM warfarin and miconazole gel 田淵陽平, 佐々木恭子, 生野芳博, 野村文香, 金本賢枝, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

	Efforts for the drug incident decrease in P0676-22-AM drug potentially serious medical errors example by the collection 菅野彩那, 宮原由香里, 太田哲徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

	We evaluate it after experience-based (early exposure) enforcement in the specialties early stage for the P0677-21-PM young person pharmacist 岸川礼子, 安藝敬生, 稲岡奈津子, 能勢誠一, 山下祐未, 一瀬菜摘, 北原隆志, 佐々木均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

	About efforts of the simulation education by the P0678-22-AM pharmacist 川崎元弘, 古賀和馬, 福永桂子, 吉田昭昌, 大倉裕祐, 木内司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2015.

Usefulness of the many types of job cooperation education (Interprofessional Education: IPE) for the practice of the P0679-21-PM team approach in medical care
後藤綾1), 半谷眞七子2), 肥田裕丈1), 長谷川章1), 椿井朋1), 毛利彰宏3), 末松三奈4), 阿部恵子4), 安井浩樹4), 亀井浩行2), 野田幸裕1),3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

	Attempts from the study drafting for the young pharmacist who utilized the cooperation between P0680-22-AM institutions to announcement 竹野伸洋1), 有野徹2), 早川真希2), 秋葉政宏1), 橋本幸輝1), 本尾美樹1), 鈴木賢一1), 清水淳一2), 濱敏弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

	Statistical analysis by usefulness of the case study by the P0681-21-PM world cafe and evaluation - SPSS 中西昭人, 大塚充, 木天麻衣子, 小西邦生, 田中志穂, 林良壮, 藤裕美, 堀哲史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

	Analysis - of discommunication - present conditions about P0682-22-AM pharmacist 伊原千晶1), 亀井美和子2), 松島哲久3), 松村人志3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

	Investigation about consciousness and the attitude toward passive smoking of P0683-21-PM pharmacy school first grader and the fourth grader 村上勲, 齋藤百枝美, 鈴木義彦, 渡辺茂和, 土屋雅勇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

The present situation of the medical therapy workshop by P0684-22-AM University of Shizuoka, hospital, the community pharmacy cooperation
井上和幸1), 辻大樹1), 平井啓太1), 浅倉候子2), 井上達秀2), 賀川義之2), 角入壽彦2), 北村修2), 柴山芳之2), 菅谷純子2), 中野眞汎2), 並木徳之2), 平野桂子2), 松山耐至2), 森本達也2), 山田静雄2), 山田浩2), 山本勝央2), 伊藤邦彦1),2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2015.

P0685-21-PM carrier formation education: An evaluation and improvement of "the self-study, participation type learning program"
栗尾和佐子, 小西元美, 中尾晃幸, 米山雅紀, 小森浩二, 邑田裕子, 稲冨由香, 山室晶子, 山本祐実, 西川智絵, 串畑太郎, 安原智久, 曽根知道
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

	Understanding degree investigation (2) about the oral P0686-22-AM supplementary water liquid 宮本悦子1), 興村桂子2), 毎田千恵子2), 梶愛2), 金子智美2), 木田美沙希2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

	The practical training (On the Job Training: OJT) in the hospital of the P0687-21-PM Keio University pharmacy school clinical system teacher 青森達1), 池谷修2), 鈴木小夜1), 丸山順也3), 山口雅也2), 中村智徳1), 岡本真一郎2),4), 望月眞弓1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

	Effect to introduce education about the risk of the use of Internet about the health information into pharmaceutical products education class of P0688-22-AM Junior High School more 淺川大樹1), 大柳賀津夫2), 沼田一也3), 松下良2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

New face pharmacist educational program Preceptor system introduction in the P0689-21-PM Sapporo east Tokushukai Hospital and future problem
比嘉耕基, 田中佑樹, 前川静香, 石川香奈子, 廣橋千恵子, 金崎修治, 山下友也, 齋藤靖弘, 徳留章, 早坂敬明, 武田契巳, 武田清孝
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

	Hold P0690-22-AM "children pharmacist experience event" 田淵沙織1), 雑賀真央1), 藤原大1), 土井光則1), 西村知恭1), 吉田薫1), 岩城久弥1), 天野賀弘2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2015.

	Attempt of the P0691-21-PM pharmacy original "medication inconvenient experience-based training" 藪本千鶴1),2), 仁木一順1), 上田幹子3), 上島悦子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

P0692-22-AM Tokyo Saiseikai center Hospital, examination of the usefulness in the laboratory of cancer Ariake Hospital both pharmacy cooperation combination meeting for the study
間宮伸幸1), 早川真希1), 高綱唯2), 杉田一男2), 中田順子1), 萩野茜2), 有野徹1), 中野泰寛2), 川上和宜2), 鈴木知則1), 鈴木賢一2), 濱敏弘2), 清水淳一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

	The case that was associated with a young woman of the deep vein thrombosis as P0693-22-PM ward permanent residence pharmacist 鹿沼奈央1), 浜野憲子1), 久岡清子1), 山本干城2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

	The acquisition of the ward drug duties enforcement addition in the P0694-23-AM neurology ward 原暦1), 安高勇気1),2), 今給黎修1),2), 鷲山厚司1), 二神幸次郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

	One patient who suspected rhabdomyolysis by the P0695-22-PM colchicine internal use, and suggested internal use cancellation 水野めぐみ, 伊藤和幸, 河井和子, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

	The effect that pain relief after the operation under laparoscopy in the P0696-23-AM ovarian cystoma gives to postoperative pain and nausea post-operative, vomiting 伊藤千裕1),2), 関野知恵1), 井上岳1),2), 柏木政憲3), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2015.

	The case that suspected a side effect of amiodarone than P0697-22-PM anamnesis and image views, and suggested administration cancellation 伊藤和幸1), 浦崎圭太1), 河井和子1), 磯谷聡1), 吉田雅博2), 加田賢治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

	Fact-finding of the pharmaceutical intervention by the ward pharmacist for the purpose of the P0698-23-AM side effect evasion 橋詰淳哉, 里加代子, 内田隆寛, 赤松隼人, 佐々木均, 樋口則英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

	Examination of the pharmacist intervention in the P0699-22-PM blood medical service 宮崎晶, 植木哲也, 和田佳菜子, 松田亜希子, 高橋昭弘, 橋口靖 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

	Intervention of the pharmacist at the P0700-23-AM hepatitis C dual therapy (Daclatasvir Asunaprevir) introduction 鹿島彩絵, 垣尾尚美, 結城紗英子, 植木彩, 若林よう子, 土井本和久, 瀬川和子, 國東ゆかり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

	Efforts and evaluation to the cooperation with a physician, the nurse by the P0701-22-PM cancer exclusive duty ward person in charge 元木孝, 高柳昌宏, 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

	Inspection of the effect of the immunosuppressive drug formulation study support by the pharmacist in the P0702-23-AM blood medical service 折山豊仁1), 湯澤薫1), 山本武人2), 長瀬幸恵1), 鈴木洋史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2015.

	About the participation of the pharmacist in septic shock patients in the P0703-22-PM regular hospital 高橋弘泰, 安井一正, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2015.

	Questionary survey about the pharmacist duties in the P0705-22-PM obstetrics and gynecology department ward 江橋優香1), 小室治孝1), 田中大1), 佐治晴哉2), 喜古康博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2015.

The crisis of cerebral apoplexy prediabetes treatment situation and the need of the pharmaceutical intervention that it showed from P0706-23-AM ward drug duties
倉内寿孝1), 目時典文2), 阿部早苗1), 久米田一喜1), 高瀬公子1), 花田和大1), 船水梨沙1), 藤田尚子3), 鳥谷部翔1),3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2015.

	Examination and problem of the ward duties case in the P0707-22-PM JCHO Sendai Hospital kidney internal medicine, hypertensive diabetes department ward 安部真一, 鈴木英則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2015.

	P0708-23-AM mild mental retardation, one case of the medication management instruction for the renal-transplant recipients with the hearing loss 松岡有紗1), 永井絵里子1), 高橋愛未1), 古川夏2), 金銅葉子1), 矢澤浩治3), 石川照久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2015.

	Efforts of the ward pharmacist to polypharmacy in the P0709-22-PM kidney disease special hospital 大津山裕美子1), 岡本祐子1), 山本絢美1), 谷口瑠里子1), 濱崎匡子1), 岡田悠子1), 中村智宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

	It is the prescription intervention competitive review in approximately eight weeks after the hospitalization in P0710-23-AM ward drug duties (medical treatment ward) 渡辺智康, 難波良平, 山崎恵, 高取孝一, 安藤哲信 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

	Number of the prescription drugs decrease and examination of the economic burden reduction that the pharmaceutical management in the P0711-22-PM medical treatment ward results in 久田亜紗美, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

	Make P0712-23-AM children medication adjuvant brochure 寺田芳弘1), 近藤千恵2), 勝又庸行3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

	Of the perioperative heparin substitution using P0713-22-PM inside the hospital guidelines, actually 天野杏南1), 荒木憲昭1), 加藤康子1), 青山智彦1), 坂本英至2), 加藤道子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

	About the efforts as establishment - children group of the ward drug duties of NICU, GCU, the children's ward in the P0714-23-AM our hospital 秋山直子, 春田倫代, 松岡由利子, 井手飛鳥, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2015.

	The present conditions and VTE onset inhibitory effect of the Edoxaban tosilate acid salt hydrate administration in the P0715-22-PM our hospital orthopedics 寺下朋江, 高嶋孝次郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

The making of the medication counseling manual for circulatory organ ward charge pharmacists by the P0716-23-AM 6 institution combination and the evaluation
清水忠洋1), 青木裕希子2), 赤木祐貴3), 伊奈川愛理2), 植草秀介5), 榎木瑞穂4), 小河原由佳4), 笠原孝宣2), 木村有揮2), 武石愛子5), 千葉達夫5), 中島優子6), 葉梨美和7), 加藤裕芳5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

	The prescription intervention contents in P0717-22-PM ward drug duties and the evaluation 武田なつ美, 光川由佳子, 小林早苗, 石井茂 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

	Pharmaceutical suggestion and adoption rate in P0718-23-AM ward drug duties 岩切貫太, 池田隆, 板倉朋恵, 阪本康典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

	Usefulness of the anticoagulant therapy which used edoxaban together with enoxaparin for the deep vein thrombosis prevention after the P0719-22-PM artificial joint replacement 古庄弘和1), 片渕咲也香1), 下石和樹1), 宮本和彦2), 陣上祥子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

	Duties standardization with administration of medication and the check sheet using the critical path in the P0720-23-AM PCI 古井恵美, 為保樹理, 西原早紀, 平出耕石, 今関孝子, 加藤武司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2015.

	About the importance of the ward drug duties to the use of P0721-22-PM tolvaptan patients 塚田寛子, 草葉一友 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

	The operation of the simple suspension method that utilized the information sharing tool by the P0722-23-AM ward pharmacist and the effect 白濱和加子, 前田美由紀, 飛田修康, 祖川倫太郎, 林章浩, 持永早希子, 田崎正信, 原英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

	Present conditions investigation after the P0723-22-PM simple suspension method introduction 細江律子, 田中みずほ, 河井良智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

Intervention example by enforcement and the ward pharmacist of a ward pharmacist, the DI meeting that started with P0724-23-AM ward drug duties enforcement addition calculation
鈴木景就, 小野徹, 柴田麻里子, 中村圭介, 芦名正生, 佐々木梨絵, 寺嶋望, 青木有希子, 一野勇太
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

It is ... through a .1 case taking advantage of examination ... at-home support center setting about the medication support of the patients after a discharge using P0725-22-PM ward duties
大久保嘉則, 床島英雄, 三砂義敬, 一ノ瀬由衣, 田中基稔, 村野仁美, 塚田寛子, 宮崎靖之, 草葉一友
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

	Usefulness evaluation - of efforts - prescription support to the medical safe improvement by the P0726-23-AM ward pharmacist 於本崇志1), 朝賀純一1), 岩渕修1), 川口さち子1), 工藤賢三1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2015.

Drug reporting ... by examination - acute phase ward charge pharmacist about the medication management at the change ridges from P0727-22-PM acute phase ward to a convalescent ward
中田早苗1), 小田真澄1), 安原梨恵1), 木村佳美1), 稲葉佳南1), 大西優菜1), 齋藤文佳1), 加納由美2), 武森三枝子2), 市川大介1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

	About the potentially serious medical errors incident analysis before and after P0728-23-AM ward drug duties 宗田一記, 三瓶台智, 高橋由香, 岩上泰崇, 猪狩政則, 景山亮平, 佐久間淳一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

	The operational situation of the preoperation protocol in the P0729-22-PM cardiovascular surgery ward and the evaluation 金澤正智, 野間口愛, 野田麻未, 高橋梨奈, 中野公, 寿眞一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

	About resumption situation confirmation of the P0730-23-AM preoperation cancellation medicine 山下涼子, 在本麻由加, 宮川祐子, 安倍さつき, 三宅麻文, 河原宏之, 石川弘子, 尾上雅英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

	From the choice of examination - drug about the standardization of the thromboembolism preventive preparation through the ward drug duties in the P0731-22-PM orthopedics ward to protocol operation - 腰岡桜, 倉田武徳, 八木下純子, 佐村優, 関根寿一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

	Device of the confirmation matter at ward duties enforcement that utilized P0732-23-AM pre-Abo id 中島誠1),2), 山本泰大3), 高橋朗4), 後藤拓也5), 小南美枝6), 小西友美7), 柴田有希子8), 寺師守彦1), 林秀樹2), 杉山正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2015.

	Efforts to clinical reasoning power improvement of the pharmacist mainly on the P0733-22-PM vital sign 上村忠聖, 伊藤智一, 鈴木信也, 関山正夫, 安藤栄輝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

	Consideration about the clinical experience and pharmacist education of the pharmacist about the P0734-23-AM patients correspondence 明神有希1), 見元尚1), 尾原喜美子2), 筒井由佳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

	Efforts to drug control using P0735-22-PM Distribution of medicine cart 田辺亮子, 森山傑, 徳武静香, 菅原順子, 安田礼子, 三代貴康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

	Activities (the first report) of the ward pharmacist in the P0736-23-AM Saitama Red Cross hospital - Effect - in the electronic chart introduction 伊賀正典, 興野克典, 町田充, 藤掛佳男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

	The calculation present conditions of the ward drug duties enforcement addition in the P0737-22-PM whole country capital municipal hospital and future problem 喜古康博1), 橋田亨2), 小竹慶子3), 舩津久美4), 向井淳治5), 田中恒明6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

	Prescription suggestion with the placement development of the P0738-23-AM ward pharmacist and quantitative qualitative evaluation of the consultation meeting a demand example 小久江伸介, 大野能之, 折山豊仁, 山口諒, 徳田篤志, 長瀬幸恵, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2015.

	Good use of accumulation and evaluation - ward drug duties outcome collection sheet ... of the outcome in P0739-22-PM ward drug duties 佐向美帆子, 満田正樹, 野際俊希, 楠本梨賀, 中谷亮介, 稲葉静香, 尾崎加織, 石本昌裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

Information sharing ... using construction and evaluation - cooperation seat of the cooperation method of P0740-23-AM floor nurse and the exclusive duty pharmacist
楠本梨賀1), 満田正樹1), 野際俊希1), 中谷亮介1), 稲葉静香1), 尾崎加織1), 染谷由紀2), 山本有美2), 石本昌裕1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

	Comparison between working full time pharmacist and duties contents to engage in P0741-22-PM ward drug duties of the additional post pharmacist 清水けいこ, 高儀佳代子, 安藤智美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

	Examination about the change of the drug duties in the P0742-23-AM area inclusion care ward shift 田中真衣, 竹内都子, 松井雄一, 北澤英徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

	About a list of remedy medicine for the purpose of the facilitation at the P0743-22-PM hospital transfer adjustment 前田祐果, 碓井紗知, 大谷寧次郎, 杉浦洋二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

	A new system for grasp of the P0744-23-AM efficiency-like medication injection situation and the effect 飛田修康1),2), 前田美由紀1), 祖川倫太郎1), 持永早希子1), 田崎正信1), 三原由起子2), 原英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2015.

	About the relation P0745-22-PM pharmacist in the Distribution of medicine (administration cart) 布施克浩, 紫桃裕造, 福士素子, 篠村五子, 上岡泰弘, 藤本佳代, 倉田奈央子, 菊池大輔, 畑中貞雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

	Transmission of the drug information in P0746-23-AM electronic chart, the prescription 金原寛子, 近澤明, 中本富士子, 山下忠明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

	Pharmaceutical products choice mistake preventive measures at the P0747-22-PM prescription order 田尻千晴1), 壁谷めぐみ1), 小澤いくこ2), 松島真弓2), 松浦三恵子3), 石川尚武4), 湯浅周1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

	Development of the foreign medication counseling support system for the purpose of the reduction of the P0748-23-AM medication counseling record work 亀井健人1), 城戸晴加1), 杉島佑美1), 益本周治1), 中野勝昭2), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

	The use actual situation of the electronic edition medicine notebook in the P0749-22-PM Kurashiki center Hospital and future problem 黒川佳津子1), 亀井健人1), 木村桃子1), 月岡良太2), 西口孝広3), 板倉正明3), 藤本健一4), 村山慶5), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

	Efforts of the drug reporting for patients using P0750-23-AM smartphone 大下萌1), 亀井健人1), 村山慶2), 黒川佳津子1), 佐藤可奈1), 高柳和伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2015.

	Construction ... of the system which linked ... electronic chart for compounding of medicines duties reinforcement at the P0751-22-PM ward pharmacist absence 岩尾恭寛, 植木亮磨, 工藤真裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

	A bringing medicine differentiation system and electronic chart cooperation in the P0752-23-AM Univ. of Toyama Hospital 川尻憲行1), 三村泰彦1), 足立伊佐雄1), 中川肇2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

	Construction of the local drug related information joint ownership system which assumed the P0753-22-PM Internet a base 寺松剛1),2), 寺島朝子1),2), 丹沢彩乃1),2), 石田昭義1),3), 豊岡坑一1), 小野俊治1),4), 柏木賢治1),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

	Effect of the automatic multidirectional approach on screening test of the P0754-23-AM HBV reactivation 山中理1),2), 益澤明3), 中山英夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

	About system repair to be able to edit the P0755-22-PM electronic chart system, and to make a use as a new use on the formulations support system side automatically at any time 松隈匠子, 高橋誠, 坂本亜沙美, 堤一貴, 有馬千代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

	Medicine investigation ... including the animal raw materials which we cannot eat for reasons of progress report - religion top of the P0756-23-AM cow pig-containing pharmaceutical products database making project 大山実, 酒井望, 中込哲, 村田恵美, 谷口聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2015.

	Construction of the P0757-22-PM injection management room duties system 宮下博幸1), 中村俊貴1), 小林由布子1), 八木澤啓司1), 左右田和枝1), 柴田壮一1), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

	Construction of monitoring duties using pharmaceutical products risk management (RMP) which cooperated with a P0758-23-AM plan DI room, a ward pharmacist 大島幹弘, 田中守, 加戸佳己, 飛鷹範明, 田坂友紀, 田中亮裕, 荒木博陽 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

	Examination about the optimal reporting judging from P0759-22-PM questions and answers record 小島庸子, 山口美穂, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

	Analysis of questions and answers data about the drug information (DI) in the P0760-23-AM our hospital 尾浜直子, 三浦誠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

	Utilization ... of an availability ratio and the information of the database compilation of questions and answers and document, literature - drug information room by the computerization for the P0761-22-PM drug information room 小橋亮, 今村陽子, 池田浩和, 高橋浩二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

	Construction of the side effect comparison system which utilized P0762-23-AM big data 佐藤篤郎, 鈴木厚志, 天野哲史, 松本薫, 板倉由縁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2015.

	Database construction of the comprehensive administration of P0763-22-PM antimicrobial index 笠井雄佑1), 池谷修1), 早川智久1), 石川春樹1), 山口雅也1), 岡本真一郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

	Study on use actual situation by the hospital pharmacist of P0764-23-AM DPC/PDPS 逸見佳代, 和泉啓司郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

	Comparison of the adverse event report in the new oral anticoagulant drug using P0765-22-PM JADER 渡邉慶剛1), 坂田洋2), 酒井隆全3), 大津史子4), 後藤伸之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

	Examination about P0766-23-AM influenza vaccine Q&A and the evaluation 海上玲子1), 柴田壮一1), 齋藤雅俊1), 松原肇2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

	Efforts to prevention of injection drug incompatibility in the P0767-22-PM our hospital 平田健志, 宇津木博明, 井原摂子, 扇麻衣子, 板倉美奈, 池谷健一, 平野桂子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

	The recognition, good use of risk communication tool situation in the P0768-23-AM medical institution 平松彩佳, 中常恵美, 星野絵里, 鳥井真由美, 近藤恵美子, 俵木登美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2015.

	Inquiry to collection of P0769-22-PM Hospital pharmaceutical products mention contents and a drug information room 大塚誠, 川原義弘, 上野雅代, 甲斐田唯, 藤金治雄, 塩塚昭一, 脇田昌子, 鷲山厚司, 今給黎修, 二神幸次郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

	The present conditions of the side effect report of the P0770-23-AM our hospital 加藤洋介, 小笠原聡子, 前田直希, 牧野勇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

Usefulness - of technique - DLST testing history surveillance and the new hiring medicine side effect questionary survey to collect more P0771-22-PM inside the hospital information on adverse drug reactions
岡本有紀子, 工藤正治, 服部慈久, 土屋翔子, 中村康夫, 鈴村宏
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

	Consideration about the reporting of the precautions for use about the sleepiness of the P0772-23-AM antiallergic agent 明石威徳, 守屋友加, 黒野俊介, 伊東亜紀雄, 山田重行, 長谷川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

Analysis about the onset report of the severe drug eruption using the P0773-22-PM adverse event spontaneous report database
阿部純子1),2), 梅津亮冴3), 又木香那子4), 加藤大和1), 上田夏実1), 中山蓉子1), 松井利亘1), 池田浩治3), 原英彰4), 紀ノ定保臣5), 稲垣直樹6), 中村光浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

	Rearranging and processing of the information for the use and application of risk management plan (RMP) in the P0774-23-AM drugstore 加藤正久1), 金子絵里奈2), 草場健司1), 井手純司1), 加留部信介1), 園田正信1), 吉川学1), 山野徹3), 瀬尾隆3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2015.

	Construction of the side effect monitoring management tool which assumes P0775-22-PM clinical test value an index 石田俊介1), 伏谷秀治1), 坂本久美子1), 中村敏己1), 寺岡和彦1), 川添和義1),2), 石澤啓介1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

Investigation about the association with the patients with otitis media patients and seasonal variation level to come to the hospital in the P0776-23-AM Tochigi north area
加藤芳徳1), 市山一樹1), 勝山繁佳1), 倉永勇希1), 本木絵梨奈1), 渡邉理基1), 真野泰成2), 大内かおり1), 前澤佳代子1), 鈴木雅史3), 橋本秀雄3), 生野登4), 旭満里子1), 百瀬泰行1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

	Efforts to drug allergy registration in the P0777-22-PM our hospital 立石裕樹1), 井上幸子1), 古賀みゆき2), 後藤佑里3), 山内晋一郎4), 斉藤律子5), 平川雅章1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

	Relation of the pharmacist for the P0778-23-AM anti doping activity 庄司理恵1), 長島章2), 中居肇1), 伊藤功治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

	Fact-finding about the effectiveness of P0779-22-PM Polyethylene glycol plus ascorbate solution and the safety 丹代恭太1), 工藤晋1), 菊池光太1), 藤原隆雄2), 蒲澤一行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

	Fact-finding about the combination of the Chinese medicine extract preparation for the P0780-23-AM medical care 井口智恵1),2), 竹治優紀1), 伊藤千裕1),2), 井上岳1),2), 清原寛章3), 松原肇1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2015.

	Use investigation of the torr vav tongue in the P0781-22-PM Nishio Municipal Hospital 山本亮子1), 川澄清孝1), 齋藤誠2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

	From the viewpoint of efforts - protector of the pharmacist for P0782-23-AM children medication adherence improvement - 佐々木美織, 比毛有理子, 佐藤圭吾, 西和哉, 阿部浩幸, 佐賀利英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

	P0783-22-PM Survey on the use situation of isradifylline for patients with Parkinson's disease in our hospital 奥野幸子1),3), 木村隆2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

	Use situation investigation of the apixaban in the P0784-23-AM our hospital 今泉有希, 長谷川晃司, 神山三佳, 和田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

	P0785-22-PM Evaluation of three drug combination therapy using Bonoprazan in H. pylori eradication therapy 福野和治1), 松川雅子1), 西部幸一1), 今井桂子1), 小泉忠史2), 定岡邦昌2), 古家乾2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

	Disease insight for P0786-23-AM cerebral infarction prevention of recurrence, investigation about the medicational self-understanding 鈴木亮平1), 柴田有希子1), 垣越咲穂1), 小島あゆみ1), 杉村勇人1), 平野淳2), 伊藤誠紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2015.

	Use of antihypertensive medications fact-finding in the P0787-22-PM practice practice 後藤渉1), 山澤理恵子1), 土橋卓也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

	About the present conditions of the use of "the dry person blood clotting factor IX complex" in the P0788-23-AM our hospital 星吉行1), 和田健太郎1), 長岡和徳1), 大森俊和1), 仲鉢英夫1), 渡辺剛史2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

Efforts to situation of the polypharmacy in the P0789-22-PM our hospital and pharmacist awareness improvement
多胡和樹, 黄前尚樹, 今井美恵子, 岡本安紀, 戸川尚美, 寺崎実希, 中森光子, 岸敬子, 仲西未佳, 平田貴大, 松山芽衣, 谷車彩夏, 常村弥生, 廣本真里, 小倉朋子, 中村美樹
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

Examination of the serum calcium requiring attention with P0790-23-AM serum potassium remover administration and serum sodium level situation investigation
村上史承, 岡本伸也, 岡田昌浩, 杉原弘記, 後藤裕香, 星野祥儀, 神垣江里奈, 山田理恵, 岡崎和子, 向井弘恵, 竹井英介
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

	Daclatasvir for P0791-22-PM chronic hepatitis C, use experience of the oral Asunaprevir dual therapy 小林晃子, 石原泰子, 益本周治, 阿曽沼和代, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

	Proper use investigation of the lamotrigine induction in the hospital attached to the P0792-23-AM Nagoya University faculty of medicine 高橋一世, 竹内典子, 鳥本真由美, 野村英宏, 千崎康司, 矢野亨治, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2015.

	The enforcement situation of the blood test including the differential white blood count of the P0793-22-PM thiamazole tablet remedy patients 阿登大次郎, 岡本知子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

	Present conditions analysis about alerting it such as the driving by the P0794-23-AM physician and the measures 青木美歌, 築地茉莉子, 長内理大, 横山威一郎, 山口洪樹, 大久保正人, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

	It is an evaluation of the withdrawal and a future problem together with one application of the P0795-22-PM injection drug 脇田恵里1), 杉村勇人1), 平野淳2), 伊藤誠紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

Relations with the drug which should consider polypharmacy and the cancellation in P0796-23-AM health center for the elderly residents
志方敏幸1),2), 近藤純1), 吉田憲史1), 浅原康代1), 三浦友里1), 木下佳彦1), 坂本淳一2),3), 小林学3), 畑中緑子1), 辻野健2),4),5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

	Examination of the drug information contents which P0797-22-PM protector transmits to the staff of a school of a kindergarten, the nursery school 吉次紗也加, 田山剛崇, 三宅勝志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

	Attitude survey of the physician about the Chinese medicine prescription in the P0798-23-AM our hospital digestive organ surgery 中塚美穂1), 山本智也1), 原伸輔1), 勝浦正人1), 門脇裕子1), 山崎誠2), 江口英利2), 萩原圭祐3), 三輪芳弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2015.

	Use fact-finding of the edoxaban in the P0799-22-PM our hospital 廣兼誠, 佐道紳一, 木下真理子, 森善洋, 吉岡大樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

	Heeltap medicine investigation of the patients in P0800-23-AM Kochi 吉岡三郎1), 乾朱里1), 吉澤麻里奈1), 京谷庄二郎1), 川添哲嗣2), 西森康夫2), 土居祥孝3), 西森郷子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

	Examination of the dose in the effectiveness of P0801-22-PM gene recombination thrombomodulin α and the decreased renal function 田實裕介, 冨山成章, 鳴海由希子, 橋元良枝, 松ヶ野聡美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

	Use situation investigation for the proper use of the P0802-23-AM recombinant thrombomodulin 花田聖典, 下澤那津, 高田正温, 植村隆, 東島彰人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

	It is the actual situation of the efforts of the pharmaceutical company in the prevention of doping carelessly P0803-22-PM 堺千紘1),2), 大久保沙知1),2), 岩本理央1),2), 山下修司1),3), 野口義紘1),4), 伊野陽子1),2), 井口和弘1),2), 寺町ひとみ1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

	The literature documentation of the drug making P0804-23-AM resilience fluctuate and recognition investigation of the hospital pharmacist 生津弘毅, 井澤美苗, 西村友宏, 登美斉俊, 中島恵美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2015.

	Prescription investigation before and after the levetiracetam monotherapy approval in the P0805-22-PM our hospital 中野智実1), 北村緋奈1), 吉田美咲1), 武田龍馬1), 原田瑞記1), 藤井亮1), 青沼光映1), 山澤祐司2), 本間和加子1), 中村博彦3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

	The use of placebo medicine situation in relations of P0806-23-AM placebo effect and the genetic polymorphism and the clinical practice 山口有貴, 井澤美苗, 西村友宏, 登美斉俊, 中島恵美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

	The use situation and patients background in our hospital outpatient of the P0807-22-PM new oral coagulant (NOAC) apixaban 中山久美子, 森田佳博, 奥美和, 上地純子, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

The effect that in-hospital adoption of the generic medicine in the P0808-23-AM Hospital gives to formulations of the generic medicine in the health insurance pharmacy
齊藤康介1), 舘知也1),2), 後藤千寿2), 吉田阿希1), 杉田郁人1), 林勇汰1), 江崎宏樹1), 臼井一将1), 加藤未紗1), 野口義紘1), 牧野哲平2), 安田昌宏2), 水井貴詞2), 寺町ひとみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

	About the smooth efforts from P0809-22-PM forerunner pharmaceutical products to a generic medicine change 富田敏章, 福地祐亮, 村井悠紀, 萩原里実, 曽我弘道, 小田原由香, 下河邉安妃子, 町田聖治, 樽善久, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

	Change to the generic drug in P0810-23-AM remote island and the Hansen sanatorium 田所正年 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2015.

About the generic drug choice of the anticancer agent in the P0811-22-PM our hospital - gemcitabine and etoposide -
森田聡子, 近藤万友美, 西山祐美, 澁谷奈穂, 長尾彰太, 下村美穂, 中川史絵, 新康憲, 橋本百世, 森本典子, 小川佳美, 正置耕一, 辻隆志
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

	The human sensory evaluation using the P0812-23-AM cromoglicic acid Na fine granule and comparison of preparation properties 岩崎徹, 船渡俊一, 村田勇, 井上裕, 金本郁男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

	Examination about the preparation of the P0813-22-PM docetaxel infusion (alcohol-free preparation) 板倉祥嗣, 舩越真理, 土谷有美, 小阪圭治, 井岡真佐夫, 竹内美智, 宮川由季, 津田正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

	About the effectiveness of the new storage medicine in the use promotion of the P0814-23-AM generic medicine 加藤寿規, 三原可奈恵, 大井夏樹, 市川敏太, 渡邊啓介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

	About the use situation changing to generic drug pharmaceutical products in P0815-22-PM inside the hospital 古川大輔, 岡村央, 佐々木優太, 伊藤紗代, 小池博文, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

	Evaluation of the ingredient content ratio in the starting pharmaceutical products and generic medicine of the P0816-23-AM Teiko plastic Nin parenteral injection 柴田寛子, 吉田寛幸, 伊豆津健一, 合田幸広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2015.

	Examination of the therapeutic equivalence of a lot of P0817-22-PM rebamipide preparation 常風興平, 阿部譲朗, 平田歩, 船戸裕樹, 石田七生, 仲井めぐみ, 飯塚美知郎, 白石久, 八木祐助, 門田亜紀, 尾木恭子, 横田淳子, 宮村充彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

	Evaluation of the clinical functionality of a lot of P0818-23-AM atorvastatin preparation 西雅恵, 石田七生, 船戸裕樹, 平田歩, 阿部譲朗, 白石久, 常風興平, 尾木恭子, 森田靖代, 横田淳子, 宮村充彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

Questionary survey with the P0819-22-PM generic medicine change
高橋文香1), 八尾祥子1), 上原哲1), 高田史1), 今井兼貴1), 竹村充代1), 児玉暁人1), 岩田智津子1), 栗本尚子1), 藤本真美加1), 水庫彩1), 角明香里1), 森信介1), 田端朋美2), 小竹武2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

	One consideration about the P0820-23-AM generic drug choice 志村賢一1), 木村朋貴2), 中村康之3), 柳澤奈緒樹4), 山口大輔4), 現海卓也5), 和田昭宏6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

	Consideration about the evaluation at the P0821-22-PM generic medicine change 新沼芳文, 芳賀貴史, 田牧直也, 伊東彩奈, 清水麻衣, 本郷文教, 佐藤誠二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

	50 mg of Utemerin (R) notes in the P0822-23-AM our hospital, adverse event comparison of 50 mg of ritodrine hydrochloride infusion liquid "Nichi-Iko Pharmaceutical" treated patients 青柳修一, 大友ひろ美, 鶴田治郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2015.

About effect to give to the effectiveness by the reshuffling, safe and medical economy on generic medicine of the P0823-22-PM Edaravone preparation
市江敏和1),2), 高橋弘泰1), 眞野加奈子1), 鈴木大介1),2), 齋藤宏明1), 岡田健3), 小林望3), 林秀樹2), 杉浦洋二1), 杉山正2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

	Comparison of safety and the effect factor in the starting pharmaceutical products and generic medicine of the ritodrine hydrochloride preparation for the P0824-23-AM injection 鈴木千波1), 樋浦一哉2), 越田晋太郎1), 門脇督1), 柴波明男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

	Side effect frequencies and drug costs reduction effect after the P0825-22-PM contrast media generic medicine introduction 長尾愛1), 細田美穂1), 安部浩美1), 都村いつこ1), 橋本幸子1), 塩田知子2), 宮川真澄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

	From problem - bioequivalence about the proper use of the P0826-23-AM generic medicine (inspection with the anticancer agent) - 迫田卓也1), 渡辺朋子2), 田中博之2), 松尾和廣1), 佐々木英久1), 篠原悦子2), 山形光正3), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

	The effect that the explanation of the pharmacist gives the change of the generic medicine recognition rate of the P0827-22-PM patients and the impression of the patients with generic medicine of the antineoplastic 平井利幸, 秋山裕史, 寺門祐介, 関利一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

	The use situation of the P0828-23-AM filgrastim bio follower product and effective and safe evaluation 元木貴大, 田中裕章, 朝倉正登, 山口佳津騎, 高橋功一, 一瀬ひろみ, 三崎彩香, 安宅可南美, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2015.

	Examination of the usefulness of the filgrastim by Osh mirror for the neutropenia in patients with P0829-22-PM solid cancer 須釜由香, 洞澤智至, 川澄賢司, 齊藤真一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

	An example with suspected cholinergic abdominal pain by P0830-23-AM irinotecan and the distigmine combination 四藤大介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

	Example that produced paronychia of Grade3 by P0831-22-PM pertuzumab + trastuzumab combination therapy 三浦篤史1), 篠原佳祐1), 杉山昌秀1), 渡邊将隆1), 由井俊文1), 石毛広雪2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

	One patient whom portal hypertension developed in after P0832-23-AM oxaliplatin administration 和田祐一1), 谷口賢二1), 岩田真2), 福永浩也1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

	Side effect onset of eye manifestation investigation of the tea S one in the P0833-22-PM our hospital 森脇典子, 山本紗織, 平良智, 福大哉, 長濱照美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

	Examination of the cytomegalovirus infection risk factor of the P0834-23-AM transplant non-adaptation ATLL patients 吉田裕生1), 福石和久1), 西村尚芳1), 尾之江剛樹1), 津曲恭一2), 前田宏一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2015.

	Pharmaceutical management of P0835-22-PM trastuzumab M tongue Shin treated patients 後藤由起子1), 山室蕗子1), 喜多岡洋樹1), 末吉栄志1), 近藤元三1), 奥村恭博2), 村上敬一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

	Regorafenib side effect of P0836-23-AM pharmacist outpatient management 原祐輔1), 川岸篤史1), 菅幸生2), 中村慶史3), 嶋田努1), 崔吉道1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

	Examination of the adverse event in the patients given paclitaxel and albumin suspension type paclitaxel in adjuvant chemotherapy after P0837-22-PM lung cancer technique 古里あかね, 福石和久, 尾之江剛樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

	Anaphylaxis with P0838-23-AM rituximab 一木万奈美, 河井和子, 伊藤和幸, 磯谷聡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

	Comparison of side effect expression and the effect of treatment of FOLFIRINOX therapy and the mFOLFIRINOX therapy to patients with P0839-22-PM pancreatic cancer impossible of excision 黒部健太郎1), 宮原強1), 秋山巧2), 嬉野紀夫3), 松永尚1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

	Information management and the inflection of the antimicrobial side effect history in the P0840-23-AM Sendai public welfare hospital 加藤大輔, 川守田早紀, 武田知明, 佐藤亜希, 本田弘, 中島繁美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2015.

	Onset of hyperkalemia in pneumocystis pneumonia onset inhibition treated patients of P0841-22-PM sulfamethoxazole / trimethoprim 梅田道, 安田昌宏, 大澤友裕, 甲田明英, 大野佑城, 青山智, 水井貴詞, 後藤千寿 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

	Study on elucidation of the pathogenesis of thrombocytopenia by the P0842-23-AM linezolid 田島正教, 高塩有希, 鈴木茉莉子, 山本真央, 松本准, 廣澤伊織, 加藤芳徳, 山田治美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

Drug-related evaluation of acute hepatic dysfunction that occurred after P0843-22-PM daptomycin administration
飯田慎也1), 大滝康一1),2), 山本譲1), 筒井真博3), 菊池信介3), 内田恒3), 田原克寿1), 山下恭範1), 都築仁美1), 井上正朝1), 山田峻史1), 小野尚志1), 小川聡1), 福土将秀1), 粟屋敏雄1),4), 東信良3), 田崎嘉一1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

	Examination of medication method, a dose and the side effect in the ST medical mixture administration for the P0844-23-AM pneumocystis pneumonia onset prevention 山内花, 和田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

	Examination ... of the problems by giving priority to the example - aim trough level that caused neutropenia and thrombocytopenia during P0845-22-PM vancomycin administration 宮崎元康1), 森脇典弘1), 永田良三郎2), 坂田俊文2), 松尾宏一1), 神村英利1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

About side effect expression in the P0846-23-AM linezolid (about thrombocytopenia)
駒井勇太, 喜多洋嗣, 喜多幸子, 高見藍, 仲村亮太, 森智子, 小松祐輔, 潮平沙貴, 田中紋乃, 人見百合子, 石井英之, 田仲祐子, 羽山沙樹乃, 則武隆佑, 松田絵理菜, 泉優貴, 菅真理子, 村雲智久
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2015.

	Consideration of one case and the article that caused hypoglycemia by P0847-22-PM levofloxacin 大野静子, 中村護, 福原伸治, 久保有子, 木村竜司, 中下愛, 野口亜樹, 松本篤, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

	Examination about the drug adverse effect in the elderly people who received P0848-23-AM emergency visit 井上大奨1), 迫田和樹1), 山形真一1), 幸邦憲1), 高橋毅2), 中川義浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

	Examination of patient factors about side effect expression of P0849-22-PM antirheumatic drug iguratimod 亀山俊1),2), 栗原沙織1), 飯塚敏美1),2), 堀口雅巳1), 平野俊彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

	One case of the drug-related rhabdomyolysis that occurred after P0850-23-AM acute myocardial infarction 木下真理子1), 吉岡大樹1), 廣兼誠1), 森善洋1), 古殿真之介2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

	One case of the rheumatoid arthritis that presented pancytopenia during P0851-22-PM methotrexate and iguratimod combination 山下博民1), 河野えみ子1), 金光盟子1), 関田理子1), 河田彩乃1), 辻みゆき2), 高山康夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

	Factor analysis about the impaired renal function by P0852-23-AM Liposomal-Amphotericin B 中山大輔, 山本真悠子, 碓井崇人, 元村朱里, 藤本佳那子, 池嶋孝広, 村中達也, 廣田育彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2015.

Pharmaceutical management of patients with severe burn that resulted in iodine poisoning by P0853-22-PM iodine-containing ointment preparation large doses
齋塲千紗登1), 竹内正幸2), 築山郁人2), 寺島嗣明3), 梶田裕加3), 青木瑠里3), 井上保介3), 三木靖雄3), 松浦克彦2), 斎藤寛子1), 脇田康志1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

	Safe examination in the Daclatasvir / Asunaprevir combination therapy for patients with P0854-23-AM hepatitis C 山本英晶1), 川上恭弘1), 藤岡真一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

	Safe comparison between NOAC continuation and heparin substitution in the P0855-22-PM atrial fibrillation catheter ablation perioperative period 土田大輔, 新井孝文, 和泉邦彦, 早瀬友和, 二神諒子, 岡部静子, 池上信昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

	Fasting effect to give to the blood clotting ability of the P0856-23-AM warfarin potassium remedy patients 滝久美子1), 杉野雅浩1), 細谷治1), 安野伸浩2), 從二和彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

	The situation of the osteoporotic therapeutic drug prophylaxis for the steroidal osteoporosis in the P0857-22-PM our hospital 安部智英, 浜野峰子, 宗広樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

	1 case with suspected cholinergic crisis by the distigmine with the P0858-23-AM postoperative decreased renal function 岩川真也1), 本間美由紀1), 浦田元樹1), 北村芳子1), 嶋田裕2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2015.

	1 case that was given the identity test of the allergy-induced drug for P0859-22-PM liver damage suspicion 安高勇気1),2), 芝口浩智2),3), 今給黎修1),2), 鷲山厚司2), 二神幸次郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

	Examination about the side effect actual situation of the P0860-23-AM oseltamivir phosphate capsule 多賀野正嗣, 澤井健太, 神谷量子, 銭瑶子, 足立易子, 藤村保夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

	Comparison ... with PMDA in the side effect report of analysis - lansoprazole of the side effect report in the P0861-22-PM our hospital 村山和真1), 清田憲吾2), 鈴木正論2), 舟越亮寛2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

	Collection and East Shizuoka side effect meeting for the study of the information on side effects of drugs in the P0862-23-AM Fujinomiya Municipal Hospital 北村修, 勝又一雄, 鈴木豊秀, 川口洋実, 小林義典, 小林豊, 井尻真理子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

	An investigation of the onset of hypocalcemia situation by the P0863-22-PM denosumab and examination of the risk factor 加藤貴志, 山崎将英, 國本雄介, 益子寛之, 中田浩雅, 野田師正, 宮本篤 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

	Evaluation of the side effect monitoring that utilized a P0864-23-AM check sheet 清水悠司1), 高木勝弘1), 野々川裕斗1), 石川将也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2015.

	Investigation - second report - about the onset of sleep loss by the steroid introduction in the P0865-22-PM collagenosis internal medicine 藤田強記1), 林稔展1), 三角紳博2), 西野隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

	The remedy cancellation situation of duloxetine in patients with P0866-23-AM chronic pain and the factor analysis 豊山美琴, 藤澤浩美, 庄司雅基, 中村豪志, 田中邦佳, 室親明, 木村健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

	About the investigation of the report data in the trial period of the P0867-22-PM patients side effect report 岡本麻依, 久保田史佳, 鳥井真由美, 佐藤玲子, 近藤恵美子, 高松昭司, 俵木登美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

	Comparison of the adverse event of the phlebothrombosis preventive preparation in the P0868-23-AM colon cancer perioperative period 丸山真一, 安藤純子, 永瀬怜司, 今浦将治, 菅野浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

	Relations of afterbleeding and antithrombotic drug taking P0869-22-PM bleeding high risk in the treatment with lower digestive tract endoscope 佐藤将嗣1), 平田淳1), 大部智栄子2), 指山浩志3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

	Poison in medicine thing analysis report of the case that fell into multiple organ failure by P0870-23-AM risk drug intake 井上嘉余子, 齋藤健一, 篠原克典, 原竜也, 藤村沙織, 岸野亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2015.

	P0871-22-PM 6-Mercaptopurine Hydrate 10% survey on actual condition on dispersant method 三ツ木英子, 池田優子, 石丸博雅, 刈込博, 眞保淳子, 高山慎司, 川名賢一郎, 後藤一美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

	Investigation about the anticancer agent content in the air generated at P0872-23-AM anticancer agent preparation 中山季昭1), 松坂和正1), 齋藤博2), 松田佳和2), 中村益美1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

	Participation in planning to hepatic artery chemistry embolus therapy by the pharmacist in the P0873-22-PM our hospital 永島貴裕1), 中村淳二1), 市原航1), 古川将利1), 浅原新吾2), 福井宗憲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

	Fact-finding about preventive measures against exposure to internal use drug with the cytotoxicity in the P0874-23-AM pediatrics domain 市東優美1),6), 佐々木孝1),6), 中尾將彦2),6), 松本美奈子3),6), 森一博4),6), 石川洋一5),6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

	The construction of the complete enforcement system of the injectable anticancer agent preparation by the P0875-22-PM pharmacist and the usefulness 中川朋美, 中尾將彦, 岡本優美, 山崎直樹, 吉田徹也, 竹内昌司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

	Instruction to patient of preventive measures against exposure from P0876-23-AM excrement 堀江都1), 堀江達夫1), 増本和子2), 須田浩一2), 坂野茂3), 水本一生4), 本田聡4), 山形真吾4), 野宗義博4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2015.

Present conditions multicenter questionnaire report of the radiation exposure of the P0877-22-PM anticancer agent and the nonproliferation
野村浩英1), 宮麻紀子1), 六車裕一1), 平井三保子2), 倉橋基尚3), 尾上雅英4), 藤田英一5), 渡邊裕之6),8), 宅和真由美7), 平田敦宏7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

	About the construction of the P0878-23-AM anticancer agent preparation remote inspection system 及川尚子, 川村晴彦, 菊池英, 田中博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

	Development of the new work sheet to use under P0879-22-PM anticancer agent preparation 佐藤淳也1),2), 吉田翔2), 古川美咲2), 掘田靖則3), 佐藤加奈3), 工藤賢三1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

	Efforts to anticancer agent exposure measures in the P0880-23-AM our hospital 名坂輝子1), 栗原康弘1), 新井裕子1), 山崎美穂2), 石原真一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

	Examination of the Taxotere division dissolution law for patients with P0881-22-PM alcohol erethism 大澤友裕, 市橋厚司, 安田昌宏, 梅田道, 牧野哲平, 川島あずさ, 長屋雄大, 甲田明英, 水井貴詞, 小林健司, 佐橋誠, 後藤千寿 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

	Effective evaluation of the closed system anesthesia preparation appliance "chemo cleveite" in the P0882-23-AM anticancer agent preparation 中川雅史, 金子淳一, 西出貴義, 泉本裕美, 狩谷佳寛, 樫葉利人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2015.

	Attempt of an attitude survey and the education about the anticancer medicine exposure to P0883-22-PM non-medical care tech job 牧野麻里, 小宮幸子, 太田一郎, 岡村央, 小池博文, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

	Conduct an exposure to anticancer medicine investigation by the P0884-23-AM sampling sheet method; and - second report - 川上典子, 近藤昌子, 栃山義徳, 長山晃, 佐藤雅也, 高田正弘, 高梨真希子, 野毛一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

	Examination of the appropriate bed bath method for the restroom pollution with the anticancer agent of P0885-22-PM excrement 林瑶子1), 名和秀起1), 兼光朝子2), 高見陽一郎2), 島田憲一2), 江川孝2), 北村佳久1), 千堂年昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

	P0886-23-AM Attempt to create a spill kit as a countermeasure against anti-cancer drug exposure 氏家靖博, 山崎勇輝, 堀江美保, 安田礼子, 三代貴康 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

	The anticancer agent exposure reduction using the P0887-22-PM sampling sheet efforts (the second report) for becoming it 中川ゆかり, 石田曜子, 大坪達弥, 友金幹視, 藤田敦夫, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

Examination of the anticancer medicine ingredient bed bath effect of Toraysee (R) in the P0888-23-AM injection drug preparation environment
吉田昭昌1), 高見陽一郎2), 田頭尚士1), 岡崎大祐2), 松岡哲史2), 佐下橋伸寧3), 島田憲一2), 江川孝2), 木内司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2015.

	Anticancer agent preparation duties in the P0889-22-PM rest holiday: An estimate and analysis of duties contents 石川美由紀1), 渡邊雅明1), 飯塚史織1), 木村あおい1), 金子卓也1), 鈴木嘉治1), 神林泰行1), 土岐浩介1),2), 本間真人1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

	Examination of the duties efficiency by the inflection of the P0890-23-AM anticancer medicine preparation robot 金野昇, 新関昌宏, 片桐彩喜, 今村優哉, 水落翔太, 青木一真, 豊口禎子, 白石正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

Leak study of the saline plastic bottle preparation which used P0891-22-PM elastomer for a rubber stopper
大澤千恵, 岩瀬利康, 坂本鉄弥, 森田美江子, 野澤孝章, 木村美貴, 瀧山慈絵, 池田真菜美, 小山朋子, 宮川潤子, 星野浩一, 大塚敏弘, 伊藤好夫, 越川千秋
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

	Stable examination after the dilution by the use of infusion pump of the P0892-23-AM etoposide parenteral injection and generic drug 鈴木悠平, 折山豊仁, 奈良克彦, 徳田篤志, 長瀬幸恵, 高田龍平, 鈴木洋史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

	Is P0893-22-PM not clogged up? Trouble, cause investigation ... at azacitidine - azacitidine subcutaneous administration 畑暁子, 田井浩子, 田代美佳, 瀬名波宏昌, 大河万顕, 村山洋子, 下村一徳, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

	One case that the patients with P0894-23-AM dysphagia were given a that mouth nib by the simple suspension method, and was effective 鈴木大介1),2), 久野亜耶奈1), 市江敏和1),2), 林秀樹2), 杉浦洋二1), 杉山正2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2015.

	Break P0895-22-PM anticancer agent exposure; examination about the clinical use of scattering prevention label packing "vial protection pack 2" 鈴木高弘1),2), 諏訪紀衛1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

	P0896-23-AM Consideration of one anticancer drug vial superior in unsealability, cushioning, and disposability for individual packaging boxes 河西麻祐子1), 溝口優2), 太田哲徳1), 村田実希郎2), 定本清美2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

	Efforts about anticancer agent preparation duties of the P0897-22-PM Kanazawa Medical University Hospital 高桑直子, 中田いちこ, 山口加代子, 高橋喜統, 丹羽修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

Use evaluation of "the R-CHOP brochure" which can continue even P0898-23-AM outpatient department chemotherapy
坂野博紀1), 鈴木善貴1), 町支優和1), 石川元章1), 原田靖彦2), 奥野真吾2), 鈴木弘太郎2), 西脇聡史2), 倉橋信悟2), 杉浦勇2), 石田隆浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

To take it in as pharmacist duties by effect - outpatient department chemotherapy that the P0899-22-PM cancer instruction to patient management charges 3 acquisition gives to drugstore duties; -
鈴木善貴1), 町支優和1), 石川元章1), 吉原基2), 平松和洋2), 杉浦勇3), 加藤岳人2), 石田隆浩1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

	Side effect management in by medical examination front in patients with P0900-23-AM cancer and the effect 堀晃代1), 田中和秀1), 大澤友裕1), 安田昌宏1), 水井貴詞1), 棚橋純子2), 中田琢巳3), 後藤千寿1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2015.

	Efforts for the enforcement of the cancer instruction to patient administrative work in the P0901-22-PM outpatient 冨田敦和, 藤井知郎, 惠谷里奈, 種村繁人, 今井邦行, 羽田勝彦, 野村賢一, 野田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

	Having seen it from the P0902-23-AM chemotherapy pharmacist outpatient department 田代美佳, 田井浩子, 大河万顕, 村山洋子, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

	Efforts of the drug instruction improvement to patients who received foreign cancer chemotherapy using the P0903-22-PM check sheet 齋藤麻衣子, 荒井秀和, 小林祥子, 須藤晴美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

	Efforts and the present conditions to P0904-23-AM cancer instruction to patient management charges 3 calculation 大羽美津子, 森秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

	Calculation - of intervention - cancer instruction to patient management charges 3 of the pharmacist to P0905-22-PM outpatient department cancer chemotherapy patients 森善洋1), 吉岡大樹1), 廣兼誠1), 木下真理子1), 小坂幹子2), 峯孝志3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

	PT-INR level change at combination of P0906-23-AM warfarin and capecitabine 伊東輝美1), 藤村拓也1), 相馬まゆ子1), 佐々木洋一1), 今田愛也2), 猪爪信夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2015.

	One case that a ward pharmacist was able to intervene in for interstitial pneumonia by the P0907-22-PM Afatinib in the second year 西尾佳奈1), 生川賀代1), 小林厚2), 米田勝晃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

	1 case of patients with head and neck cancer which presented withdrawal symptom by the P0908-23-AM opioid 小原香那1),2),3),4), 大道淳二1), 姫井健吾2), 渡辺啓太郎3), 喜多嶋拓士3), 小山貴久4), 石原久司4), 竹内彩子4), 赤木成子4), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

	About a side effect of P0909-22-PM Brentuximab Vedotin and the prevention 霜多博孝, 篠原梨絵, 荒川昌史, 須藤俊明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

	The case that caused activities of daily living (ADL) drop for tardive eruption in the P0910-23-AM regorafenib administration 常友友紀1), 泉早苗1), 横田早苗1), 江口真知子2), 大橋一郎3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

	Usefulness of the supportive care suggestion in the P0911-22-PM outpatient department cancer chemotherapy room 坪井伸也, 葉山達也, 内池明博, 小林直子, 堤大輔, 山本裕子, 早坂正敏, 吉田善一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

	Role of the pharmacist in the treatment with P0912-23-AM colon cancer internal use anticancer agent 牛膓沙織, 高取裕司, 野村翔, 新井孝文, 中村敏史, 池上信昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2015.

	Examination ... of the appropriate patients explanation for the generic medicine (injection drug) by questionary survey - pharmacist about the patients explanation of the P0913-22-PM cancer chemotherapy 野村久祥1),3), 吉尾隆2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

	Examination ... of the satisfaction of the patients about questionary survey - generic medicine (injection drug) about the use of the anticancer medicine in patients with P0914-23-AM breast cancer 吉尾隆1),3), 野村久祥2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

	Efforts to cancer instruction to patient management charges 3 in the P0915-22-PM outpatient department 石岡美樹, 賀川智子, 針ヶ谷義久, 廣井順子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

	P0916-23-AM Examination of bone marrow suppression status and termination cause in Trifluridine, Tipiracil administered patients 山田剛1), 都留君佳1), 大森由紀1), 長谷川綾美1), 神代竜一2), 梅田健二2), 米村祐輔2), 坂東登志雄2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

The present conditions of the prescription suggestion at patients medication counseling in the P0917-22-PM outpatient department chemotherapy room
菊池昌之1), 早坂望1), 山田廉1), 千葉侑希1), 西村忠晃1), 小笠原尚紀1), 齋藤純哉2), 藤原真智子1), 高橋果奈1), 高濱志保1), 奥尚1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

Questionary survey for the chemotherapy explanation tool improvement that matched P0918-23-AM patients needs
樋本繭子1), 中田日早枝1), 三木育子1), 高瀬尚武1), 田中智也1), 村井良平1), 米澤圭祐1), 遠藤幹子1), 浅田佳代2), 辻聡子2), 原美紀2), 喜多川千種2), 末次弘実3), 高原秀典3), 高尾雄二郎3), 井谷淳3), 横山正3), 小野成樹3), 室井延之1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2015.

Efforts investigation of the pharmacist about P0919-22-PM cancer instruction to patient management charges 3
中川麻子1),2), 植松俊成1),3), 久保田厚子1),4), 宮川貴行1),5), 玉一久美1),6), 永見康男1),7), 村上輝明1),8), 守田和彦1),9), 藤田亜弓1),10), 松久哲章1),11), 古川裕之3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

	The present conditions of the doubt inquiry in the P0920-23-AM our hospital outpatient department chemotherapy room 岩永陽子, 平川智規, 前間邦生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

	1 case that a side effect appeared by P0921-22-PM crizotinib administration, and became hard to cure, but succeeded after a change to a that mouth nib 金子憲太郎1), 杉本誠1), 川口文誉1), 吉川明彦1), 夏目一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

The present conditions of EGFR mutation in the gene-positive progress non-small cell lung cancer treatment in the P0922-23-AM our hospital
上原友美1), 中島理恵1), 中村有莉恵1), 赤星真広1), 石神誠子1), 池増鮎美1), 神門孝典1), 佐多照正1), 副島賢忠2), 西島浩雄3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

	Relation of the pharmacist in the regorafenib case which we stopped use of by P0923-22-PM liver damage 平瀬陽子1), 青柳京子1), 金内幸子1), 栗原直人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

	Telephone support in the P0924-23-AM oral anticancer agent remedy patients 熊谷要1), 枝廣茂樹1), 西島弘二2), 二上文夫2), 西村元一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2015.

P0925-22-PM "Efforts towards the calculation and implementation of cancer patient guidance management fee 3 at our hospital : Enhancement of cancer patient guidance management"
殿村直也, 高沢真央, 赤瀬麻希, 高木茂実, 大釜真美, 横山礼子, 塩地園代, 白石範子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

Usefulness of pharmacist duties by the P0926-23-AM cancer instruction to patient management charges 3 calculation
岸本早百合, 多々見俊輔, 遠藤由里香, 逸見結衣, 渡邊小百合, 伊勢原祐子, 菰渕利香, 藤原正幸, 小田中みのり, 安達嘉織, 佐倉小百合, 中晴徹, 大前隆広, 川高菜緒, 大谷祐子, 見上千昭, 柴田博子, 松本敏明
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

Construction and the calculation enforcement situation of the medicine manual making system corresponding to the calculation of P0927-22-PM "cancer instruction to patient management charges 3"
薮田直希, 森井博朗, 須藤正朝, 阪中美紀, 野田哲史, 若杉吉宣, 山本優, 井堀仁美, 野村文香, 星野伸夫, 寺田智祐
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

	About the calculation situation of cancer instruction to patient management charges 3 in the P0928-23-AM our hospital 島田健, 瀧真由子, 大里勇二, 福山正人, 山口くき, 大谷知奈美, 高嶋梨恵, 西田優香, 喜多良昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

	The case that P0929-22-PM gefitinib EGFR gene-resistant (T790M) became clear, and shifted to Carboplatin and pemetrexed combined treatment 大久保節子1), 大久保正2),3), 田中真理子3), 大久保七枝4), 阿部慧5), 角田美佐子6), 大久保美穂5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

The case that alternate-day administration of S-1 by the suggestion of the P0930-23-AM pharmacist relieved a side effect, and became available for medication continuation
大久保美穂1), 大久保節子2), 大久保正3), 田中真理子4), 大久保七枝5), 角田美佐子6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2015.

Analysis of the calculation situation and doubt inquiry contents of cancer instruction to patient management charges 3 in the hospital attached to the P0931-22-PM Chiba University faculty of medicine
佐伯宏美, 今井千晶, 横山威一郎, 中村貴子, 鈴木貴明, 有吉範高, 石井伊都子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

	Treatment intervention case ... by the cooperation with the medication support - outpatient department chemotherapy room to patients with foreign chemotherapy enforcement in the P0932-23-AM health insurance pharmacy 沼崎香, 岩瀬裕治, 鯨明美, 丹羽直人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

Medicine medicine cooperation ... which used a hospital and present conditions investigation - Internet and FAX of the information sharing with the health insurance pharmacy at the beginning of the treatment with P0933-22-PM oral anticancer medicine
間俊男, 川崎玄博, 竹葉美香, 藤近拓弥, 示野健介, 谷幸美, 宮村憲明, 三浦雅典
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

	Unification and evaluation of the antiemesis therapy in the P0934-23-AM hepatic artery chemistry embolus therapy 塩坂育子, 平野和加, 村上通康, 仙波昌三 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

Examination of the palonosetron, aprepitant,dezamethasone3 agent combination antiemesis therapy at the autologous peripheral blood stem cell transplantation in the P0935-22-PM multiple myeloma
斎藤理恵1), 磯田淳2), 小松史法1), 眞中章弘4), 大澤則八寿1), 石川哲也2), 宮澤悠里2), 松本守生2), 澤村守夫3), 蟻川勝1), 横手信昭1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

	Efforts to adequacy of the use of antiemetic drug in the cancer chemotherapy of the P0936-23-AM our hospital 一色靖洋, 相川優子, 大室直樹, 生島五郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2015.

Multicenter observational, prospective study about retching, vomiting under 5HT3 receptor blocker and the dexamethasone combination with the P0937-22-PM moderate degree emetogenicity chemotherapy
原田知彦1), 松井礼子2), 清水哲1), 鈴木賢一3), 瀧口友美3), 西尾誠人3), 小池健志2), 林稔展4), 瀬戸貴司5), 小暮友毅6), 野上尚之6), 藤原季美子7), 金田裕靖7), 木村仁8), 剱持広知8), 下川元継5), 後藤功一2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

	Examination about the antiemesis effect of the dexamethasone in the cisplatin liver intraarterial injection therapy using P0938-23-AM retching, the vomiting evaluation tool 彦坂麻美1), 島田泉1), 新井三紗子1), 間瀬広樹2), 林誠3), 阿部康治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

	About the use situation investigation of the antiemetic before the P0939-22-PM CHOP therapy enforcement and the effect 長谷悠紀, 岸川春樹, 曽我弘道, 山下悟史, 新治嘉一, 前田朱香, 坪根未歩, 平野真健, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

	Effect of aprepitant by the TC therapy in retching, the vomiting risk factor with the P0940-23-AM chemotherapy 阿部一仁1), 伊藤敏谷2), 岸本彩子2), 矢田大輔2), 鈴木康之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

	Investigation of the effectiveness for the antiemesis therapy to patients who received P0941-22-PM cisplatin + docetaxel therapy 及川嵩人, 高橋典哉, 和賀信継, 村上正一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

	Symptom control and antiemesis measures for the case that P0942-23-AM bevacizumab and Fosaprepitant caused an infusion reaction symptom 平出耕石1),4), 今井直基2), 小林洋子3),4), 鈴木文子3),4), 今関孝子1), 加藤武司1), 尾関豊2),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2015.

	Examination of the usefulness of aprepitant in gemcitabine and the low-dose cisplatin therapy for the P0943-22-PM biliary cancer 杉本智哉1), 藤野泰孝1), 矢野亨治1), 菅原元2), 梛野正人2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

	Examination of the antiemetic in P0944-23-AM hydrochloric acid gemcitabine and the albumin suspension type paclitaxel combination therapy 亀島理沙, 片岡智美, 宮崎雅之, 熊倉康郎, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

	P0945-22-PM Comparison of gastrointestinal toxicity such as antiemetic effect and diarrhea of Indisetron and Tropisetron in combination with Carboplatin + Irinotecan 小岡亜矢1), 梅原健吾2), 高田寛奈2), 若本あずさ2), 初山多恵2), 佐藤秀紀1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

Evaluation of the expression situation and uneasiness, the depression of the adverse event at the P0946-23-AM hepatic artery chemistry embolus therapy (TACE) enforcement
原田桂作1),3),4), 末吉宏成1),3), 山本朗子1), 坂本佳子1), 野口純也2),3), 木戸川秀生2),3), 岡本好司2),3), 村本眞由美1), 名倉弘哲4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

	Evaluation - second report - of the prophylactic hot compress for the vascular pain at the Fosaprepitant administration in patients who received P0947-22-PM AC/FEC therapy 今津邦智, 西川千晶, 中野愛子, 岩見裕信, 中田恭子, 前田昌徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

	Examination of the risk factor about the onset of retching with the P0948-23-AM FEC75 therapy 長谷康史, 加藤加奈恵, 木幡華子, 荒木良介, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2015.

Contents of the antiemetic drug reinforcement for retching, vomiting in the P0949-22-PM uterine cervix cancer cisplatin +5-FU therapy and the effectiveness
久米初枝1), 宮崎典子1), 市川和哉1), 田上聖実1), 杉本亜弥1), 矢野亨治1), 梶山広明2), 吉川史隆2), 山田清文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

	We weigh usefulness of aprepitant against the Fosaprepitant for patients with P0950-23-AM gastric cancer 清水浩幸1), 廣岡賢輔1), 前田祥花1), 米田栄子1), 牧問美和子2), 滝田敬子3), 川西幸一4), 熊谷務3), 澤山友里3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

	Effective comparison between palonosetron and granisetron + metoclopramide lorazepam prophylaxis for nausea vomiting at the P0951-22-PM cisplatin administration 森本清香1), 三好孝法2), 林稔展1), 西野隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

	Effect of the aprepitant extension administration on retching of the P0952-23-AM breast cancer chemotherapy 近藤祐樹1), 松山奈央2), 鬼頭典子1), 黒田純子1), 木村和哲1),2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

	Association between carnitine change and lassitude in the P0953-22-PM cisplatin-containing chemotherapy 池崎友明1), 鈴木健介4), 神原健太3), 猪又峰彦3), 岡澤成祐3), 安田初奈2), 梶浦新也2), 三輪敏郎2), 田辺公一5), 菓子井達彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

	Examination of the nephropathic risk factor by the cisplatin under the P0954-23-AM Mg administration 須藤頌, 三浦惇史, 前淳之介, 荒川ちづる, 曽我部直美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2015.

	Examination about RDI of P0955-22-PM CHOP and the cyclophosphamide in the CHOP homeotherapy 兼松哲史1), 山田佳代1), 中村英明1), 吉田均2), 伊藤貴彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

	Fact-finding of the drug choice for the esophagitis with the P0956-23-AM cancer of the esophagus chemoradiotherapy 滝田美紀子1), 野村久祥1), 鳩貝健2), 牧陽介3), 小島隆嗣2), 齊藤真一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

	Examination about the expression situation of the vascular pain with P0957-22-PM bendamustine and the measures 中山順子, 鎌田瑞菜, 細田美穂, 沖上朋美, 仲川三春, 宮川真澄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

	Effect of the weight loss by the platinum system anticancer agent enforcement in patients with P0958-23-AM progress lung cancer 森尾佳代子1), 南俊行2),3), 寒水孝司4), 仁木一順1), 木島貴志2), 上島悦子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

	Screening of hepatitis B by P0959-22-PM cancer chemotherapy and the pharmacist 西塔志織, 川原裕, 九鬼亜衣子, 衞藤麻里子, 中尾佳人, 宮崎宏美, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

	Investigation about the prophylaxis of steroid eye drops in the equivalent cytarabine therapy out of P0960-23-AM 米窪恭子, 疋田絵梨, 清美奈, 白石範子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2015.

	Examination of the administration according to the risk classification of RAS yellowtail gauze in P0961-22-PM senior Popes 中村和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

	Evaluation of the therapeutic drug for the hiccups by the P0962-23-AM cisplatin 山本知佳1), 波多野義純1), 鷲山厚司1),2), 今給黎修1), 二神幸次郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

	Positive hepatitis B reactivation measures by the P0963-22-PM pharmacist 松田圭一郎, 延川正雄, 齋藤順, 荒井浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

	Examination of vasculitis measures by the raw diet flash after the epirubicin administration in the P0964-23-AM EC therapy 前田祥花, 廣岡賢輔, 米田栄子, 清水浩幸, 國森公明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

	Examination of the usefulness of the mild cathartic prophylaxis in the P0965-22-PM CHOP therapy 大畑紘一1), 林寛子1), 石原正志1), 小林亮1), 鈴木昭夫1), 中村信彦2), 中村博2), 北川順一2), 鶴見寿2), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

	The effect expression situation of use experience of the peg filgrastim in the P0966-23-AM our hospital and the other G-CSF preparation supplementation 森川由梨, 牛之濱風見, 池田龍二, 山下八重乃, 岡島隼輔, 新田美奈, 武田泰生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2015.

	A use case and examination of the Goshajinkigan in P0967-22-PM nab-Paclitaxel treated patients 眞木秀子1), 金谷典子1), 西村雅次1), 和田幸治1), 太田圭治2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

Examination of the impaired renal function protective efficacy with the magnesium administration in the P0968-23-AM head and neck cancer TPF therapy
北山秀則1), 坪内孝敏1), 出町拓也1), 村紗苗1), 芦崎雅之1), 平田力1), 早坂州生1), 竹内公美1), 渡邉昭仁2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

Research about the elevated blood pressure in the sorafenib therapy for patients with P0969-22-PM progress hepatocytes cancer
高橋亨1), 篠原悦子2), 宇田川涼子3), 田中博之2), 松尾和廣1), 佐々木英久1), 渡辺朋子2), 篠原旭3), 小林美沙樹3), 齊藤真一郎3), 池田公史4), 吉尾隆1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

	Investigation of the side effect expression situation of the nab-paclitaxel+gemcitabine therapy in the P0970-23-AM Sapporo public welfare hospital and the intensity of treatment 能登数馬1), 小原秀治1), 小林龍1), 渡辺浩明1), 高橋栄2), 阿部雅一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

	More than role - 8 cycles of the pharmacist for the side effect management of P0971-22-PM FOLFIRINOX, it is ... through 3 cases that we conducted to PD 三浦恵理, 奥野昌宏, 中田学 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

	Prophylactic skin treatment ... of dermatopathy measures - steroid drug for external use of the P0972-23-AM cetuximab panitumumab 高取裕司1),2), 牛膓沙織1),2), 新井孝文1),2), 野村翔1),2), 田中亜喜美193), 池上信昭2), 米山文彦1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2015.

	Investigation about the onset of diarrhea situation in the concurrent chemoradiotherapy for P0973-22-PM cervical cancer 木永舞1),2),3), 政賢悟1), 本田万里子2), 本原剛志3), 本田義輝1), 齋藤秀之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

We look at the rear about the side effect of difference in medication method expression of P0974-23-AM nanoparticles albumin-binding paclitaxel and examine a mark
石原祥史1), 遠藤拓未2), 浅野まゆみ3), 岩井美奈4), 浅野裕紀4), 伊藤大輔4), 安達志乃4), 岡田和智4), 宇佐美英績4), 吉村知哲4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

	Development of stomatitis situation analysis with the Everolimus lock in the P0975-22-PM Fukui Prefectural hospital 宇野美津江, 坂井伸成, 加藤秀明, 中村尚未, 森富男, 佐澤佳彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

	Use situation investigation of the conventional and sustained G-CSF preparation in P0976-23-AM blood-forming organ tumor 薮内由里香1), 衛藤智章1), 魚井みゆき1), 杉枝里香2), 林稔展2), 三角紳博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

	P0977-22-PM Study of safety by kidney function of Trifluridine / Tipiracil monotherapy 庄野裕志, 中村さやか, 宮城和代, 宮部貴識, 土井敏行, 上野裕之, 山崎邦夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

	Inhibitory effect of the steroid for the fever by P0978-23-AM bleomycin, the bleomycin at the etoposide, cisplatin (BEP) therapy 牛之濱風見, 森川由梨, 池田龍二, 山下八重乃, 岡島隼輔, 新田美奈, 武田泰生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2015.

	The effectiveness of the P0979-22-PM peg filgrastim and proper use fact-finding 京谷充崇, 原田知彦, 櫻井学, 楠原義宏, 菊地正孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

	Effect of aprepitant at the hypersensitivity prophylaxis of the P0980-23-AM dexamethasone 山崎将英1),2), 菊池敦子1), 中村勝之1), 佐々木直美1), 戸田貴大2), 山崎紀恵子1), 中田浩雅1), 野田師正1), 宮本篤1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

	Examination of the white-cell count change by the use of peg filgrastim in the CHOP like regimen in the P0981-22-PM Higashisapporo Hospital 小池奈穂1), 加藤遥平1), 中脇誠一1), 町野孝幸2), 平山泰生2), 照井健2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

	Examination of the expression situation about proteinuria derived from P0982-23-AM Bevacizumab 青木望1),2), 中村和代1), 嘉屋道裕1), 木村緑1), 角入壽彦1), 勝山徹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

Examination of the protective efficacy that is lower than 200 mg/day of aciclovir for the herpes zoster by the P0983-22-PM bortezomib
田中広大, 山脇まり絵, 松本尚子, 山崎好恵, 高平豊, 川田敬, 岡崎弘志, 橋田真佐, 田中聡, 岡崎由紀, 宮本典文, 山本創一
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

	Comparison with the effectiveness and the lenograstim of the peg filgrastim in the P0984-23-AM breast cancer FEC100 therapy 藤原大一朗1),2), 眞下惠次1),2), 木村佳世1), 野田明宏1), 多喜和夫1), 武田朋也2), 椿正寛2), 西田升三2), 阪口勝彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2015.

	Examination of stress inhibitory effect and the immunity reinforcement effect with the aromatherapy that assumed the IgA out of P0985-22-PM saliva an index 中田彩花1), 下枝貞彦1), 酒井優花1), 坂口佐穂子1), 中川沙織2), 大和進2), 太田伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

	Examination about the usefulness of the magnesium supplement for the renal failure at the P0986-23-AM Cisplatin+S-1 therapy 渥美仁, 加藤安宏, 浅井澄子, 中山貴美子, 澤口和代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

	Examination of the onset of electrolyte abnormality with expression situation and that of hypomagnesemia by the P0987-22-PM panitumumab 島田泉, 彦坂麻美, 阿部康治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

Investigation of the patients background in the onset of vascular pain with P0988-23-AM oxaliplatin
坂本和央1), 久保田康生2), 速水章一1), 大江利治3), 齋藤佳敬2), 熊井正貴2), 笠師久美子2), 山田武宏2), 小松嘉人4), 柴山良彦2), 小林正紀5), 井関健2),5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

	Efforts of the pharmacist to hepatitis B (HBV) reactivation measures in the P0989-22-PM Fukuoka Red Cross hospital 川野昭, 上杉聡美, 福重昇吾, 平野俊訓, 大石泰也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

	About cisplatin-related renal failure inhibitory effect by the P0990-23-AM magnesium supplement 立道貴清, 越野優希, 山本高成, 山口佳津騎, 磯部芳江, 田中裕章, 小坂信二, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2015.

	Efforts based on hepatitis B measures guidelines to occur by P0991-22-PM immunodepression, chemotherapy 遠藤篤, 山崎有子, 國分洋, 小村裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

Examination about the use situation, side effect expression of sustained G-CSF (peg filgrastim) in the P0992-23-AM Konan public welfare hospital and the contribution to intensity of treatment maintenance
今井邦行, 藤井知郎, 種村繁人, 惠谷里奈, 冨田敦和, 羽田勝彦, 野村賢一, 野田直樹
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

	Examination of stress inhibitory effect and the immunity reinforcement effect with the gamma-aminobutyric acid which assumed IgA out of the P0993-22-PM liquid an index 酒井優花1), 下枝貞彦1), 中田彩花1), 大塚沙穂里1), 中川沙織2), 大和進2), 太田伸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

Side effect investigation of the Afatinib for patients with chemotherapy existing treatment EGFR mutation in the gene-positive non-small cell lung cancer including EGFR-TKI in the P0994-23-AM our hospital
梅原健吾1), 高田寛奈1), 後藤桂輔1), 若本あずさ1), 初山多恵1), 佐藤秀紀2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

	Patients explanation booklet making about the mouth care during use of P0995-22-PM Everolimus and the evaluation 原田沙枝子1), 下川福子1), 澤田奈津子1), 川端俊介1), 安本祥子1), 船越幸代1), 尾崎清香2), 松岡裕大2), 北村龍二2), 池上英文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

	Report about the case that used P0996-23-AM Saireito together at MTX massive dose therapy 木内直美, 関根佳代, 松本美奈子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2015.

Examination of the risk factor of the serious neutropenia with the S-1+CDDP therapy for patients with P0997-22-PM progress stomach cancer
栗原竜也1), 山口天士1), 向後麻里1), 加藤和佳奈1), 石井正和1), 石橋正祥1), 久保田祐太郎2), 米山啓一郎3), 吉田仁2), 木内祐二1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

	One patient who presented with hyperammonemia during the P0998-23-AM mFOLFOX6 enforcement 池井健, 堀部正記, 大谷仁士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

	Examination about the expression situation of peripheral neuropathy in the P0999-22-PM paclitaxel (albumin suspension type) and the factor 鈴木訓史, 後藤達也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

	Consideration about the actual situation of a blood pressure change and the onset by the P1000-23-AM bevacizumab of proteinuria 沖田健太郎, 奥美和, 植中英恵, 長谷川将, 末武亜依子, 中村宏, 面田恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

	Use fact-finding of the peg filgrastim in the P1001-22-PM our hospital 佐々扶美, 山下愛子, 市川洋一, 田上治美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

	Relation of the pharmacist in the proper use of P1002-23-AM pegfilgrastim 荻原好章, 神原康佑, 石井一也, 河本敏貴, 大塚識稔, 原景子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2015.

	About CDTM about proper use of the oral P1003-22-PM molecules target medicine and the usefulness 鈴木敦詞, 鈴木大吾, 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

	Intervention ... in role - HBV reactivation prevention of the pharmacist in the P1004-23-AM our hospital cancer chemotherapy 平川裕美子, 早野絢子, 川崎美紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

	Than the good use of consideration - side effect check seat about the association of adverse event and the EGFR mutation in the gene type of the P1005-22-PM Afatinib ... 上ノ段友里1), 倉光絵梨奈3), 渡辺抄子2), 波呂祥3), 縄田好一1), 福山康朗3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

	Possibility ... of the treatment with Kamikihito administration continuation maintenance for attempt - thrombocytopenia to continue P1006-23-AM pancreatic cancer chemotherapy effectively 龍伸和, 石川雄大, 三村泰彦, 加藤敦, 足立伊佐雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

	Rearward investigation about the effectiveness when we used fludroxycortide tapes as paronychia symptom measures by the P1007-22-PM Afatinib 渕崎加奈絵, 入江慶, 増田義雄, 岡田裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

	Example that vascular pain with the P1008-23-AM vinorelbine reduced by anteroposterior administration of prednisolone 合津貴志, 伊與田友和, 渡邊弘枝, 渡部照美, 田崎政則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2015.

Supportive care in both regimens enforcement equivalence patients of P1009-22-PM cisplatin and the Carboplatin, comparison analysis of the test value
塚本あゆみ1),2), 長楽寿子1),2), 安井友佳子1), 石坂敏彦1), 八野芳巳1), 田端朋美2), 井上知美2), 石渡俊二2), 小竹武2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

	About hepatitis B reactivation measures of the P1010-23-AM our hospital and the present conditions 尾垣光彦1), 相馬沙希1), 佐々木恭子1), 近藤裕志1), 森垣和馬1), 田中聡之1), 椿正寛2), 西田升三2), 高垣佳史1), 畑中智子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

	Examination of the FN protective efficacy in the P1011-22-PM continuation type G-CSF preparation administration 根岸由貴1), 斎藤理恵1), 大澤則八寿1), 蟻川勝1), 松本守生2), 横手信昭1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

Change of the renal function by the difference in Mg doses to use by the short hydration method in the P1012-23-AM CDDP combination chemotherapy
西和哉, 川田彰彦, 和地徹, 佐藤美里, 高橋舞, 菊地慶, 樫村まどか, 佐藤圭吾, 佐々木崇, 鈴木雄太, 追木正人, 阿部浩幸, 佐賀利英
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

	Phase II study about the 1.35%menthol application protective efficacy for the peripheral neuropathy onset by P1013-22-PM Oxaliplatin 鬼窪利英1), 中村久美1), 内堀和也1), 中村将人2), 田内克典3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

	Use experience of the valproic acid Na bougie in the P1014-23-AM Shonan center Hospital palliative care unit 宮澤正幸1), 櫛引智子1), 片町守男2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2015.

The use fact-finding of the fentanyl sublingual tablet in the P1015-22-PM our hospital and making of the management sheet
日下部鮎子1), 藤原陽子1), 堀金妙子1), 遠藤麻紀1), 佐藤佳華1), 福井里佳2), 菊池一樹1), 明田克之3), 江副英理2), 八十島孝博2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

	Use of steroid investigation in patients with P1016-23-AM end-stage cancer 野際俊希, 辻直子, 石本昌裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

	Examination in the transluminal administration of P1017-22-PM Okiko Don controlled release capsule 後藤愛実1),2), 今井麻里子2),3), 桑門心2),4), 高橋智恵子1),2), 牧智恵子1), 樫木淑恵2), 河邑真衣2), 西原雅美1), 勝間田敬弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

Effect on bowel movement ... multicenter study ... by changes from oral P1018-23-AM oxycodone preparation to fentanyl patch
衛藤智章1), 林稔展2), 福山雄卯介2), 築田晃直3), 仲田浩成4), 山下愛登5), 糸永昇平6), 大園ゆかり7), 小薮真紀子8), 三角紳博1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

Opioid example that rotated from tramadol capsule 400mg/Day of P1019-22-PM High School doses to Osh codon controlled release capsule
松井駿亮1), 上中敏弘1), 長谷川英利1), 川端一功1), 田中巧1), 北村将司3), 上田桂子2), 大内政嗣2), 尾崎良智2), 井上修平2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

	Case report about opioid switching by the oral methadone difficulty of the terminally ill patients in the P1020-23-AM palliative care unit 増田多加子1), 藤澤重樹1), 後藤珠代1), 文元佑1), 我喜屋成香1), 竹井清純2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2015.

	P1021-22-PM Preparation of protocol for introduction of oral mucosa absorption immediate release opioid rescue preparation 海老根香里1), 平井利幸1), 神谷未加2), 神賀正博3), 関利一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

	For all human painful relaxation with making - team approach in medical care of the P1022-23-AM oxycodone introduction pass - 池田宗彦1), 阿曽沼伸一1), 藤井美沙2), 二神咲子1), 江見泰徳3), 鹿田康紀2), 由井薗陽一1), 槇林智子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

	Examination of the usefulness of the pain evaluation sheet common throughout P1023-22-PM inside the hospital 黒岩彩乃1), 高柳論也1), 大場拓史2), 平井栄一3), 諸星総一1), 小林恵美子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

	It is ... about fact-finding - pharmacist background and an instruction booklet of the medication counseling of the opioid analgesic for the P1024-23-AM cancer pain 榎南祥太1), 原伸輔2), 吉野新太郎3), 榎本幸子4), 前田一石5), 百海有二1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

	Efforts to the electronic chart mention unification that utilized a template in the use of drug for the P1025-22-PM medical care 高橋典哉, 及川嵩人, 佐藤和文, 和賀信継, 熊谷敏宏, 村上正一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

	One case that the prophylaxis of the P1026-23-AM fentanyl sublingual tablet succeeded for a body movement ache with the diet 鶴島克将, 山本明紀, 安井友佳子, 石坂敏彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2015.

	Effect of the cancer cachexia on pain control with the P1027-22-PM fentanyl patch 千葉健史1), 高橋宏彰2), 平舩寛彦1),2), 長澤佳昭2), 工藤賢三1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

	1 case that P1028-23-AM hospital pharmacist intervened, and started a fentanyl citrate sublingual tablet in outpatient department 上島聖秀, 浜元孝, 細江律子, 高橋慎太郎, 河井良智 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

	The use situation and the effectiveness of the internal use antiemetic drug for nausea, vomiting at the P1029-22-PM opioid introduction 坂井良美, 馬場奈津美, 瀬川和子, 垣尾尚美, 國東ゆかり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

	Examination about the effectiveness of the diclofenac gargle water for the P1030-23-AM oral mucosa disorder 枝廣茂樹, 高橋怜史, 大川浩子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

	Efforts of a use situation investigation and the proper use of the Abstral (R) lower lock in the P1031-22-PM our hospital 神原諒, 山中理, 中山英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

	Example that quetiapine was given for P1032-23-AM delirium and a drug-related akathisia symptom, and followed the good course 勝又一雄, 小林義典, 川口洋実, 北村修 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2015.

One case of the progress breast cancer that was useful in quality of life improvement by combination with P1033-22-PM Mohs ointment and the metronidazole ointment
益子里美1), 市川由美子2), 須田篤博1), 豊田真史1), 藤井美代子2), 松本啓一1), 西村和彦3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

	Use experience of the P1034-23-AM tapentadol hydrochloride extended-release 山田千代子, 米澤美和, 久保杏奈, 台蔵剛士, 中川敏, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

The uneasiness, interest matter of the patients in the drug medication counseling for the P1035-22-PM medical care and the change over time
原伸輔1), 榎南祥太2), 吉野新太郎3), 榎本幸子4), 前田一石5), 山本智也1), 勝浦正人1), 門脇裕子1), 三輪芳弘1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

	Use experience of the tolvaptan for the intractable fluid retention with the P1036-23-AM advanced cancer 芦崎雅之1), 早坂州生1), 出町拓也1), 北山秀則1), 平田力1), 竹内公美1), 奥田博介2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

	Cancerous prominence ache treatment by the P1037-22-PM fentanyl citrate sublingual tablet and the evaluation 増田博也, 福井圭亮, 鈴鹿隆晃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

About the usefulness of the oxycodone continuous intravenous infusion for the pain due to the oral mucosa disorder after the P1038-23-AM hematopoietic stem cell transplantation
曽我弘道, 長谷悠紀, 町田聖治, 岸川春樹, 平野真健, 福地祐亮, 村井悠紀, 入江利行
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2015.

	Use experience of the tapentadol in the P1039-22-PM our hospital 後藤健志, 西村美馨子, 伴竜典, 竹尾恵理子, 石川真平 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

	The effectiveness of sterilization adjustment talc for the P1040-23-AM malignant pleural effusion and safe examination 表忍1),2),3), 松本剛1), 嶋貫和紗1), 辰巳秀爾2), 山下直己3), 橋元誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

	Use experience of the tapentadol in the P1041-22-PM our hospital 伊藤洸介1), 吉澤忍1), 山田武志2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

	Making of the palliative care "medicine and palliative care" brochure which P1042-23-AM pharmacist receives 中永かおり1), 赤木徹2), 林憲一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

	The effect that precedent introduction of P1043-22-PM tramadol gives for cancerous pain control 三田恭平, 荒木良介, 小島正照, 田中恒明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

	Use fact-finding of the peg filgrastim in the hospital attached to P1044-23-AM Nippon Medical School 長谷綾1), 鈴木藍1), 岸田悦子1),2), 輪湖哲也1),2), 片山志郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2015.

	1 case that relieved pain by the preprandial administration of P1045-22-PM fentanyl buccal tablet at body movement 関裕佳里1), 杉山哲大1), 青木純子2), 徳田佳之3), 野中泰幸5), 川上恭弘4), 近藤祥代1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

	Examination and problem of the effect of opioid rounds in the P1046-23-AM our hospital 遠藤征裕1), 山田郁恵1), 鈴木聡子2), 山崎豊3), 森川和夫1), 橋本正治4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

	Use fact-finding of the P1047-22-PM fentanyl sublingual tablet 奥田隆史, 高木雄一, 米澤摩衣子, 松本富夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

	It is ... through at-home visit instruction by efforts - hospital pharmacist aiming at support without the break to patients with cancer by the P1048-23-AM pharmacist 片山広美, 榊原ゆかり, 鈴木めぐみ, 永田実, 板倉由縁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

	Efforts to stocktaking and entrenchment of the drug knowledge in the P1049-22-PM drug department 川畑大輔, 和下田真美, 井上味波, 矢敷祐子, 川村めぐみ, 小川智孝, 岩城晶文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

Investigation of the expression situation of retching in all aprepitant patients introduction of the P1050-23-AM bladder cancer preoperation GC therapy and the preoperative nutritional status
堀尾秀明, 寺澤麻実, 松田麻奈, 水谷貴樹, 宮川佐和子, 林浩之, 宇都宮純平, 戸田康裕, 神間康
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2015.

	Side effect of bevacizumab combination expression situation investigation in the P1051-22-PM ovarian cancer Carboplatin + paclitaxel therapy 細田美穂, 長尾愛, 鎌田瑞菜, 中山順子, 仲川三春, 安部浩美, 橋本幸子, 宮川真澄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

	Hepatitis B reactivation measures and the reactivation development situation in the P1052-23-AM our hospital 祖父江彰, 山本桂子, 森仁美, 堀内保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

	The effectiveness of the THP-COP therapy for the P1053-22-PM diffuse-related large B-cell lymphoma and safe examination 渡瀬美登里1),2),3), 篠原義剛2), 高橋浩二郎1), 東丈裕3), 塚田順一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

	Investigation of the nutritional status change with the P1054-23-AM head and neck radiation combination chemotherapy 川俣洋生, 大園ゆかり, 山口泰弘, 山元光平, 林淳一郎, 平山俊一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

	About an edematous expression case in our hospital under the maintenance therapy by the pemetrexed after the P1055-22-PM platinum combination 石崎文子, 相原敏彦, 岩本留奈, 増尾昌則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

	About a relationship with a dose and the efficacy of the P1056-23-AM rasburicase 山瀬大雄1), 平井三保子1), 岩本義弘1), 松本早織1), 能木沙織1), 平田藍1), 籠本基成1), 土井孝尚1), 今田和典2), 小林政彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2015.

	A neutropenic onset risk by the difference in medication method of the P1057-22-PM taxane system antineoplastic drug: Examination using the technique of Meta-analysis 本西哲, 大植謙一, 廣田育彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

	Examination about the expression situation and measures of the vascular pain by the saline route flash after the P1058-23-AM Carboplatin administration 永瀬怜司1), 深澤拓也1), 上原望1), 藤森律子2), 相澤雄介3), 曽根原亘3), 菅野浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

Side effect investigation in the P1059-22-PM clofarabine etoposide cyclophosphamide combination therapy
赤松規子, 永井浩章, 蝉川由美, 小林知世, 中山淳司, 籾井佳奈, 愛甲佳未, 坂本有里恵, 三輪祐太朗, 北村晃子, 藤永仁美, 上田里恵, 福井由美子, 加古学
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

	Investigation of the enforcement situation and the side effect expression situation of the treatment with P1060-23-AM ibritumomab tiuxetan 吉川博, 櫻下弘志, 泉谷悟, 佐伯康之, 垰越崇範, 畝井浩子, 松尾裕彰 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

	Examination of the usefulness of the sustained G-CSF preparation in the P1061-22-PM MAID strange law therapy 赤瀬麻希1), 鈴木礼乃1), 綿田陽子1), 白石範子1), 五嶋孝博2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

	Evaluation about the enforcement situation of the P1062-23-AM colon cancer adjuvant postoperative treatment 岩井美奈1), 木村美智男1), 伊藤大輔1), 浅野裕紀1), 安達志乃1), 岡田和智1), 宇佐美英績1), 吉村知哲1), 寺町ひとみ2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2015.

	The effect that P1063-22-PM renal function gives to adverse event occurrence of the pemetrexed 村井淑恵1),2),3), 安藤洋介2), 氏田萌子1), 太田秀基2), 林高弘2), 山田成樹2), 河田健司3), 池田義明1), 安田公夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

	Examination of safety and the effect in the weight loss administration of the hippopotamus diTaki cell in patients with P1064-23-AM prostate cancer 羽田勝彦, 冨田敦和, 野村賢一, 野田直樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

	About the fact-finding of the cancellation reason of the foreign chemotherapy in the P1065-22-PM our hospital 浜元孝1), 上島聖秀1), 細江律子1), 高橋慎太郎1), 森谷道生1), 能澤真希子1), 田中みずほ1), 宮島玲子2), 河井良智1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

	An example of recurrent urothelium cancer which examined Carboplatin medication method under the haemodialysis based on a P1066-23-AM actual survey AUC level 近藤勝弘1), 山本優子2), 田代雄祐1), 杉山洋介1), 内木拓3), 小松弘和4), 木村和哲1),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

	Nephropathic investigation with the chronic administration of the GC therapy for the P1067-22-PM biliary cancer 大本奈緒子1), 辻直子1), 石本昌裕1), 西村知恭2), 岩城久弥2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

	Examination of the validity of the second prophylactic administration of pegfilgrastim in P1068-23-AM FEC follow by DTX 米澤美和, 久保杏奈, 山田千代子, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2015.

	P1069-22-PM Survey on the use of Enzartamide, Avirateron for castration-resistant prostate cancer in our hospital 鈴木薫1),2), 松田美樹子2), 小野裕紀1), 小林由佳1), 遠藤尚美1), 押切翼1), 武田彰1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

	Investigation of the renal failure development situation in our hospital at the P1070-23-AM cisplatin administration 渡部早苗, 松岡葉子, 玉井宏一, 烏谷政和, 久保さつき, 倉田知久, 藤原光代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

	1 case that was treated effectively with tolvaptan for SIADH in the P1071-22-PM small-cell lung cancer 宮武望1), 小野原未由来2), 岸和2), 向井淳治2), 長谷川喜一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

	Analysis of the factor contributing to the sleeplessness that occurred in the patients during the P1072-23-AM cancer chemotherapy enforcement 岡村和彦, 池本雅章, 佐々木啓雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

	Adverse event frequencies at bevacizumab addition to the temozolomide + radiotherapy in patients with P1073-22-PM malignant glioma 藤井良平1), 田中雅幸1),2), 今井雄介1), 西山徳人1),2), 打谷和記1), 廣田育彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

	Diachronic quality of life change with the foreign cancer chemotherapy in patients with P1074-23-AM breast cancer 田中和秀1), 堀晃代1), 大澤友裕1), 安田昌宏1), 水井貴詞1), 中田琢巳2), 後藤千寿1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2015.

	One case of the patients who received Bevacizumab combination capecitabine therapy for a colon cancer multiple metastases case with whole P1075-22-PM haemodialysis enforcement 本間信次, 大植謙一, 廣田育彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

	Examination of the dose regulation factor of the P1076-23-AM Afatinib 魚井みゆき1), 瀬戸貴司2), 三角紳博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

	Application to a malignant meningioma of the rays dynamics therapy using the P1077-22-PM talaporfin 三木雄一1), 前田潤1), 市川恵2), 秋元治朗2), 藤原泰之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

	Examination about bortezomib treatment continuity and the relief therapy in patients with P1078-23-AM multiple myeloma 福岡智宏1), 宇佐美英績2), 岡田和智2), 木村美智男2), 吉村知哲2), 土本大輔1), 宇都宮純平1), 神間康1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

	The cisplatin-resistant conquest that assumed P1079-22-PM amino acid transporter a target 中山優子1), 深澤郁也1), 木下淳2), 峯垣哲也3), 山本和宏4), 高良恒史1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

	The present conditions of the treatment with chemotherapeutic drug of elderly patients in the P1080-23-AM our hospital 土谷有美, 小阪圭治, 井岡真佐夫, 板倉祥嗣, 津田正博 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2015.

	Examination about the onset of mucositis risk in the P1081-22-PM head and neck cancer chemoradiotherapy 永谷明子1),2), 田口由美子1),2), 須永登美子1),2), 藤居直和3), 岡部尚行5), 橋本東児4), 向後麻里1),2), 佐々木忠徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

Cost effectiveness analysis ... in drug economic examination - sunitinib of the molecular target medicine in P1082-23-AM progress nephrocyte cancer vs. interferon alpha
戸村和希1),2), 内藤由貴1),2), 須永登美子1),2), 栗原竜也3), 佐々木春明4), 向後麻里1),2), 佐々木忠徳1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

	Effect of bisphosphonate drugs giving it to an increase of the human cancer of the esophagus cell line under the P1083-22-PM hypoxia environment 道家雄太郎, 峯垣哲也, 戀木沙耶, 山根千尋, 鈴木藍, 森美里, 辻本雅之, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

	The examination that P1084-23-AM nab- paclitaxel (for the oil xanthan gum (R) infusion) has an influence on the serum albumin level 長山晃, 森下和美, 近藤昌子, 川上典子, 高田正弘, 野毛一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

	Examination about the preparation method of the P1085-22-PM albumin suspension type paclitaxel 鶴久阿矢佳1), 西田恵美1), 守田研一1), 柿本秀樹1), 真島宏太1), 川田哲史1), 萩原知佳1), 鷲山厚司1), 今給黎修1),2), 二神幸次郎1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

One case that a β-D-glucan level became the high level for P1086-23-AM Candida glabrata fungal infection, and treatment suffered from because of severe impaired renal function and allergy to micafungin
出町拓也1), 芦崎雅之1), 坪内孝敏1), 北山秀則1), 平田力1), 早坂州生1), 竹内公美1), 澄川宗祐2), 佐々木邦明2), 久須美貴哉2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2015.

	Relation for the vancomycin chronic administration case in the P1087-22-PM our hospital 福井圭亮, 増田博也, 片山貴久美, 北野恵莉子, 奥澤文敏, 山下紗希, 鈴鹿隆晃 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

	We look at the rear for the acute prostatitis that occurred after P1088-23-AM transrectal prostate biopsy and examine a mark 中村翔吾, 基村佳代, 三浦裕介, 瀬戸崇光, 寺沢匡史, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

	The effectiveness of ampicillin for the P1089-22-PM children respiratory organs infection 冨山育朗1), 工藤晋1), 丹代恭太1), 田中健太郎2), 蒲澤一行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

	Efforts and effect of pharmacy leadership type Antimicrobial Stewardship using P1090-23-AM CDTM 伊藤広樹1), 今関孝子1), 平出耕石1), 石原哲2), 加藤武司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

	1 case that was associated with pyogenic arthritis due to P1091-22-PM intractable Pseudomonas aeruginosa 仲井修一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

	Investigation of antimicrobial consumption and chemosensitivity, the resistant bacteria change with the P1092-23-AM sulbactam / ampicillin high dose 中本晶大1),2), 星野路弘1), 菊本直樹2),3), 木村町子2),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2015.

	Comparison of the antibiotic exposure in the febrile neutropenia of patients with P1093-22-PM solid carcinoma 坂本拓也1), 奥田和貴1), 土佐直子1), 松田俊之2), 福澤祐幸1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

The detection situation of consumption of the carbapenem-based antimicrobial in the P1094-23-AM Iizuka Hospital and carbapenem-resistant Pseudomonas aeruginosa and substrate expansion type beta lactamase-producing bacteria
梅田勇一1), 内田守次1), 金澤康範1), 吉野麻衣2), 中村権一2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

	The use of antimicrobial situation according to the disease severity for P1095-22-PM acute cholangitis, the cholecystitis 藤本真美加1), 高橋文香1), 児玉暁人1), 岩田智津子1), 山崎恭平1), 木下佐昌子1), 森信介1), 小竹武2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

Examination of thrombocytopenia in the P1096-23-AM antiMRSA medicine linezolid
浅野愛1), 松尾和廣1), 花井雄貴1),2), 日下部太一3), 木村伊都紀2), 平山忍2), 東綾香2), 小川美希4), 佐々木英久1), 渡辺朋子5), 篠原悦子5), 小杉隆祥2), 西澤健司2), 加藤恵介3), 吉尾隆1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

	Did you result in a change for treatment of the aspiration pneumonia by adopting P1097-22-PM high dose SBT/ABPC? 山崎恭平1), 児玉暁人1), 今井兼貴1), 瓦侑馬1), 藤本真美加1), 水庫彩1), 森信介1), 小竹武2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

	The present conditions and evaluation of the treatment for ESBL-producing bacteria in the P1098-23-AM our hospital 竹内祐介1),2), 覚前盟1), 川崎奈美江1), 小泉祐一1), 野村真美1), 改田幸子2), 河村美里2), 畑中重克2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2015.

	Examination about the use situation of a risk factor and the antifungal agent of the P1099-22-PM candidemia 滝波昇悟1), 矢島尚子2), 織田慶子3), 監物英男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

	The use situation of the metronidazole IV preparation in the P1100-23-AM our hospital 實松絵美子, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

	One case of the MRSA bacteremia that got tolerance in daptomycin during P1101-22-PM daptomycin administration 草島宏平1), 大井直子1), 若松由紀子2), 安在冬虹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

	Efforts to appropriate drug choice in the P1102-23-AM bacteremia 石田篤世1),3), 河野えみ子2), 中村奈緒美1), 三箇山宏樹1), 藤井由美子3), 中矢秀雄3),4), 富田浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

	Relations of Pseudomonas aeruginosa in the P1103-22-PM Sapporo public welfare hospital-sensitive rate and use of antimicrobial density (AUD) 谷口知明, 高橋英里, 能登数馬, 樋浦一哉, 桂川みき, 小林龍, 小原秀治, 渡辺浩明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

	Efforts of the antimicrobial proper use promotion by the format change of the report of use of P1104-23-AM antimicrobial 青田真理子, 坂野昌志, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2015.

	The ICT in P1105-22-PM carbapenem-resistant Enterobacteriacae bacteria measures and efforts of the pharmacy 花房伸幸1), 小池彩子1), 廣田あゆ子1), 小原香那1), 小川一恵2), 奥格3), 森英樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

	Examination of ICT duties for P1106-23-AM Antimicrobial Stewardship 相曽啓史1),2), 森美奈子1), 佐瀬裕子3), 永田将司1), 貫井陽子2), 高橋弘充1), 安原眞人4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

	Examination of the factor having an influence on the clinical response of the amikacin sulfate once a day administration method in P1107-22-PM elderly people 松木祥彦1), 矢嶋美樹1), 細山田真2), 渡部多真紀3), 渡辺茂和3), 土屋雅勇3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

	The present conditions of the septicemic treatment in the cottage-hospital out of P1108-23-AM 坂野昌志, 青田真理子, 佐野元基, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

Efforts of the antimicrobial proper use promotion in the P1109-22-PM mental hospital
小黒夏子, 清水俊洋, 川邉東子, 中村陽子, 櫻山智子, 灘谷聡昭, 井戸澤弘美, 湯村守, 寺口勝久, 石井正巳, 伊藤信, 川瀬公一, 與田美穂子, 中野佐紀子, 西宮美保, 山村康比古
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

	P1110-23-AM Experience of using Delamanid against multidrug-resistant tuberculosis bacteria at our hospital 右川浩, 阿部和史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2015.

	We look at the rear about the effectiveness of SBT/ABPC and CTRX for the P1111-22-PM aspiration pneumonia and examine a mark 寺原史貴1), 横川祐美1), 田村広志1), 木佐健悟2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

	The present conditions of the treatment for the drug-resistant tubercle bacillus patients of the P1112-23-AM our hospital 三森竜司1), 永江朋子1), 小川佳亮2), 中川幹也1), 高橋恭久1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

	Comparison of the effectiveness by the antimycotic spectrum in the treatment with empirical antifungal agent for patients with P1113-22-PM febrile neutropenia 入口慎史1), 今井徹2), 折井孝男1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

	Examination of the critical path in P1114-23-AM transurethral bladder tumor resection and the transurethral prostatectomy 福石和久, 尾之江剛樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

	Efforts and result of the pharmacist to P1115-22-PM Antimicrobial Stewardship (AMS) promotion 菅野雄太1),2), 中谷紀之1),2), 塚本英範1), 小林俊之1), 三宮乙恵1), 土師美和1), 川口泰1), 米澤和彦1), 森本淳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

	Early intervention and clinical response to vancomycin administration suggestion by the P1116-23-AM pharmacist 瓜智都1), 菅野雄太1),2), 森本淳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2015.

	The round enforcement situation to blood culture-positive patients in the P1117-22-PM our hospital and the evaluation 天野哲史1),2), 生田幸江1),3), 山崎均1),4), 佐藤篤郎2), 稲塚信郎1),5), 杉浦誠治1),5), 板倉由縁2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

	The effect that P1118-23-AM ASP results in to the incidence of fungemia 杉生雅和1), 新康憲1), 石津智司1), 若松雄太1), 小林敦子2), 辻隆志1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

	The methicillin resistance is not a risk factor of the poor prognosis in P1119-22-PM Staphylococcus aureus bacteremia 新谷智則1), 塚本仁1),2), 東高士1), 飛田征男2), 室井洋子2), 西村一美2), 池ヶ谷諭史2), 中村敏明1), 岩崎博道2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

About association of number of P1120-23-AM methicillin-resistant staphylococcus aureus bacteria carriers and antimicrobial consumption and An antibiotic homogeneity index (AHI)
吉岡祐貴1),6), 小林義和1),6), 山田昌矢2),6), 浅井雅彦3),6), 織田元4),6), 生田宏次5),6), 浅野昌彦5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

	Relative examination with multidrug resistance and the antimicrobial consumption of P1121-22-PM Pseudomonas aeruginosa 佐藤和人1),2), 猪瀬祐亮1), 稲田寛之1), 小川和奈1), 中根智美2), 関利一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

	It is 1 case in consultation with the many types of job about P1122-23-AM antibiotic exposure 平田貴宏, 池田久雄, 吉岡亮, 野村浩英 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2015.

	Efforts and problem of our hospital for the promotion of P1123-22-PM Antimicrobial Stewardship 潮平英郎1),2), 仲松正司2), 鍋谷大二郎2),3), 健山正男2),3), 外間惟夫1), 植田真一郎4), 藤田次郎2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

	Antimicrobial of P1124-23-AM in-hospital ESBL-producing E.coli-sensitive rate investigation 久田瑛吉, 野澤正徳, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

	Intervention effect of the ICT on P1125-22-PM antimicrobial long-term use 香川真徳1),2),3),4),5),6),7), 三浦隆2), 香川浩一3), 添田徹4), 徳永裕一5), 稲田志信6), 黒瀬孝二7), 梶原直美1), 永野俊玲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

An antimicrobial of P1126-23-AM gram-negative bacilli-sensitive change and effect of resistant bacteria
小関崇文, 松木祥彦, 大貫敏明, 安田麻美, 松木浩子, 高橋優香, 杉浦健一, 畦元智子, 中村友美, 藤岡敬子, 小林健太郎, 西關由梨子, 芦澤由佳, 浦邉恵里, 笠井洋輝, 安西美咲, 加藤由紀, 小杉英恵
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

	Examination of the ESBL-producing Escherichia coli risk factor with the strain derived from urine samples in the P1127-22-PM our hospital 末永拓也1), 岩尾恭寛1), 工藤真裕1), 植山寛2), 高橋康一3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

	Examination of the background factor in P1128-23-AM Clostridium difficile-related loose bowels 飯尾志帆1),2), 八木浩志2), 亀山礼子2), 船屋諭史2), 竹原朗2), 川根隆志2), 蛭谷一彦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2015.

We look at promotion of the P1129-22-PM antimicrobial proper use and the rear about the association with the number of the detection of metalloβ-lactamase production bacteria and examine a mark
中蔵伊知郎1),2), 坂倉広大1),2), 廣田和之2), 上平朝子2), 多和昭雄2), 土井敏行1), 上野裕之1), 山崎邦夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

	Development of the P1130-23-AM epidemicity virus disease antibody titers management software and examination of the titration method 尾形和哉1), 橋本隆信1),2), 竹内亜紀2), 岸由希枝2), 西谷由里子2), 中園雅彦2), 山本高也3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

	Comparison of the use of antimicrobial situation by prescription restrictions of the P1131-22-PM identification antimicrobial and the report book prior presentation imposition 根岸大輔1),2), 木村英晃1),2), 川尻尚子1), 寺嶋毅2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

	It is the fact of measures after HIV exposure in the antiHIV medicine and occupation in the hospital in P1132-23-AM Toyama 成田綾香1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

	The introduction of comprehensive hospital infection measures mainly on the proper use of the waterless hand disinfectants by the P1133-22-PM pharmacist and the effect 森直樹1), 吉森友紀1), 有水かなみ1), 門脇大介2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

	Present conditions report of the prophylaxis of the antiinfluenza medicine of our hospital in the P1134-23-AM H26/27 season 後藤恵利佳, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2015.

Examination of the risk factor to affect the development situation and the occurrence of aspiration pneumonia in the P1135-22-PM D2 receptor blockade remedy patients
佐々木雄啓1), 横田智美1), 伊藤瑠美1), 岡村和彦1), 池本雅章1), 上田充展2), 川島英史2), 中村寛2), 佐和章弘2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

Making of "use of disinfectant guidelines 2015" by the P1136-23-AM J infection control network supervision
中居肇1), 荒川裕明2), 岡村祐嗣3), 金子俊幸4), 工藤香澄5), 工藤晋6), 後藤敏晴7), 齋藤梢8), 齊藤伸7), 杉山昌宏9), 平浩幸10), 丹代恭太6), 田村健悦11), 千葉博暁12), 十日市文子13), 西村孝一郎14), 花房喜子2), 本間絵里15), 由良温宣16), 平賀元17), 白石正18), 賀来満夫19)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

	Proper use promotion of the antimicrobial led by the P1137-22-PM ward pharmacist 北村好申1),2), 篠崎陽一2), 河野真二1), 中澤靖1), 北村正樹2), 川久保孝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

Usefulness of the modi operandi called the pharmacist subcommittee in the preventive measures against P1138-23-AM infection hospital cooperation combination conference
池田久雄1), 平田貴宏1), 須摩恵子2), 大隅奈奈3), 矢倉裕里3), 丸山潔4), 乾有希子1), 吉岡亮1), 千原亜紀子1), 野村浩英1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

	Measures of the HBV reactivation in the P1139-22-PM Saiseikai Yamaguchi General Hospital and the evaluation 後藤志典, 林幹也, 山崎博子, 赤崎淳子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

	Examination about the CR-BSI infection in the P1140-23-AM Hokuriku center Hospital 守内匡, 浅野聡美, 田中治, 松井ひろみ, 松田芳美, 西恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2015.

	Activity report (the first report) of the ICT position pharmacist in the P1141-22-PM our hospital 塚本貴庸子, 岩本凌, 荒井未来, 岩田沙紀, 薄田昌彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

About calculation of examination of the index in the P1142-23-AM antimicrobial consumption evaluation and Days of Therapy (DOT)
亀田敬子1), 高橋えりか1), 木本信介1), 山田周平1), 西田直史1),2), 初田輝1), 重高正行2), 下津武津美2), 山下敦志1), 赤坂聡一郎2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

Standard precaution improvement - Pharmaceutical Affairs Bureau hand hygiene compliance target 100% of pharmacists ... by the P1143-22-PM Pharmaceutical Affairs Bureau ICT team
鈴木大地, 齋藤祥子, 樫村拓也, 松崎宣裕, 田口綾, 宮下潤子, 鈴木貴弘, 赤津義文, 野原美代子, 大森友子, 小宅泰郎, 名和健, 渡辺泰徳, 青山芳文
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

	About fever 2-day after an operation in the P1144-23-AM SSI surveillance 違口晴子1), 前岡良輔2), 木村ひとみ3), 佐野唯4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

About a simultaneous facility suspension method application of a liquid for P1145-22-PM lopinavir ritonavir combination or combination lock and the abacavir sulfate, Lamivudine combination tablet
坪田有加1), 松尾理世1), 寺岡麗子1), 矢倉裕輝2), 湯谷玲子1), 北河修治1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

	The present conditions of the ART start time of the P1146-23-AM outpatient and the intervention time of the pharmacist 下川千賀子1), 安田明子1), 辻典子2), 柏原宏暢1), 中谷安宏3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2015.

	The lipid control situation including apolipoprotein of patients with P1147-22-PM HIV infection 日笠真一1), 秀田恭子1), 安田恵2), 日笠聡3), 澤田暁宏3), 徳川多津子3), 柳井美奈1), 木村健1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

	Case study about the medical treatment considered in P1148-23-AM HIV case conference 中山梢, 小林庸子, 若林進, 西圭史, 篠原高雄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

	Liver function level change investigation at the P1149-22-PM lipid microsphere administration 川道直子, 花沢直子, 荒井美織, 日高博司, 浅原稔生 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

	One case that vitamin K included in the lipid microsphere was thought to affect for anticoagulant action of the P1150-23-AM warfarin 日浦亜実, 石橋真実, 横田幸子, 大森麻江, 森英樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

The nourishment evaluation of elderly patients in the P1151-22-PM community pharmacy: For a liaison pharmacist
相宮幸典, 植田恵子, 指宿城, 糸川知沙, 中島広貴, 滝岡由美, 奥田まなみ, 榎本友紀, 大西姿子, 松田隆太郎, 横井貴明, 山田侑奈, 杉浦伸哉
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

Efforts for simple suspension method introduction promotion in the P1152-23-AM Kanazawa Medical University Hospital
中田いちこ1),2),3),4), 宮東利恵1), 鷹見沙八佳1), 平木祥子1), 相川正則1), 今川静代1), 高桑直子1), 桶谷純子1), 西川美香子1), 小池田玲子1), 高橋喜統1), 丹羽修1), 中村光宏2), 毎田千恵子3), 宮本悦子4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2015.

	Examination about the use situation in the clinical practice of the amino acid for the P1153-22-PM renal failure 倉地果純, 島本玲奈, 鈴木薫, 西原雅美, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

	The ferritin measurement during P1154-23-AM trace element-containing central venous hyperalimentation therapy and fact-finding of the iron excess 今川貴仁, 小園幸輝, 小杉隆祥, 西澤健司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

Use fact-finding of the lipid microsphere in the intravenous alimentation for the nutrition therapy that P1155-22-PM is appropriate
植平紗矢香1), 竹野淳2), 柳智恵子3), 吉野加那枝3), 渡邊佳世子1), 澤田奈津子1), 小山拓弥1), 船越幸代1), 池上英文1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

	P1156-23-AM Studies on defecation control by ingestion of fruit oligosaccharide 小島俊彦1),2), 大巻良子3), 海老名勇2), 後藤敬仁4), 遠藤雅史4), 松村美栄4), 金子俊幸1), 安部晶子1), 齋藤秀樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

	P1157-22-PM Survey on side effects and usage of ENEVO after use 恩田愛子, 高梨愛, 稲田佑亮, 吉沢純, 加瀬和也, 内田佳菜子, 松田俊之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

	Examination about the combined effect of the enterokinesis accelerating agent (mosapride citrate) giving it to P1158-23-AM half solidification fluid food 相澤優子1), 赤沼かおり1), 井上尚彦1), 阿部康代2), 廣井明夫1), 寺山昌宏1), 高橋邦雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2015.

	Making of Nutritional Chemotherapy Assessment Sheet for the nourishment evaluation elimination of the P1159-22-PM cancer chemotherapy 相良克海1), 吉川聡美1), 関口知紗2), 柴田愛3), 小田慎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

Relations of modified Glasgow Prognostic Score (mGPS) and a survival period, the adverse event in patients who received P1160-23-AM stomach cancer chemotherapy
森千夏1), 小暮友毅1), 二五田基文1), 岡崎ちか2), 彦坂亜美3), 高松寿4), 浅野由紀江4), 羽藤慎二5)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

	Examination of the preoperative nutrition evaluation using the CONUT method for the P1161-22-PM perioperative hypothermia 奥村佳史, 木村麻奈加, 加戸義大, 森田孝子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

	Fact-finding of clostridium difficile-related loose bowels in the P1162-23-AM Fukuoka University Hospital 上田裕1),2), 高木聡子1),2), 岡崎美和1),2), 大倉野将広1),2), 青柳邦彦2),3), 二神幸次郎1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

	It is undergone a change of the hospitalization after the days and intervention until the intervention of the patients targeted for NST in P1163-22-PM elderly people 佐野元基, 寺井文廣, 坂野昌志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

	Many types of job cooperation ... which changes a fault of the activity - single department Hospital in NST team in the P1164-23-AM psychiatry single department hospital into a plus 小林真美1), 小林重太2), 平山麻実子3), 馬場真佐美3), 木戸敏文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2015.

	One case that overall status and a pressure sore improved by P1165-22-PM NST intervention 大西秀美1),2), 乾有希子1), 池田久雄1), 居平典久2), 出口暁子2), 田中敬子2), 大野典子2), 片岡宏一郎2), 野村浩英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

	Effect on diarrhea risk of the flavor for the P1166-23-AM ingredient nutrient preparation (the second report) 武井佐和子, 影山美穂, 戸張裕子, 別生伸太郎, 濱田真向, 大山勝宏, 勝山壮, 井上みち子, 倉本敬二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

	One bowel control by the P1167-22-PM glutamine addition 大津貴寛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

	P1168-23-AM Evaluation of renewed Aminoleban EN blended proprietary flavor 矢嶋隆宏1), 佐藤友香2), 池田知子2), 三田地泉美2), 武内泰司郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

	High-speed simple suspension, development of the disposable infusion bag for the P1169-22-PM transluminal administration 北村滋郎, 兼次眞貴子, 野崎雅男, 盛本修司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

	Examination of the secondary carnitine deficiency by an antiepileptic drug and the nutritional status of the P1170-23-AM seriously disabled child (person) 加藤貴之1), 山本秀紀1), 佐々木みずえ1), 仙波靖士1), 山本宏1), 伊藤道徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2015.

	The effectiveness of the jellification of the P1171-22-PM ingredient nutrient preparation 辻由梨子1), 高良美紀1), 志垣奏子2), 野明俊裕3), 荒木靖三3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

	Analysis of the doubt inquiry example in the P1172-23-AM General Hospital psychiatry 福山雄卯介1), 大波多友規2), 西野隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

	Prescription situation investigation of the P1173-22-PM Clozapine (clozapine (R)) 濱田武, 畑武生, 鈴木薫, 西原雅美, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

	Efforts about the prescription order representation in the P1174-23-AM psychopathic ward and the evaluation 進健司, 梅田勇一, 大谷達郎, 牛島悠一, 橋本政弘, 川波宏隆, 草野充裕, 内田守次, 金澤康範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

	Prescription suggestion enforcement situation investigation of the pharmacist in the P1175-22-PM psychopathic ward protection room case conference 大谷達郎, 進健司, 牛島悠一, 金澤康範 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

	Efforts to the blood lithium carbonate levels measurement in the P1176-23-AM outpatient department: Introduction of the lithium measurement card 島田治子1), 角本亮二1), 辻慶子2), 岩野輝次2), 浦瀬千恵2), 森芳乃3), 西脇健三郎4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2015.

	It is efforts toward becoming it the single agent of antipsychotics in the P1177-22-PM Dazaifu Hospital 宮本奈緒美, 中川伴子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

	Effect of the medical service fees revision on psychotropic drug polypharmacy of the P1178-23-AM Shimane Prefectural center Hospital 勝部直美, 安食健一, 原直之, 寺西正充, 平野榮作, 横手克樹, 竹下和男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

	One patient who raised hypoglycemia with the bringing medicine for patients with mental disorder with P1179-22-PM body complications 小林泰子1), 大塚桂子1), 鈴木利人2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

	Analysis of the risk factor of the weight gain that antipsychotics by the data mining using P1180-23-AM JADER were associated with 畑武生, 濱田武, 鈴木薫, 西原雅美, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

	Examination of the factor of the hyperammonemia in the P1181-22-PM valproic acid remedy patients 今岡広輔, 岩元陽香, 大仁田哲修, 曽田重人, 中元隆浩, 難波優里, 春木ちひろ, 村上正樹, 玉木宏樹, 西村信弘, 直良浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

	Examination of the fall risk of antipsychotics and the benzodiazepine system medicine in the P1182-23-AM psychiatry chronic phase ward 和田智仁1),4), 伊藤由香1), 羽佐田祥浩1), 南出孝雄3), 中村友喜4), 伊藤直美1), 三輪高市4), 藤田康平2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2015.

	Examination about the effect on infection in the use of P1183-22-PM antipsychotics 新保一, 勝俣寛成, 山田昌彦, 山口正和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

	Efforts to the lifestyle improvement program by the many types of job in the P1184-23-AM psychiatry daycare 松野憲作, 横山美和子, 尾頭芳郎, 桂昭博, 木村あや, 井上裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

	Relation of use experience and the pharmacist of the Clozapine in the P1185-22-PM Fukui Prefectural hospital 川崎美雪1), 笠嶋悠1), 下山祐依1), 森富男1), 佐澤佳彦1), 平賀貴志2), 水野智之3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

	Attitude survey about the medical treatment in the P1186-23-AM alcohol addict 宮浦淳一1), 畑尾由佳1), 大草英文2), 奥田正英3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

	Intervention of the pharmacist for the present conditions investigation of the dose of medicine in the P1187-22-PM chronic phase psychopathic ward and the proper use 玉地亜衣1), 加瀬浩二1), 松田公子1), 儘田孝2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

	A remedy continuance rate of the P1188-23-AM acamprosate preparation and going to hospital continuance rate 後藤史子1), 福山雄卯介2), 福嶋翔3), 鈴田浩孝4), 宮崎敦1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2015.

The abdominal supersonic wave views, blood test views in the P1189-22-PM alcohol addict and correlation with the drinking period
池澤舞1), 高野美菜1), 北廣優実1), 郷原宏章1), 富田保子1), 山口哲史1), 岡村武彦2), 藤原祥子3), 後山尚久3), 島本史夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

	Correlation of long-term alcohol intake and complications in the P1190-23-AM alcohol addict 北廣優実1), 高野美菜1), 池澤舞1), 郷原宏章1), 富田保子1), 山口哲史1), 岡村武彦2), 藤原祥子3), 後山尚久3), 島本史夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

Change of the age distribution to be able to put in the past 26 years of the P1191-22-PM alcohol addict and the upper gastrointestinal tract disease
富田保子1), 高野美菜1), 池澤舞1), 北廣優実1), 郷原宏章1), 山口哲史1), 内藤雅人1), 岡村武彦2), 島本史夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

Medicine medicine cooperation questionary survey of P1192-23-AM mental hospital and the pharmacy service under health insurance drugstore
齋木良太1), 石動郁子2),13), 高橋満里3),13), 柳智之4),13), 鶴谷勝実5),13), 山本勇樹6),13), 志田雅彦7),13), 藤野知美2),13), 林千尋8),13), 石塚淑子3),13), 上野太佑9),13), 飯田美桜10),13), 根岸健太11),13), 齊藤浩司12),13)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

	Association of a fall, a fall and benzodiazepine drugs according to the time in the P1193-22-PM psychiatry medical treatment ward 赤瀬川豊1), 武田龍一郎2), 井上雅文3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

Subanalysis - about the usefulness of pharmacist, the psychiatry medical therapy authorization pharmacist specialized in questionary survey - psychiatry about the pharmacist duties in the P1194-23-AM mental hospital
永田健一郎1), 齋藤百枝美2), 馬場寛子3), 桑原秀徳4), 野田幸裕5), 高橋結花6), 村野哲雄7)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2015.

	Evaluation of the medication adherence using DAI-10 in the P1195-22-PM psychiatry acute phase ward 堀田彰悟1), 千崎康司1), 伊藤教道1), 村松千鶴1), 尾崎紀夫2), 山田清文1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

	It is investigated the delirium onset after the operation of the benzodiazepine system (BZ system) sleeping drug in the P1196-23-AM artificial joint replacement 松本拓真1), 田頭尚士1), 吉田昭昌1), 大倉裕祐1), 塩田直史2), 木内司1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

	The medicine classroom holding of mom and the baby about the use of commercial drug during the P1197-22-PM nursing and examination of the usefulness 古谷未希1), 安間保恵1), 中村光世2), 爪田久美子2), 大木茂3), 村越毅4), 塩川満1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

	Efforts aiming at standardization of the medical treatment for the constipation of the P1198-23-AM early or threatened labour patients 木村純子1), 高木祥子1), 立松あき2), 江口美智2), 青山智彦1), 加藤紀子3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

	Correspondence of the pharmacist at obstetric critical bleeding in the P1199-22-PM our hospital 板垣有紀1),2), 遠藤清香1), 和田幸治1), 阪西通夫2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

	Examination about the drug administration advisability to P1200-23-AM breast-feeding mother 松岡加恵, 能登英子, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2015.

The present conditions of the reporting about the nursing carried out for P1201-22-PM psychotropic drug remedy pregnant woman
八島一史1), 中川直人1), 小原拓2), 千葉和美3), 山本美由紀3), 西郡秀和4), 加藤佳子1), 松浦正樹1), 秋山志津子5), 菊地紗耶6), 小林奈津子6), 久道周彦1), 眞野成康1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

	Fact-finding of the prescription for the women whom there is possibility of the pregnant woman nursing mother in the emergency visit in in the P1202-23-AM night 萩歩美, 組橋由記, 鈴江朋子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

	Attitude survey about the pregnancy and the medicine for patients with rheumatic disease in the P1203-22-PM our hospital 大城真理奈1),2), 橋本孝夫1), 潮平芳樹2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

	Use situation investigation of the Cenozoic era antiepileptic drug in women of the P1204-23-AM childbearing age 西村あや子1), 高村茂生1), 古堅彩子2), 黒川瞳1), 小林正紀2), 笠師久美子1), 山田武宏1), 井関健1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

	The actual situation of the reporting for a pregnant woman, the nursing mother by the P1205-22-PM hospital pharmacist and the future prospects 永澤佑佳1), 鈴木敬雄1), 小山田光孝1), 佐藤秀子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

	One case that gave information to use of sentinel lymph node biopsy identification medicine for the P1206-23-AM breast cancer merger pregnancy patients 平原亮 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2015.

	Efforts and evaluation to mother's milk child care rate improvement by the P1207-22-PM pharmacist 山下恵, 山岡慶子, 鈴木亜矢子, 橋本真梨, 木村丈司, 西岡達也, 久米学, 槇本博雄, 平井みどり Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

A tendency to consultation and present conditions investigation of the use of drug nursing in the P1208-23-AM pregnancy and the medicine information center
三大寺紀子1),2), 中島研1),2), 八鍬奈穂1),2), 石井真理子1), 石川洋一1),2), 渡邉央美1), 伊藤直樹1), 後藤美賀子1),3), 肥沼幸1), 鈴木朋1),3), 和田友香1),3), 三戸麻子1),3), 村島温子1),3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

	Fact-finding about the medication counseling to a pregnant woman, a nursing mother in the P1209-22-PM health insurance pharmacy 松井実美, 中島勝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

	The need of the reporting to consider from the use situation of medicine, the supplement during the P1210-23-AM nursing and an attitude survey for the use 松下久美, 瀧祐介 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

	A consultation example in the medical treatment of the P1211-22-PM nursing mother and future problem 櫛屋敷裕子, 鈴木弘文, 蒲澤一行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

	Usefulness examination of the 24 hours blood pressure monitoring of patients with P1212-23-AM pregnancy-induced hypertension syndrome 勝本絵美1), 鴻丸晴菜1), 市川絵美子1), 植松和子1), 鈴木恵子2), 宮内彰人3), 安藤一道3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2015.

	One case of the pregnant woman using the P1213-22-PM carperitide 奥野真里絵, 賀来文治, 桑間直志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

Examination of problems when we investigate the P1214-23-AM pregnancy and the effect on children of the specific drug in the medicine information center
八鍬奈穂1),2), 中島研1),2), 三大寺紀子1),2), 石井真理子1), 石川洋一1),2), 渡邉央美1), 伊藤直樹1), 後藤美賀子1),3), 肥沼幸1), 鈴木朋1),3), 和田友香1),3), 三戸麻子1),3), 村島温子1),3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

	Example that making of the P1215-22-PM insulin technical aid allowed a self-injection 河村紳介1),2),3),4), 飯野和美3), 鈴木智恵子4), 鈴木貴宏2), 後藤良重3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

	1 case that we experienced by self-injection maneuver confirmation in the P1216-23-AM diabetes outpatient department 小山貴夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

	The effect of the hypoglycemic agent in patients with P1217-22-PM outpatient department diabetes and investigation about the medicine charge 堅石法子, 西尾明香, 菊地佑季, 高井宏幸, 中村雅敏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

Introduction of the prescription representation protocol (joint medical treatment management: PBPM) of the P1218-23-AM insulin-related prescription
小田千枝1), 濱石華乃子1), 中村和行1), 米山英二1), 山下雅代1), 秀野功典2), 石川孝太3), 水谷直広3), 近藤國和3), 勝見章男1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2015.

	Adverse event investigation of the hyperglycemia with the leuprorelin acetate which utilized P1219-22-PM PMDA side effect spontaneous report 田中伸明, 沢田俊朗, 鈴木敦詞, 村山まりこ, 服部芳明, 前田剛司, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

	Examination - by actual situation - questionary survey of the folk remedy in the clinic specialized in P1220-23-AM diabetes 向井潤一1), 平塚優加1), 金森晃2), 尾鳥勝也1), 厚田幸一郎1),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

	The effectiveness in the changes from P1221-22-PM alogliptin to other DPP-4 inhibitors and safe examination 草野仁美1), 戸倉由美子1), 白石彩乃1), 猪子美保1), 坪井伸治1), 加藤大也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

	Questionary survey and analysis about the satisfaction of the P1222-23-AM insulin device change patients 梶本佑輔, 下田剛志, 笹尾武史, 川澄清孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

	An evaluation of the insulin preparation in the P1223-22-PM health insurance pharmacy and patients satisfaction investigation 飯塚敏美, 内籐卓也, 宮北寛也, 吉川昌美, 中野匡介, 小塩真以子, 穂田美由季, 小鷹篤, 三堀賢太郎, 堀口雅巳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

	Investigation about lipohypertrophy in the use of P1224-23-AM insulin patients 今井智重子1), 金子由梨2), 浅川隆重1), 宮崎文子1), 織田佳人1), 伊藤三恵1), 金子伸吾3), 鳥巣真幹2), 大森拓朗2), 岡田眞一2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2015.

	Effect to give to a blood sugar control improvement effect and the life of the P1225-22-PM SGLT2 inhibitor 中島啓二1), 宇佐美英績1), 安部絵里1), 吉村知哲1), 柴田大河2), 傍島裕司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

	Development of the preparation aiming at improvement of the bioavailability of morin which was a P1226-23-AM shortage solution antioxidation material 寒川瑶子1), 池内由里1), 石原千津子2), 大西啓1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

	Development of the emulsion preparation aiming at improvement of the bioavailability of P1227-22-PM morin 村井万莉菜1), 池内由里1), 石原千津子2), 大西啓1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

	Examination about frequency and the patients risk factor of the digestive organ symptom of the P1228-23-AM GLP-1 agonist 黒崎友亮, 中川博雄, 内田隆寛, 樋口則英, 中村忠博, 佐々木均, 北原隆志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

	Comparison of the DPP-4 inhibitor in patients with P1229-22-PM stroke 高瀬公子1), 花田和大1), 船水梨沙1), 阿部早苗1), 久米田一喜1), 倉内寿孝1), 鳥谷部翔1),2), 藤田尚子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

P1230-23-AM Frequency of dehydration caused by taking Tofogliflozin and survey of concomitant drugs
松尾多恵, 二見早希, 今市沙有美, 岡紗智子, 井上美穂, 松下比奈子, 石田あい, 久保智士, 藤本智大, 山崎瑞貴, 鶴崎亮, 北森翔子, 青木美沙, 松谷和子, 三嶋仁美, 木村真策
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2015.

Examination about the effectiveness when we used DPP-4 inhibitor together during P1231-22-PM insulin medical treatment newly
原美由紀1), 早川伸樹1),2), 桑原宏貴3), 戸田貴洋3), 林高弘1),3), 福井愛子1), 亀井浩行1), 牧野真樹2), 鈴木敦詞2), 山田成樹3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

The effect that P1232-23-AM DPP-4 inhibitor gives to renal function and examination about the association with the patients attribute
江崎宏樹1), 舘知也1),2), 後藤千寿2), 杉田郁人1), 林勇汰1), 吉田阿希1), 齊藤康介1), 臼井一将1), 加藤未紗1), 野口義紘1), 大野佑城2), 青山智2), 安田昌宏2), 水井貴詞2), 寺町ひとみ1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

Change comparison between HbA1c and LDL - cholesterol that paid its attention to combination and BMI of statin in patients with P1233-22-PM sitagliptin remedy start type 2 diabetes
岩川精吾1), 青木万穂1), 越川奈菜1), 細川美香1), 上田久美子1), 増本憲生1),2), 大槻裕朗2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

	The effectiveness of the DPP-4 inhibitor addition therapy for patients with adult type 2 diabetes that blood sugar control is insufficient by P1234-23-AM insulin therapy and safe evaluation 澁木克也, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

	Effective and safe evaluation of the SGLT2 inhibitor for P1235-22-PM type 2 diabetes 久保実季, 嶋田修治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

	Examination of the effect on blood lipid in the P1236-23-AM teneligliptin remedy patients 増田晃, 岡田浩司, 白畑政憲, 本間絵里, 浅沼智美, 信田磨堯, 松川幸市 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2015.

	P1237-22-PM Clinical efficacy of selective SGLT2 inhibitor a Plug Frozin for Type 2 diabetic patients in our hospital 高森愛子1), 清水一紀2), 森田孝子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

Examination about merger dyslipidemia with the insulin therapy using the P1238-23-AM type 2 diabetes model rat and the small intestinal morphological functional change
高橋唯1), 高野美菜1), 川瀬寛子1), 木村美保子1), 藤田純佳1), 鎌野安紀子1), 堀口まり奈1), 渡邉直美1), 宮崎誠2), 島本史夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

Examination about merger dyslipidemia with the low fat dietary cure using the P1239-22-PM type 2 diabetes model rat and the small intestinal morphological functional change
川瀬寛子1), 高野美菜1), 木村美保子1), 高橋唯1), 藤田純佳1), 鎌野安紀子1), 堀口まり奈1), 渡邉直美1), 宮崎誠2), 島本史夫1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

	The case that we introduced SGLT2 inhibitor into under P1240-23-AM hospitalization 松田千佳1), 志田里志1), 佐藤貴大1), 齋藤尚子1), 坂本昌也2),3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

	A factor and tendency of the rehospitalization in patients with P1241-22-PM diabetes 小畑紋菓, 瀬名波宏昌, 中西晶子, 下村一徳, 田井浩子, 冨田由美, 川口進一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

	Report about the use situation of the SGLT2 inhibitor in the P1242-23-AM our hospital 濱里真耶, 村上とよみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2015.

	About prescription fact-finding at the DPP-4 inhibitor introduction for the P1243-22-PM outpatient and cooperation with the health insurance pharmacy 辻未希子1), 麻生美佐子1), 吉川英里1), 浜手ひとみ1), 蜂谷春雄2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

	About the need to confirm an insulin maneuver at P1244-23-AM diabetes dialysis prevention instruction 益成宏1),2),3),4), 實近彩子2), 飯塚晶子2), 田中佳江3), 畑尾克裕4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

	About carbon in patients with P1245-22-PM type 2 diabetes hair and a nitrogen stable isotope and trace element analysis 藤野陵二1), 堀田洋平2), 木村治3), 佐藤英二1), 遠藤哲也3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

	Use experience in our hospital of the P1246-23-AM SGLT-2 inhibitor 稲田庸平1), 澤田和紀1), 星野史朗1), 並木愛1), 後喜多綾香1), 横田洋子1), 石田恵子1), 荻野啓子2), 出倉良美2), 最上康生3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

	All inpatient diabetes practice management (hospitalwide diabetes management, HDM) by P1247-22-PM CDE-J 伊藤隆哉1),2),3),4),5),6), 小山貴夫1), 高見由理1), 中野和佳1), 矢野目英樹2), 石津美紀3), 武井哲也4), 田内克典5), 山内恵史6), 相澤徹6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

	-related examination of the serious side effect of the important identified risk and package insert prescribed to the pharmaceutical products risk management plan in the P1248-23-AM DPP-4 inhibitor 千田泰健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2015.

	Efforts for the medical therapy adequacy of the P1249-22-PM decreased renal function patients 藤野優子, 柴田陽子, 原幸世, 広江智子, 大坪博子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

	Inspection of the effectiveness by renal function test value mention to P1250-23-AM prescription 多賀志乃, 野口絢加, 台蔵剛士, 下川千賀子, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

	The present situation of the steroid mental disease in the kidney medical service of the P1251-22-PM our hospital 田中理子, 千崎康司, 山田清文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

	Efforts to the renal function evaluation of the P1252-23-AM inpatient and dose confirmation of the renal function attention medicine 波多晶子, 中澤美樹子, 三谷和恵, 窪田真弓, 鶴居勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

	Efforts of the drug proper use conference of the P1253-22-PM decreased renal function patients 大熊範和, 小材直人, 土屋敦史, 山本未来, 橋本碧, 田子尚史, 村田文, 森田淳介, 千吉良幸子, 新木美枝, 田子加代子, 山賀章一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

Tolvaptan introduction case to patients with autosomal dominant polycystic kidney with the P1254-23-AM decreased renal function
池田瑞季1), 成田勇樹1),2), 山根亜美1), 内田朋子1), 中村有紀子1), 成田さわな1), 政賢悟1), 藤本大介3), 平松晶子3), 城野博史1),4), 向山政志3), 齋藤秀之1),4)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2015.

	Examination of the concomitant drug affecting the serum magnesium (Mg) in consideration of the renal function in the P1255-22-PM magnesium oxide (MgO) preparation internal use patients 森田啓嗣, 川上恭弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

	Use trend of the digitalis preparations in the P1256-23-AM our hospital 大岩拓馬, 浅野嘉之, 伊東和真, 坂田洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

	Investigation of the thrombocytopenia to stop by according to renal function of P1257-22-PM linezolid (LZD) 阪野和重, 中西俊介, 奥本真巳, 武内恭範, 篝忠弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

	1 case using the Teiko plastic Nin note high-dose for patients with renal failure sex after P1258-23-AM kidney 中西俊介, 阪野和重, 奥本正巳, 武内恭範, 篝忠宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

	Use of the DPP-4 inhibitor in the P1259-22-PM our hospital 武内恭範1),2), 喜多薫1), 阪野和重1), 中西俊介1), 篝忠宏1), 吉本航2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

The need of the pharmacist intervention for the seriously ill hypoglycemia prevention of the P1260-23-AM decreased renal function patients
鈴木雄太1), 和地徹1), 佐藤美里1), 佐藤圭吾1), 菅野和1), 追木正人1), 西和哉1), 竹内陽一2), 松田謙2), 長澤将2), 佐賀利英1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2015.

	Examination of the usefulness of the carnitine preparation administration in P1261-22-PM patients on dialysis 星貴薫, 渡邉雅紀, 後藤圭介, 佐賀敬太, 水戸麻未, 武田瑛司, 田中正臣, 宮越貴之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

	One patient who received desensitization for renal-transplant recipients with the P1262-23-AM sulfamethoxazole trimethoprim (formulates it with ST) allergy history 大城瑠奈1), 大田守仁2), 橋本孝夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

	Safe examination of the agent for MOVIPREP R combination for the colonoscopic examination pre-treatment in patients on dialysis of the P1263-22-PM our hospital 和田祐一郎1), 北沢望美1), 穂積廣1), 加藤香奈1), 栗本拓也2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

	Prescription drug investigation of elderly people in the P1264-23-AM Swertia Herb station 竹下秀司1), 鈴木孝史1), 芦川祐貴子1), 安藤誠2), 前嶋克幸2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

	Stocktaking of our hospital which caught safe medical therapy guidelines on P1265-22-PM elderly people 2015 (plan) 小出賢吾, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

	May it be said that MMSE is useful for the efficacy evaluation of the dementia therapeutic agent of the P1266-23-AM pharmacist as a tool? 妻鹿宏美, 近藤幸男, 奥野靖隆, 永田文恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2015.

	Present conditions investigation of the list of drugs pertinence drug needing careful administration for elderly people in the P1267-22-PM Joetsu community health center Hospital 宮川哲也, 山田潤也, 清水岳広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

	Examination of the time crush method as the pitch prescription method at P1268-23-AM dysphagia for 古川俊子, 遠山幸男, 久田達也, 辻秀樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

	It is ... from a point of medical - nourishment, condition of a patient, polypharmacy to surround patients with femoral cervical bone fracture of the P1269-22-PM our hospital 川尻さおり, 入江貞治, 藤田靖之, 池田能利子, 町田毅 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

	Intervention effect to pressure sore treatment by the P1270-23-AM medical treatment ward permanent residence pharmacist 細野真吾1), 森彩矢香1), 矢野理沙2), 遠藤秀竜1), 河村千晶1), 堀浩子1), 山崎崇1), 久野治人3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

	Use situation investigation of the drug for external use in P1271-22-PM pressure sore treatment 篠崎聡, 大谷道輝, 並木路広, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

	P1272-23-AM Usage situation survey of Lubiprostone (Amitiza(R)) at our hospital 北森靖隆, 市村行典, 深田章, 澤田邦子, 中山志織, 可徳桃子, 石田英明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2015.

	The present conditions and problems of the use of the P1273-22-PM sleeping drug 戸村文郁, 金子知紘, 松元美香, 並木路広, 大谷道輝, 山村喜一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

	You experience P1274-23-AM thyroid crisis, and learn as a pharmacist 簑島隆仁, 桃井歩, 長岡和徳, 山下敦哉, 大森俊和, 仲鉢英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

	P1275-22-PM A case of considering change to baniprevir at the time of total bilirubin increase by simprevir 松元麻美1), 池田久雄1), 乾有希子1), 吉岡亮1), 居平典久2), 中村秀次2), 野村浩英1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

	Examination about the drug control instruction duties that we performed to the patients who were operated on in P1276-23-AM oral surgery, and were hospitalized 武田恵美1), 小野間麻実1), 牧田道明1), 山本庸介2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

	Examination about the convalescence rule factor in the P1277-22-PM acute spinal cord injury 小林由香, 倉井岳史, 高野尊行, 中丸朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

	Be associated with the inhalational instruction of patients with bronchial asthma indicating the nitric oxide concentration (FeNO) high level during the P1278-23-AM expiration 神浦茉奈実1), 宇都宮励子1), 廣田憲威1), 大野啓文2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2015.

	Treatment support ... in intervention - pharmacist outpatient department to DAAs (direct anti-viral agents) therapy for the P1279-22-PM hepatitis C 島谷桜子1), 坪谷綾子1), 工藤真弓1), 小宮詠子1), 浅見妥江1), 濱野公俊1), 坂下裕子1), 増原慶壮2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

Efforts (the second report) of the pharmacist for the Operation asthmatic death zero in P1280-23-AM Okayama
監物英男1),2),3), 森英樹2),3),4), 小野浩重2),5), 立野朋志2),6), 小笠原加代2),7), 出石啓治2),5),8), 赤澤昌樹2),9), 木村五郎10),11), 谷本安10),11), 宗田良10),11), 千堂年昭3),12)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

	Fact-finding in the outside Parliament prescription of the P1281-22-PM new anticoagulant 井上優子, 吉田知広, 土佐直子, 福澤祐幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

	Investigation about the method of consciousness and the medication counseling of the patients in P1282-23-AM high blood pressure treatment 宇野洋司, 菊池雄一, 橋本容子, 笹瀬優斗, 小島昌徳, 橋本真也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

Research about the thromboembolism onset and the side effect under the rivaroxaban administration in patients with P1283-22-PM non-valvular atrial fibrillation
秋元祐香1), 篠原悦子2), 千葉達夫3), 田中博之2), 佐々木英久1), 松尾和廣1), 渡辺朋子2), 横井妙子3), 加藤裕芳3), 吉尾隆1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

	Research about the use of the low dose pill for the P1284-23-AM premenstrual syndrome 川口友理1), 渡辺朋子2), 田中博之2), 松尾和廣1), 佐々木英久1), 篠原悦子2), 竹下直樹4), 真坂亙3), 木下俊彦4), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2015.

	Rise in effect of treatment by the pharmacist intervention to the inhalation therapy of patients with P1285-22-PM chronic obstructive pulmonary disease 伊東佳美1), 池元洋平2), 村上美穂1), 島森美光1), 坂東勉1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

Inhalational adherence investigation of the tiotropium bromide hydrate preparation using P1286-23-AM medical service fees data
前澤佳代子1), 伊藤藍1), 鈴木里香1), 田村文香1), 永井美帆1), 三関彩友美1), 大内かおり1), 加藤芳徳1), 真野泰成2), 百瀬泰行1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

	Effect of the inhalational pattern visual instruction on P1287-22-PM dry powder inhaler (DPI) without experience 増尾昌則, 近藤哲理, 高嶋友理, 小島香奈 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

	The mouthpiece shape of P1288-23-AM dry powder inhaler (DPI) does not affect the maximal intake speed. 高嶋友理, 近藤哲理, 小島香奈, 増尾昌則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

	Examination of the edoxaban dosage after the P1289-22-PM total hip replacement 間宵聖太, 小林貴志, 内坪誉歳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

Present conditions investigation about the pain relief treatment of the P1290-23-AM amyotrophic lateral sclerosis (ALS) patients
熊野文香1),2), 本郷修也2), 八田裕之1),2), 蛭谷牧子3), 座光寺伸幸3), 河合眞弘4), 山本吉章1),4), 青野裕史1),5), 對木萌絵1),6), 熊田顕浩6), 鈴木亮平1),7), 柴田有希子7), 花満裕1),8), 若杉栄作9), 高橋昌明9), 石田奈津子1),2),10), 山谷明正1),11)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2015.

	Examination of the associated factor about cardiac activity in P1291-22-PM acute myocardial infarction and the tolerability of the beta-blocker 南雲成, 小川一歩, 中村千佳子, 舩津久美 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

	Investigation of the P1292-23-AM chronic hepatitis C DCV+ASV combination therapy 齋藤巨樹1), 宮崎靖之2), 高田正温1), 植村隆1), 東島彰人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

	Effect on PT-INR by P1293-22-PM vitamin K doses 長岡和徳, 仲鉢英夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

	New introduction - of efforts - inhalant explanation document to inhalational instruction unionization in the P1294-23-AM our hospital 安田陽子1), 林恵子1), 浅利貴奈1), 一戸麻以子1), 中田潤子2),3), 玉置淳3), 越田晃1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

	Effect of the oxidative stress in the cells level of P1295-22-PM nonionic detergent Clemo fall EL 岡野善郎1), 石田志朗2), 木奈崎昭男2), 小山保夫3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

	Examination - about the factor having an influence on the internal use rate of triple-drug therapy - ribavirin of P1296-23-AM chronic hepatitis C 柴田久美子1), 平野茂樹1), 近藤綾子1), 神間康1), 舘佳彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2015.

Study on side effect to lead to P1297-22-PM azathioprine administration cancellation
山下友輝1), 加藤梢1), 畑侑里1), 道下美穂1), 八幡弘子1), 山本千秋1), 田中悠季1), 小林龍1), 小原秀治1), 宮川麻希2), 那須野正尚2), 田中浩紀2), 本谷聡2), 渡辺浩明1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

	About association with tolvaptan and the renal function in patients with P1298-23-AM cirrhosis 野村祐司1),2), 櫛原秀之1), 櫛原朋恵1), 河瀬洋平1), 成瀬徳彦1), 水谷年男1), 土居崎正雄2), 春田純一2), 森一博1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

	Examination about the effect to give to blood pressure, the pulse of the P1299-22-PM Yokukansan 横山匡1), 小野孝彦2), 浅原慶徳1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

Examination of the factor affecting the change of the thyroid function in the P1300-23-AM Graves' disease treatment
安藤ゆかり1), 早川伸樹1),2), 桑原宏貴3), 戸田貴洋3), 林高弘1),3), 福井愛子1), 亀井浩行1), 平塚いづみ2), 鈴木敦詞2), 山田成樹3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

	Examination of the risk factor of the hypernatremia with the P1301-22-PM tolvaptan administration 難波和行, 小森均, 橋本義宏, 和泉秀明, 村上貴洋, 金高勇介, 中野史也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

	PBPM activity about the P1302-23-AM digoxin preparation remedy 嶋田聖子, 納富貴子, 武田典子, 濱邊秋芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2015.

	Examination about the usefulness of the tiotropium preoperation intervention for the P1303-22-PM lung cancer surgery case 藤田剛平, 石王麻里乃, 久保淳一, 津田雅大, 和泉秀明, 橋本義宏, 小森均 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

	The effectiveness and safety of old and new triple-drug therapies for P1304-23-AM chronic hepatitis C 森尚義1), 森谷勲2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

	One case that raised medication adherence by the viscosity adjustment of the liquid for ITCZ in patients with P1305-22-PM dysphagia 小西喜昭1), 森章哉1), 黒川公恵1), 下地康雄2), 中谷理恵3), 森川静香3), 山川卓哉1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

	Association of refractory epilepsy and the oxidative stress of the P1306-23-AM seriously disabled child (person) 森本真仁1),2), 里村茂子2), 橋本俊顕2), 浜田茂明2), 吉岡三郎1), 京谷庄二郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

Examination of analgesic effect and the side effect risk of the fentanyl which we used together in Ropivacaine of autoregulation epidural analgesia method (PCEA) after the P1307-22-PM cesarean operation surgery technique
池田貴之1), 長谷川哲也1), 寺田享志2), 大岩彩乃2), 花井雄貴1), 馬渕匠1), 結束さやか2), 落合亮一2), 小杉隆祥1), 西澤健司1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

	Effect of sex hormone and statin on adiponectin production of the P1308-23-AM humans fat cell 川合結乃1), 菊池千草1),2), 壁谷知樹2), 堀英生2),3), 松永民秀1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2015.

	1 case that fentanyl patch succeeded, and patients on dialysis with the P1309-22-PM chronic pain were able to be discharged from at home 原圭子, 岸本千絵, 田畑貴康, 山口伸二, 中村徹志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

	One case of hepatitis C treatment in patients with P1310-23-AM living renal transplantation plan 廣瀬雅人, 小川光広, 樋口浩輔, 木村謙吾, 市川照文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

	Examination about the renal function change by taking P1311-22-PM SGLT2 inhibitor 九鬼亜衣子, 西塔志織, 松本芳信, 川原裕, 佐野雅昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

The use situation of ferric citrate in the P1312-23-AM our hospital
足立圭司, 佐賀嘉英, 門脇隼也, 塩見明日香, 小田智晴, 谷田有花, 大槻和也, 藤本華衣, 芦田理沙, 村上由樹, 川見里奈, 堀雅博, 足垣亮介, 宮谷正哉, 勝井靖, 山本真世, 立道直美
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

	Examination of the renal function improvement effect by the P1313-22-PM serum uric acid level drop 鈴木一志, 松本晃一, 高橋利幸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

	Relation of a treatment result and the pharmacist of the Daclatasvir / Asunaprevir in the P1314-23-AM our hospital 横田千明1), 眞弓健介1), 杉和洋2), 安森奈緒子1), 幸邦憲1), 山形真一1), 中川義浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2015.

	For prevention of P1315-22-PM drug abuse: Problems in the acquisition of the smart drug through the Internet 大塚邦子1),2), 奈良政寿1), 内田直樹2), 安原一2), 細野哲司1), 篠塚達雄1), 鈴木啓太郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

	About a treatment continuance rate of teriparatide in the P1316-23-AM our hospital 石川奈央佳, 野澤正徳, 三浦毅, 畔柳敏弥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

	The present conditions of a prescription turn of eventss of the teriparatide preparation by the P1317-22-PM DPC introduction and the instruction system 森下槙子, 澤柳直樹, 藤井友和, 中村治彦, 辻博幸, 塚本久之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

	One case of the juvenile idiopathic joint pain that complicated P1318-23-AM osteoporosis 星野有吾1), 神谷洋子1), 森真澄1), 川澄清孝1), 馬庭浩子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

	Use experience of the triple-drug therapy in a P1319-22-PM chronic hepatitis C genotype1 type, the high viral load 三澤延司1), 鳥巣勇一2), 中野真範2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

	It is examined three cases receiving the Omalizumab for P1320-23-AM COPD merger asthma 高武嘉道, 竹添達也, 田口清章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2015.

	Questionnaire research for the ethical pharmacy affecting a dentistry trouble and medication counseling content associated with the P1321-22-PM medication 上田幹子, 上田紘子, 戸田史恵, 森功美子, 大石美奈子, 高安敏子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2015.

	Related examination of PT-INR change and the thromboembolism onset during P1322-23-AM warfarin administration 岩本翔平1), 有山智博1), 東丸貴信2), 石井敏浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2015.

One case that stent thrombosis prophylaxis was performed in with a clopidogrel single agent after the percutaneous transluminal coronary angioplasty (PCI) enforcement for the patients during P1323-22-PM apixaban administration
中島一1), 天野佑1), 今村陽子1), 大石貴裕1), 池田浩和1), 高橋浩二郎1), 近藤克洋2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2015.

	Usefulness of the methylprednisolone supplementation after the NASCIS2 protocol to patients with P1324-23-AM acute phase spinal cord injury 倉井岳史, 小林由香, 高野尊行, 中丸朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2015.

	Example that tolvaptan was effective for fluid retention in the P1326-23-AM cirrhosis 内山良子, 木村麻紀, 林千麗, 吉村尋典 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2015.

Inflection to the use situation and inhalational instruction of the inhalant in our P1327-22-PM center
西川友梨, 嶋津史恵, 植田有希, 黒岩沙也佳, 碓氷尚子, 上田理絵, 口分田章典, 中野寛之, 長谷川聡司, 岩田浩幸, 志村和子, 田中恵美子
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

	P1328-23-AM On the initial effects and side effects of Daglatasville + asnaprevil combination therapy for chronic hepatitis C 大谷綾1), 加藤愛梨1), 小林真菜1), 杉本佳世1), 笹谷佳菜子1), 中尾啓子1), 笹瀬典子1), 金啓二1), 金守良2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

Examination of the effectiveness for peripheral airway inflammation by the P1329-22-PM Flutiform inhalation
水口侑子1), 西川友梨1), 植田有希1), 碓氷尚子1), 嶋津史恵1), 口分田章典1), 中野寛之1), 長谷川聡司1), 木村貴1), 岩田浩幸1), 志村和子1), 田中恵美子1), 橋本章司2)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

	Maintenance of the support system by the trial center for P1330-23-AM efficiency-like clinical studies promotion 白澤宏美1), 山下克也1), 久保美紀子1), 山形真一2), 幸邦憲2), 中川義浩2), 芳賀克夫3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

	Evaluation of the central IRB operation using P1331-22-PM iPad 寺師守彦1), 鳥居博行1), 野間口寛1), 稲森恵弥子2), 黒木沙織2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

	Database making aiming at duties efficiency such as subjects progress management, the costs request of the P1332-23-AM trial 山下克也1), 林淳一郎2), 白澤宏美1), 高本由紀子1), 久保美紀子1), 山形真一3), 幸邦憲3), 中川義浩3), 芳賀克夫4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2015.

	Inspection of the pharmaceutical products storage for the disaster in the P1333-22-PM tsunami damage hospital 早瀬友和, 和泉邦彦, 二神諒子, 土田大輔, 岡部静子, 池上信昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

	Preliminary investigation about the people of the P1334-23-AM Great East Japan Earthquake stricken area expecting it from a pharmacist 小倉未来1), 有田悦子1), 田辺記子1), 荒井きより1), 池谷博美1), 大坂敏夫2), 金野良則2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

	Questionary survey about consciousness and the education to face each other at emergency, the disaster of the P1335-22-PM pharmacy student 久保田洋子1), 中野将志1), 南角明歩1), 笠羽平誉1), 石井里佳1), 毎田千恵子1), 杉山朋美1), 北山朱美2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

	It is ... from the viewpoint of ... pharmacist about a role of our hospital in P1336-23-AM Chiba for disaster 勝田恵, 渡邉暁洋, 福田恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

	Usefulness of the action card for the unification of the early period of P1337-22-PM disaster behavior 八木啓太, 篠原克典, 神田茜, 松本嵩史, 松村隆, 鍵山智樹, 齋藤健一, 岸野亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

	Trial of the IPE pharmacy education program to cultivate ability for P1338-23-AM team approach in medical care practice 大津友紀1), 首藤英樹2), 平川雅章3), 片岡泰文2), 二神幸次郎1),4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2015.

Report ... of the instruction pharmacist class for 1 - instruction technology improvement (the fourth report) with the role of the pharmacist participating in P1339-22-PM "business true taking lessons previous learning"
南恵理子1),2), 中尾幸代1),3), 松田裕子1), 村田明子1),4), 山中智香1),5), 波多江崇1), 沼田千賀子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

Inspection ... of the improvement effect by problems and the class that 2 - students feel with the role of the pharmacist participating in P1340-23-AM "business true taking lessons previous learning" (the fourth report)
村田明子1),2), 中尾幸代1),3), 松田裕子1), 南恵理子1),4), 山中智香1),5), 波多江崇1), 沼田千賀子1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

	About a knowledge acquisition effect about the diabetes medical treatment instruction in the P1341-22-PM Hospital business training 椿井朋1),3), 久保田亜希2), 野田幸裕3), 山田清文2), 中尾誠1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

	The case contents which upbringing (the first report) - trainee of the pharmacist carrying the P1342-23-AM next generation experiences during training: Analysis ... from a disease 猪田宏美, 久保和子, 林瑶子, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

	The case contents which upbringing (the second report) - trainee of the pharmacist carrying the P1343-22-PM next generation experiences during training: Analysis ... from medical treatment 久保和子, 猪田宏美, 林瑶子, 北村佳久, 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

Efforts ... to the business training in upbringing (the third report) ... super acute phase ward (ICU, EICU, NICU) of the pharmacist carrying the P1344-23-AM next generation
田坂健, 武本あかね, 日野隼人, 勝部理早, 大川恭昌, 猪田宏美, 久保和子, 林瑶子, 北村佳久, 千堂年昭
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2015.

Attempt ... using the association map to deepen patients understanding necessary for upbringing (the fourth report) - prescription suggestion of the pharmacist carrying the P1345-22-PM next generation
名和秀起, 猪田宏美, 林瑶子, 久保和子, 北村佳久, 千堂年昭
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

Learning effect of the lecture for the purpose of knowledge about the cancer treatment for the student having uneasiness in the relation with patients with P1346-23-AM cancer and the technical improvement
高橋喜統1), 山口加代子1), 多賀允俊1), 野村政明2), 尾山治2), 久保田洋子2), 高瀬久光2), 大本まさのり2), 岡本晃典2), 毎田千恵子2), 丹羽修1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

It is ... for the regional alliances pharmacy business training & education with the from P1347-22-PM Oshu-shi, Iwate "pharmacy education gold strategy in Iwate" - characteristic
小野寺健1),6), 石川久美2),6), 南川賢治1),6), 松浦誠3),6), 三浦清明4),6), 三浦俊弘5),6)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

	The consciousness change of the trainee before and after examination - training schedule modification of the pharmacy student long-term business training schedule in the institution specialized in P1348-23-AM cancer for an index - 大西早紀, 槇恒雄, 二五田基文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

	Association between framework of business training and self-assessment of the pharmacy student about the arrival degree of the basic nature of the P1349-22-PM act 黒野俊介, 守屋友加, 伊東亜紀雄, 山田重行, 長谷川洋一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

	Attitude survey of the trainee using the revision of the efforts training curriculum to the hospital business training in the P1350-23-AM Kyoto medical center 水津智樹1), 畑裕基1), 竹松茂樹1), 辻琢己2), 河合実1), 玉田太志1), 北村良雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2015.

Efforts to the P1351-22-PM pharmaceutical clinical reasoning training
川口崇1),15), 東加奈子2),15), 今井徹3),15), 岩井大4),15), 臼井浩明5),15), 小久江伸介6),15), 北原加奈之7),15), 小暮宗介8),15), 添田博2),15), 平井浩二9),15), 高橋良10),15), 岸田直樹11),15), 柴田喜幸12),15), 徳田安春13),15), 源川奈穂14),15), 明石貴雄2),15)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

	Construction - second report ... of the education system for the early duties acquirement for the P1352-23-AM new adoption pharmacist 佐藤仁宣, 小沼大祐, 本郷知世, 古林園子, 伊藤博, 加藤一郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

	Efforts of the pharmacist resident system in the P1353-22-PM civilian Hospital 寺沢匡史, 中村翔吾, 三浦裕介, 廣田麻衣子, 中村有理, 瀬戸崇光, 内山ひとみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

Extraction of an evaluation and the improvement item of the physical assessment class for pharmacists by the P1354-23-AM CS analysis (Customer Satisfaction analysis)
大鳥徹1), 井上知美1), 細見光一1), 伊藤栄次1), 中山隆志1), 和田哲幸1), 石渡俊二1), 船上仁範1), 中村真也1), 平出敦2), 窪田愛恵2), 松山賢治1), 西田升三1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

The training system that fixed its eyes on the authorized acquisition from new face education in the P1355-22-PM metropolitan association institution Hospital
舩津久美1),2),3), 白石範子2),3), 阿部和史2),3), 安藤恵2),3), 石原溶子2),3), 内川清次2),3), 木内智香子2),3), 越田晃2),3), 小竹慶子2),3), 田中三枝子2),3), 中村英子2),3), 林みどり2),3), 廣井順子2),3), 松本啓一2),3), 八木原栄2),3), 山村康比古2),3)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

	Efforts - second report ... of the clinical competence improvement program of the P1356-23-AM pharmacist 川添潤1), 金正興1), 嶋村久美子1), 星茜1),2), 塩田一博1), 北原加奈之1),2), 高橋良3), 垂水庸子4), 峯村純子2),5), 佐々木忠徳1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 491-491, 2015.

	Instruction upbringing to the Shinnyu staff for P1357-22-PM ward drug duties 宍倉啓介, 渕真由子, 松澤弘志, 野地良子, 小竹慶子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

	Introduction ... of the medical treatment management based on 1 relation - protocol of the pharmacist in the P1358-23-AM stroke support team 清水誉志, 萩原里実, 丸子浩, 福島将友, 前田朱香, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

	Questionary survey ... about regional alliances (medicine medicine cooperation) in 2 relation - stroke practice of the pharmacist in the P1359-22-PM stroke support team 萩原里実, 清水誉志, 丸子浩, 福地祐亮, 村井悠紀, 町田聖治, 入江利行 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

	About an evaluation of the P1360-23-AM drug-related QT prolonged examination - of the unevenness between the comparison between - viewing law and tangent line method and gaugers 尾上洋1), 中田和枝2), 伊丹久美子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

	Efforts of the experience-based training instruction of the injection drug mixed preparation for the P1361-22-PM resident 守谷顕人, 村上賢次, 森のどか, 橋本恵梨花, 井本陽子, 吉田尚史, 宅和真由美, 平田敦宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

	The prospects to the future for P1362-23-AM balun strike scorecard (BSC) making and the utilization 吉川飛鳥, 柏崎友紀江, 田村真代, 吉川円, 齋藤義貴, 定村洋士 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 492-492, 2015.

	Facilitator upbringing ... in efforts - balun strike scorecard introduction to the P1363-22-PM pharmacy management 小串興平1),2), 前田拓哉1),3), 大久保淑子1),4), 山内泰一1),5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

	The drugstore management by the balun strike scorecard (BSC) introduction in the P1364-23-AM Tokyo kidney urinary organ center Yamato Hospital 廣實愼吾, 森田はづき, 折本小夜子, 上野拓 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

Efforts and result tenth report for the BSC introduction for P1365-22-PM hospital pharmacist
井口恵美子1),2), 赤瀬朋秀1), 上原君男1), 小田切正美1), 小林岳1), 菅野豪輝1), 関口信香1), 大幸淳1), 根岸大輔1), 吉田博史1), 岡添進1), 中村葉月1), 舟越亮寛1), 佐藤透1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

	Of the P1366-23-AM balun strike scorecard introduction third year look back; change ... of the ... strategy target 金田昌之1), 奈良部修弘1), 畠山英司1), 田邉晃子1), 三田村朋1), 米澤禎貴1), 藤田明宏2), 赤瀬朋秀3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

	Evaluation by the number about the efforts to the duties improvement using the balun strike scorecard in the P1367-22-PM light law of nature society Chuo General Hospital 今井由恵, 星佳代子, 染谷洋和, 菊池昌彦, 廣澤達哉 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

	Factor to have an influence on the at-home return of patients with stroke in the rehabilitation ward for P1368-23-AM convalescence 細田矢佳1), 岡添進1), 矢嶋美樹2), 小瀬英司3), 林宏行3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2015.

Inspection of the usefulness by the proof experiment in the institution of the autonomy conveyance robot in the P1369-22-PM Hospital
植野聖子1), 小森正貴1), 神農理衣1), 王宏維1), 村上賢次1), 三木郁帆1), 守谷顕人1), 津田里香1), 宅和真由美1), 村井亮介2), 酒井龍雄2), 平田敦宏1)
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2015.

	For the enlightenment activity at research - pharmacy service under health insurance drugstore of the food poisoning by the false meal of the P1370-23-AM poisonous plant - 國正淳一, 堺陽子, 宮松史人, 浦野公彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2015.

	P1371-22-PM A case of tyrosinemia type I with good course due to long-term administration of nicothinone 中山幹子1), 藤本千安紀1), 藤田由香1), 佐々木みずえ1), 山本宏1), 伊藤道徳2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2015.

	Study on accumulation characteristics of the polymerization initiator to mix in P1372-23-AM parenteral injection 河崎陽一1), 久原典子2), 三浦太郎2), 江角悟1), 北村佳久1),2), 千堂年昭1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2015.

Upbringing ... of relationship of mutual trust improvement and the chief pharmacist with the P1373-22-PM Quality Improvement in the Department of Pharmacy 6 - subordinate
小木篤仁, 池田鮎美, 石井友恵, 内海綾, 田中友佳, 長島真洋, 蓮池由夏, 本藤真太郎, 見崎昭子, 武笠裕優, 矢島里菜, 安村吉彦
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2015.

	IN-01 Reason analysis and countermeasures on long waiting time in automated outpatient pharmacy CHEN Rong1), ZHU Jian2), GU Bao-Chen1), BAO Jian-An1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2015.

	IN-02 Clinical risk factors associated with postoperative delirium in lung and esophageal cancer patients Yoshihisa Kitamura1),2), Kiminaka Murakawa1), Shiho Hongo2), Toshiaki Sendo1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2015.

	IN-03 Two kinds of treatments of breast cancer after chemotherapy granulocytopenia disease clinicalcurative effect evaluation We YU, Ruixiang XIE, Fang FAN Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2015.

	IN-04 Photoinitiators initiated estrogenic activity in human breast cancer cell line MCF-7 Yoichi Kawasaki1), Miwa Morizane2), Taro Miura2), Satoru Esumi1), Yoshihisa Kitamura1),2), Toshiaki Sendo1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2015.

	IN-05 Pharmacogenomics and personalized medicine of immunosuppressant Yan Mei-Ling, Liu Li-Wei, Zhang Yi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2015.

	IN-06 Development of proper Simple Suspension Method of valganciclovir medication Yasuyuki Masaoka1), Yoichi Kawasaki1), Ryo Kikuoka2), Atsushi Ogawa1), Satoru Esumi1), Yoshihisa Kitamura1),2), Toshiaki Sendo1),2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2015.

	IN-07 Analysis of Medication Compliance and Influnencing in Patients Liu wensheng, Wen xiaona Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2015.

	IN-08 The toxicity and the rational use of Chinese patent medicine containing heavy metal LIU YING, FAN Xiu-rong, LV Zhi-hui, LI Zhen-quan Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2015.

	IN-09 Research Progress in Chinese medicine treatment of coronary heart disease Liang Shuang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2015.

	IN-10 2014-2015 Activities Report of the Japanese Society of Hospital Pharmacists Takao Orii, Yoshikazu Tasaki, Emiko Iguchi, Itsuko Ishii, Keishiro Izumi, Akio Katsumi, Yasuo Takeda, Satohiro Masuda, Kojiro Yamamoto, Kazuo Matsubara, Mitsukazu Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2015.

	The participation of the pharmacist starting academic F-01 polypharmacy measures and research of the usefulness 武藤浩司1),2), 小田慎1),3), 佐藤康一1),4), 樋島学1),5), 吉岡睦展1),6), 別所千枝1),7), 澁田憲一1),8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 503-503, 2015.

	It is examination about the investigation support after production sale of the hospital pharmacist for the academic F-02 pharmaceutical products risk management plan 有馬秀樹1), 近藤直樹2), 近藤智子3), 田崎正信4), 寺元剛5), 水井貴詞6), 渡邉達也7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2015.

	Research about the pharmaceutical management of the academic F-03 perioperative patients and the pharmacist duties in the operating room 舟越亮寛1), 柴田ゆうか2), 小西寿子3), 柴田みづほ4), 堀内賢一5), 佐藤裕紀6), 古谷一平7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 504-504, 2015.

	Research about the appropriate medical therapy to patients with academic F-04 mental disorder 齋藤百枝美1), 馬場寛子2), 桑原秀徳3), 永田健一郎4), 野田幸裕5), 高橋結花6), 村野哲雄7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2015.

	Research about the intervention of the pharmacist in the proper use of a vein, the nutrient for intestinal administration which is academic F-05 pharmaceutical products 増田修三1), 林宏行2), 樋島学3), 林勝次4), 中村直人5), 杉浦伸一6), 松原肇7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 505-505, 2015.

	Research about the interaction between a drug, medical materials in the academic F-06 medication 中村浩規1), 杉浦伸一2), 荒井有美3), 古田康之4), 金澤佐知子5), 石井健介6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 506-506, 2015.

	Research about the duties development of the pharmacist in the academic F-07 outpatient department chemotherapy 松尾宏一1),2), 吉村知哲3), 飯原大稔4), 岩本卓也5), 緒方憲太郎1), 川上和宜6), 組橋由記7), 黒田純子8), 林稔展9), 米村雅人10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2015.

	Research about the medical therapy that is appropriate by the security to academic F-08 transluminal treated patients 倉田なおみ1), 新井克明2), 近藤幸雄3), 藤原琴4), 宮川哲也5), 岸本真6), 石田志朗7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 507-507, 2015.

	We conduct research for becoming it the marketing of the drug necessary for the academic F-09 healthcare setting 渡辺享平1),2), 後藤伸之3), 佐々木忠徳4), 濱宏仁5), 原田幸子6), 松浦克彦7), 山川雅之8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 508-508, 2015.

	Proper use and side effect management ... in LS1 immunity checkpoint inhibitor - true clinical practice 吉川周佐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 510-510, 2015.

	The prevention, therapeutic drug development of Alzheimer's dementia based on the LS2 condition of a patient 小野賢二郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 511-511, 2015.

	Real ... of team approach in medical care - pharmacist outpatient department in the LS3 gastrointestinal carcinoma chemotherapy 高張大亮, 式部さあ里 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 512-512, 2015.

	It is medication support ... for ... deglutition functional disorder patients for internal use, the medication management that LS4 is safe 岸本真 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 513-513, 2015.

	One or - that the physician of drug choice - settings of the LS5 circulatory organ physician thinks about what and prescribes it how 香坂俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 514-514, 2015.

	Expectation to a jelly agent as the LS6-1 universal preparation 花輪剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2015.

	How to use therapeutic drug to think about from true clinical practice of LS6-2 osteoporosis treatment and bone metabolic turnover 沖本信和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 515-515, 2015.

	LS7-1 heart failure and way of thinking of diuretics - nowadays 猪又孝元 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-516, 2015.

	The condition of a patient and treatment of the LS7-2 polycystic kidney 乳原善文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 516-516, 2015.

	Knowledge - of the Sino-Japanese traditional medicine necessary for LS8 hospital pharmacist particularly commentary - from a practice case of the cooperation of team approach in medical care and the Chinese medicine 丹村敏則 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 517-517, 2015.

	LS9 drug-related nephropathic non-invasive urinary biomarker 増田智先 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 518-518, 2015.

	Recent progress ... problem that should be settled in the proper use of the LS10 antimicrobial is some ... 堀誠治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 519-519, 2015.

	LS11 osteoarthritis: Domestic and foreign treatment guidelines and the future prospects 川口浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 520-520, 2015.

	A diagnosis and treatment of the LS12 inflammatory bowel disease: Mainly on the effect of the biological drug 松本主之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 521-521, 2015.

	Point to use Everolimus in LS13 breast cancer treatment 坂東裕子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 522-522, 2015.

	About the present conditions of the LS14 community medical care design and the future prospects 遠藤久夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 523-523, 2015.

	It is ... about "behavior aim W realizes the workplace environment that there is not of the anticancer agent exposure" LS15 anticancer medicine exposure measures and medical safe national joint behavior ... 中西弘和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 524-524, 2015.

	LS16 eating, dysphagia and dosage form of medicine 倉田なおみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 525-525, 2015.

	Side effect - vascular pain, lassitude, taste disturbance that are a gap in the LS17 cancer medical therapy, hiccups ... 野村久祥 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 526-526, 2015.

	Point - that you should note generic medicine adoption from the viewpoint of use of LS18 generic medicine and medical safe - medical care security 土屋文人 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 527-527, 2015.

	Thing - hospital pharmacy where there is pharmacy for management contribution for LS19 2025 is ... from the cost center to the profit center 工藤高 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 528-528, 2015.

	The new prospects of the treatment strategy with the change of the LS20 advanced stage melanoma treatment and the molecular target medicine 中村泰大 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 529-529, 2015.

	The inflection of the pharmacist loanword aiming at LS21 anticancer agent adherence improvement! 橋田亨 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 530-530, 2015.

	The role of the pharmacist in the team approach in medical care of the LS22 cancer domain and the future prospects 橋本浩伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 531-531, 2015.

	In one focal as for directional - "separation of pharmacy and clinic" of the medical care, the care system reform to see to LS23 large-boned 2015 - 高橋進 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 532-532, 2015.

	Cost effectiveness and drug choice of the drug in the LS24-1 relaxation medical care 児玉佳之 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 533-533, 2015.

	Role of the insurance pharmacist in LS24-2 cancer treatment 秋山理恵 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 533-533, 2015.

	Role - hospital pharmacist of directionality and the hospital pharmacist of the LS25 health care overhaul is ... from the viewpoint of latest information and plasma derivative proper use that you should know 谷澤正明 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 534-534, 2015.

	The latest treatment of LS26 chronic hepatitis C 高口浩一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 535-535, 2015.

	Efforts of the pharmacist who fixed the eyes on qualitative improvement and medical service fees in the LS27 cancer team approach in medical care 吉村知哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 536-536, 2015.

	Knowledge - antiarrhythmic drug and new oral anticoagulant drug - to help the atrial fibrillation medical treatment that LS28 pharmacist should know 志賀剛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 537-537, 2015.

	We change at human front ridge water shift transtime of a lot of LS29-1 latanoprost instillation preparation 関根祐子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2015.

	The present conditions and problem of LS29-2 glaucoma eye drops 相原一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 538-538, 2015.

	A negative chain of periphery immunity increase aggravation and the cranial nerve immune network which LS30 pain brings: Dynamic "homeostasis restorative effect" with the pain-killer 成田年 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 539-539, 2015.

	Importance - cancer instruction to patient management charges 3 of the role that a basic tone lecture pharmacist should fulfil in cancer treatment is set why, and result in what kind of benefit to the patients; or ... 千堂年昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 542-542, 2015.

	Efforts and the present conditions of the example introduction 1 cancer instruction to patient management 中本恵理 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2015.

	Systems construction and the present conditions for cancer instruction to patient management for patients who received example introduction 2 outpatient department cancer chemotherapy 若杉吉宣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 543-543, 2015.

	An example introduction 3 cancer treatment working full time pharmacist is involved from regimen choice positively and utilizes cancer instruction to patient management 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 544-544, 2015.